date	size'/'remotesize	flags(request:Update,Range state:File response:Modified,Chunked,gZipped)	statuscode	status ('servermsg')	MIME	Etag|Date	URL	localfile	(from URL)
02:48:04	166/166	---MCZ	200	added ('OK')	text/plain	etag:W/%2266829be9-c2%22	https://bridgebio.com/robots.txt		(from )
02:48:05	52765/52765	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:05%20GMT	https://bridgebio.com/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index.html	(from )
02:48:05	88708/88708	---M--	200	added ('OK')	image/png	etag:%2266829c0a-1acb1%22	https://bridgebio.com/wp-content/uploads/2019/02/BridgeBio_Share.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2019/02/BridgeBio_Share.png	(from https://bridgebio.com/)
02:48:06	1776/1776	---M-Z	200	added ('OK')	text/css	etag:%2265999b44-23c%22	https://cdnjs.cloudflare.com/ajax/libs/slick-carousel/1.8.1/slick.css?ver=6.6.2	C:/Users/HP/Documents/programming/clones/bridge-original/cdnjs.cloudflare.com/ajax/libs/slick-carousel/1.8.1/slick109c.css	(from https://bridgebio.com/)
02:48:07	44/44	---MC-	302	error ('Found')	text/plain	date:Wed,%2018%20Dec%202024%2010:48:07%20GMT	https://unpkg.com/aos@next/dist/aos.css?ver=6.6.2	C:/Users/HP/Documents/programming/clones/bridge-original/unpkg.com/aos@next/dist/aos.2109c.delayed	(from https://bridgebio.com/)
02:48:07	52/52	---MC-	302	error ('Found')	text/plain	date:Wed,%2018%20Dec%202024%2010:48:07%20GMT	https://unpkg.com/aos@next/dist/aos.css	C:/Users/HP/Documents/programming/clones/bridge-original/unpkg.com/aos@next/dist/aos.css	(from https://bridgebio.com/)
02:48:07	28765/28765	---MCZ	200	added ('OK')	text/css	etag:W/%22705d-miajSdIaS4cfRd/RJKQ/raT5S5g%22	https://unpkg.com/aos@3.0.0-beta.6/dist/aos.css	C:/Users/HP/Documents/programming/clones/bridge-original/unpkg.com/aos@3.0.0-beta.6/dist/aos.css	(from https://bridgebio.com/)
02:48:08	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734518160	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style2112.css	(from https://bridgebio.com/)
02:48:08	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734518160	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css2112.css	(from https://bridgebio.com/)
02:48:08	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734518160	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust2112.css	(from https://bridgebio.com/)
02:48:08	87553/87553	---MCZ	200	added ('OK')	application/javascript	etag:W/%2264ecd5ef-15601%22	https://bridgebio.com/wp-includes/js/jquery/jquery.min.js?ver=3.7.1	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-includes/js/jquery/jquery.minf43b.js	(from https://bridgebio.com/)
02:48:09	13577/13577	---MCZ	200	added ('OK')	application/javascript	etag:W/%226482bd64-3509%22	https://bridgebio.com/wp-includes/js/jquery/jquery-migrate.min.js?ver=3.4.1	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-includes/js/jquery/jquery-migrate.min5589.js	(from https://bridgebio.com/)
02:48:09	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734518160	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts2112.js	(from https://bridgebio.com/)
02:48:09	88955/88955	---M-Z	200	added ('OK')	application/javascript	etag:%2265999b45-39e1%22	https://cdnjs.cloudflare.com/ajax/libs/slick-carousel/1.8.1/slick.js?ver=6.6.2	C:/Users/HP/Documents/programming/clones/bridge-original/cdnjs.cloudflare.com/ajax/libs/slick-carousel/1.8.1/slick109c.js	(from https://bridgebio.com/)
02:48:10	43/43	---MC-	302	error ('Found')	text/plain	date:Wed,%2018%20Dec%202024%2010:48:10%20GMT	https://unpkg.com/aos@next/dist/aos.js?ver=6.6.2	C:/Users/HP/Documents/programming/clones/bridge-original/unpkg.com/aos@next/dist/aos109c.js	(from https://bridgebio.com/)
02:48:10	51/51	---MC-	302	error ('Found')	text/plain	date:Wed,%2018%20Dec%202024%2010:48:10%20GMT	https://unpkg.com/aos@next/dist/aos.js	C:/Users/HP/Documents/programming/clones/bridge-original/unpkg.com/aos@next/dist/aos.js	(from https://bridgebio.com/)
02:48:10	13800/13800	---MCZ	200	added ('OK')	application/javascript	etag:W/%2235e8-44lQwbzmXp8EjjBbNWf/kKDJI+M%22	https://unpkg.com/aos@3.0.0-beta.6/dist/aos.js	C:/Users/HP/Documents/programming/clones/bridge-original/unpkg.com/aos@3.0.0-beta.6/dist/aos.js	(from https://bridgebio.com/)
02:48:10	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734518160	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal2112.js	(from https://bridgebio.com/)
02:48:11	382894/382894	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:48:11%20GMT	https://bridgebio.com/wp-json/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/index.html	(from https://bridgebio.com/)
02:48:11	10481/10481	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:48:11%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/852	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/852.json	(from https://bridgebio.com/)
02:48:12	793/793	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:48:12%20GMT	https://bridgebio.com/xmlrpc.php?rsd	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/xmlrpc0db0.php	(from https://bridgebio.com/)
02:48:12	2358/2358	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:48:12%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedaac7.json	(from https://bridgebio.com/)
02:48:12	2551/2551	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:48:12%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd8d4	(from https://bridgebio.com/)
02:48:12	766/766	---M--	200	added ('OK')	image/png	etag:%2266829bf4-425%22	https://bridgebio.com/wp-content/uploads/2024/02/cropped-cropped-favicon-32x32.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/02/cropped-cropped-favicon-32x32.png	(from https://bridgebio.com/)
02:48:13	5633/5633	---M--	200	added ('OK')	image/png	etag:%2266829bfe-1a56%22	https://bridgebio.com/wp-content/uploads/2024/02/cropped-cropped-favicon-192x192.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/02/cropped-cropped-favicon-192x192.png	(from https://bridgebio.com/)
02:48:13	5931/5931	---M--	200	added ('OK')	image/png	etag:%2266829bfe-1c5d%22	https://bridgebio.com/wp-content/uploads/2024/02/cropped-cropped-favicon-180x180.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/02/cropped-cropped-favicon-180x180.png	(from https://bridgebio.com/)
02:48:14	22446/22446	---M-Z	200	added ('OK')	application/javascript	etag:0x8DD1DE4B7A34202	https://cdn.cookielaw.org/scripttemplates/otSDKStub.js	C:/Users/HP/Documents/programming/clones/bridge-original/cdn.cookielaw.org/scripttemplates/otSDKStub.js	(from https://bridgebio.com/)
02:48:15	1555/1555	---M--	400	error ('Bad%20Request')	text/html	date:Wed,%2018%20Dec%202024%2010:48:15%20GMT	https://www.googletagmanager.com/gtm.js?id=	C:/Users/HP/Documents/programming/clones/bridge-original/www.googletagmanager.com/gtm.185445.delayed	(from https://bridgebio.com/)
02:48:16	37425/37425	---MCZ	200	added ('OK')	text/javascript	etag:W/%22acef795c672bbb8b4307fc86de6f1974%22	https://edge.marker.io/latest/shim.js	C:/Users/HP/Documents/programming/clones/bridge-original/edge.marker.io/latest/shim.js	(from https://bridgebio.com/)
02:48:16	4932/4932	---M--	200	added ('OK')	image/png	etag:%226740f476-2937%22	https://bridgebio.com/bridge logo.webp	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/bridge logo.webp	(from https://bridgebio.com/)
02:48:16	9871/9871	---M--	200	added ('OK')	image/png	etag:%2266829bfd-bfdd%22	https://bridgebio.com/bridge logo.webp	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/bridge logo.webp	(from https://bridgebio.com/)
02:48:16	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:17%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/)
02:48:17	53079/53079	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:17%20GMT	https://bridgebio.com/about-us/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us/index.html	(from https://bridgebio.com/)
02:48:17	39224/39224	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:17%20GMT	https://bridgebio.com/licensing-opportunities	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/licensing-opportunities.html	(from https://bridgebio.com/)
02:48:17	71693/71693	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:17%20GMT	https://bridgebio.com/people/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/people/index.html	(from https://bridgebio.com/)
02:48:18	1147/1147	---MCZ	200	added ('OK')	image/svg+xml	etag:W/%226740f476-47b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/img/icons/x-circle.svg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/img/icons/x-circle.svg	(from https://bridgebio.com/)
02:48:19	67704/67704	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:18%20GMT	https://bridgebio.com/pipeline/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline/index.html	(from https://bridgebio.com/)
02:48:19	41465/41465	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:18%20GMT	https://bridgebio.com/partners/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners/index.html	(from https://bridgebio.com/)
02:48:19	84559/84559	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:18%20GMT	https://bridgebio.com/careers/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/index.html	(from https://bridgebio.com/)
02:48:19	59998/59998	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:19%20GMT	https://bridgebio.com/publications/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/publications/index.html	(from https://bridgebio.com/)
02:48:19	37556/37556	---M--	200	added ('OK')	image/png	etag:%226740f476-b8dc%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/img/attruby-logo.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/img/attruby-logo.png	(from https://bridgebio.com/)
02:48:20	50939/50939	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:19%20GMT	https://bridgebio.com/patients-and-families/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/patients-and-families/index.html	(from https://bridgebio.com/)
02:48:20	558/558	---MCZ	200	added ('OK')	image/svg+xml	etag:W/%226740f476-22e%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/img/icons/icon-front.svg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/img/icons/icon-front.svg	(from https://bridgebio.com/)
02:48:20	40231/40231	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:20%20GMT	https://bridgebio.com/patients-and-families/elliott/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/patients-and-families/elliott/index.html	(from https://bridgebio.com/)
02:48:20	43890/43890	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:20%20GMT	https://bridgebio.com/patients-and-families/alexis/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/patients-and-families/alexis/index.html	(from https://bridgebio.com/)
02:48:20	40577/40577	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:20%20GMT	https://bridgebio.com/patients-and-families/miguel/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/patients-and-families/miguel/index.html	(from https://bridgebio.com/)
02:48:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:20%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/)
02:48:21	51638/51638	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:21%20GMT	https://bridgebio.com/news/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/index.html	(from https://bridgebio.com/)
02:48:21	39786/39786	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:21%20GMT	https://bridgebio.com/patients-and-families/tobin/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/patients-and-families/tobin/index.html	(from https://bridgebio.com/)
02:48:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:21%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/)
02:48:22	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:22%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/)
02:48:22	3377073/3377073	---M--	200	added ('OK')	video/mp4	etag:%2266829c00-3387b1%22	https://bridgebio.com/wp-content/uploads/2019/02/BBIO-Homepage-Slider_01.mp4	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2019/02/BBIO-Homepage-Slider_01.mp4	(from https://bridgebio.com/)
02:48:22	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:22%20GMT	https://bridgebio.com/patients-and-families/len	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/patients-and-families/len	(from https://bridgebio.com/)
02:48:22	42392/42392	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:22%20GMT	https://bridgebio.com/patients-and-families/len/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/patients-and-families/len/index.html	(from https://bridgebio.com/)
02:48:23	3353014/3353014	---M--	200	added ('OK')	video/mp4	etag:%2266829bfd-3329b6%22	https://bridgebio.com/wp-content/uploads/2021/08/BBIO-Homepage-Slide2.mp4	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/08/BBIO-Homepage-Slide2.mp4	(from https://bridgebio.com/)
02:48:23	266278/266278	---M--	200	added ('OK')	image/png	etag:%2266829c06-5bfb5%22	https://bridgebio.com/wp-content/uploads/2021/08/Len-centered.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/08/Len-centered.png	(from https://bridgebio.com/)
02:48:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:23%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/)
02:48:23	110753/110753	---M--	200	added ('OK')	image/png	etag:%226740f474-1f5a1%22	https://bridgebio.com/wp-content/uploads/2024/11/image-wrapper.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/11/image-wrapper.png	(from https://bridgebio.com/)
02:48:25	617/617	---MCZ	200	added ('OK')	image/svg+xml	etag:W/%226740f476-269%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/img/icons/chevron-down-light.svg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/img/icons/chevron-down-light.svg	(from https://bridgebio.com/)
02:48:27	203635/203635	---MCZ	200	added ('OK')	application/x-javascript	etag:%22140b78-31b73-6265f08639be7%22	http://pages.bridgebio.com/js/forms2/js/forms2.min.js	C:/Users/HP/Documents/programming/clones/bridge-original/pages.bridgebio.com/js/forms2/js/forms2.min.js	(from https://bridgebio.com/)
02:48:27	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:25%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/)
02:48:27	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:27%20GMT	https://bridgebio.com/sms-policy	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/sms-policy	(from https://bridgebio.com/)
02:48:27	70719/70719	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:27%20GMT	https://bridgebio.com/terms-of-use/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/terms-of-use/index.html	(from https://bridgebio.com/)
02:48:28	45365/45365	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:28%20GMT	https://bridgebio.com/social-policy	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/social-policy.html	(from https://bridgebio.com/)
02:48:28	47209/47209	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:28%20GMT	https://bridgebio.com/cookies-notice/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/cookies-notice/index.html	(from https://bridgebio.com/)
02:48:28	73619/73619	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:28%20GMT	https://bridgebio.com/bridgebio-global-privacy-policy/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/bridgebio-global-privacy-policy/index.html	(from https://bridgebio.com/)
02:48:29	44794/44794	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:29%20GMT	https://bridgebio.com/us-expanded-access-policy/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/us-expanded-access-policy/index.html	(from https://bridgebio.com/)
02:48:29	38331/38331	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:29%20GMT	https://bridgebio.com/contact-us/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/contact-us/index.html	(from https://bridgebio.com/)
02:48:29	4689/4689	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:29%20GMT	https://bridgebio.com/cdn-cgi/l/email-protection	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/cdn-cgi/l/email-protection.html	(from https://bridgebio.com/)
02:48:29	42132/42132	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:29%20GMT	https://bridgebio.com/sms-policy/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/sms-policy/index.html	(from https://bridgebio.com/)
02:48:30	1239/1239	---MCZ	200	added ('OK')	application/javascript	etag:W/%22675318bd-4d7%22	https://bridgebio.com/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js	(from https://bridgebio.com/)
02:48:30	59312/59312	---MCZ	200	added ('OK')	application/vnd.ms-fontobject	etag:W/%2266829bfd-e7b0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/fonts/lineto-circular-bold.eot?	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/fonts/lineto-circular-boldd41d.eot	(from https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734518160)
02:48:31	59312/59312	---MCZ	200	added ('OK')	application/vnd.ms-fontobject	etag:W/%2266829bfd-e7b0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/fonts/lineto-circular-bold.eot	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/fonts/lineto-circular-bold.eot	(from https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734518160)
02:48:31	56928/56928	---M--	200	added ('OK')	font/woff2	etag:%2266829bfd-de60%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/fonts/lineto-circular-bold.woff2	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/fonts/lineto-circular-bold.woff2	(from https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734518160)
02:48:31	78100/78100	---M--	200	added ('OK')	font/woff	etag:%2266829bfd-13114%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/fonts/lineto-circular-bold.woff	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/fonts/lineto-circular-bold.woff	(from https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734518160)
02:48:31	61292/61292	---MCZ	200	added ('OK')	application/vnd.ms-fontobject	etag:W/%2266829bfd-ef6c%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/fonts/lineto-circular-bolditalic.eot	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/fonts/lineto-circular-bolditalic.eot	(from https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734518160)
02:48:32	61292/61292	---MCZ	200	added ('OK')	application/vnd.ms-fontobject	etag:W/%2266829bfd-ef6c%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/fonts/lineto-circular-bolditalic.eot?	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/fonts/lineto-circular-bolditalicd41d.eot	(from https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734518160)
02:48:32	58508/58508	---M--	200	added ('OK')	font/woff2	etag:%2266829bfe-e48c%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/fonts/lineto-circular-bolditalic.woff2	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/fonts/lineto-circular-bolditalic.woff2	(from https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734518160)
02:48:32	80504/80504	---M--	200	added ('OK')	font/woff	etag:%2266829bfe-13a78%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/fonts/lineto-circular-bolditalic.woff	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/fonts/lineto-circular-bolditalic.woff	(from https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734518160)
02:48:33	62474/62474	---M--	200	added ('OK')	image/png	etag:%226740f476-1088e%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/img/attruby-bg-modal.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/img/attruby-bg-modal.png	(from https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734518160)
02:48:33	8507/8507	---M--	200	added ('OK')	image/png	etag:%226740f476-4841%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/img/attruby-bg-mobile-modal.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/img/attruby-bg-mobile-modal.png	(from https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734518160)
02:48:33	10688/10688	---M--	200	added ('OK')	image/png	etag:%226740f476-5877%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/img/attruby-bg-mobile-modal-n.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/img/attruby-bg-mobile-modal-n.png	(from https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734518160)
02:48:34	191/191	---MCZ	200	added ('OK')	image/svg+xml	etag:W/%2266829bfe-bf%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/img/icons/expand_collapsible.svg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/img/icons/expand_collapsible.svg	(from https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734518160)
02:48:34	190/190	---MCZ	200	added ('OK')	image/svg+xml	etag:W/%2266829bfd-be%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/img/icons/collapse_collapsible.svg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/img/icons/collapse_collapsible.svg	(from https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734518160)
02:48:34	43775/43775	---M--	200	added ('OK')	image/jpeg	etag:%2266e85bb7-b139%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/img/modal-bg-theme.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/img/modal-bg-theme.jpg	(from https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734518160)
02:48:35	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734517980	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/styleff4e.css	(from https://bridgebio.com/about-us/)
02:48:35	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734517980	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-cssff4e.css	(from https://bridgebio.com/about-us/)
02:48:35	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734517980	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrustff4e.css	(from https://bridgebio.com/about-us/)
02:48:35	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734517980	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptsff4e.js	(from https://bridgebio.com/about-us/)
02:48:36	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734517980	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modalff4e.js	(from https://bridgebio.com/about-us/)
02:48:36	15900/15900	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:48:36%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/857	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/857.json	(from https://bridgebio.com/about-us/)
02:48:37	2339/2339	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:48:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fabout-us%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2b67.json	(from https://bridgebio.com/about-us/)
02:48:37	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:37%20GMT	https://bridgebio.com/?p=857	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index6374.html	(from https://bridgebio.com/about-us/)
02:48:37	2530/2530	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:48:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fabout-us%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed09ae	(from https://bridgebio.com/about-us/)
02:48:37	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:38%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/about-us/)
02:48:38	4028/4028	---M--	200	added ('OK')	image/png	etag:%2266829bfc-132e%22	https://bridgebio.com/wp-content/uploads/2021/07/icon-product-platform-discover.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/07/icon-product-platform-discover.png	(from https://bridgebio.com/about-us/)
02:48:39	4331/4331	---M--	200	added ('OK')	image/png	etag:%2266829bfc-11e9%22	https://bridgebio.com/wp-content/uploads/2021/07/icon-product-platform-create.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/07/icon-product-platform-create.png	(from https://bridgebio.com/about-us/)
02:48:39	3116/3116	---M--	200	added ('OK')	image/png	etag:%2266829bfc-f13%22	https://bridgebio.com/wp-content/uploads/2021/07/icon-product-platform-test.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/07/icon-product-platform-test.png	(from https://bridgebio.com/about-us/)
02:48:39	6689/6689	---M--	200	added ('OK')	image/png	etag:%2266829bfc-1fb5%22	https://bridgebio.com/wp-content/uploads/2021/07/icon-product-platform-deliver.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/07/icon-product-platform-deliver.png	(from https://bridgebio.com/about-us/)
02:48:39	5600145/5600145	---M--	200	added ('OK')	video/mp4	etag:%2266829c11-557391%22	https://bridgebio.com/wp-content/uploads/2021/08/about-page-hero-background-video.mp4	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/08/about-page-hero-background-video.mp4	(from https://bridgebio.com/about-us/)
02:48:40	14631/14631	---M--	200	added ('OK')	image/png	etag:%2266829c1f-3982%22	https://bridgebio.com/wp-content/uploads/2019/02/science-icon.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2019/02/science-icon.png	(from https://bridgebio.com/about-us/)
02:48:40	16529/16529	---M--	200	added ('OK')	image/png	etag:%2266829c1f-40f4%22	https://bridgebio.com/wp-content/uploads/2019/02/business-icon.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2019/02/business-icon.png	(from https://bridgebio.com/about-us/)
02:48:40	14582/14582	---M--	200	added ('OK')	image/png	etag:%2266829c1f-38f6%22	https://bridgebio.com/wp-content/uploads/2019/02/speed-icon.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2019/02/speed-icon.png	(from https://bridgebio.com/about-us/)
02:48:41	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:41%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/about-us/)
02:48:41	1179821/1179821	---M--	200	added ('OK')	image/png	etag:%2266829c11-23c461%22	https://bridgebio.com/wp-content/uploads/2021/08/about-us-page-callout.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/08/about-us-page-callout.png	(from https://bridgebio.com/about-us/)
02:48:41	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:41%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/about-us/)
02:48:42	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:42%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/about-us/)
02:48:43	45519/45519	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:48:43%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/862	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/862.json	(from https://bridgebio.com/people/)
02:48:44	2339/2339	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:48:43%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fpeople%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9658.json	(from https://bridgebio.com/people/)
02:48:44	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:43%20GMT	https://bridgebio.com/?p=862	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexd399.html	(from https://bridgebio.com/people/)
02:48:45	2530/2530	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:48:45%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fpeople%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0614	(from https://bridgebio.com/people/)
02:48:46	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:45%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/people/)
02:48:47	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:47%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/people/)
02:48:47	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:47%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/people/)
02:48:48	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734518520	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style0306.css	(from https://bridgebio.com/partners/)
02:48:48	49227162/49227162	---M--	200	added ('OK')	video/mp4	etag:%2266829bf9-2ef259a%22	https://bridgebio.com/wp-content/uploads/2023/12/1AB_BridgeBio_About-Us-Nov-Revs_v3_comp_960x450.mp4	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2023/12/1AB_BridgeBio_About-Us-Nov-Revs_v3_comp_960x450.mp4	(from https://bridgebio.com/about-us/)
02:48:48	1915379/1915379	---M--	200	added ('OK')	image/png	etag:%2266829bf8-25756d%22	https://bridgebio.com/wp-content/uploads/2021/08/BBIO21_Website-Refresh-CAREERS-1.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/08/BBIO21_Website-Refresh-CAREERS-1.png	(from https://bridgebio.com/people/)
02:48:48	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734518520	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css0306.css	(from https://bridgebio.com/partners/)
02:48:48	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734518520	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust0306.css	(from https://bridgebio.com/partners/)
02:48:48	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734518520	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts0306.js	(from https://bridgebio.com/partners/)
02:48:49	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734518520	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal0306.js	(from https://bridgebio.com/partners/)
02:48:49	10774/10774	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:48:49%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/4096	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/4096.json	(from https://bridgebio.com/partners/)
02:48:50	2350/2350	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:48:50%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fpartners%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedff34.json	(from https://bridgebio.com/partners/)
02:48:50	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:50%20GMT	https://bridgebio.com/?p=4096	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index0b79.html	(from https://bridgebio.com/partners/)
02:48:50	2541/2541	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:48:50%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fpartners%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9990	(from https://bridgebio.com/partners/)
02:48:50	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:50%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/partners/)
02:48:51	168166/168166	---M--	200	added ('OK')	image/png	etag:%226740f474-344ff%22	https://bridgebio.com/wp-content/uploads/2024/11/94d06841d4a91a9159b8da34a7bfa826.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/11/94d06841d4a91a9159b8da34a7bfa826.png	(from https://bridgebio.com/partners/)
02:48:51	21366/21366	---M--	200	added ('OK')	image/png	etag:%2266829bf7-8174%22	https://bridgebio.com/wp-content/uploads/2021/04/Alexion_Pharmaceuticals.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/04/Alexion_Pharmaceuticals.png	(from https://bridgebio.com/partners/)
02:48:51	12030/12030	---M--	200	added ('OK')	image/png	etag:%2266a7e5e1-4d86%22	https://bridgebio.com/wp-content/uploads/2024/07/output-onlinepngtools-1.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/07/output-onlinepngtools-1.png	(from https://bridgebio.com/partners/)
02:48:52	2949/2949	---M--	200	added ('OK')	image/png	etag:%2266faf58c-c80%22	https://bridgebio.com/wp-content/uploads/2024/09/KyowaKirin_BrandLogo_colorv2-PhotoRoom-1-1024x216-1.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/KyowaKirin_BrandLogo_colorv2-PhotoRoom-1-1024x216-1.png	(from https://bridgebio.com/partners/)
02:48:52	4145/4145	---M--	200	added ('OK')	image/png	etag:%2266829bf4-12ce%22	https://bridgebio.com/wp-content/uploads/2024/01/02-PNG-Res-Logo-Black-1.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/01/02-PNG-Res-Logo-Black-1.png	(from https://bridgebio.com/partners/)
02:48:53	11420/11420	---M--	200	added ('OK')	image/png	etag:%2266829bfa-529e%22	https://bridgebio.com/wp-content/uploads/2022/03/sentynl_logo_PNG-black_trans.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2022/03/sentynl_logo_PNG-black_trans.png	(from https://bridgebio.com/partners/)
02:48:53	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:53%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/partners/)
02:48:53	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734518880	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/stylee596.css	(from https://bridgebio.com/careers/)
02:48:54	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734518880	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-csse596.css	(from https://bridgebio.com/careers/)
02:48:54	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734518880	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetruste596.css	(from https://bridgebio.com/careers/)
02:48:54	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734518880	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptse596.js	(from https://bridgebio.com/careers/)
02:48:55	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734518880	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modale596.js	(from https://bridgebio.com/careers/)
02:48:55	3534/3534	---MCZ	200	added ('OK')	application/javascript	etag:W/%2266829bfd-dce%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/careers.js?ver=1734518880	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/careerse596.js	(from https://bridgebio.com/careers/)
02:48:56	13777/13777	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:48:56%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/1040	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/1040.json	(from https://bridgebio.com/careers/)
02:48:56	2343/2343	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:48:56%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed4b98.json	(from https://bridgebio.com/careers/)
02:48:56	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:56%20GMT	https://bridgebio.com/?p=1040	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index2b79.html	(from https://bridgebio.com/careers/)
02:48:56	2536/2536	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:48:56%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7da5	(from https://bridgebio.com/careers/)
02:48:57	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:57%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/)
02:48:57	166453/166453	---M--	200	added ('OK')	image/png	etag:%226740f474-340d8%22	https://bridgebio.com/wp-content/uploads/2024/11/asian_woman_asian_doctor_hex0044c2.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/11/asian_woman_asian_doctor_hex0044c2.png	(from https://bridgebio.com/careers/)
02:48:57	29882/29882	---M--	200	added ('OK')	image/png	etag:%2266829bf7-8e59%22	https://bridgebio.com/wp-content/uploads/2021/12/best_place_to_work_2022.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/12/best_place_to_work_2022.png	(from https://bridgebio.com/careers/)
02:48:58	5480339/5480339	---M--	200	added ('OK')	video/mp4	etag:%2266829c10-539f93%22	https://bridgebio.com/wp-content/uploads/2021/08/UMA_Looping_03_1440x700_03.mp4	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/08/UMA_Looping_03_1440x700_03.mp4	(from https://bridgebio.com/careers/)
02:48:58	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:48:58%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/)
02:48:59	47257/47257	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:59%20GMT	https://bridgebio.com/careers/manager-revenue/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/manager-revenue/index.html	(from https://bridgebio.com/careers/)
02:48:59	46625/46625	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:48:59%20GMT	https://bridgebio.com/careers/associate-director-biostatistics/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/associate-director-biostatistics/index.html	(from https://bridgebio.com/careers/)
02:49:00	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734517440	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style5afc.css	(from https://bridgebio.com/pipeline/)
02:49:00	46197/46197	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:00%20GMT	https://bridgebio.com/careers/director-biostatistics/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/director-biostatistics/index.html	(from https://bridgebio.com/careers/)
02:49:01	55854/55854	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:00%20GMT	https://bridgebio.com/careers/associate-director-director-business-development-and-operations/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/associate-director-director-business-development-and-operations/index.html	(from https://bridgebio.com/careers/)
02:49:02	45243/45243	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:01%20GMT	https://bridgebio.com/careers/associate-director-commercial-strategy-operations/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/associate-director-commercial-strategy-operations/index.html	(from https://bridgebio.com/careers/)
02:49:03	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734517440	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css5afc.css	(from https://bridgebio.com/pipeline/)
02:49:03	46174/46174	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:01%20GMT	https://bridgebio.com/careers/sr-manager-associate-director-commercial-analytics/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/sr-manager-associate-director-commercial-analytics/index.html	(from https://bridgebio.com/careers/)
02:49:04	46516/46516	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:03%20GMT	https://bridgebio.com/careers/associate-statistical-geneticist-statistical-geneticist/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/associate-statistical-geneticist-statistical-geneticist/index.html	(from https://bridgebio.com/careers/)
02:49:04	32781288/32781288	---M--	200	added ('OK')	video/mp4	etag:%2266829bf7-1f433e8%22	https://bridgebio.com/wp-content/uploads/2021/09/BBIO21_Uma-Compress.mp4	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/09/BBIO21_Uma-Compress.mp4	(from https://bridgebio.com/careers/)
02:49:04	48881/48881	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:04%20GMT	https://bridgebio.com/careers/associate-senior-associate-asset-acquisition/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/associate-senior-associate-asset-acquisition/index.html	(from https://bridgebio.com/careers/)
02:49:05	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734517440	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust5afc.css	(from https://bridgebio.com/pipeline/)
02:49:05	52039/52039	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:04%20GMT	https://bridgebio.com/careers/director-biology-and-translational-research/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/director-biology-and-translational-research/index.html	(from https://bridgebio.com/careers/)
02:49:05	45630/45630	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:05%20GMT	https://bridgebio.com/careers/director-sr-director-business-development-operations/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/director-sr-director-business-development-operations/index.html	(from https://bridgebio.com/careers/)
02:49:06	47866/47866	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:05%20GMT	https://bridgebio.com/careers/senior-medical-director-vp-clinical-development/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/senior-medical-director-vp-clinical-development/index.html	(from https://bridgebio.com/careers/)
02:49:07	48733/48733	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:06%20GMT	https://bridgebio.com/careers/director-patient-services-hub-field-access-operations/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/director-patient-services-hub-field-access-operations/index.html	(from https://bridgebio.com/careers/)
02:49:07	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734517440	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts5afc.js	(from https://bridgebio.com/pipeline/)
02:49:07	46595/46595	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:06%20GMT	https://bridgebio.com/careers/associate-director-marketing-2/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/associate-director-marketing-2/index.html	(from https://bridgebio.com/careers/)
02:49:07	46611/46611	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:06%20GMT	https://bridgebio.com/careers/associate-director-marketing/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/associate-director-marketing/index.html	(from https://bridgebio.com/careers/)
02:49:07	45388/45388	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:07%20GMT	https://bridgebio.com/careers/manager-digital-marketing/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/manager-digital-marketing/index.html	(from https://bridgebio.com/careers/)
02:49:08	47138/47138	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:07%20GMT	https://bridgebio.com/careers/director-kol-management-engagement-east/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/director-kol-management-engagement-east/index.html	(from https://bridgebio.com/careers/)
02:49:08	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734517440	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal5afc.js	(from https://bridgebio.com/pipeline/)
02:49:08	46912/46912	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:08%20GMT	https://bridgebio.com/careers/manager-sr-manager-commercial-training/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/manager-sr-manager-commercial-training/index.html	(from https://bridgebio.com/careers/)
02:49:09	46859/46859	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:08%20GMT	https://bridgebio.com/careers/sr-medical-director-medical-affairs-achondroplasia-lead/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/sr-medical-director-medical-affairs-achondroplasia-lead/index.html	(from https://bridgebio.com/careers/)
02:49:09	11067/11067	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:49:08%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/4090	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/4090.json	(from https://bridgebio.com/pipeline/)
02:49:09	47279/47279	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:09%20GMT	https://bridgebio.com/careers/director-drug-safety-pharmacovigilance-international/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/director-drug-safety-pharmacovigilance-international/index.html	(from https://bridgebio.com/careers/)
02:49:09	2386/2386	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:49:09%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fpipeline%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0ed9.json	(from https://bridgebio.com/pipeline/)
02:49:09	47329/47329	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:09%20GMT	https://bridgebio.com/careers/director-drug-safety-pharmacovigilance-international-2/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/director-drug-safety-pharmacovigilance-international-2/index.html	(from https://bridgebio.com/careers/)
02:49:10	53355/53355	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:09%20GMT	https://bridgebio.com/careers/director-clinical-quality-assurance/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/director-clinical-quality-assurance/index.html	(from https://bridgebio.com/careers/)
02:49:10	44904/44904	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:10%20GMT	https://bridgebio.com/careers/sr-director-quality-assurance/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/sr-director-quality-assurance/index.html	(from https://bridgebio.com/careers/)
02:49:10	2579/2579	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:49:10%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fpipeline%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed91d4	(from https://bridgebio.com/pipeline/)
02:49:10	47418/47418	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:10%20GMT	https://bridgebio.com/careers/sr-director-quality-assurance-cmc/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/sr-director-quality-assurance-cmc/index.html	(from https://bridgebio.com/careers/)
02:49:11	47437/47437	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:11%20GMT	https://bridgebio.com/careers/director-sr-director-regulatory-affairs/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/director-sr-director-regulatory-affairs/index.html	(from https://bridgebio.com/careers/)
02:49:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:10%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/pipeline/)
02:49:11	46331/46331	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:11%20GMT	https://bridgebio.com/careers/sr-director-global-regulatory-affairs-labeling/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/sr-director-global-regulatory-affairs-labeling/index.html	(from https://bridgebio.com/careers/)
02:49:11	45205/45205	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:11%20GMT	https://bridgebio.com/careers/vp-regulatory-affairs/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/vp-regulatory-affairs/index.html	(from https://bridgebio.com/careers/)
02:49:11	45584/45584	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:11%20GMT	https://bridgebio.com/careers/executive-assistant-sales/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers/executive-assistant-sales/index.html	(from https://bridgebio.com/careers/)
02:49:11	306192/306192	---M--	200	added ('OK')	image/png	etag:%226740f474-5d7e1%22	https://bridgebio.com/wp-content/uploads/2024/11/image-1-4.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/11/image-1-4.png	(from https://bridgebio.com/pipeline/)
02:49:12	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:12%20GMT	https://bridgebio.com/?p=4090	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index3175.html	(from https://bridgebio.com/pipeline/)
02:49:12	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:12%20GMT	https://bridgebio.com/publications	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/publications	(from https://bridgebio.com/pipeline/)
02:49:12	899/899	---M--	200	added ('OK')	image/png	etag:%2266829c17-7f0%22	https://bridgebio.com/wp-content/uploads/2019/02/Modality-Icons_Small-Molecule.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2019/02/Modality-Icons_Small-Molecule.png	(from https://bridgebio.com/pipeline/)
02:49:12	806/806	---MCZ	200	added ('OK')	image/svg+xml	etag:W/%226740f476-326%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/img/icons/arrow-circle-right.svg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/img/icons/arrow-circle-right.svg	(from https://bridgebio.com/pipeline/)
02:49:13	54366/54366	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:13%20GMT	https://bridgebio.com/what-is-adh1/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/what-is-adh1/index.html	(from https://bridgebio.com/pipeline/)
02:49:13	1179/1179	---M--	200	added ('OK')	image/png	etag:%2266829bfe-a89%22	https://bridgebio.com/wp-content/uploads/2020/01/Modality-Icons_Gene-Theraphy.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2020/01/Modality-Icons_Gene-Theraphy.png	(from https://bridgebio.com/pipeline/)
02:49:13	52299/52299	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:49:13%20GMT	https://bridgebio.com/lgmd2i-r9/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/lgmd2i-r9/index.html	(from https://bridgebio.com/pipeline/)
02:49:13	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:13%20GMT	https://bridgebio.com/publications	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/publications	(from https://bridgebio.com/pipeline/)
02:49:14	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:14%20GMT	https://bridgebio.com/patients-and-families/alexis	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/patients-and-families/alexis	(from https://bridgebio.com/pipeline/)
02:49:14	1245685/1245685	---M--	200	added ('OK')	image/png	etag:%2266829bf7-37a715%22	https://bridgebio.com/wp-content/uploads/2022/04/Alexis.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2022/04/Alexis.png	(from https://bridgebio.com/pipeline/)
02:49:14	1588727/1588727	---M--	200	added ('OK')	image/png	etag:%2266829bff-2c68eb%22	https://bridgebio.com/wp-content/uploads/2020/04/Elliott.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2020/04/Elliott.png	(from https://bridgebio.com/pipeline/)
02:49:14	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:14%20GMT	https://bridgebio.com/patients-and-families/elliott	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/patients-and-families/elliott	(from https://bridgebio.com/pipeline/)
02:49:15	381288/381288	---M--	200	added ('OK')	image/png	etag:%2266829bfc-794e7%22	https://bridgebio.com/wp-content/uploads/2020/09/2.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2020/09/2.png	(from https://bridgebio.com/pipeline/)
02:49:15	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:15%20GMT	https://bridgebio.com/patients-and-families/miguel	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/patients-and-families/miguel	(from https://bridgebio.com/pipeline/)
02:49:16	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:16%20GMT	https://bridgebio.com/patients-and-families/tobin	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/patients-and-families/tobin	(from https://bridgebio.com/pipeline/)
02:49:16	1364140/1364140	---M--	200	added ('OK')	image/png	etag:%2266829c0b-2ec545%22	https://bridgebio.com/wp-content/uploads/2020/04/Tobin.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2020/04/Tobin.png	(from https://bridgebio.com/pipeline/)
02:49:16	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:16%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/pipeline/)
02:49:16	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734517260	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style66eb.css	(from https://bridgebio.com/publications/)
02:49:17	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734517260	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css66eb.css	(from https://bridgebio.com/publications/)
02:49:17	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734517260	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust66eb.css	(from https://bridgebio.com/publications/)
02:49:17	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734517260	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts66eb.js	(from https://bridgebio.com/publications/)
02:49:18	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734517260	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal66eb.js	(from https://bridgebio.com/publications/)
02:49:18	9169/9169	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:49:18%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/1078	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/1078.json	(from https://bridgebio.com/publications/)
02:49:18	2344/2344	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:49:19%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fpublications%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed63ee.json	(from https://bridgebio.com/publications/)
02:49:19	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:19%20GMT	https://bridgebio.com/?p=1078	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index98bd.html	(from https://bridgebio.com/publications/)
02:49:19	2535/2535	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:49:19%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fpublications%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeddea7	(from https://bridgebio.com/publications/)
02:49:19	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:19%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/publications/)
02:49:19	832/832	---M--	200	added ('OK')	image/png	etag:%2266829bfe-971%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/img/Right.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/img/Right.png	(from https://bridgebio.com/publications/)
02:49:20	789971/789971	---M--	200	added ('OK')	application/pdf	etag:%2266ba33ab-c0dd3%22	https://bridgebio.com/wp-content/uploads/2024/08/Judge-D-et-al-20190723-JACC-Ph2-ms.pdf	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/08/Judge-D-et-al-20190723-JACC-Ph2-ms.pdf	(from https://bridgebio.com/publications/)
02:49:20	1022/1022	---M--	200	added ('OK')	image/png	etag:%2266829bfe-b19%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/img/Down.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/img/Down.png	(from https://bridgebio.com/publications/)
02:49:21	1570798/1570798	---M--	200	added ('OK')	application/pdf	etag:%2266abc8b0-17f7ee%22	https://bridgebio.com/wp-content/uploads/2024/08/Infigratinib-in-children-with-ACH_the-PROPEL-and-PROPEL-2-studies.pdf	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/08/Infigratinib-in-children-with-ACH_the-PROPEL-and-PROPEL-2-studies.pdf	(from https://bridgebio.com/publications/)
02:49:21	440205/440205	---M--	200	added ('OK')	application/pdf	etag:%2266abc90b-6b78d%22	https://bridgebio.com/wp-content/uploads/2024/08/International-consensus-guidelines-for-ACH.pdf	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/08/International-consensus-guidelines-for-ACH.pdf	(from https://bridgebio.com/publications/)
02:49:21	1306734/1306734	---M--	200	added ('OK')	application/pdf	etag:%2266abc9d0-13f06e%22	https://bridgebio.com/wp-content/uploads/2024/08/Hoover-Fong-Bone-2021_ACH-natural-history.pdf	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/08/Hoover-Fong-Bone-2021_ACH-natural-history.pdf	(from https://bridgebio.com/publications/)
02:49:21	674785/674785	---M--	200	added ('OK')	application/pdf	etag:%2266abc9a6-a4be1%22	https://bridgebio.com/wp-content/uploads/2024/08/Hoover-Fong-Genetics-in-Medicine-2021_ACH-natural-hitsory-CLARITY-study.pdf	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/08/Hoover-Fong-Genetics-in-Medicine-2021_ACH-natural-hitsory-CLARITY-study.pdf	(from https://bridgebio.com/publications/)
02:49:29	977166/977166	---M--	200	added ('OK')	application/pdf	etag:%2266a8ea7a-ee90e%22	https://bridgebio.com/wp-content/uploads/2024/07/Roszko_Autosomal-Dominant-Hypocalcemia-Type-1-A-Systematic-Review_JBMR_2022-2.pdf	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/07/Roszko_Autosomal-Dominant-Hypocalcemia-Type-1-A-Systematic-Review_JBMR_2022-2.pdf	(from https://bridgebio.com/publications/)
02:49:30	1313051/1313051	---M--	200	added ('OK')	application/pdf	etag:%2266abcb01-14091b%22	https://bridgebio.com/wp-content/uploads/2024/08/Ornitz-DM-et-al.-Dev-Dynamics-2017.pdf	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/08/Ornitz-DM-et-al.-Dev-Dynamics-2017.pdf	(from https://bridgebio.com/publications/)
02:49:30	10685075/10685075	---M--	200	added ('OK')	application/pdf	etag:%2266abca65-a30a93%22	https://bridgebio.com/wp-content/uploads/2024/08/Pauli-et-al-Orphanet-2019.pdf	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/08/Pauli-et-al-Orphanet-2019.pdf	(from https://bridgebio.com/publications/)
02:49:30	10685075/10685075	---M--	200	added ('OK')	application/pdf	etag:%2266abcabe-a30a93%22	https://bridgebio.com/wp-content/uploads/2024/08/Pauli-et-al-Orphanet-2019-1.pdf	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/08/Pauli-et-al-Orphanet-2019-1.pdf	(from https://bridgebio.com/publications/)
02:49:30	1773642/1773642	---M--	200	added ('OK')	application/pdf	etag:%2266a946d0-1b104a%22	https://bridgebio.com/wp-content/uploads/2024/07/Rajasingham-2024.pdf	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/07/Rajasingham-2024.pdf	(from https://bridgebio.com/publications/)
02:49:31	1487188/1487188	---M--	200	added ('OK')	application/pdf	etag:%2266829bfe-16b154%22	https://bridgebio.com/wp-content/uploads/2021/09/BBIO-Canavan-GTx-BBP-812-ASGCT-2021-NHP.pdf	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/09/BBIO-Canavan-GTx-BBP-812-ASGCT-2021-NHP.pdf	(from https://bridgebio.com/publications/)
02:49:32	4407250/4407250	---M--	200	added ('OK')	application/pdf	etag:%2266a9462e-433fd2%22	https://bridgebio.com/wp-content/uploads/2024/07/Cataldi-2018.pdf	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/07/Cataldi-2018.pdf	(from https://bridgebio.com/publications/)
02:49:32	3732398/3732398	---M--	200	added ('OK')	application/pdf	etag:%2266a9471a-38f3ae%22	https://bridgebio.com/wp-content/uploads/2024/07/Wu-2022_ribitol-6-month-p448L-mouse.pdf	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/07/Wu-2022_ribitol-6-month-p448L-mouse.pdf	(from https://bridgebio.com/publications/)
02:49:32	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:32%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/publications/)
02:49:33	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734515640	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style22a9.css	(from https://bridgebio.com/licensing-opportunities)
02:49:33	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:33%20GMT	https://bridgebio.com/licensing-opportunities/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/licensing-opportunities/index.html	(from https://bridgebio.com/licensing-opportunities)
02:49:33	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734515640	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css22a9.css	(from https://bridgebio.com/licensing-opportunities)
02:49:33	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734515640	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust22a9.css	(from https://bridgebio.com/licensing-opportunities)
02:49:34	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734515640	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts22a9.js	(from https://bridgebio.com/licensing-opportunities)
02:49:34	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734515640	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal22a9.js	(from https://bridgebio.com/licensing-opportunities)
02:49:34	10329/10329	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:49:34%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/5450	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/5450.json	(from https://bridgebio.com/licensing-opportunities)
02:49:35	2438/2438	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:49:35%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Flicensing-opportunities	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedbfb5.json	(from https://bridgebio.com/licensing-opportunities)
02:49:35	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:35%20GMT	https://bridgebio.com/?p=5450	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index73eb.html	(from https://bridgebio.com/licensing-opportunities)
02:49:35	2630/2630	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:49:35%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Flicensing-opportunities&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf864	(from https://bridgebio.com/licensing-opportunities)
02:49:35	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:35%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/licensing-opportunities)
02:49:36	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:36%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/licensing-opportunities)
02:49:36	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734517080	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/stylec2d0.css	(from https://bridgebio.com/patients-and-families/)
02:49:36	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734517080	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-cssc2d0.css	(from https://bridgebio.com/patients-and-families/)
02:49:37	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734517080	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrustc2d0.css	(from https://bridgebio.com/patients-and-families/)
02:49:37	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734517080	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptsc2d0.js	(from https://bridgebio.com/patients-and-families/)
02:49:37	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734517080	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modalc2d0.js	(from https://bridgebio.com/patients-and-families/)
02:49:38	20772/20772	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:49:38%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/4314	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/4314.json	(from https://bridgebio.com/patients-and-families/)
02:49:39	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:39%20GMT	https://bridgebio.com/?p=4314	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexb999.html	(from https://bridgebio.com/patients-and-families/)
02:49:39	2424/2424	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:49:39%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fpatients-and-families%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9100.json	(from https://bridgebio.com/patients-and-families/)
02:49:40	2629/2629	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:49:40%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fpatients-and-families%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed40d3	(from https://bridgebio.com/patients-and-families/)
02:49:40	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:40%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/patients-and-families/)
02:49:40	138362/138362	---M--	200	added ('OK')	image/webp	etag:%2266b4e50c-21c7a%22	https://bridgebio.com/wp-content/uploads/2024/08/BBIO21_Website-PATIENTS-FAMILY-3.webp	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/08/BBIO21_Website-PATIENTS-FAMILY-3.webp	(from https://bridgebio.com/patients-and-families/)
02:49:41	109622/109622	---M--	200	added ('OK')	image/png	etag:%226740f474-1c9fa%22	https://bridgebio.com/wp-content/uploads/2024/11/image-wrapper-2.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/11/image-wrapper-2.png	(from https://bridgebio.com/patients-and-families/)
02:49:41	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:41%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/patients-and-families/)
02:49:42	239536/239536	---M--	200	added ('OK')	image/png	etag:%226740f474-459ed%22	https://bridgebio.com/wp-content/uploads/2024/11/broadcasters_hex0044c2.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/11/broadcasters_hex0044c2.png	(from https://bridgebio.com/patients-and-families/)
02:49:42	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:42%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/patients-and-families/)
02:49:42	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734516180	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/styledc2b.css	(from https://bridgebio.com/patients-and-families/alexis/)
02:49:43	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734516180	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-cssdc2b.css	(from https://bridgebio.com/patients-and-families/alexis/)
02:49:43	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734516180	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrustdc2b.css	(from https://bridgebio.com/patients-and-families/alexis/)
02:49:43	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734516180	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptsdc2b.js	(from https://bridgebio.com/patients-and-families/alexis/)
02:49:43	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734516180	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modaldc2b.js	(from https://bridgebio.com/patients-and-families/alexis/)
02:49:44	14097/14097	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:49:44%20GMT	https://bridgebio.com/wp-json/wp/v2/stories/4623	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/stories/4623.json	(from https://bridgebio.com/patients-and-families/alexis/)
02:49:44	2471/2471	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:49:44%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fpatients-and-families%2Falexis%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed4b23.json	(from https://bridgebio.com/patients-and-families/alexis/)
02:49:45	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:45%20GMT	https://bridgebio.com/?p=4623	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index2d40.html	(from https://bridgebio.com/patients-and-families/alexis/)
02:49:45	2664/2664	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:49:45%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fpatients-and-families%2Falexis%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3b35	(from https://bridgebio.com/patients-and-families/alexis/)
02:49:45	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:45%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/patients-and-families/alexis/)
02:49:46	156025/156025	---M--	200	added ('OK')	image/jpeg	etag:%2266829bfc-2784d%22	https://bridgebio.com/wp-content/uploads/2021/09/Alexis_photo-1024x683.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/09/Alexis_photo-1024x683.jpg	(from https://bridgebio.com/patients-and-families/alexis/)
02:49:46	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:46%20GMT	https://bridgebio.com/patients-and-families	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/patients-and-families	(from https://bridgebio.com/patients-and-families/alexis/)
02:49:46	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:46%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/patients-and-families/alexis/)
02:49:47	12531/12531	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:49:47%20GMT	https://bridgebio.com/wp-json/wp/v2/stories/4625	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/stories/4625.json	(from https://bridgebio.com/patients-and-families/elliott/)
02:49:47	2457/2457	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:49:47%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fpatients-and-families%2Felliott%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb6c8.json	(from https://bridgebio.com/patients-and-families/elliott/)
02:49:47	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:47%20GMT	https://bridgebio.com/?p=4625	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index5da1.html	(from https://bridgebio.com/patients-and-families/elliott/)
02:49:48	2646/2646	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:49:48%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fpatients-and-families%2Felliott%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed220c	(from https://bridgebio.com/patients-and-families/elliott/)
02:49:48	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:48%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/patients-and-families/elliott/)
02:49:48	34470/34470	---M--	200	added ('OK')	image/jpeg	etag:%2266829bf8-90b3%22	https://bridgebio.com/wp-content/uploads/2021/09/Elliot_photo.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/09/Elliot_photo.jpg	(from https://bridgebio.com/patients-and-families/elliott/)
02:49:48	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:49%20GMT	https://bridgebio.com/patients-and-families	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/patients-and-families	(from https://bridgebio.com/patients-and-families/elliott/)
02:49:49	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:49%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/patients-and-families/elliott/)
02:49:49	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734518340	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style8e4d.css	(from https://bridgebio.com/patients-and-families/miguel/)
02:49:50	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734518340	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css8e4d.css	(from https://bridgebio.com/patients-and-families/miguel/)
02:49:50	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734518340	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust8e4d.css	(from https://bridgebio.com/patients-and-families/miguel/)
02:49:50	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734518340	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts8e4d.js	(from https://bridgebio.com/patients-and-families/miguel/)
02:49:51	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734518340	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal8e4d.js	(from https://bridgebio.com/patients-and-families/miguel/)
02:49:51	12827/12827	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:49:51%20GMT	https://bridgebio.com/wp-json/wp/v2/stories/2772	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/stories/2772.json	(from https://bridgebio.com/patients-and-families/miguel/)
02:49:52	2471/2471	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:49:52%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fpatients-and-families%2Fmiguel%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed944e.json	(from https://bridgebio.com/patients-and-families/miguel/)
02:49:52	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:52%20GMT	https://bridgebio.com/?p=2772	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index27bf.html	(from https://bridgebio.com/patients-and-families/miguel/)
02:49:52	2660/2660	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:49:52%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fpatients-and-families%2Fmiguel%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1491	(from https://bridgebio.com/patients-and-families/miguel/)
02:49:53	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:53%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/patients-and-families/miguel/)
02:49:53	23417/23417	---M--	200	added ('OK')	image/jpeg	etag:%2266829bfa-60a8%22	https://bridgebio.com/wp-content/uploads/2021/09/Miguel_photo.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/09/Miguel_photo.jpg	(from https://bridgebio.com/patients-and-families/miguel/)
02:49:53	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:53%20GMT	https://bridgebio.com/patients-and-families	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/patients-and-families	(from https://bridgebio.com/patients-and-families/miguel/)
02:49:54	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:54%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/patients-and-families/miguel/)
02:49:57	153/153	---MCZ	404	error ('Not%20Found')	text/html	date:Wed,%2018%20Dec%202024%2010:49:57%20GMT	https://bbio2019.azurewebsites.net/wp-content/uploads/2021/08/ASP_Cnvn_Tobin_0820.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bbio2019.azurewebsites.net/wp-content/uploads/2021/08/ASP_Cnvn_Tobin_0820.e3.delayed	(from https://bridgebio.com/patients-and-families/tobin/)
02:49:57	12452/12452	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:49:57%20GMT	https://bridgebio.com/wp-json/wp/v2/stories/4629	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/stories/4629.json	(from https://bridgebio.com/patients-and-families/tobin/)
02:49:58	2639/2639	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:49:58%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fpatients-and-families%2Ftobin%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0ab3.json	(from https://bridgebio.com/patients-and-families/tobin/)
02:49:58	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:58%20GMT	https://bridgebio.com/?p=4629	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index0e82.html	(from https://bridgebio.com/patients-and-families/tobin/)
02:49:58	2799/2799	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:49:58%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fpatients-and-families%2Ftobin%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7a98	(from https://bridgebio.com/patients-and-families/tobin/)
02:49:58	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:58%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/patients-and-families/tobin/)
02:49:59	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:59%20GMT	https://bridgebio.com/patients-and-families	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/patients-and-families	(from https://bridgebio.com/patients-and-families/tobin/)
02:49:59	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:49:59%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/patients-and-families/tobin/)
02:50:00	10187/10187	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:00%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/869	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/869.json	(from https://bridgebio.com/news/)
02:50:00	2278/2278	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:00%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed109b.json	(from https://bridgebio.com/news/)
02:50:00	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:00%20GMT	https://bridgebio.com/?p=869	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index71e2.html	(from https://bridgebio.com/news/)
02:50:01	2469/2469	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:50:01%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2f4f	(from https://bridgebio.com/news/)
02:50:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:01%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/news/)
02:50:01	153978/153978	---M--	200	added ('OK')	image/png	etag:%226740f474-300a0%22	https://bridgebio.com/wp-content/uploads/2024/11/29c6e090-4eb3-404d-a455-ab31a30c3664.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/11/29c6e090-4eb3-404d-a455-ab31a30c3664.png	(from https://bridgebio.com/news/)
02:50:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:02%20GMT	https://bridgebio.com/news/page/2	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/2	(from https://bridgebio.com/news/)
02:50:02	48544/48544	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:02%20GMT	https://bridgebio.com/news/7135-2/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/7135-2/index.html	(from https://bridgebio.com/news/)
02:50:02	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:02%20GMT	https://bridgebio.com/news/page/3	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/3	(from https://bridgebio.com/news/)
02:50:02	55488/55488	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:02%20GMT	https://bridgebio.com/news/attruby-acoramidis-a-near-complete-ttr-stabilizer-%e2%89%a590-approved-by-fda-to-reduce-cardiovascular-death-and-cardiovascular-related-hospitalization-in-attr-cm-patients/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/attruby-acoramidis-a-near-complete-ttr-stabiliz/index.html	(from https://bridgebio.com/news/)
02:50:03	53920/53920	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:03%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-publication-in-the-n/index.html	(from https://bridgebio.com/news/)
02:50:03	51709/51709	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:03%20GMT	https://bridgebio.com/news/bridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024/index.html	(from https://bridgebio.com/news/)
02:50:03	45367/45367	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:03%20GMT	https://bridgebio.com/news/bridgebio-to-present-outcomes-data-through-42-months-from-the-open-label-extension-of-attribute-cm-the-phase-3-study-of-acoramidis-for-treatment-of-attr-cm-at-2024-aha-scientific-sessions/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-to-present-outcomes-data-through-42-m/index.html	(from https://bridgebio.com/news/)
02:50:03	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:03%20GMT	https://bridgebio.com/news/page/4	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/4	(from https://bridgebio.com/news/)
02:50:04	51243/51243	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:04%20GMT	https://bridgebio.com/news/bridgebio-shares-recurrent-event-analysis-of-attribute-cm-demonstrating-a-42-reduction-by-acoramidis-on-the-composite-endpoint-of-all-cause-mortality-and-recurrent-cardiovascular-related-hospitalizat/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-shares-recurrent-event-analysis-of-at/index.html	(from https://bridgebio.com/news/)
02:50:04	51344/51344	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:03%20GMT	https://bridgebio.com/news/bridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/index.html	(from https://bridgebio.com/news/)
02:50:04	51139/51139	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:04%20GMT	https://bridgebio.com/news/bridgebio-announces-infigratinib-is-the-first-ever-investigational-therapeutic-option-for-achondroplasia-to-be-awarded-breakthrough-therapy-designation-by-the-fda/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-announces-infigratinib-is-the-first-e/index.html	(from https://bridgebio.com/news/)
02:50:04	51386/51386	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:04%20GMT	https://bridgebio.com/news/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program/index.html	(from https://bridgebio.com/news/)
02:50:04	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:04%20GMT	https://bridgebio.com/news/page/5	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/5.f2.delayed	(from https://bridgebio.com/news/)
02:50:05	41861/41861	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:05%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-42/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-42/index.html	(from https://bridgebio.com/news/)
02:50:05	51480/51480	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:05%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-topline-results-from-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-topline-results-from-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/index.html	(from https://bridgebio.com/news/)
02:50:05	52427/52427	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:05%20GMT	https://bridgebio.com/news/bridgebio-shares-data-on-serum-ttr-increase-when-switching-participants-from-placebo-and-tafamidis-to-acoramidis-in-attribute-cm-and-its-open-label-extension/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-shares-data-on-serum-ttr-increase-whe/index.html	(from https://bridgebio.com/news/)
02:50:05	44621/44621	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:05%20GMT	https://bridgebio.com/news/bridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-to-present-additional-analyses-from-t/index.html	(from https://bridgebio.com/news/)
02:50:05	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:05%20GMT	https://bridgebio.com/news/page/6	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/6	(from https://bridgebio.com/news/)
02:50:06	41713/41713	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:06%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events-2/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events-2/index.html	(from https://bridgebio.com/news/)
02:50:06	50866/50866	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:06%20GMT	https://bridgebio.com/news/bridgebio-partners-with-leading-cardiovascular-data-science-lab-cards-lab-to-improve-transthyretin-amyloid-cardiomyopathy-attr-cm-diagnosis-in-diverse-patient-populations-with-multimodal-artificia/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-partners-with-leading-cardiovascular-/index.html	(from https://bridgebio.com/news/)
02:50:06	49212/49212	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:06%20GMT	https://bridgebio.com/news/bridgebio-launches-myachonjourney-a-new-resource-for-families-navigating-achondroplasia/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-launches-myachonjourney-a-new-resource-for-families-navigating-achondroplasia/index.html	(from https://bridgebio.com/news/)
02:50:06	41732/41732	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:06%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-41/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-41/index.html	(from https://bridgebio.com/news/)
02:50:06	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:06%20GMT	https://bridgebio.com/news/page/7	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/7	(from https://bridgebio.com/news/)
02:50:07	67367/67367	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:07%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update/index.html	(from https://bridgebio.com/news/)
02:50:07	43059/43059	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:07%20GMT	https://bridgebio.com/news/bridgebio-announces-appointment-of-thomas-trimarchi-ph-d-as-president-and-chief-operating-officer/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-announces-appointment-of-thomas-trimarchi-ph-d-as-president-and-chief-operating-officer/index.html	(from https://bridgebio.com/news/)
02:50:07	41741/41741	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:07%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-40/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-40/index.html	(from https://bridgebio.com/news/)
02:50:07	51250/51250	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:07%20GMT	https://bridgebio.com/news/page/2/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/2/index.html	(from https://bridgebio.com/news/)
02:50:08	51272/51272	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:08%20GMT	https://bridgebio.com/news/page/3/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/3/index.html	(from https://bridgebio.com/news/)
02:50:08	51619/51619	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:08%20GMT	https://bridgebio.com/news/page/4/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/4/index.html	(from https://bridgebio.com/news/)
02:50:08	50815/50815	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:08%20GMT	https://bridgebio.com/news/page/5/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/5/index.html	(from https://bridgebio.com/news/)
02:50:08	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:07%20GMT	https://bridgebio.com/news/page/8	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/8	(from https://bridgebio.com/news/)
02:50:08	51498/51498	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:08%20GMT	https://bridgebio.com/news/page/6/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/6/index.html	(from https://bridgebio.com/news/)
02:50:09	50656/50656	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:09%20GMT	https://bridgebio.com/news/page/8/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/8/index.html	(from https://bridgebio.com/news/)
02:50:09	50836/50836	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:08%20GMT	https://bridgebio.com/news/page/7/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/7/index.html	(from https://bridgebio.com/news/)
02:50:09	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:09%20GMT	https://bridgebio.com/news/page/9	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/9	(from https://bridgebio.com/news/)
02:50:09	50866/50866	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:09%20GMT	https://bridgebio.com/news/page/9/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/9/index.html	(from https://bridgebio.com/news/)
02:50:10	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:09%20GMT	https://bridgebio.com/news/page/10	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/10	(from https://bridgebio.com/news/)
02:50:10	50647/50647	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:10%20GMT	https://bridgebio.com/news/page/10/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/10/index.html	(from https://bridgebio.com/news/)
02:50:10	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:10%20GMT	https://bridgebio.com/news/page/11	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/11	(from https://bridgebio.com/news/)
02:50:10	50978/50978	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:10%20GMT	https://bridgebio.com/news/page/11/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/11/index.html	(from https://bridgebio.com/news/)
02:50:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:11%20GMT	https://bridgebio.com/news/page/12	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/12	(from https://bridgebio.com/news/)
02:50:11	50105/50105	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:11%20GMT	https://bridgebio.com/news/page/12/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/12/index.html	(from https://bridgebio.com/news/)
02:50:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:11%20GMT	https://bridgebio.com/news/page/13	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/13	(from https://bridgebio.com/news/)
02:50:12	50837/50837	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:11%20GMT	https://bridgebio.com/news/page/13/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/13/index.html	(from https://bridgebio.com/news/)
02:50:12	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:12%20GMT	https://bridgebio.com/news/page/14	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/14	(from https://bridgebio.com/news/)
02:50:12	50768/50768	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:12%20GMT	https://bridgebio.com/news/page/14/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/14/index.html	(from https://bridgebio.com/news/)
02:50:12	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:12%20GMT	https://bridgebio.com/news/page/15	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/15	(from https://bridgebio.com/news/)
02:50:13	50630/50630	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:13%20GMT	https://bridgebio.com/news/page/15/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/15/index.html	(from https://bridgebio.com/news/)
02:50:13	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:13%20GMT	https://bridgebio.com/news/page/16	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/16	(from https://bridgebio.com/news/)
02:50:13	42188/42188	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:13%20GMT	https://bridgebio.com/news/page/16/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/page/16/index.html	(from https://bridgebio.com/news/)
02:50:13	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:13%20GMT	https://bridgebio.com/news/archive	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/archive	(from https://bridgebio.com/news/)
02:50:14	49243/49243	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:14%20GMT	https://bridgebio.com/news/archive/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/archive/index.html	(from https://bridgebio.com/news/)
02:50:14	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:14%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/)
02:50:15	18406/18406	---M--	200	added ('OK')	image/jpeg	etag:%2266829bf9-4b82%22	http://bridgebio.com/wp-content/uploads/2023/08/couple-bw-300x300.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2023/08/couple-bw-300x300.jpg	(from https://bridgebio.com/patients-and-families/len/)
02:50:15	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734516900	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style9c51.css	(from https://bridgebio.com/patients-and-families/len/)
02:50:15	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734516900	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css9c51.css	(from https://bridgebio.com/patients-and-families/len/)
02:50:15	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734516900	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust9c51.css	(from https://bridgebio.com/patients-and-families/len/)
02:50:16	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734516900	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts9c51.js	(from https://bridgebio.com/patients-and-families/len/)
02:50:16	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734516900	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal9c51.js	(from https://bridgebio.com/patients-and-families/len/)
02:50:16	15308/15308	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:16%20GMT	https://bridgebio.com/wp-json/wp/v2/stories/4627	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/stories/4627.json	(from https://bridgebio.com/patients-and-families/len/)
02:50:17	2374/2374	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:17%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fpatients-and-families%2Flen%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1de5.json	(from https://bridgebio.com/patients-and-families/len/)
02:50:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:17%20GMT	https://bridgebio.com/?p=4627	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index0b0c.html	(from https://bridgebio.com/patients-and-families/len/)
02:50:17	2530/2530	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:50:17%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fpatients-and-families%2Flen%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7cf2	(from https://bridgebio.com/patients-and-families/len/)
02:50:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:18%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/patients-and-families/len/)
02:50:18	41375/41375	---M--	200	added ('OK')	image/jpeg	etag:%2266829c08-a19f%22	https://bridgebio.com/wp-content/uploads/2021/08/Len_attr-patient.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/08/Len_attr-patient.jpg	(from https://bridgebio.com/patients-and-families/len/)
02:50:18	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:18%20GMT	https://bridgebio.com/patients-and-families	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/patients-and-families	(from https://bridgebio.com/patients-and-families/len/)
02:50:18	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:19%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/patients-and-families/len/)
02:50:19	146/146	---MCZ	404	error ('Not%20Found')	text/html	date:Wed,%2018%20Dec%202024%2010:50:19%20GMT	https://bridgebio.com/jquery.build.js	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/jquery.build.js	(from http://pages.bridgebio.com/js/forms2/js/forms2.min.js)
02:50:19	33623/33623	---MCZ	404	error ('Not%20Found')	text/html	date:Wed,%2018%20Dec%202024%2010:50:19%20GMT	https://bridgebio.com/ABCDEFGHIJKLMNOPQRSTUVWXYZabcdefghijklmnopqrstuvwxyz0123456789+/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/ABCDEFGHIJKLMNOPQRSTUVWXYZabcdefghijklmnopqrstuvwxyz0123456789+/index.html	(from http://pages.bridgebio.com/js/forms2/js/forms2.min.js)
02:50:19	146/146	---MCZ	404	error ('Not%20Found')	text/html	date:Wed,%2018%20Dec%202024%2010:50:19%20GMT	https://bridgebio.com/jquery.js	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/jquery.js	(from http://pages.bridgebio.com/js/forms2/js/forms2.min.js)
02:50:20	146/146	---MCZ	404	error ('Not%20Found')	text/html	date:Wed,%2018%20Dec%202024%2010:50:20%20GMT	https://bridgebio.com/comparators.js	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/comparators.js	(from http://pages.bridgebio.com/js/forms2/js/forms2.min.js)
02:50:20	146/146	---MCZ	404	error ('Not%20Found')	text/html	date:Wed,%2018%20Dec%202024%2010:50:20%20GMT	https://bridgebio.com/fields/fieldhelpers.js	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/fields/fieldhelpers.js	(from http://pages.bridgebio.com/js/forms2/js/forms2.min.js)
02:50:20	146/146	---MCZ	404	error ('Not%20Found')	text/html	date:Wed,%2018%20Dec%202024%2010:50:20%20GMT	https://bridgebio.com/fieldHelpers.js	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/fieldHelpers.js	(from http://pages.bridgebio.com/js/forms2/js/forms2.min.js)
02:50:21	42829/42829	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:21%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/1067	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/1067.json	(from https://bridgebio.com/terms-of-use/)
02:50:21	2357/2357	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:21%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fterms-of-use%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1549.json	(from https://bridgebio.com/terms-of-use/)
02:50:22	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:22%20GMT	https://bridgebio.com/?p=1067	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index1ce2.html	(from https://bridgebio.com/terms-of-use/)
02:50:22	2548/2548	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:50:22%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fterms-of-use%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedcc79	(from https://bridgebio.com/terms-of-use/)
02:50:22	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:22%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/terms-of-use/)
02:50:22	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:22%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/terms-of-use/)
02:50:23	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734516540	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style01ab.css	(from https://bridgebio.com/bridgebio-global-privacy-policy/)
02:50:23	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734516540	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css01ab.css	(from https://bridgebio.com/bridgebio-global-privacy-policy/)
02:50:23	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734516540	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust01ab.css	(from https://bridgebio.com/bridgebio-global-privacy-policy/)
02:50:24	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734516540	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts01ab.js	(from https://bridgebio.com/bridgebio-global-privacy-policy/)
02:50:24	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734516540	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal01ab.js	(from https://bridgebio.com/bridgebio-global-privacy-policy/)
02:50:24	45663/45663	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:25%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/3275	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/3275.json	(from https://bridgebio.com/bridgebio-global-privacy-policy/)
02:50:25	2443/2443	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:25%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fbridgebio-global-privacy-policy%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf7a3.json	(from https://bridgebio.com/bridgebio-global-privacy-policy/)
02:50:25	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:25%20GMT	https://bridgebio.com/?p=3275	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index50ff.html	(from https://bridgebio.com/bridgebio-global-privacy-policy/)
02:50:25	2634/2634	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:50:26%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fbridgebio-global-privacy-policy%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed438b	(from https://bridgebio.com/bridgebio-global-privacy-policy/)
02:50:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:26%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/bridgebio-global-privacy-policy/)
02:50:26	49913/49913	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:26%20GMT	https://bridgebio.com/bridgebio-hcp-privacy-notice	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/bridgebio-hcp-privacy-notice.html	(from https://bridgebio.com/bridgebio-global-privacy-policy/)
02:50:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:26%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/bridgebio-global-privacy-policy/)
02:50:27	63318/63318	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:50:27%20GMT	https://bridgebio.com/bridgebio-eea-swiss-and-uk-candidate-privacy-notice/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/bridgebio-eea-swiss-and-uk-candidate-privacy-notice/index.html	(from https://bridgebio.com/bridgebio-global-privacy-policy/)
02:50:27	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734507000	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style4c31.css	(from https://bridgebio.com/cookies-notice/)
02:50:27	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734507000	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css4c31.css	(from https://bridgebio.com/cookies-notice/)
02:50:27	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734507000	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust4c31.css	(from https://bridgebio.com/cookies-notice/)
02:50:27	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734507000	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts4c31.js	(from https://bridgebio.com/cookies-notice/)
02:50:28	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734507000	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal4c31.js	(from https://bridgebio.com/cookies-notice/)
02:50:28	19007/19007	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:28%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/3841	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/3841.json	(from https://bridgebio.com/cookies-notice/)
02:50:28	2377/2377	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:29%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcookies-notice%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede1c9.json	(from https://bridgebio.com/cookies-notice/)
02:50:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:29%20GMT	https://bridgebio.com/?p=3841	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index1f1e.html	(from https://bridgebio.com/cookies-notice/)
02:50:29	2568/2568	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:50:29%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcookies-notice%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1b2f	(from https://bridgebio.com/cookies-notice/)
02:50:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:29%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/cookies-notice/)
02:50:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:29%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/cookies-notice/)
02:50:30	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734508800	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style29f1.css	(from https://bridgebio.com/us-expanded-access-policy/)
02:50:30	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734508800	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css29f1.css	(from https://bridgebio.com/us-expanded-access-policy/)
02:50:30	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734508800	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust29f1.css	(from https://bridgebio.com/us-expanded-access-policy/)
02:50:30	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734508800	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts29f1.js	(from https://bridgebio.com/us-expanded-access-policy/)
02:50:31	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734508800	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal29f1.js	(from https://bridgebio.com/us-expanded-access-policy/)
02:50:31	16325/16325	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:31%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/6644	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/6644.json	(from https://bridgebio.com/us-expanded-access-policy/)
02:50:32	2662/2662	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:32%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fus-expanded-access-policy%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeded44.json	(from https://bridgebio.com/us-expanded-access-policy/)
02:50:32	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:32%20GMT	https://bridgebio.com/?p=6644	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index5186.html	(from https://bridgebio.com/us-expanded-access-policy/)
02:50:32	2853/2853	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:50:32%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fus-expanded-access-policy%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5c24	(from https://bridgebio.com/us-expanded-access-policy/)
02:50:32	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:32%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/us-expanded-access-policy/)
02:50:33	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:33%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/us-expanded-access-policy/)
02:50:33	9133/9133	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:33%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/6654	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/6654.json	(from https://bridgebio.com/contact-us/)
02:50:34	2549/2549	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:34%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcontact-us%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3297.json	(from https://bridgebio.com/contact-us/)
02:50:34	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:34%20GMT	https://bridgebio.com/?p=6654	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexa3f2.html	(from https://bridgebio.com/contact-us/)
02:50:34	2740/2740	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:50:34%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcontact-us%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8ae8	(from https://bridgebio.com/contact-us/)
02:50:34	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:35%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/contact-us/)
02:50:35	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:35%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/contact-us/)
02:50:35	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734510420	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style9f8a.css	(from https://bridgebio.com/sms-policy/)
02:50:35	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734510420	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css9f8a.css	(from https://bridgebio.com/sms-policy/)
02:50:36	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734510420	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust9f8a.css	(from https://bridgebio.com/sms-policy/)
02:50:36	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734510420	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts9f8a.js	(from https://bridgebio.com/sms-policy/)
02:50:36	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734510420	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal9f8a.js	(from https://bridgebio.com/sms-policy/)
02:50:37	13921/13921	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:37%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/6886	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/6886.json	(from https://bridgebio.com/sms-policy/)
02:50:37	2699/2699	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fsms-policy%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf771.json	(from https://bridgebio.com/sms-policy/)
02:50:37	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:37%20GMT	https://bridgebio.com/?p=6886	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexea7d.html	(from https://bridgebio.com/sms-policy/)
02:50:38	2898/2898	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:50:38%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fsms-policy%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1b9e	(from https://bridgebio.com/sms-policy/)
02:50:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:38%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/sms-policy/)
02:50:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:38%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/sms-policy/)
02:50:39	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734508980	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style5f1a.css	(from https://bridgebio.com/social-policy)
02:50:39	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734508980	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css5f1a.css	(from https://bridgebio.com/social-policy)
02:50:39	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:39%20GMT	https://bridgebio.com/social-policy/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/social-policy/index.html	(from https://bridgebio.com/social-policy)
02:50:39	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734508980	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust5f1a.css	(from https://bridgebio.com/social-policy)
02:50:39	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734508980	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts5f1a.js	(from https://bridgebio.com/social-policy)
02:50:40	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734508980	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal5f1a.js	(from https://bridgebio.com/social-policy)
02:50:40	16486/16486	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:40%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/7107	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/7107.json	(from https://bridgebio.com/social-policy)
02:50:41	2666/2666	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:41%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fsocial-policy	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embededf9.json	(from https://bridgebio.com/social-policy)
02:50:41	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:41%20GMT	https://bridgebio.com/?p=7107	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexd9aa.html	(from https://bridgebio.com/social-policy)
02:50:41	2858/2858	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:50:41%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fsocial-policy&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedfb54	(from https://bridgebio.com/social-policy)
02:50:41	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:41%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/social-policy)
02:50:42	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:42%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/social-policy)
02:50:43	17426/17426	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:43%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/7130	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/7130.json	(from https://bridgebio.com/careers/manager-revenue/)
02:50:43	2396/2396	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:43%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fmanager-revenue%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0327.json	(from https://bridgebio.com/careers/manager-revenue/)
02:50:43	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:43%20GMT	https://bridgebio.com/?p=7130	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index17c2.html	(from https://bridgebio.com/careers/manager-revenue/)
02:50:44	2585/2585	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:50:44%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fmanager-revenue%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed4f78	(from https://bridgebio.com/careers/manager-revenue/)
02:50:44	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:44%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/manager-revenue/)
02:50:44	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:44%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/manager-revenue/)
02:50:45	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:45%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/manager-revenue/)
02:50:45	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:45%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/manager-revenue/)
02:50:45	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:45%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/manager-revenue/)
02:50:46	17008/17008	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:46%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/7101	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/7101.json	(from https://bridgebio.com/careers/associate-director-biostatistics/)
02:50:46	2508/2508	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:47%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fassociate-director-biostatistics%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed616f.json	(from https://bridgebio.com/careers/associate-director-biostatistics/)
02:50:47	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:47%20GMT	https://bridgebio.com/?p=7101	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexaa43.html	(from https://bridgebio.com/careers/associate-director-biostatistics/)
02:50:47	2697/2697	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:50:47%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fassociate-director-biostatistics%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc564	(from https://bridgebio.com/careers/associate-director-biostatistics/)
02:50:48	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:48%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/associate-director-biostatistics/)
02:50:48	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:48%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/associate-director-biostatistics/)
02:50:49	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:49%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/associate-director-biostatistics/)
02:50:49	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:49%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/associate-director-biostatistics/)
02:50:50	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:50%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/associate-director-biostatistics/)
02:50:50	16406/16406	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:51%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/6808	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/6808.json	(from https://bridgebio.com/careers/director-biostatistics/)
02:50:51	2448/2448	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:51%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fdirector-biostatistics%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedfdfc.json	(from https://bridgebio.com/careers/director-biostatistics/)
02:50:51	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:51%20GMT	https://bridgebio.com/?p=6808	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index1217.html	(from https://bridgebio.com/careers/director-biostatistics/)
02:50:51	2637/2637	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:50:52%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fdirector-biostatistics%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5060	(from https://bridgebio.com/careers/director-biostatistics/)
02:50:52	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:52%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/director-biostatistics/)
02:50:52	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:52%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/director-biostatistics/)
02:50:52	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:52%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/director-biostatistics/)
02:50:53	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:53%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/director-biostatistics/)
02:50:53	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:53%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/director-biostatistics/)
02:50:54	26957/26957	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:54%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/6762	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/6762.json	(from https://bridgebio.com/careers/associate-director-director-business-development-and-operations/)
02:50:54	2688/2688	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:54%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fassociate-director-director-business-development-and-operations%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9bec.json	(from https://bridgebio.com/careers/associate-director-director-business-development-and-operations/)
02:50:54	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:54%20GMT	https://bridgebio.com/?p=6762	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexa645.html	(from https://bridgebio.com/careers/associate-director-director-business-development-and-operations/)
02:50:55	2873/2873	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:50:55%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fassociate-director-director-business-development-and-operations%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed122c	(from https://bridgebio.com/careers/associate-director-director-business-development-and-operations/)
02:50:55	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:55%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/associate-director-director-business-development-and-operations/)
02:50:55	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:55%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/associate-director-director-business-development-and-operations/)
02:50:56	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:56%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/associate-director-director-business-development-and-operations/)
02:50:56	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:56%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/associate-director-director-business-development-and-operations/)
02:50:56	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:56%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/associate-director-director-business-development-and-operations/)
02:50:57	15844/15844	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:57%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/7103	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/7103.json	(from https://bridgebio.com/careers/associate-director-commercial-strategy-operations/)
02:50:57	2616/2616	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:50:57%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fassociate-director-commercial-strategy-operations%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed6c54.json	(from https://bridgebio.com/careers/associate-director-commercial-strategy-operations/)
02:50:57	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:57%20GMT	https://bridgebio.com/?p=7103	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexb39a.html	(from https://bridgebio.com/careers/associate-director-commercial-strategy-operations/)
02:50:58	2813/2813	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:50:58%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fassociate-director-commercial-strategy-operations%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1935	(from https://bridgebio.com/careers/associate-director-commercial-strategy-operations/)
02:50:58	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:58%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/associate-director-commercial-strategy-operations/)
02:50:58	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:58%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/associate-director-commercial-strategy-operations/)
02:50:59	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:59%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/associate-director-commercial-strategy-operations/)
02:50:59	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:59%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/associate-director-commercial-strategy-operations/)
02:50:59	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:50:59%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/associate-director-commercial-strategy-operations/)
02:51:00	16831/16831	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:00%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/6946	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/6946.json	(from https://bridgebio.com/careers/sr-manager-associate-director-commercial-analytics/)
02:51:00	2630/2630	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:00%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fsr-manager-associate-director-commercial-analytics%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0e38.json	(from https://bridgebio.com/careers/sr-manager-associate-director-commercial-analytics/)
02:51:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:01%20GMT	https://bridgebio.com/?p=6946	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexd8f4.html	(from https://bridgebio.com/careers/sr-manager-associate-director-commercial-analytics/)
02:51:01	2813/2813	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:51:01%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fsr-manager-associate-director-commercial-analytics%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0ee1	(from https://bridgebio.com/careers/sr-manager-associate-director-commercial-analytics/)
02:51:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:01%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/sr-manager-associate-director-commercial-analytics/)
02:51:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:01%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/sr-manager-associate-director-commercial-analytics/)
02:51:02	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:02%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/sr-manager-associate-director-commercial-analytics/)
02:51:02	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:02%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/sr-manager-associate-director-commercial-analytics/)
02:51:02	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:03%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/sr-manager-associate-director-commercial-analytics/)
02:51:03	17210/17210	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:03%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/6828	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/6828.json	(from https://bridgebio.com/careers/associate-statistical-geneticist-statistical-geneticist/)
02:51:03	2646/2646	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:04%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fassociate-statistical-geneticist-statistical-geneticist%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc9b2.json	(from https://bridgebio.com/careers/associate-statistical-geneticist-statistical-geneticist/)
02:51:04	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:04%20GMT	https://bridgebio.com/?p=6828	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index5eb9.html	(from https://bridgebio.com/careers/associate-statistical-geneticist-statistical-geneticist/)
02:51:04	2831/2831	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:51:04%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fassociate-statistical-geneticist-statistical-geneticist%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed85fd	(from https://bridgebio.com/careers/associate-statistical-geneticist-statistical-geneticist/)
02:51:04	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:04%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/associate-statistical-geneticist-statistical-geneticist/)
02:51:05	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:05%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/associate-statistical-geneticist-statistical-geneticist/)
02:51:05	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:05%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/associate-statistical-geneticist-statistical-geneticist/)
02:51:05	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:05%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/associate-statistical-geneticist-statistical-geneticist/)
02:51:06	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:06%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/associate-statistical-geneticist-statistical-geneticist/)
02:51:06	19491/19491	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:06%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/7131	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/7131.json	(from https://bridgebio.com/careers/associate-senior-associate-asset-acquisition/)
02:51:07	2566/2566	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:07%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fassociate-senior-associate-asset-acquisition%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed02d1.json	(from https://bridgebio.com/careers/associate-senior-associate-asset-acquisition/)
02:51:07	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:07%20GMT	https://bridgebio.com/?p=7131	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index76cc.html	(from https://bridgebio.com/careers/associate-senior-associate-asset-acquisition/)
02:51:07	2751/2751	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:51:07%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fassociate-senior-associate-asset-acquisition%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0df5	(from https://bridgebio.com/careers/associate-senior-associate-asset-acquisition/)
02:51:07	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:07%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/associate-senior-associate-asset-acquisition/)
02:51:08	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:08%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/associate-senior-associate-asset-acquisition/)
02:51:08	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:08%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/associate-senior-associate-asset-acquisition/)
02:51:08	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:08%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/associate-senior-associate-asset-acquisition/)
02:51:09	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:09%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/associate-senior-associate-asset-acquisition/)
02:51:09	22796/22796	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:09%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/7132	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/7132.json	(from https://bridgebio.com/careers/director-biology-and-translational-research/)
02:51:10	2598/2598	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:10%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fdirector-biology-and-translational-research%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb17e.json	(from https://bridgebio.com/careers/director-biology-and-translational-research/)
02:51:10	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:10%20GMT	https://bridgebio.com/?p=7132	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexdf62.html	(from https://bridgebio.com/careers/director-biology-and-translational-research/)
02:51:10	2785/2785	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:51:10%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fdirector-biology-and-translational-research%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed523e	(from https://bridgebio.com/careers/director-biology-and-translational-research/)
02:51:10	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:10%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/director-biology-and-translational-research/)
02:51:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:11%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/director-biology-and-translational-research/)
02:51:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:11%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/director-biology-and-translational-research/)
02:51:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:11%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/director-biology-and-translational-research/)
02:51:12	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:12%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/director-biology-and-translational-research/)
02:51:12	16274/16274	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:12%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/6996	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/6996.json	(from https://bridgebio.com/careers/director-sr-director-business-development-operations/)
02:51:13	2634/2634	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:13%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fdirector-sr-director-business-development-operations%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed214e.json	(from https://bridgebio.com/careers/director-sr-director-business-development-operations/)
02:51:13	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:13%20GMT	https://bridgebio.com/?p=6996	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index1d47.html	(from https://bridgebio.com/careers/director-sr-director-business-development-operations/)
02:51:13	2827/2827	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:51:13%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fdirector-sr-director-business-development-operations%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1eeb	(from https://bridgebio.com/careers/director-sr-director-business-development-operations/)
02:51:13	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:13%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/director-sr-director-business-development-operations/)
02:51:14	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:14%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/director-sr-director-business-development-operations/)
02:51:14	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:14%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/director-sr-director-business-development-operations/)
02:51:14	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:15%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/director-sr-director-business-development-operations/)
02:51:15	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:15%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/director-sr-director-business-development-operations/)
02:51:15	18515/18515	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:16%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/7136	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/7136.json	(from https://bridgebio.com/careers/senior-medical-director-vp-clinical-development/)
02:51:16	2634/2634	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:16%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fsenior-medical-director-vp-clinical-development%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9f9e.json	(from https://bridgebio.com/careers/senior-medical-director-vp-clinical-development/)
02:51:16	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:16%20GMT	https://bridgebio.com/?p=7136	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index49a5.html	(from https://bridgebio.com/careers/senior-medical-director-vp-clinical-development/)
02:51:16	2817/2817	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:51:16%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fsenior-medical-director-vp-clinical-development%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0a5a	(from https://bridgebio.com/careers/senior-medical-director-vp-clinical-development/)
02:51:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:17%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/senior-medical-director-vp-clinical-development/)
02:51:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:17%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/senior-medical-director-vp-clinical-development/)
02:51:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:17%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/senior-medical-director-vp-clinical-development/)
02:51:18	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:18%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/senior-medical-director-vp-clinical-development/)
02:51:18	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:18%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/senior-medical-director-vp-clinical-development/)
02:51:18	19458/19458	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:19%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/7072	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/7072.json	(from https://bridgebio.com/careers/director-patient-services-hub-field-access-operations/)
02:51:19	2644/2644	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:19%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fdirector-patient-services-hub-field-access-operations%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd5e6.json	(from https://bridgebio.com/careers/director-patient-services-hub-field-access-operations/)
02:51:19	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:19%20GMT	https://bridgebio.com/?p=7072	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index49f8.html	(from https://bridgebio.com/careers/director-patient-services-hub-field-access-operations/)
02:51:19	2841/2841	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:51:19%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fdirector-patient-services-hub-field-access-operations%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed896e	(from https://bridgebio.com/careers/director-patient-services-hub-field-access-operations/)
02:51:20	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:20%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/director-patient-services-hub-field-access-operations/)
02:51:20	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:20%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/director-patient-services-hub-field-access-operations/)
02:51:20	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:20%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/director-patient-services-hub-field-access-operations/)
02:51:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:21%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/director-patient-services-hub-field-access-operations/)
02:51:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:21%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/director-patient-services-hub-field-access-operations/)
02:51:22	16940/16940	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:22%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/7061	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/7061.json	(from https://bridgebio.com/careers/associate-director-marketing-2/)
02:51:22	2478/2478	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:22%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fassociate-director-marketing-2%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed249c.json	(from https://bridgebio.com/careers/associate-director-marketing-2/)
02:51:22	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:22%20GMT	https://bridgebio.com/?p=7061	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexdd6b.html	(from https://bridgebio.com/careers/associate-director-marketing-2/)
02:51:22	2667/2667	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:51:22%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fassociate-director-marketing-2%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3779	(from https://bridgebio.com/careers/associate-director-marketing-2/)
02:51:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:23%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/associate-director-marketing-2/)
02:51:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:23%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/associate-director-marketing-2/)
02:51:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:23%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/associate-director-marketing-2/)
02:51:24	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:24%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/associate-director-marketing-2/)
02:51:24	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:24%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/associate-director-marketing-2/)
02:51:25	16985/16985	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:25%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/6804	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/6804.json	(from https://bridgebio.com/careers/associate-director-marketing/)
02:51:25	2522/2522	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:25%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fassociate-director-marketing%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeda755.json	(from https://bridgebio.com/careers/associate-director-marketing/)
02:51:25	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:25%20GMT	https://bridgebio.com/?p=6804	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index613e.html	(from https://bridgebio.com/careers/associate-director-marketing/)
02:51:25	2709/2709	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:51:26%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fassociate-director-marketing%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed6627	(from https://bridgebio.com/careers/associate-director-marketing/)
02:51:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:26%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/associate-director-marketing/)
02:51:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:26%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/associate-director-marketing/)
02:51:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:26%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/associate-director-marketing/)
02:51:27	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:27%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/associate-director-marketing/)
02:51:27	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:27%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/associate-director-marketing/)
02:51:28	17668/17668	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:28%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/6854	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/6854.json	(from https://bridgebio.com/careers/director-kol-management-engagement-east/)
02:51:28	2596/2596	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:28%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fdirector-kol-management-engagement-east%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb466.json	(from https://bridgebio.com/careers/director-kol-management-engagement-east/)
02:51:28	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:28%20GMT	https://bridgebio.com/?p=6854	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index9e6d.html	(from https://bridgebio.com/careers/director-kol-management-engagement-east/)
02:51:28	2795/2795	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:51:29%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fdirector-kol-management-engagement-east%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedbd2b	(from https://bridgebio.com/careers/director-kol-management-engagement-east/)
02:51:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:29%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/director-kol-management-engagement-east/)
02:51:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:29%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/director-kol-management-engagement-east/)
02:51:30	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:30%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/director-kol-management-engagement-east/)
02:51:30	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:30%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/director-kol-management-engagement-east/)
02:51:30	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:30%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/director-kol-management-engagement-east/)
02:51:31	15655/15655	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:31%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/6903	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/6903.json	(from https://bridgebio.com/careers/manager-digital-marketing/)
02:51:31	2472/2472	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:31%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fmanager-digital-marketing%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd411.json	(from https://bridgebio.com/careers/manager-digital-marketing/)
02:51:31	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:32%20GMT	https://bridgebio.com/?p=6903	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index8bc5.html	(from https://bridgebio.com/careers/manager-digital-marketing/)
02:51:32	2659/2659	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:51:32%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fmanager-digital-marketing%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed986d	(from https://bridgebio.com/careers/manager-digital-marketing/)
02:51:32	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:32%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/manager-digital-marketing/)
02:51:32	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:32%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/manager-digital-marketing/)
02:51:33	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:33%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/manager-digital-marketing/)
02:51:33	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:33%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/manager-digital-marketing/)
02:51:33	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:33%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/manager-digital-marketing/)
02:51:34	17385/17385	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:34%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/6995	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/6995.json	(from https://bridgebio.com/careers/manager-sr-manager-commercial-training/)
02:51:35	2542/2542	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:35%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fmanager-sr-manager-commercial-training%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8e0e.json	(from https://bridgebio.com/careers/manager-sr-manager-commercial-training/)
02:51:35	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:35%20GMT	https://bridgebio.com/?p=6995	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index7035.html	(from https://bridgebio.com/careers/manager-sr-manager-commercial-training/)
02:51:35	2727/2727	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:51:35%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fmanager-sr-manager-commercial-training%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed19e3	(from https://bridgebio.com/careers/manager-sr-manager-commercial-training/)
02:51:35	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:35%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/manager-sr-manager-commercial-training/)
02:51:36	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:36%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/manager-sr-manager-commercial-training/)
02:51:36	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:36%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/manager-sr-manager-commercial-training/)
02:51:36	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:36%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/manager-sr-manager-commercial-training/)
02:51:37	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:37%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/manager-sr-manager-commercial-training/)
02:51:37	17598/17598	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:37%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/6861	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/6861.json	(from https://bridgebio.com/careers/sr-medical-director-medical-affairs-achondroplasia-lead/)
02:51:38	2658/2658	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:38%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fsr-medical-director-medical-affairs-achondroplasia-lead%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5bb7.json	(from https://bridgebio.com/careers/sr-medical-director-medical-affairs-achondroplasia-lead/)
02:51:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:38%20GMT	https://bridgebio.com/?p=6861	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index5d51.html	(from https://bridgebio.com/careers/sr-medical-director-medical-affairs-achondroplasia-lead/)
02:51:38	2847/2847	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:51:38%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fsr-medical-director-medical-affairs-achondroplasia-lead%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7041	(from https://bridgebio.com/careers/sr-medical-director-medical-affairs-achondroplasia-lead/)
02:51:39	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:39%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/sr-medical-director-medical-affairs-achondroplasia-lead/)
02:51:39	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:39%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/sr-medical-director-medical-affairs-achondroplasia-lead/)
02:51:39	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:39%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/sr-medical-director-medical-affairs-achondroplasia-lead/)
02:51:39	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:40%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/sr-medical-director-medical-affairs-achondroplasia-lead/)
02:51:40	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:40%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/sr-medical-director-medical-affairs-achondroplasia-lead/)
02:51:41	17826/17826	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:41%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/7133	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/7133.json	(from https://bridgebio.com/careers/director-drug-safety-pharmacovigilance-international/)
02:51:41	2636/2636	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:41%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fdirector-drug-safety-pharmacovigilance-international%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed980f.json	(from https://bridgebio.com/careers/director-drug-safety-pharmacovigilance-international/)
02:51:41	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:41%20GMT	https://bridgebio.com/?p=7133	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index59d9.html	(from https://bridgebio.com/careers/director-drug-safety-pharmacovigilance-international/)
02:51:42	2833/2833	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:51:42%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fdirector-drug-safety-pharmacovigilance-international%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedfa7e	(from https://bridgebio.com/careers/director-drug-safety-pharmacovigilance-international/)
02:51:42	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:42%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/director-drug-safety-pharmacovigilance-international/)
02:51:42	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:42%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/director-drug-safety-pharmacovigilance-international/)
02:51:43	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:43%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/director-drug-safety-pharmacovigilance-international/)
02:51:43	17879/17879	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:43%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/7138	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/7138.json	(from https://bridgebio.com/careers/director-drug-safety-pharmacovigilance-international-2/)
02:51:44	2648/2648	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:44%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fdirector-drug-safety-pharmacovigilance-international-2%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9ead.json	(from https://bridgebio.com/careers/director-drug-safety-pharmacovigilance-international-2/)
02:51:44	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:44%20GMT	https://bridgebio.com/?p=7138	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index870e.html	(from https://bridgebio.com/careers/director-drug-safety-pharmacovigilance-international-2/)
02:51:44	2845/2845	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:51:44%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fdirector-drug-safety-pharmacovigilance-international-2%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed53d4	(from https://bridgebio.com/careers/director-drug-safety-pharmacovigilance-international-2/)
02:51:45	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:45%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/director-drug-safety-pharmacovigilance-international-2/)
02:51:45	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:45%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/director-drug-safety-pharmacovigilance-international-2/)
02:51:45	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:45%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/director-drug-safety-pharmacovigilance-international-2/)
02:51:46	24063/24063	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:46%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/7129	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/7129.json	(from https://bridgebio.com/careers/director-clinical-quality-assurance/)
02:51:47	2526/2526	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:47%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fdirector-clinical-quality-assurance%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed545b.json	(from https://bridgebio.com/careers/director-clinical-quality-assurance/)
02:51:47	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:47%20GMT	https://bridgebio.com/?p=7129	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexa0a6.html	(from https://bridgebio.com/careers/director-clinical-quality-assurance/)
02:51:47	2715/2715	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:51:47%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fdirector-clinical-quality-assurance%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc396	(from https://bridgebio.com/careers/director-clinical-quality-assurance/)
02:51:48	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:48%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/director-clinical-quality-assurance/)
02:51:48	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:48%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/director-clinical-quality-assurance/)
02:51:48	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:48%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/director-clinical-quality-assurance/)
02:51:49	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:49%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/director-clinical-quality-assurance/)
02:51:50	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:50%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/director-clinical-quality-assurance/)
02:51:50	15262/15262	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:50%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/6844	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/6844.json	(from https://bridgebio.com/careers/sr-director-quality-assurance/)
02:51:51	2500/2500	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:51%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fsr-director-quality-assurance%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed30dc.json	(from https://bridgebio.com/careers/sr-director-quality-assurance/)
02:51:51	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:51%20GMT	https://bridgebio.com/?p=6844	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexe188.html	(from https://bridgebio.com/careers/sr-director-quality-assurance/)
02:51:51	2687/2687	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:51:51%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fsr-director-quality-assurance%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc182	(from https://bridgebio.com/careers/sr-director-quality-assurance/)
02:51:52	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:52%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/sr-director-quality-assurance/)
02:51:52	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:52%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/sr-director-quality-assurance/)
02:51:52	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:52%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/sr-director-quality-assurance/)
02:51:53	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:53%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/sr-director-quality-assurance/)
02:51:53	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:53%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/sr-director-quality-assurance/)
02:51:54	17881/17881	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:54%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/6465	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/6465.json	(from https://bridgebio.com/careers/sr-director-quality-assurance-cmc/)
02:51:54	2524/2524	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:54%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fsr-director-quality-assurance-cmc%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed4e8d.json	(from https://bridgebio.com/careers/sr-director-quality-assurance-cmc/)
02:51:54	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:54%20GMT	https://bridgebio.com/?p=6465	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index2758.html	(from https://bridgebio.com/careers/sr-director-quality-assurance-cmc/)
02:51:55	2711/2711	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:51:55%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fsr-director-quality-assurance-cmc%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedfbd7	(from https://bridgebio.com/careers/sr-director-quality-assurance-cmc/)
02:51:55	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:55%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/sr-director-quality-assurance-cmc/)
02:51:55	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:55%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/sr-director-quality-assurance-cmc/)
02:51:56	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:56%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/sr-director-quality-assurance-cmc/)
02:51:56	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:56%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/sr-director-quality-assurance-cmc/)
02:51:57	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:57%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/sr-director-quality-assurance-cmc/)
02:51:57	17985/17985	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:57%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/6803	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/6803.json	(from https://bridgebio.com/careers/director-sr-director-regulatory-affairs/)
02:51:58	2564/2564	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:51:58%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fdirector-sr-director-regulatory-affairs%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5532.json	(from https://bridgebio.com/careers/director-sr-director-regulatory-affairs/)
02:51:58	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:58%20GMT	https://bridgebio.com/?p=6803	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index0618.html	(from https://bridgebio.com/careers/director-sr-director-regulatory-affairs/)
02:51:59	2747/2747	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:51:58%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fdirector-sr-director-regulatory-affairs%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embededba	(from https://bridgebio.com/careers/director-sr-director-regulatory-affairs/)
02:51:59	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:59%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/director-sr-director-regulatory-affairs/)
02:51:59	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:59%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/director-sr-director-regulatory-affairs/)
02:51:59	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:51:59%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/director-sr-director-regulatory-affairs/)
02:52:00	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:52:00%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/director-sr-director-regulatory-affairs/)
02:52:00	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:52:00%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/director-sr-director-regulatory-affairs/)
02:52:01	16896/16896	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:52:01%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/7091	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/7091.json	(from https://bridgebio.com/careers/sr-director-global-regulatory-affairs-labeling/)
02:52:02	2596/2596	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:52:01%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fsr-director-global-regulatory-affairs-labeling%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3d6b.json	(from https://bridgebio.com/careers/sr-director-global-regulatory-affairs-labeling/)
02:52:02	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:52:02%20GMT	https://bridgebio.com/?p=7091	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexdd2e.html	(from https://bridgebio.com/careers/sr-director-global-regulatory-affairs-labeling/)
02:52:02	2785/2785	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:52:02%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fsr-director-global-regulatory-affairs-labeling%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc833	(from https://bridgebio.com/careers/sr-director-global-regulatory-affairs-labeling/)
02:52:03	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:52:03%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline	(from https://bridgebio.com/careers/sr-director-global-regulatory-affairs-labeling/)
02:52:03	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:52:03%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/sr-director-global-regulatory-affairs-labeling/)
02:52:03	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:52:03%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/sr-director-global-regulatory-affairs-labeling/)
02:52:04	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:52:04%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/sr-director-global-regulatory-affairs-labeling/)
02:52:04	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:52:04%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/sr-director-global-regulatory-affairs-labeling/)
02:52:05	15455/15455	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:52:05%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/6812	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/6812.json	(from https://bridgebio.com/careers/vp-regulatory-affairs/)
02:52:58	2448/2448	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:52:05%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fvp-regulatory-affairs%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedabb6.json	(from https://bridgebio.com/careers/vp-regulatory-affairs/)
02:52:59	2635/2635	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:52:59%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fvp-regulatory-affairs%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3c44	(from https://bridgebio.com/careers/vp-regulatory-affairs/)
02:53:00	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:00%20GMT	https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.216.delayed	(from https://bridgebio.com/careers/vp-regulatory-affairs/)
02:53:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:01%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/vp-regulatory-affairs/)
02:53:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:01%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/vp-regulatory-affairs/)
02:53:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:02%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/vp-regulatory-affairs/)
02:53:02	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:02%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/vp-regulatory-affairs/)
02:53:02	15868/15868	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:03%20GMT	https://bridgebio.com/wp-json/wp/v2/job-listing/7137	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/job-listing/7137.json	(from https://bridgebio.com/careers/executive-assistant-sales/)
02:53:03	2456/2456	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:03%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fexecutive-assistant-sales%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeddd8b.json	(from https://bridgebio.com/careers/executive-assistant-sales/)
02:53:03	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:03%20GMT	https://bridgebio.com/?p=7137	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexca63.html	(from https://bridgebio.com/careers/executive-assistant-sales/)
02:53:04	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.21e.delayed	(from https://bridgebio.com/careers/executive-assistant-sales/)
02:53:04	2645/2645	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:53:04%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fcareers%2Fexecutive-assistant-sales%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2df4	(from https://bridgebio.com/careers/executive-assistant-sales/)
02:53:04	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:04%20GMT	https://bridgebio.com/about	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about	(from https://bridgebio.com/careers/executive-assistant-sales/)
02:53:04	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:04%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/careers/executive-assistant-sales/)
02:53:05	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:05%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/executive-assistant-sales/)
02:53:05	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:05%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/careers/executive-assistant-sales/)
02:53:06	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734513480	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style0fbf.css	(from https://bridgebio.com/what-is-adh1/)
02:53:06	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734513480	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css0fbf.css	(from https://bridgebio.com/what-is-adh1/)
02:53:06	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734513480	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust0fbf.css	(from https://bridgebio.com/what-is-adh1/)
02:53:07	30604/30604	---MCZ	200	added ('OK')	text/css	etag:W/%2266e85bb7-778c%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/affiliates.css?ver=1734513480	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/affiliates0fbf.css	(from https://bridgebio.com/what-is-adh1/)
02:53:07	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734513480	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts0fbf.js	(from https://bridgebio.com/what-is-adh1/)
02:53:07	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734513480	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal0fbf.js	(from https://bridgebio.com/what-is-adh1/)
02:53:07	3058/3058	---MCZ	200	added ('OK')	application/javascript	etag:W/%2266e85bb7-bf2%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/affiliates.js?ver=1734513480	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/affiliates0fbf.js	(from https://bridgebio.com/what-is-adh1/)
02:53:08	154397/154397	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:08%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/6118	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/6118.json	(from https://bridgebio.com/what-is-adh1/)
02:53:08	2378/2378	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:08%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fwhat-is-adh1%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed07f1.json	(from https://bridgebio.com/what-is-adh1/)
02:53:08	2569/2569	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:53:09%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fwhat-is-adh1%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedfdc2	(from https://bridgebio.com/what-is-adh1/)
02:53:09	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.22d.delayed	(from https://bridgebio.com/what-is-adh1/)
02:53:09	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:09%20GMT	https://bridgebio.com/?p=6118	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index9e16.html	(from https://bridgebio.com/what-is-adh1/)
02:53:09	52787/52787	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:53:09%20GMT	https://bridgebio.com/what-is-adh1/encaleret/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/what-is-adh1/encaleret/index.html	(from https://bridgebio.com/what-is-adh1/)
02:53:09	154737/154737	---M--	200	added ('OK')	image/png	etag:%2266829bfd-2fe82%22	https://bridgebio.com/wp-content/uploads/2024/02/calcilytix-hero-bg.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/02/calcilytix-hero-bg.png	(from https://bridgebio.com/what-is-adh1/)
02:53:10	81138/81138	---MCZ	200	added ('OK')	image/svg+xml	etag:W/%2266829bf9-13cf2%22	https://bridgebio.com/wp-content/uploads/2024/02/about-adh1.svg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/02/about-adh1.svg	(from https://bridgebio.com/what-is-adh1/)
02:53:10	49612/49612	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:53:10%20GMT	https://bridgebio.com/what-is-adh1/patient-resources/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/what-is-adh1/patient-resources/index.html	(from https://bridgebio.com/what-is-adh1/)
02:53:10	589004/589004	---M--	200	added ('OK')	image/png	etag:%2266829bfb-bac8c%22	https://bridgebio.com/wp-content/uploads/2024/02/adh1-header.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/02/adh1-header.png	(from https://bridgebio.com/what-is-adh1/)
02:53:11	48099/48099	---MCZ	200	added ('OK')	image/svg+xml	etag:W/%2266829bfd-bbe3%22	https://bridgebio.com/wp-content/uploads/2024/02/clinical-features-of-adh1.svg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/02/clinical-features-of-adh1.svg	(from https://bridgebio.com/what-is-adh1/)
02:53:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:11%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/what-is-adh1/)
02:53:13	53319/53319	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:53:11%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-new-england-journal-of-medicine-publication-of-positive-encaleret-proof-of-concept-phase-2b-results-in-patients-with-autosomal-dominant-hypocalcemia-type-1-adh1/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-new-england-journal-/index.html	(from https://bridgebio.com/what-is-adh1/)
02:53:13	52630/52630	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:53:12%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-present-phase-2b-data-and-pivotal-phase-3-study-design-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-at-the-endocrine-society-endo-2022-annual-conference/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-present-phase-2b-data-and-p/index.html	(from https://bridgebio.com/what-is-adh1/)
02:53:13	53491/53491	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:53:12%20GMT	https://bridgebio.com/news/bridgebio-pharma-initiates-calibrate-a-pivotal-phase-3-study-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-initiates-calibrate-a-pivotal-phase-3-study-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1/index.html	(from https://bridgebio.com/what-is-adh1/)
02:53:14	57211/57211	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:53:12%20GMT	https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-/index.html	(from https://bridgebio.com/what-is-adh1/)
02:53:14	49973/49973	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:53:13%20GMT	https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1/index.html	(from https://bridgebio.com/what-is-adh1/)
02:53:14	56301/56301	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:53:14%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data/index.html	(from https://bridgebio.com/what-is-adh1/)
02:53:14	53680/53680	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:53:14%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting/index.html	(from https://bridgebio.com/what-is-adh1/)
02:53:14	30604/30604	---MCZ	200	added ('OK')	text/css	etag:W/%2266e85bb7-778c%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/affiliates.css?ver=1734517080	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/affiliatesc2d0.css	(from https://bridgebio.com/lgmd2i-r9/)
02:53:15	49767/49767	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:53:14%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-announce-proof-of-concept-data-from-adh1-at-the-endocrine-societys-2021-annual-meeting/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-announce-proof-of-concept-data-from-adh1-at-the-endocrine-societys-2021-annual-meeting/index.html	(from https://bridgebio.com/what-is-adh1/)
02:53:15	48309/48309	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:53:15%20GMT	https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1-2/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1-2/index.html	(from https://bridgebio.com/what-is-adh1/)
02:53:16	3058/3058	---MCZ	200	added ('OK')	application/javascript	etag:W/%2266e85bb7-bf2%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/affiliates.js?ver=1734517080	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/affiliatesc2d0.js	(from https://bridgebio.com/lgmd2i-r9/)
02:53:16	162/162	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:15%20GMT	http://bridgebio.com/adh1/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/adh1/index.html	(from https://bridgebio.com/what-is-adh1/)
02:53:16	30010/30010	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:16%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/6774	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/6774.json	(from https://bridgebio.com/lgmd2i-r9/)
02:53:16	2403/2403	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:16%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Flgmd2i-r9%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed18c5.json	(from https://bridgebio.com/lgmd2i-r9/)
02:53:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:17%20GMT	https://bridgebio.com/?p=6774	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index9b4a.html	(from https://bridgebio.com/lgmd2i-r9/)
02:53:17	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.238.delayed	(from https://bridgebio.com/lgmd2i-r9/)
02:53:17	2588/2588	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:53:17%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Flgmd2i-r9%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed048c	(from https://bridgebio.com/lgmd2i-r9/)
02:53:17	50736/50736	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:53:17%20GMT	https://bridgebio.com/lgmd2i-r9/bbp-418/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/lgmd2i-r9/bbp-418/index.html	(from https://bridgebio.com/lgmd2i-r9/)
02:53:17	238577/238577	---M--	200	added ('OK')	image/jpeg	etag:%2266e85bb5-3c7c2%22	https://bridgebio.com/wp-content/uploads/2024/09/affiliate-bg-green.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/affiliate-bg-green.jpg	(from https://bridgebio.com/lgmd2i-r9/)
02:53:17	24739/24739	---MCZ	200	added ('OK')	image/svg+xml	etag:W/%2266e85bb5-60a3%22	https://bridgebio.com/wp-content/uploads/2024/09/MLBioSolutions_Inline_KO_White.svg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/MLBioSolutions_Inline_KO_White.svg	(from https://bridgebio.com/lgmd2i-r9/)
02:53:18	63456/63456	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:53:18%20GMT	https://bridgebio.com/lgmd2i-r9/patient-resources/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/lgmd2i-r9/patient-resources/index.html	(from https://bridgebio.com/lgmd2i-r9/)
02:53:18	170964/170964	---M--	200	added ('OK')	image/webp	etag:%2266e85bb7-29bd4%22	https://bridgebio.com/wp-content/uploads/2024/09/what-is-hero.webp	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/what-is-hero.webp	(from https://bridgebio.com/lgmd2i-r9/)
02:53:18	91740/91740	---M--	200	added ('OK')	image/webp	etag:%2266e85bb7-1665c%22	https://bridgebio.com/wp-content/uploads/2024/09/what-is-hero-mobile.webp	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/what-is-hero-mobile.webp	(from https://bridgebio.com/lgmd2i-r9/)
02:53:18	116966/116966	---MCZ	200	added ('OK')	image/svg+xml	etag:W/%2266e85bb5-1c8e6%22	https://bridgebio.com/wp-content/uploads/2024/09/affected-muscles-graphic-green.svg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/affected-muscles-graphic-green.svg	(from https://bridgebio.com/lgmd2i-r9/)
02:53:18	124994/124994	---MCZ	200	added ('OK')	image/svg+xml	etag:W/%2266e85bb5-1e842%22	https://bridgebio.com/wp-content/uploads/2024/09/healthy-muscle-tissue-graphic.svg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/healthy-muscle-tissue-graphic.svg	(from https://bridgebio.com/lgmd2i-r9/)
02:53:19	112428/112428	---MCZ	200	added ('OK')	image/svg+xml	etag:W/%2266e85bb5-1b72c%22	https://bridgebio.com/wp-content/uploads/2024/09/muscle-tissue-graphic-right-1.svg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/muscle-tissue-graphic-right-1.svg	(from https://bridgebio.com/lgmd2i-r9/)
02:53:19	451/451	---MCZ	200	added ('OK')	image/svg+xml	etag:W/%2266e85bb7-1c3%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/img/icons/close-button-modal.svg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/img/icons/close-button-modal.svg	(from https://bridgebio.com/lgmd2i-r9/)
02:53:19	162/162	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:19%20GMT	http://bridgebio.com/news/bridgebio-pharma-surpasses-interim-analysis-enrollment-target-and-receives-u-s-fda-rare-pediatric-disease-designation-for-bbp-418-a-potential-treatment-for-limb-girdle-muscular-dystrophy-type-2i-r9/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-surpasses-interim-analysis-enr/index.html	(from https://bridgebio.com/lgmd2i-r9/)
02:53:20	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:19%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/lgmd2i-r9/)
02:53:21	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734514740	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/stylec89c.css	(from https://bridgebio.com/news/7135-2/)
02:53:21	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/7135-2/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/7135-2/feed/index.html	(from https://bridgebio.com/news/7135-2/)
02:53:21	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734514740	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-cssc89c.css	(from https://bridgebio.com/news/7135-2/)
02:53:21	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734514740	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrustc89c.css	(from https://bridgebio.com/news/7135-2/)
02:53:22	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734514740	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptsc89c.js	(from https://bridgebio.com/news/7135-2/)
02:53:22	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734514740	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modalc89c.js	(from https://bridgebio.com/news/7135-2/)
02:53:22	20586/20586	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:22%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/7135	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/7135.json	(from https://bridgebio.com/news/7135-2/)
02:53:23	2890/2890	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:23%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2F7135-2%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7b30.json	(from https://bridgebio.com/news/7135-2/)
02:53:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:23%20GMT	https://bridgebio.com/?p=7135	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index63e1.html	(from https://bridgebio.com/news/7135-2/)
02:53:23	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.24a.delayed	(from https://bridgebio.com/news/7135-2/)
02:53:23	3081/3081	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:53:23%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2F7135-2%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedaabc	(from https://bridgebio.com/news/7135-2/)
02:53:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:23%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/7135-2/)
02:53:24	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:24%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/7135-2/)
02:53:24	28715/28715	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:24%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/7123	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/7123.json	(from https://bridgebio.com/news/attruby-acoramidis-a-near-complete-ttr-stabilizer-%e2%89%a590-approved-by-fda-to-reduce-cardiovascular-death-and-cardiovascular-related-hospitalization-in-attr-cm-patients/)
02:53:25	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/attruby-acoramidis-a-near-complete-ttr-stabilizer-%e2%89%a590-approved-by-fda-to-reduce-cardiovascular-death-and-cardiovascular-related-hospitalization-in-attr-cm-patients/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/attruby-acoramidis-a-near-complete-ttr-stabiliz/feed/index.html	(from https://bridgebio.com/news/attruby-acoramidis-a-near-complete-ttr-stabilizer-%e2%89%a590-approved-by-fda-to-reduce-cardiovascular-death-and-cardiovascular-related-hospitalization-in-attr-cm-patients/)
02:53:25	3415/3415	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:25%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fattruby-acoramidis-a-near-complete-ttr-stabilizer-%25e2%2589%25a590-approved-by-fda-to-reduce-cardiovascular-death-and-cardiovascular-related-hospitalization-in-attr-cm-patients%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf5b1.json	(from https://bridgebio.com/news/attruby-acoramidis-a-near-complete-ttr-stabilizer-%e2%89%a590-approved-by-fda-to-reduce-cardiovascular-death-and-cardiovascular-related-hospitalization-in-attr-cm-patients/)
02:53:25	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:25%20GMT	https://bridgebio.com/?p=7123	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexedb8.html	(from https://bridgebio.com/news/attruby-acoramidis-a-near-complete-ttr-stabilizer-%e2%89%a590-approved-by-fda-to-reduce-cardiovascular-death-and-cardiovascular-related-hospitalization-in-attr-cm-patients/)
02:53:25	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.250.delayed	(from https://bridgebio.com/news/attruby-acoramidis-a-near-complete-ttr-stabilizer-%e2%89%a590-approved-by-fda-to-reduce-cardiovascular-death-and-cardiovascular-related-hospitalization-in-attr-cm-patients/)
02:53:25	3618/3618	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:53:25%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fattruby-acoramidis-a-near-complete-ttr-stabilizer-%25e2%2589%25a590-approved-by-fda-to-reduce-cardiovascular-death-and-cardiovascular-related-hospitalization-in-attr-cm-patients%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedcca7	(from https://bridgebio.com/news/attruby-acoramidis-a-near-complete-ttr-stabilizer-%e2%89%a590-approved-by-fda-to-reduce-cardiovascular-death-and-cardiovascular-related-hospitalization-in-attr-cm-patients/)
02:53:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:26%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/attruby-acoramidis-a-near-complete-ttr-stabilizer-%e2%89%a590-approved-by-fda-to-reduce-cardiovascular-death-and-cardiovascular-related-hospitalization-in-attr-cm-patients/)
02:53:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:26%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/attruby-acoramidis-a-near-complete-ttr-stabilizer-%e2%89%a590-approved-by-fda-to-reduce-cardiovascular-death-and-cardiovascular-related-hospitalization-in-attr-cm-patients/)
02:53:26	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734517620	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style8366.css	(from https://bridgebio.com/news/bridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia/)
02:53:27	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734517620	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css8366.css	(from https://bridgebio.com/news/bridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia/)
02:53:27	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734517620	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust8366.css	(from https://bridgebio.com/news/bridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia/)
02:53:27	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-publication-in-the-n/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia/)
02:53:27	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734517620	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts8366.js	(from https://bridgebio.com/news/bridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia/)
02:53:27	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734517620	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal8366.js	(from https://bridgebio.com/news/bridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia/)
02:53:28	27044/27044	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:28%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/7121	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/7121.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia/)
02:53:28	3341/3341	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:28%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede57e.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia/)
02:53:28	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:28%20GMT	https://bridgebio.com/?p=7121	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexff2f.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia/)
02:53:29	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.25b.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia/)
02:53:29	3531/3531	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:53:29%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed990a	(from https://bridgebio.com/news/bridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia/)
02:53:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:29%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia/)
02:53:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:29%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-publication-in-the-new-england-journal-of-medicine-of-phase-2-propel-2-study-of-infigratinib-for-children-living-with-achondroplasia/)
02:53:30	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734511140	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style73fa.css	(from https://bridgebio.com/news/bridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024/)
02:53:30	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024/feed/index.html	(from https://bridgebio.com/news/bridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024/)
02:53:30	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734511140	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css73fa.css	(from https://bridgebio.com/news/bridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024/)
02:53:30	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734511140	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust73fa.css	(from https://bridgebio.com/news/bridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024/)
02:53:31	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734511140	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts73fa.js	(from https://bridgebio.com/news/bridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024/)
02:53:31	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734511140	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal73fa.js	(from https://bridgebio.com/news/bridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024/)
02:53:31	24810/24810	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:31%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6842	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6842.json	(from https://bridgebio.com/news/bridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024/)
02:53:32	3304/3304	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:32%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0f49.json	(from https://bridgebio.com/news/bridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024/)
02:53:32	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:32%20GMT	https://bridgebio.com/?p=6842	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index5403.html	(from https://bridgebio.com/news/bridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024/)
02:53:32	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.266.delayed	(from https://bridgebio.com/news/bridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024/)
02:53:32	3494/3494	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:53:32%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3336	(from https://bridgebio.com/news/bridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024/)
02:53:33	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:33%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024/)
02:53:33	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:33%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-shares-positive-data-from-high-dose-cohort-of-phase-1-2-canaspire-study-of-gene-therapy-bbp-812-for-canavan-disease-at-esgct-2024/)
02:53:34	18649/18649	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:34%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6826	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6826.json	(from https://bridgebio.com/news/bridgebio-to-present-outcomes-data-through-42-months-from-the-open-label-extension-of-attribute-cm-the-phase-3-study-of-acoramidis-for-treatment-of-attr-cm-at-2024-aha-scientific-sessions/)
02:53:34	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-to-present-outcomes-data-through-42-months-from-the-open-label-extension-of-attribute-cm-the-phase-3-study-of-acoramidis-for-treatment-of-attr-cm-at-2024-aha-scientific-sessions/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-to-present-outcomes-data-through-42-m/feed/index.html	(from https://bridgebio.com/news/bridgebio-to-present-outcomes-data-through-42-months-from-the-open-label-extension-of-attribute-cm-the-phase-3-study-of-acoramidis-for-treatment-of-attr-cm-at-2024-aha-scientific-sessions/)
02:53:34	3517/3517	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:34%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-to-present-outcomes-data-through-42-months-from-the-open-label-extension-of-attribute-cm-the-phase-3-study-of-acoramidis-for-treatment-of-attr-cm-at-2024-aha-scientific-sessions%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8fa7.json	(from https://bridgebio.com/news/bridgebio-to-present-outcomes-data-through-42-months-from-the-open-label-extension-of-attribute-cm-the-phase-3-study-of-acoramidis-for-treatment-of-attr-cm-at-2024-aha-scientific-sessions/)
02:53:34	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:34%20GMT	https://bridgebio.com/?p=6826	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index038e.html	(from https://bridgebio.com/news/bridgebio-to-present-outcomes-data-through-42-months-from-the-open-label-extension-of-attribute-cm-the-phase-3-study-of-acoramidis-for-treatment-of-attr-cm-at-2024-aha-scientific-sessions/)
02:53:35	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.26c.delayed	(from https://bridgebio.com/news/bridgebio-to-present-outcomes-data-through-42-months-from-the-open-label-extension-of-attribute-cm-the-phase-3-study-of-acoramidis-for-treatment-of-attr-cm-at-2024-aha-scientific-sessions/)
02:53:35	3715/3715	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:53:35%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-to-present-outcomes-data-through-42-months-from-the-open-label-extension-of-attribute-cm-the-phase-3-study-of-acoramidis-for-treatment-of-attr-cm-at-2024-aha-scientific-sessions%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed74b9	(from https://bridgebio.com/news/bridgebio-to-present-outcomes-data-through-42-months-from-the-open-label-extension-of-attribute-cm-the-phase-3-study-of-acoramidis-for-treatment-of-attr-cm-at-2024-aha-scientific-sessions/)
02:53:35	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:35%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-to-present-outcomes-data-through-42-months-from-the-open-label-extension-of-attribute-cm-the-phase-3-study-of-acoramidis-for-treatment-of-attr-cm-at-2024-aha-scientific-sessions/)
02:53:35	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:35%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-to-present-outcomes-data-through-42-months-from-the-open-label-extension-of-attribute-cm-the-phase-3-study-of-acoramidis-for-treatment-of-attr-cm-at-2024-aha-scientific-sessions/)
02:53:36	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734515100	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/styleb756.css	(from https://bridgebio.com/news/bridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/)
02:53:36	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/feed/index.html	(from https://bridgebio.com/news/bridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/)
02:53:36	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734515100	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-cssb756.css	(from https://bridgebio.com/news/bridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/)
02:53:36	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734515100	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrustb756.css	(from https://bridgebio.com/news/bridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/)
02:53:37	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734515100	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptsb756.js	(from https://bridgebio.com/news/bridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/)
02:53:37	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734515100	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modalb756.js	(from https://bridgebio.com/news/bridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/)
02:53:37	24306/24306	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:38%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6815	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6815.json	(from https://bridgebio.com/news/bridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/)
02:53:38	3249/3249	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:38%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed173a.json	(from https://bridgebio.com/news/bridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/)
02:53:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:38%20GMT	https://bridgebio.com/?p=6815	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexddbf.html	(from https://bridgebio.com/news/bridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/)
02:53:38	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.277.delayed	(from https://bridgebio.com/news/bridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/)
02:53:38	3435/3435	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:53:38%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0214	(from https://bridgebio.com/news/bridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/)
02:53:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:39%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/)
02:53:39	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:39%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-completes-enrollment-of-fortify-phase-3-registrational-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-r9-lgmd2i-r9/)
02:53:40	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734512760	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/stylefacf.css	(from https://bridgebio.com/news/bridgebio-shares-recurrent-event-analysis-of-attribute-cm-demonstrating-a-42-reduction-by-acoramidis-on-the-composite-endpoint-of-all-cause-mortality-and-recurrent-cardiovascular-related-hospitalizat/)
02:53:40	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-shares-recurrent-event-analysis-of-attribute-cm-demonstrating-a-42-reduction-by-acoramidis-on-the-composite-endpoint-of-all-cause-mortality-and-recurrent-cardiovascular-related-hospitalizat/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-shares-recurrent-event-analysis-of-at/feed/index.html	(from https://bridgebio.com/news/bridgebio-shares-recurrent-event-analysis-of-attribute-cm-demonstrating-a-42-reduction-by-acoramidis-on-the-composite-endpoint-of-all-cause-mortality-and-recurrent-cardiovascular-related-hospitalizat/)
02:53:40	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734512760	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-cssfacf.css	(from https://bridgebio.com/news/bridgebio-shares-recurrent-event-analysis-of-attribute-cm-demonstrating-a-42-reduction-by-acoramidis-on-the-composite-endpoint-of-all-cause-mortality-and-recurrent-cardiovascular-related-hospitalizat/)
02:53:40	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734512760	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrustfacf.css	(from https://bridgebio.com/news/bridgebio-shares-recurrent-event-analysis-of-attribute-cm-demonstrating-a-42-reduction-by-acoramidis-on-the-composite-endpoint-of-all-cause-mortality-and-recurrent-cardiovascular-related-hospitalizat/)
02:53:40	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734512760	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptsfacf.js	(from https://bridgebio.com/news/bridgebio-shares-recurrent-event-analysis-of-attribute-cm-demonstrating-a-42-reduction-by-acoramidis-on-the-composite-endpoint-of-all-cause-mortality-and-recurrent-cardiovascular-related-hospitalizat/)
02:53:41	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734512760	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modalfacf.js	(from https://bridgebio.com/news/bridgebio-shares-recurrent-event-analysis-of-attribute-cm-demonstrating-a-42-reduction-by-acoramidis-on-the-composite-endpoint-of-all-cause-mortality-and-recurrent-cardiovascular-related-hospitalizat/)
02:53:41	24714/24714	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:41%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6819	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6819.json	(from https://bridgebio.com/news/bridgebio-shares-recurrent-event-analysis-of-attribute-cm-demonstrating-a-42-reduction-by-acoramidis-on-the-composite-endpoint-of-all-cause-mortality-and-recurrent-cardiovascular-related-hospitalizat/)
02:53:42	3594/3594	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:42%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-shares-recurrent-event-analysis-of-attribute-cm-demonstrating-a-42-reduction-by-acoramidis-on-the-composite-endpoint-of-all-cause-mortality-and-recurrent-cardiovascular-related-hospitalizat%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd353.json	(from https://bridgebio.com/news/bridgebio-shares-recurrent-event-analysis-of-attribute-cm-demonstrating-a-42-reduction-by-acoramidis-on-the-composite-endpoint-of-all-cause-mortality-and-recurrent-cardiovascular-related-hospitalizat/)
02:53:42	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.282.delayed	(from https://bridgebio.com/news/bridgebio-shares-recurrent-event-analysis-of-attribute-cm-demonstrating-a-42-reduction-by-acoramidis-on-the-composite-endpoint-of-all-cause-mortality-and-recurrent-cardiovascular-related-hospitalizat/)
02:53:42	3785/3785	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:53:42%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-shares-recurrent-event-analysis-of-attribute-cm-demonstrating-a-42-reduction-by-acoramidis-on-the-composite-endpoint-of-all-cause-mortality-and-recurrent-cardiovascular-related-hospitalizat%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8136	(from https://bridgebio.com/news/bridgebio-shares-recurrent-event-analysis-of-attribute-cm-demonstrating-a-42-reduction-by-acoramidis-on-the-composite-endpoint-of-all-cause-mortality-and-recurrent-cardiovascular-related-hospitalizat/)
02:53:42	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:42%20GMT	https://bridgebio.com/?p=6819	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexb5ee.html	(from https://bridgebio.com/news/bridgebio-shares-recurrent-event-analysis-of-attribute-cm-demonstrating-a-42-reduction-by-acoramidis-on-the-composite-endpoint-of-all-cause-mortality-and-recurrent-cardiovascular-related-hospitalizat/)
02:53:42	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:42%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-shares-recurrent-event-analysis-of-attribute-cm-demonstrating-a-42-reduction-by-acoramidis-on-the-composite-endpoint-of-all-cause-mortality-and-recurrent-cardiovascular-related-hospitalizat/)
02:53:43	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:43%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-shares-recurrent-event-analysis-of-attribute-cm-demonstrating-a-42-reduction-by-acoramidis-on-the-composite-endpoint-of-all-cause-mortality-and-recurrent-cardiovascular-related-hospitalizat/)
02:53:44	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734508080	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style2cf5.css	(from https://bridgebio.com/news/bridgebio-announces-infigratinib-is-the-first-ever-investigational-therapeutic-option-for-achondroplasia-to-be-awarded-breakthrough-therapy-designation-by-the-fda/)
02:53:44	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-announces-infigratinib-is-the-first-ever-investigational-therapeutic-option-for-achondroplasia-to-be-awarded-breakthrough-therapy-designation-by-the-fda/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-announces-infigratinib-is-the-first-e/feed/index.html	(from https://bridgebio.com/news/bridgebio-announces-infigratinib-is-the-first-ever-investigational-therapeutic-option-for-achondroplasia-to-be-awarded-breakthrough-therapy-designation-by-the-fda/)
02:53:44	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734508080	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css2cf5.css	(from https://bridgebio.com/news/bridgebio-announces-infigratinib-is-the-first-ever-investigational-therapeutic-option-for-achondroplasia-to-be-awarded-breakthrough-therapy-designation-by-the-fda/)
02:53:44	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734508080	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust2cf5.css	(from https://bridgebio.com/news/bridgebio-announces-infigratinib-is-the-first-ever-investigational-therapeutic-option-for-achondroplasia-to-be-awarded-breakthrough-therapy-designation-by-the-fda/)
02:53:44	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734508080	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts2cf5.js	(from https://bridgebio.com/news/bridgebio-announces-infigratinib-is-the-first-ever-investigational-therapeutic-option-for-achondroplasia-to-be-awarded-breakthrough-therapy-designation-by-the-fda/)
02:53:45	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734508080	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal2cf5.js	(from https://bridgebio.com/news/bridgebio-announces-infigratinib-is-the-first-ever-investigational-therapeutic-option-for-achondroplasia-to-be-awarded-breakthrough-therapy-designation-by-the-fda/)
02:53:45	24304/24304	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:45%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6801	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6801.json	(from https://bridgebio.com/news/bridgebio-announces-infigratinib-is-the-first-ever-investigational-therapeutic-option-for-achondroplasia-to-be-awarded-breakthrough-therapy-designation-by-the-fda/)
02:53:45	3421/3421	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:46%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-announces-infigratinib-is-the-first-ever-investigational-therapeutic-option-for-achondroplasia-to-be-awarded-breakthrough-therapy-designation-by-the-fda%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed08d4.json	(from https://bridgebio.com/news/bridgebio-announces-infigratinib-is-the-first-ever-investigational-therapeutic-option-for-achondroplasia-to-be-awarded-breakthrough-therapy-designation-by-the-fda/)
02:53:46	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:46%20GMT	https://bridgebio.com/?p=6801	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexf461.html	(from https://bridgebio.com/news/bridgebio-announces-infigratinib-is-the-first-ever-investigational-therapeutic-option-for-achondroplasia-to-be-awarded-breakthrough-therapy-designation-by-the-fda/)
02:53:46	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.28d.delayed	(from https://bridgebio.com/news/bridgebio-announces-infigratinib-is-the-first-ever-investigational-therapeutic-option-for-achondroplasia-to-be-awarded-breakthrough-therapy-designation-by-the-fda/)
02:53:46	3614/3614	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:53:46%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-announces-infigratinib-is-the-first-ever-investigational-therapeutic-option-for-achondroplasia-to-be-awarded-breakthrough-therapy-designation-by-the-fda%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9095	(from https://bridgebio.com/news/bridgebio-announces-infigratinib-is-the-first-ever-investigational-therapeutic-option-for-achondroplasia-to-be-awarded-breakthrough-therapy-designation-by-the-fda/)
02:53:46	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:46%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-announces-infigratinib-is-the-first-ever-investigational-therapeutic-option-for-achondroplasia-to-be-awarded-breakthrough-therapy-designation-by-the-fda/)
02:53:47	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:47%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-announces-infigratinib-is-the-first-ever-investigational-therapeutic-option-for-achondroplasia-to-be-awarded-breakthrough-therapy-designation-by-the-fda/)
02:53:47	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734512040	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style3c4d.css	(from https://bridgebio.com/news/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program/)
02:53:48	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program/feed/index.html	(from https://bridgebio.com/news/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program/)
02:53:48	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734512040	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css3c4d.css	(from https://bridgebio.com/news/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program/)
02:53:48	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734512040	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust3c4d.css	(from https://bridgebio.com/news/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program/)
02:53:48	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734512040	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts3c4d.js	(from https://bridgebio.com/news/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program/)
02:53:48	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734512040	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal3c4d.js	(from https://bridgebio.com/news/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program/)
02:53:49	24299/24299	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:49%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6767	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6767.json	(from https://bridgebio.com/news/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program/)
02:53:49	3220/3220	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:49%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd423.json	(from https://bridgebio.com/news/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program/)
02:53:50	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:50%20GMT	https://bridgebio.com/?p=6767	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexd287.html	(from https://bridgebio.com/news/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program/)
02:53:50	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.298.delayed	(from https://bridgebio.com/news/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program/)
02:53:50	3416/3416	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:53:50%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3393	(from https://bridgebio.com/news/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program/)
02:53:50	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:50%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program/)
02:53:50	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:51%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-receives-fdas-regenerative-medicine-advanced-therapy-rmat-designation-for-bbp-812-canavan-disease-gene-therapy-program/)
02:53:51	24324/24324	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:51%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6766	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6766.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-topline-results-from-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/)
02:53:51	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-topline-results-from-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-topline-results-from-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-topline-results-from-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/)
02:53:52	3205/3205	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:52%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-topline-results-from-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf296.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-topline-results-from-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/)
02:53:52	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:52%20GMT	https://bridgebio.com/?p=6766	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexab01.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-topline-results-from-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/)
02:53:52	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.29e.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-topline-results-from-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/)
02:53:52	3394/3394	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:53:52%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-topline-results-from-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed74c1	(from https://bridgebio.com/news/bridgebio-pharma-reports-topline-results-from-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/)
02:53:52	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:53%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-topline-results-from-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/)
02:53:53	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:53%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-topline-results-from-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/)
02:53:53	14132/14132	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:54%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6761	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6761.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-42/)
02:53:54	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-42/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-42/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-42/)
02:53:54	2984/2984	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:54%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-42%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0586.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-42/)
02:53:55	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.2a4.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-42/)
02:53:55	3184/3184	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:53:55%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-42%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7a31	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-42/)
02:53:55	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:54%20GMT	https://bridgebio.com/?p=6761	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index1d95.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-42/)
02:53:55	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:55%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-42/)
02:53:55	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:55%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-42/)
02:53:56	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734511320	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style3779.css	(from https://bridgebio.com/news/bridgebio-shares-data-on-serum-ttr-increase-when-switching-participants-from-placebo-and-tafamidis-to-acoramidis-in-attribute-cm-and-its-open-label-extension/)
02:53:56	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-shares-data-on-serum-ttr-increase-when-switching-participants-from-placebo-and-tafamidis-to-acoramidis-in-attribute-cm-and-its-open-label-extension/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-shares-data-on-serum-ttr-increase-whe/feed/index.html	(from https://bridgebio.com/news/bridgebio-shares-data-on-serum-ttr-increase-when-switching-participants-from-placebo-and-tafamidis-to-acoramidis-in-attribute-cm-and-its-open-label-extension/)
02:53:56	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734511320	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css3779.css	(from https://bridgebio.com/news/bridgebio-shares-data-on-serum-ttr-increase-when-switching-participants-from-placebo-and-tafamidis-to-acoramidis-in-attribute-cm-and-its-open-label-extension/)
02:53:57	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734511320	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust3779.css	(from https://bridgebio.com/news/bridgebio-shares-data-on-serum-ttr-increase-when-switching-participants-from-placebo-and-tafamidis-to-acoramidis-in-attribute-cm-and-its-open-label-extension/)
02:53:57	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734511320	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts3779.js	(from https://bridgebio.com/news/bridgebio-shares-data-on-serum-ttr-increase-when-switching-participants-from-placebo-and-tafamidis-to-acoramidis-in-attribute-cm-and-its-open-label-extension/)
02:53:57	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734511320	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal3779.js	(from https://bridgebio.com/news/bridgebio-shares-data-on-serum-ttr-increase-when-switching-participants-from-placebo-and-tafamidis-to-acoramidis-in-attribute-cm-and-its-open-label-extension/)
02:53:58	25392/25392	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:58%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6753	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6753.json	(from https://bridgebio.com/news/bridgebio-shares-data-on-serum-ttr-increase-when-switching-participants-from-placebo-and-tafamidis-to-acoramidis-in-attribute-cm-and-its-open-label-extension/)
02:53:58	3283/3283	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:53:58%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-shares-data-on-serum-ttr-increase-when-switching-participants-from-placebo-and-tafamidis-to-acoramidis-in-attribute-cm-and-its-open-label-extension%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0085.json	(from https://bridgebio.com/news/bridgebio-shares-data-on-serum-ttr-increase-when-switching-participants-from-placebo-and-tafamidis-to-acoramidis-in-attribute-cm-and-its-open-label-extension/)
02:53:58	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:59%20GMT	https://bridgebio.com/?p=6753	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index6bb9.html	(from https://bridgebio.com/news/bridgebio-shares-data-on-serum-ttr-increase-when-switching-participants-from-placebo-and-tafamidis-to-acoramidis-in-attribute-cm-and-its-open-label-extension/)
02:53:59	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.2af.delayed	(from https://bridgebio.com/news/bridgebio-shares-data-on-serum-ttr-increase-when-switching-participants-from-placebo-and-tafamidis-to-acoramidis-in-attribute-cm-and-its-open-label-extension/)
02:53:59	3471/3471	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:53:59%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-shares-data-on-serum-ttr-increase-when-switching-participants-from-placebo-and-tafamidis-to-acoramidis-in-attribute-cm-and-its-open-label-extension%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5245	(from https://bridgebio.com/news/bridgebio-shares-data-on-serum-ttr-increase-when-switching-participants-from-placebo-and-tafamidis-to-acoramidis-in-attribute-cm-and-its-open-label-extension/)
02:53:59	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:53:59%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-shares-data-on-serum-ttr-increase-when-switching-participants-from-placebo-and-tafamidis-to-acoramidis-in-attribute-cm-and-its-open-label-extension/)
02:54:00	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:00%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-shares-data-on-serum-ttr-increase-when-switching-participants-from-placebo-and-tafamidis-to-acoramidis-in-attribute-cm-and-its-open-label-extension/)
02:54:00	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734514920	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/styleaaa1.css	(from https://bridgebio.com/news/bridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual/)
02:54:01	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-to-present-additional-analyses-from-t/feed/index.html	(from https://bridgebio.com/news/bridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual/)
02:54:01	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734514920	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-cssaaa1.css	(from https://bridgebio.com/news/bridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual/)
02:54:01	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734514920	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrustaaa1.css	(from https://bridgebio.com/news/bridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual/)
02:54:01	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734514920	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptsaaa1.js	(from https://bridgebio.com/news/bridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual/)
02:54:01	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734514920	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modalaaa1.js	(from https://bridgebio.com/news/bridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual/)
02:54:02	18043/18043	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:54:02%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6751	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6751.json	(from https://bridgebio.com/news/bridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual/)
02:54:02	3616/3616	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:54:02%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7127.json	(from https://bridgebio.com/news/bridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual/)
02:54:02	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:02%20GMT	https://bridgebio.com/?p=6751	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexfa05.html	(from https://bridgebio.com/news/bridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual/)
02:54:03	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.2ba.delayed	(from https://bridgebio.com/news/bridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual/)
02:54:03	3814/3814	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:54:03%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd1b9	(from https://bridgebio.com/news/bridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual/)
02:54:03	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:03%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual/)
02:54:03	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:03%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-to-present-additional-analyses-from-the-phase-3-attribute-cm-trial-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-esc-congress-2024-and-the-hfsa-annual/)
02:54:04	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734512580	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style322a.css	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events-2/)
02:54:04	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events-2/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events-2/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events-2/)
02:54:04	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734512580	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css322a.css	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events-2/)
02:54:04	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734512580	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust322a.css	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events-2/)
02:54:05	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734512580	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts322a.js	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events-2/)
02:54:05	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734512580	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal322a.js	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events-2/)
02:54:05	13908/13908	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:54:06%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6749	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6749.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events-2/)
02:54:06	2906/2906	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:54:06%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-september-investor-events-2%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedaf8b.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events-2/)
02:54:06	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:06%20GMT	https://bridgebio.com/?p=6749	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index64d8.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events-2/)
02:54:06	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.2c5.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events-2/)
02:54:06	3096/3096	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:54:06%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-september-investor-events-2%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed6067	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events-2/)
02:54:07	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:07%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events-2/)
02:54:07	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:07%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events-2/)
02:54:08	24434/24434	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:54:08%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6739	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6739.json	(from https://bridgebio.com/news/bridgebio-partners-with-leading-cardiovascular-data-science-lab-cards-lab-to-improve-transthyretin-amyloid-cardiomyopathy-attr-cm-diagnosis-in-diverse-patient-populations-with-multimodal-artificia/)
02:54:08	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-partners-with-leading-cardiovascular-data-science-lab-cards-lab-to-improve-transthyretin-amyloid-cardiomyopathy-attr-cm-diagnosis-in-diverse-patient-populations-with-multimodal-artificia/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-partners-with-leading-cardiovascular-/feed/index.html	(from https://bridgebio.com/news/bridgebio-partners-with-leading-cardiovascular-data-science-lab-cards-lab-to-improve-transthyretin-amyloid-cardiomyopathy-attr-cm-diagnosis-in-diverse-patient-populations-with-multimodal-artificia/)
02:54:08	3605/3605	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:54:08%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-partners-with-leading-cardiovascular-data-science-lab-cards-lab-to-improve-transthyretin-amyloid-cardiomyopathy-attr-cm-diagnosis-in-diverse-patient-populations-with-multimodal-artificia%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1d22.json	(from https://bridgebio.com/news/bridgebio-partners-with-leading-cardiovascular-data-science-lab-cards-lab-to-improve-transthyretin-amyloid-cardiomyopathy-attr-cm-diagnosis-in-diverse-patient-populations-with-multimodal-artificia/)
02:54:08	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:08%20GMT	https://bridgebio.com/?p=6739	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index4f52.html	(from https://bridgebio.com/news/bridgebio-partners-with-leading-cardiovascular-data-science-lab-cards-lab-to-improve-transthyretin-amyloid-cardiomyopathy-attr-cm-diagnosis-in-diverse-patient-populations-with-multimodal-artificia/)
02:54:08	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.2cb.delayed	(from https://bridgebio.com/news/bridgebio-partners-with-leading-cardiovascular-data-science-lab-cards-lab-to-improve-transthyretin-amyloid-cardiomyopathy-attr-cm-diagnosis-in-diverse-patient-populations-with-multimodal-artificia/)
02:54:09	3796/3796	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:54:09%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-partners-with-leading-cardiovascular-data-science-lab-cards-lab-to-improve-transthyretin-amyloid-cardiomyopathy-attr-cm-diagnosis-in-diverse-patient-populations-with-multimodal-artificia%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed523c	(from https://bridgebio.com/news/bridgebio-partners-with-leading-cardiovascular-data-science-lab-cards-lab-to-improve-transthyretin-amyloid-cardiomyopathy-attr-cm-diagnosis-in-diverse-patient-populations-with-multimodal-artificia/)
02:54:09	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:09%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-partners-with-leading-cardiovascular-data-science-lab-cards-lab-to-improve-transthyretin-amyloid-cardiomyopathy-attr-cm-diagnosis-in-diverse-patient-populations-with-multimodal-artificia/)
02:54:09	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:09%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-partners-with-leading-cardiovascular-data-science-lab-cards-lab-to-improve-transthyretin-amyloid-cardiomyopathy-attr-cm-diagnosis-in-diverse-patient-populations-with-multimodal-artificia/)
02:54:10	21626/21626	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:54:10%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6730	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6730.json	(from https://bridgebio.com/news/bridgebio-launches-myachonjourney-a-new-resource-for-families-navigating-achondroplasia/)
02:54:10	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-launches-myachonjourney-a-new-resource-for-families-navigating-achondroplasia/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-launches-myachonjourney-a-new-resource-for-families-navigating-achondroplasia/feed/index.html	(from https://bridgebio.com/news/bridgebio-launches-myachonjourney-a-new-resource-for-families-navigating-achondroplasia/)
02:54:10	3034/3034	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:54:10%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-launches-myachonjourney-a-new-resource-for-families-navigating-achondroplasia%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5817.json	(from https://bridgebio.com/news/bridgebio-launches-myachonjourney-a-new-resource-for-families-navigating-achondroplasia/)
02:54:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:11%20GMT	https://bridgebio.com/?p=6730	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index37fa.html	(from https://bridgebio.com/news/bridgebio-launches-myachonjourney-a-new-resource-for-families-navigating-achondroplasia/)
02:54:11	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.2d1.delayed	(from https://bridgebio.com/news/bridgebio-launches-myachonjourney-a-new-resource-for-families-navigating-achondroplasia/)
02:54:11	3224/3224	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:54:11%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-launches-myachonjourney-a-new-resource-for-families-navigating-achondroplasia%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed6563	(from https://bridgebio.com/news/bridgebio-launches-myachonjourney-a-new-resource-for-families-navigating-achondroplasia/)
02:54:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:11%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-launches-myachonjourney-a-new-resource-for-families-navigating-achondroplasia/)
02:54:12	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:12%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-launches-myachonjourney-a-new-resource-for-families-navigating-achondroplasia/)
02:54:12	13981/13981	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:54:12%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6711	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6711.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-41/)
02:54:13	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-41/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-41/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-41/)
02:54:13	2979/2979	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:54:13%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-41%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1e9f.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-41/)
02:54:13	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:13%20GMT	https://bridgebio.com/?p=6711	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index8350.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-41/)
02:54:13	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.2d7.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-41/)
02:54:13	3179/3179	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:54:13%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-41%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed499f	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-41/)
02:54:14	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:14%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-41/)
02:54:14	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:14%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-41/)
02:54:17	41313/41313	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:54:16%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6672	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6672.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update/)
02:54:18	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update/)
02:54:19	2941/2941	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:54:17%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0e08.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update/)
02:54:19	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.2de.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update/)
02:54:19	3097/3097	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:54:18%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed50a1	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update/)
02:54:22	130040/130040	---M--	200	added ('OK')	image/jpeg	etag:%2266aad8aa-3069e%22	http://bridgebio.com/wp-content/uploads/2024/08/Program-tables.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/08/Program-tables.jpg	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update/)
02:54:23	163980/163980	---M--	200	added ('OK')	image/jpeg	etag:%2266aad359-4158c%22	https://bridgebio.com/wp-content/uploads/2024/08/Q224-Earnings-Release-Financial-Tables_F_Page_2.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/08/Q224-Earnings-Release-Financial-Tables_F_Page_2.jpg	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update/)
02:54:23	217500/217500	---M--	200	added ('OK')	image/jpeg	etag:%2266aad35f-4f6f8%22	https://bridgebio.com/wp-content/uploads/2024/08/Q224-Earnings-Release-Financial-Tables_F_Page_1.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/08/Q224-Earnings-Release-Financial-Tables_F_Page_1.jpg	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update/)
02:54:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:18%20GMT	https://bridgebio.com/?p=6672	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index37c9.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update/)
02:54:24	287267/287267	---M--	200	added ('OK')	image/jpeg	etag:%2266aad35c-61ba9%22	https://bridgebio.com/wp-content/uploads/2024/08/Q224-Earnings-Release-Financial-Tables_F_Page_3.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/08/Q224-Earnings-Release-Financial-Tables_F_Page_3.jpg	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update/)
02:54:24	95240/95240	---M--	200	added ('OK')	image/jpeg	etag:%2266aad356-2f063%22	https://bridgebio.com/wp-content/uploads/2024/08/Q224-Earnings-Release-Financial-Tables_F_Page_4.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/08/Q224-Earnings-Release-Financial-Tables_F_Page_4.jpg	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update/)
02:54:24	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:24%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update/)
02:54:24	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:24%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2024-financial-results-and-business-update/)
02:54:25	15492/15492	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:54:25%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6639	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6639.json	(from https://bridgebio.com/news/bridgebio-announces-appointment-of-thomas-trimarchi-ph-d-as-president-and-chief-operating-officer/)
02:54:25	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-announces-appointment-of-thomas-trimarchi-ph-d-as-president-and-chief-operating-officer/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-announces-appointment-of-thomas-trimarchi-ph-d-as-president-and-chief-operating-officer/feed/index.html	(from https://bridgebio.com/news/bridgebio-announces-appointment-of-thomas-trimarchi-ph-d-as-president-and-chief-operating-officer/)
02:54:25	3100/3100	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:54:25%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-announces-appointment-of-thomas-trimarchi-ph-d-as-president-and-chief-operating-officer%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed00ca.json	(from https://bridgebio.com/news/bridgebio-announces-appointment-of-thomas-trimarchi-ph-d-as-president-and-chief-operating-officer/)
02:54:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:26%20GMT	https://bridgebio.com/?p=6639	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index4261.html	(from https://bridgebio.com/news/bridgebio-announces-appointment-of-thomas-trimarchi-ph-d-as-president-and-chief-operating-officer/)
02:54:26	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.2e8.delayed	(from https://bridgebio.com/news/bridgebio-announces-appointment-of-thomas-trimarchi-ph-d-as-president-and-chief-operating-officer/)
02:54:26	3298/3298	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:54:26%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-announces-appointment-of-thomas-trimarchi-ph-d-as-president-and-chief-operating-officer%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed71cc	(from https://bridgebio.com/news/bridgebio-announces-appointment-of-thomas-trimarchi-ph-d-as-president-and-chief-operating-officer/)
02:54:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:26%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-announces-appointment-of-thomas-trimarchi-ph-d-as-president-and-chief-operating-officer/)
02:54:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:27%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-announces-appointment-of-thomas-trimarchi-ph-d-as-president-and-chief-operating-officer/)
02:54:27	13955/13955	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:54:27%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6615	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6615.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-40/)
02:54:27	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-40/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-40/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-40/)
02:54:27	2977/2977	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:54:28%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-40%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8be9.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-40/)
02:54:28	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:28%20GMT	https://bridgebio.com/?p=6615	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexa4f2.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-40/)
02:54:28	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.2ee.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-40/)
02:54:28	3177/3177	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:54:28%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-40%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed40a2	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-40/)
02:54:28	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:28%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-40/)
02:54:28	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:29%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-40/)
02:54:29	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.2f1.delayed	(from https://bridgebio.com/news/page/2/)
02:54:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:29%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/page/2/)
02:54:29	41457/41457	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:29%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-39/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-39/index.html	(from https://bridgebio.com/news/page/2/)
02:54:30	42951/42951	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:30%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference/index.html	(from https://bridgebio.com/news/page/2/)
02:54:30	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734518700	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/styleaf1d.css	(from https://bridgebio.com/news/page/3/)
02:54:30	60676/60676	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:30%20GMT	https://bridgebio.com/news/bridgebio-announces-durable-month-12-and-18-phase-2-cohort-5-results-of-oral-infigratinib-in-achondroplasia-and-first-participant-consented-in-accel-for-hypochondroplasia/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-announces-durable-month-12-and-18-pha/index.html	(from https://bridgebio.com/news/page/2/)
02:54:30	42071/42071	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:30%20GMT	https://bridgebio.com/news/achondroplasia-investor-call/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/achondroplasia-investor-call/index.html	(from https://bridgebio.com/news/page/2/)
02:54:30	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734518700	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-cssaf1d.css	(from https://bridgebio.com/news/page/3/)
02:54:30	56832/56832	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:30%20GMT	https://bridgebio.com/news/additional-data-showing-acoramidis-increases-serum-transthyretin-which-is-associated-with-improved-cardiovascular-outcomes-presented-at-isa-from-bridgebio-pharmas-phase-3-attribute-cm-study-i/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/additional-data-showing-acoramidis-increases-se/index.html	(from https://bridgebio.com/news/page/2/)
02:54:30	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734518700	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrustaf1d.css	(from https://bridgebio.com/news/page/3/)
02:54:31	56452/56452	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:31%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-present-additional-analyses-from-the-phase-3-attribute-cm-study-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-2024-isa-meeting/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-present-additional-analyses/index.html	(from https://bridgebio.com/news/page/2/)
02:54:31	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734518700	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptsaf1d.js	(from https://bridgebio.com/news/page/3/)
02:54:31	41752/41752	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:31%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-38/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-38/index.html	(from https://bridgebio.com/news/page/2/)
02:54:32	41583/41583	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:31%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024/index.html	(from https://bridgebio.com/news/page/2/)
02:54:32	55002/55002	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:32%20GMT	https://bridgebio.com/news/bridgebio-pharma-presents-additional-data-and-analyses-from-its-phase-3-attribute-cm-study-in-transthyretin-amyloid-cardiomyopathy-attr-cm-at-esc-hf-including-that-acoramidis-treatment-significantl/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-presents-additional-data-and-a/index.html	(from https://bridgebio.com/news/page/2/)
02:54:32	50772/50772	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:32%20GMT	https://bridgebio.com/news/bridgebio-launches-bridgebio-oncology-therapeutics-bbot-with-200m-of-private-external-capital-to-accelerate-the-development-of-its-novel-precision-oncology-pipeline/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-launches-bridgebio-oncology-therapeut/index.html	(from https://bridgebio.com/news/page/2/)
02:54:32	59507/59507	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:32%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/index.html	(from https://bridgebio.com/news/page/2/)
02:54:33	41732/41732	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:32%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37/index.html	(from https://bridgebio.com/news/page/2/)
02:54:33	52836/52836	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:33%20GMT	https://bridgebio.com/news/bridgebio-pharma-presents-cardiac-magnetic-resonance-cmr-imaging-evidence-consistent-with-clinical-improvement-observed-in-the-attribute-cm-phase-3-study-in-patients-with-transthyretin-amyloid-cardi/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-presents-cardiac-magnetic-reso/index.html	(from https://bridgebio.com/news/page/2/)
02:54:33	45094/45094	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:33%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock-2/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock-2/index.html	(from https://bridgebio.com/news/page/2/)
02:54:33	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734518700	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modalaf1d.js	(from https://bridgebio.com/news/page/3/)
02:54:33	45242/45242	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:33%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock-2/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock-2/index.html	(from https://bridgebio.com/news/page/2/)
02:54:33	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.2f8.delayed	(from https://bridgebio.com/news/page/3/)
02:54:33	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:33%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36/index.html	(from https://bridgebio.com/news/page/2/)
02:54:34	49918/49918	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:34%20GMT	https://bridgebio.com/news/bridgebio-pharma-and-bayer-announce-european-licensing-agreement-for-acoramidis-in-attr-cm/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-bayer-announce-european-licensing-agreement-for-acoramidis-in-attr-cm/index.html	(from https://bridgebio.com/news/page/2/)
02:54:34	64497/64497	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:34%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/index.html	(from https://bridgebio.com/news/page/2/)
02:54:34	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:34%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/page/3/)
02:54:35	53651/53651	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:34%20GMT	https://bridgebio.com/news/bridgebio-pharma-and-kyowa-kirin-announce-partnership-with-an-upfront-payment-of-100-million-for-an-exclusive-license-on-infigratinib-in-skeletal-dysplasias-in-japan/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-kyowa-kirin-announce-partn/index.html	(from https://bridgebio.com/news/page/2/)
02:54:35	41744/41744	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:35%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-35/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-35/index.html	(from https://bridgebio.com/news/page/3/)
02:54:35	50764/50764	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:35%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-u-s-food-and-drug-administration-fda-acceptance-of-new-drug-application-nda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-attr/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-u-s-food-and-drug-ad/index.html	(from https://bridgebio.com/news/page/3/)
02:54:35	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734516720	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style5b88.css	(from https://bridgebio.com/news/page/4/)
02:54:35	48843/48843	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:35%20GMT	https://bridgebio.com/news/bridgebio-pharma-shares-positive-results-of-single-arm-phase-3-study-of-acoramidis-in-japanese-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-including-no-mortality-reported-in-the-trial/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-shares-positive-results-of-sin/index.html	(from https://bridgebio.com/news/page/3/)
02:54:36	52897/52897	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:36%20GMT	https://bridgebio.com/news/bridgebio-pharma-secures-up-to-1-25-billion-of-capital-from-blue-owl-and-cpp-investments-to-accelerate-the-development-and-launch-of-genetic-medicines/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-secures-up-to-1-25-billion-of-/index.html	(from https://bridgebio.com/news/page/3/)
02:54:36	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734516720	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css5b88.css	(from https://bridgebio.com/news/page/4/)
02:54:36	51162/51162	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:36%20GMT	https://bridgebio.com/news/nejm-pr-post/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/nejm-pr-post/index.html	(from https://bridgebio.com/news/page/3/)
02:54:36	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734516720	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust5b88.css	(from https://bridgebio.com/news/page/4/)
02:54:36	41733/41733	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:36%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-34/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-34/index.html	(from https://bridgebio.com/news/page/3/)
02:54:36	41317/41317	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:36%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference-2/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference-2/index.html	(from https://bridgebio.com/news/page/3/)
02:54:36	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734516720	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts5b88.js	(from https://bridgebio.com/news/page/4/)
02:54:37	48543/48543	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:37%20GMT	https://bridgebio.com/news/bridgebio-announces-fda-clearance-of-ind-application-for-bbo-8520-a-first-in-class-direct-inhibitor-of-krasg12c-on/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-announces-fda-clearance-of-ind-application-for-bbo-8520-a-first-in-class-direct-inhibitor-of-krasg12c-on/index.html	(from https://bridgebio.com/news/page/3/)
02:54:37	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734516720	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal5b88.js	(from https://bridgebio.com/news/page/4/)
02:54:37	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.2ff.delayed	(from https://bridgebio.com/news/page/4/)
02:54:37	52838/52838	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:37%20GMT	https://bridgebio.com/news/bridgebio-announces-first-child-dosed-with-infigratinib-in-propel-3-its-phase-3-clinical-trial-in-children-with-achondroplasia/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-announces-first-child-dosed-with-infigratinib-in-propel-3-its-phase-3-clinical-trial-in-children-with-achondroplasia/index.html	(from https://bridgebio.com/news/page/3/)
02:54:37	41708/41708	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:37%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-33/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-33/index.html	(from https://bridgebio.com/news/page/3/)
02:54:38	50720/50720	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:37%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-submission-of-new-drug-application-nda-to-u-s-food-and-drug-administration-fda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-a/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-submission-of-new-dr/index.html	(from https://bridgebio.com/news/page/3/)
02:54:38	44680/44680	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:38%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-present-additional-data-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-american-heart-association-aha-scientific-sessi/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-present-additional-data-fro/index.html	(from https://bridgebio.com/news/page/3/)
02:54:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:37%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/page/4/)
02:54:39	41720/41720	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:38%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-32/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-32/index.html	(from https://bridgebio.com/news/page/3/)
02:54:40	68892/68892	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:38%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update/index.html	(from https://bridgebio.com/news/page/3/)
02:54:40	42408/42408	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:39%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-31/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-31/index.html	(from https://bridgebio.com/news/page/3/)
02:54:40	52663/52663	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:40%20GMT	https://bridgebio.com/news/bridgebio-pharma-shares-positive-long-term-data-from-an-ongoing-phase-2-study-which-support-the-potential-use-of-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-as-a-surrogate-endpoint-in-limb-g/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-shares-positive-long-term-data/index.html	(from https://bridgebio.com/news/page/3/)
02:54:40	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.301.delayed	(from https://bridgebio.com/news/page/5/)
02:54:40	52832/52832	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:40%20GMT	https://bridgebio.com/news/bridgebio-and-resilience-announce-strategic-multi-year-partnership-to-advance-bbp-631-bbp-812-and-future-gene-therapy-treatments/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-and-resilience-announce-strategic-multi-year-partnership-to-advance-bbp-631-bbp-812-and-future-gene-therapy-treatments/index.html	(from https://bridgebio.com/news/page/3/)
02:54:41	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:38%20GMT	https://bridgebio.com/news/aha-data-placeholder/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/aha-data-placeholder/index.html	(from https://bridgebio.com/news/page/3/)
02:54:41	46024/46024	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:41%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-250-million-private-placement-equity-financing/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-250-million-private-placement-equity-financing/index.html	(from https://bridgebio.com/news/page/3/)
02:54:41	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:41%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/page/5/)
02:54:41	41720/41720	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:41%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-30/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-30/index.html	(from https://bridgebio.com/news/page/4/)
02:54:41	41638/41638	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:41%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-morgan-stanley-21st-annual-global-healthcare-conference/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-the-morgan-stanley-21st-annual-global-healthcare-conference/index.html	(from https://bridgebio.com/news/page/4/)
02:54:42	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734502500	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style396a.css	(from https://bridgebio.com/news/page/6/)
02:54:42	52119/52119	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:41%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-positive-feedback-from-the-u-s-fda-and-eu-ema-on-the-regulatory-path-for-a-pivotal-phase-3-trial-of-infigratinib-in-children-with-achondroplasia/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-positive-feedback-fr/index.html	(from https://bridgebio.com/news/page/4/)
02:54:42	56624/56624	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:42%20GMT	https://bridgebio.com/news/bridgebio-presents-detailed-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-european-society-of-cardiology-congress-2/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-presents-detailed-positive-results-fr/index.html	(from https://bridgebio.com/news/page/4/)
02:54:42	46541/46541	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:42%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-present-detailed-results-from-the-phase-3-attribute-study-in-patients-with-transthyretin-amyloidosis-cardiomyopathy-attr-cm-at-european-society-of-cardiology-esc-congress-2023/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-present-detailed-results-fr/index.html	(from https://bridgebio.com/news/page/4/)
02:54:43	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734502500	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css396a.css	(from https://bridgebio.com/news/page/6/)
02:54:43	41719/41719	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:43%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-29/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-29/index.html	(from https://bridgebio.com/news/page/4/)
02:54:43	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734502500	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust396a.css	(from https://bridgebio.com/news/page/6/)
02:54:43	63824/63824	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:43%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2023-financial-results-and-business-update/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2023-financial-results-and-business-update/index.html	(from https://bridgebio.com/news/page/4/)
02:54:43	54939/54939	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:43%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-opportunity-for-accelerated-approval-pathway-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i-r9-based-on-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-and-announ/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-opportunity-for-acce/index.html	(from https://bridgebio.com/news/page/4/)
02:54:44	41905/41905	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:43%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-28/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-28/index.html	(from https://bridgebio.com/news/page/4/)
02:54:44	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734502500	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts396a.js	(from https://bridgebio.com/news/page/6/)
02:54:44	54505/54505	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:44%20GMT	https://bridgebio.com/news/bridgebio-announces-consistently-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-announces-consistently-positive-resul/index.html	(from https://bridgebio.com/news/page/4/)
02:54:44	42820/42820	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:44%20GMT	https://bridgebio.com/news/bridgebio-to-host-investor-call-to-share-topline-30-month-results-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-on-july-17-2023/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-to-host-investor-call-to-share-toplin/index.html	(from https://bridgebio.com/news/page/4/)
02:54:44	53336/53336	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:44%20GMT	https://bridgebio.com/news/burjeel-holdings-to-launch-rare-disease-research-development-project-nader-in-partnership-with-us-based-bridgebio-pharma/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/burjeel-holdings-to-launch-rare-disease-research-development-project-nader-in-partnership-with-us-based-bridgebio-pharma/index.html	(from https://bridgebio.com/news/page/4/)
02:54:45	51904/51904	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:44%20GMT	https://bridgebio.com/news/bridgebio-pharma-presents-updated-six-month-results-from-its-phase-2-cohort-5-trial-of-infigratinib-in-achondroplasia-at-the-endocrine-society-endo-2023-annual-conference/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-presents-updated-six-month-res/index.html	(from https://bridgebio.com/news/page/4/)
02:54:45	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734502500	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal396a.js	(from https://bridgebio.com/news/page/6/)
02:54:45	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.308.delayed	(from https://bridgebio.com/news/page/6/)
02:54:45	41878/41878	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:45%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-27/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-27/index.html	(from https://bridgebio.com/news/page/4/)
02:54:45	47578/47578	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:45%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-present-updated-six-month-results-from-its-phase-2-cohort-5-study-of-infigratinib-in-achondroplasia-in-a-late-breaker-oral-presentation-at-the-endocrine-society-endo-2023-annual/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-present-updated-six-month-r/index.html	(from https://bridgebio.com/news/page/4/)
02:54:45	50767/50767	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:45%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-present-updated-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-meeting/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-present-updated-data-from-i/index.html	(from https://bridgebio.com/news/page/4/)
02:54:45	55478/55478	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:45%20GMT	https://bridgebio.com/news/bridgebio-pharma-presents-updated-encouraging-clinical-and-biomarker-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-mee/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-presents-updated-encouraging-c/index.html	(from https://bridgebio.com/news/page/4/)
02:54:46	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:46%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/page/6/)
02:54:47	58791/58791	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:46%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2023-financial-results-and-business-update/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2023-financial-results-and-business-update/index.html	(from https://bridgebio.com/news/page/4/)
02:54:48	41876/41876	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:46%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-26/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-26/index.html	(from https://bridgebio.com/news/page/4/)
02:54:48	41400/41400	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:46%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-25/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-25/index.html	(from https://bridgebio.com/news/page/5/)
02:54:48	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.30a.delayed	(from https://bridgebio.com/news/page/7/)
02:54:48	41669/41669	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:46%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference/index.html	(from https://bridgebio.com/news/page/4/)
02:54:48	51208/51208	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:48%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-trial-for-shp2-inhibitor-bbp-398-in-combination-with-bristol-myers-squibbs-opdivo-nivolumab/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-pa/index.html	(from https://bridgebio.com/news/page/5/)
02:54:48	53559/53559	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:48%20GMT	https://bridgebio.com/news/bridgebio-pharma-shares-preliminary-findings-on-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-shares-preliminary-findings-on/index.html	(from https://bridgebio.com/news/page/5/)
02:54:48	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:48%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/page/7/)
02:54:49	50528/50528	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:49%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-present-preliminary-findings-on-its-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-present-preliminary-finding/index.html	(from https://bridgebio.com/news/page/5/)
02:54:49	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734503220	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style4783.css	(from https://bridgebio.com/news/page/8/)
02:54:49	45453/45453	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:49%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock/index.html	(from https://bridgebio.com/news/page/5/)
02:54:50	45000/45000	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:49%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock/index.html	(from https://bridgebio.com/news/page/5/)
02:54:50	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734503220	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css4783.css	(from https://bridgebio.com/news/page/8/)
02:54:50	82043/82043	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:50%20GMT	https://bridgebio.com/news/bridgebio-announces-positive-phase-2-cohort-5-results-of-infigratinib-in-achondroplasia/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-announces-positive-phase-2-cohort-5-results-of-infigratinib-in-achondroplasia/index.html	(from https://bridgebio.com/news/page/5/)
02:54:50	42387/42387	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:50%20GMT	https://bridgebio.com/news/bridgebio-to-host-investor-call-to-discuss-phase-2-cohort-5-data-for-achondroplasia-on-march-6-2023/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-to-host-investor-call-to-discuss-phase-2-cohort-5-data-for-achondroplasia-on-march-6-2023/index.html	(from https://bridgebio.com/news/page/5/)
02:54:51	65043/65043	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:50%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update/index.html	(from https://bridgebio.com/news/page/5/)
02:54:51	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734503220	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust4783.css	(from https://bridgebio.com/news/page/8/)
02:54:51	41411/41411	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:51%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-23/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-23/index.html	(from https://bridgebio.com/news/page/5/)
02:54:51	42354/42354	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:51%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-host-educational-roundtable-with-esteemed-achondroplasia-expert-on-february-16-2023/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-host-educational-roundtable-with-esteemed-achondroplasia-expert-on-february-16-2023/index.html	(from https://bridgebio.com/news/page/5/)
02:54:51	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734503220	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts4783.js	(from https://bridgebio.com/news/page/8/)
02:54:52	41614/41614	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:51%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-february-and-march-investor-events/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-february-and-march-investor-events/index.html	(from https://bridgebio.com/news/page/5/)
02:54:52	41300/41300	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:52%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference/index.html	(from https://bridgebio.com/news/page/5/)
02:54:52	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734503220	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal4783.js	(from https://bridgebio.com/news/page/8/)
02:54:52	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.311.delayed	(from https://bridgebio.com/news/page/8/)
02:54:52	41174/41174	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:52%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-november-investor-events/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-november-investor-events/index.html	(from https://bridgebio.com/news/page/5/)
02:54:53	90865/90865	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:52%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2022-financial-results-and-business-update/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2022-financial-results-and-business-update/index.html	(from https://bridgebio.com/news/page/5/)
02:54:53	54260/54260	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:52%20GMT	https://bridgebio.com/news/bridgebio-pharma-highlights-its-ras-precision-oncology-portfolio-and-shares-compelling-data-from-next-generation-g12c-inhibitor-and-novel-pi3k%ce%b1ras-breaker-mechanism-at-the-fourth-ras-initiative/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-highlights-its-ras-precision-o/index.html	(from https://bridgebio.com/news/page/5/)
02:54:53	51682/51682	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:53%20GMT	https://bridgebio.com/news/bridgebio-pharma-presents-12-month-results-from-phase-2-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-presents-12-month-results-from-phase-2-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/index.html	(from https://bridgebio.com/news/page/5/)
02:54:53	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:52%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/page/8/)
02:54:54	54275/54275	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:53%20GMT	https://bridgebio.com/news/bridgebio-pharma-presents-updated-positive-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-51st-annual-meeting-of-the-child-neurology-society/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-presents-updated-positive-data/index.html	(from https://bridgebio.com/news/page/5/)
02:54:55	53962/53962	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:53%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-2-trial-and-us-fda-fast-track-designation-for-shp2-inhibitor-bbp-398-in-combination-with-amgens-lumakras-sotorasib/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-pa/index-2.html	(from https://bridgebio.com/news/page/5/)
02:54:55	49575/49575	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:54%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-present-new-data-on-its-novel-approaches-to-ras-driven-cancers-at-the-fourth-ras-initiative-symposium/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-present-new-data-on-its-novel-approaches-to-ras-driven-cancers-at-the-fourth-ras-initiative-symposium/index.html	(from https://bridgebio.com/news/page/6/)
02:54:55	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.313.delayed	(from https://bridgebio.com/news/page/9/)
02:54:56	53660/53660	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:54%20GMT	https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-marketing-authorization-in-the-eu-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-marketing-authorization-in-the-eu-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/index.html	(from https://bridgebio.com/news/page/6/)
02:54:56	41817/41817	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:55%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events/index.html	(from https://bridgebio.com/news/page/6/)
02:54:56	50722/50722	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:55%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-trial-of-bbp-671-a-potential-best-in-class-treatment-for-propionic-acidemia-pa-and-methylmalonic-acidemia-mma/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-pati/index.html	(from https://bridgebio.com/news/page/6/)
02:54:56	55415/55415	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:55%20GMT	https://bridgebio.com/news/bridgebio-pharma-sentynl-therapeutics-and-medison-pharma-announce-approval-in-israel-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-sentynl-therapeutics-and-medison-pharma-announce-approval-in-israel-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/index.html	(from https://bridgebio.com/news/page/6/)
02:54:56	72794/72794	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:56%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update/index.html	(from https://bridgebio.com/news/page/6/)
02:54:57	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:54:57%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/page/9/)
02:54:59	51566/51566	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:57%20GMT	https://bridgebio.com/news/5706-2/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/5706-2/index.html	(from https://bridgebio.com/news/page/6/)
02:54:59	52449/52449	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:57%20GMT	https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-positive-chmp-opinion-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-positive-chmp-opinion-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/index.html	(from https://bridgebio.com/news/page/6/)
02:54:59	47061/47061	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:57%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-founding-affiliation-with-bakar-labs-incubator-at-uc-berkeleys-bakar-bioenginuity-hub/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-founding-affiliation-with-bakar-labs-incubator-at-uc-berkeleys-bakar-bioenginuity-hub/index.html	(from https://bridgebio.com/news/page/6/)
02:54:59	46541/46541	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:54:57%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-academic-collaboration-with-baylor-college-of-medicine-to-advance-potential-therapies-to-treat-genetic-diseases/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-academic-collaboration-with-baylor-college-of-medicine-to-advance-potential-therapies-to-treat-genetic-diseases/index.html	(from https://bridgebio.com/news/page/6/)
02:54:59	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.315.delayed	(from https://bridgebio.com/news/page/10/)
02:55:00	52192/52192	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:00%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-early-positive-data-for-bbp-812-its-investigational-aav9-gene-therapy-for-canavan-disease/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-early-positive-data-for-bbp-812-its-investigational-aav9-gene-therapy-for-canavan-disease/index.html	(from https://bridgebio.com/news/page/6/)
02:55:00	51181/51181	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:00%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-1-data-and-phase-2-3-trial-design-for-bbp-711-a-potentially-best-in-class-go-inhibitor-for-primary-hyperoxaluria-type-1-ph1-and-recurrent-kidney-stone-form/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-positive-phase-1-dat/index.html	(from https://bridgebio.com/news/page/6/)
02:55:00	47935/47935	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:00%20GMT	https://bridgebio.com/news/bridgebio-pharma-affiliate-venthera-presents-preliminary-results-from-clinical-trial-of-vt30-bbp-681-for-venous-lymphatic-and-venolymphatic-malformations/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-affiliate-venthera-presents-pr/index.html	(from https://bridgebio.com/news/page/6/)
02:55:00	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:55:00%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/page/10/)
02:55:01	43289/43289	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:01%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-june-investor-events/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-june-investor-events/index.html	(from https://bridgebio.com/news/page/6/)
02:55:01	49935/49935	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:01%20GMT	https://bridgebio.com/news/bridgebio-pharma-presents-positive-phase-1-data-in-healthy-volunteers-advancing-development-of-bbp-671-for-pantothenate-kinase-associated-neurodegeneration-pkan-and-organic-acidemias/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-presents-positive-phase-1-data/index.html	(from https://bridgebio.com/news/page/6/)
02:55:01	52501/52501	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:01%20GMT	https://bridgebio.com/news/bridgebio-pharma-affiliate-phoenix-tissue-repair-announces-positive-results-from-phase-2-trial-of-ptr-01-a-protein-replacement-therapy-for-the-treatment-of-recessive-dystrophic-epidermolysis-bullosa/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-affiliate-phoenix-tissue-repai/index.html	(from https://bridgebio.com/news/page/6/)
02:55:01	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734501960	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style6e1b.css	(from https://bridgebio.com/news/page/11/)
02:55:02	40592/40592	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:02%20GMT	https://bridgebio.com/news/5481-2/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/5481-2/index.html	(from https://bridgebio.com/news/page/6/)
02:55:02	47007/47007	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:02%20GMT	https://bridgebio.com/news/bridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years/index.html	(from https://bridgebio.com/news/page/6/)
02:55:02	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734501960	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css6e1b.css	(from https://bridgebio.com/news/page/11/)
02:55:02	49662/49662	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:02%20GMT	https://bridgebio.com/news/bridgebio-announces-exclusive-license-agreement-with-bristol-myers-squibb-to-develop-and-commercialize-bbp-398-a-potentially-best-in-class-shp2-inhibitor-in-oncology/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-announces-exclusive-license-agreement/index.html	(from https://bridgebio.com/news/page/7/)
02:55:02	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734501960	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust6e1b.css	(from https://bridgebio.com/news/page/11/)
02:55:02	41918/41918	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:02%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference/index.html	(from https://bridgebio.com/news/page/7/)
02:55:02	63317/63317	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:02%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2022-financial-results-and-business-update/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2022-financial-results-and-business-update/index.html	(from https://bridgebio.com/news/page/7/)
02:55:03	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734501960	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts6e1b.js	(from https://bridgebio.com/news/page/11/)
02:55:03	51491/51491	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:03%20GMT	https://bridgebio.com/news/bridgebio-pharma-presents-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-presents-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/index.html	(from https://bridgebio.com/news/page/7/)
02:55:03	48854/48854	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:03%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-present-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-present-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/index.html	(from https://bridgebio.com/news/page/7/)
02:55:03	52799/52799	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:03%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-positive-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/index.html	(from https://bridgebio.com/news/page/7/)
02:55:04	48181/48181	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:04%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-to-host-investor-call-to-discuss-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-to-host-investor-call-to-discuss-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/index.html	(from https://bridgebio.com/news/page/7/)
02:55:04	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734501960	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal6e1b.js	(from https://bridgebio.com/news/page/11/)
02:55:04	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.31c.delayed	(from https://bridgebio.com/news/page/11/)
02:55:04	52744/52744	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:04%20GMT	https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-announce-asset-purchase-agreement-for-bridgebio-pharmas-nulibry-fosdenopterin/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-announce-asset-purchase-agreement-for-bridgebio-pharmas-nulibry-fosdenopterin/index.html	(from https://bridgebio.com/news/page/7/)
02:55:04	60457/60457	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:04%20GMT	https://bridgebio.com/news/helsinn-group-and-bridgebio-pharma-announce-update-to-strategic-collaboration/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/helsinn-group-and-bridgebio-pharma-announce-update-to-strategic-collaboration/index.html	(from https://bridgebio.com/news/page/7/)
02:55:04	52865/52865	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:04%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/index.html	(from https://bridgebio.com/news/page/7/)
02:55:04	63673/63673	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:04%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2021-financial-results-and-business-update/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2021-financial-results-and-business-update/index.html	(from https://bridgebio.com/news/page/7/)
02:55:05	48828/48828	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:04%20GMT	https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-amgen-to-study-bbp-398/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-amgen-to-study-bbp-398/index.html	(from https://bridgebio.com/news/page/7/)
02:55:05	41396/41396	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:05%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-22/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-22/index.html	(from https://bridgebio.com/news/page/7/)
02:55:05	53566/53566	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:05%20GMT	https://bridgebio.com/news/bridgebio-pharma-and-helsinn-group-announce-strategic-collaboration/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-helsinn-group-announce-strategic-collaboration/index.html	(from https://bridgebio.com/news/page/7/)
02:55:05	53839/53839	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:05%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-month-12-topline-results-from-phase-3-attribute-cm-study/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-month-12-topline-results-from-phase-3-attribute-cm-study/index.html	(from https://bridgebio.com/news/page/7/)
02:55:05	49662/49662	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:05%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-secures-up-to-750-million-in-non-dilutive-debt-financing/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-secures-up-to-750-million-in-non-dilutive-debt-financing/index.html	(from https://bridgebio.com/news/page/7/)
02:55:05	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:55:04%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/page/11/)
02:55:07	44342/44342	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:06%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-appoints-pioneering-national-leader-in-genomics-and-workforce-diversity-hannah-valantine-to-its-board-of-directors/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-appoints-pioneering-national-leader-in-genomics-and-workforce-diversity-hannah-valantine-to-its-board-of-directors/index.html	(from https://bridgebio.com/news/page/7/)
02:55:07	63068/63068	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:06%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2021-financial-results-and-business-update/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2021-financial-results-and-business-update/index.html	(from https://bridgebio.com/news/page/7/)
02:55:08	50363/50363	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:06%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-columbia-university-and-mount-sinai-to-develop-potential-therapies-for-genetic-diseases-and-cancers/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-columbia-university-and-mount-sinai-to-develop-potential-therapies-for-genetic-diseases-and-cancers/index.html	(from https://bridgebio.com/news/page/7/)
02:55:08	51512/51512	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:06%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-canavan-disease/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-canavan-disease/index.html	(from https://bridgebio.com/news/page/7/)
02:55:08	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.31e.delayed	(from https://bridgebio.com/news/page/12/)
02:55:09	45160/45160	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:08%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-october-12-2021/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-october-12-2021/index.html	(from https://bridgebio.com/news/page/8/)
02:55:10	59347/59347	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:08%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/index.html	(from https://bridgebio.com/news/page/8/)
02:55:10	52657/52657	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:08%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-first-publication-of-preclinical-data/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-first-publication-of-preclinical-data/index.html	(from https://bridgebio.com/news/page/8/)
02:55:10	56465/56465	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:08%20GMT	https://bridgebio.com/news/helsinn-group-and-bridgebio-pharmas-affiliate-qed-therapeutics-announce-health-canada-conditional-approval-of-truseltiq-infigratinib/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/helsinn-group-and-bridgebio-pharmas-affiliate-qed-therapeutics-announce-health-canada-conditional-approval-of-truseltiq-infigratinib/index.html	(from https://bridgebio.com/news/page/8/)
02:55:10	51095/51095	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:10%20GMT	https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-therapy-for-the-treatment-of-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-therapy-for-the-treatment-of-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/index.html	(from https://bridgebio.com/news/page/8/)
02:55:11	41193/41193	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:10%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-21/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-21/index.html	(from https://bridgebio.com/news/page/8/)
02:55:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:55:11%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/page/12/)
02:55:12	53115/53115	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:11%20GMT	https://bridgebio.com/news/bridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib-in-patients-with-gastric-cancer-and-other-advanced-solid-tumors/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-lianbio-announce-first-pat/index.html	(from https://bridgebio.com/news/page/8/)
02:55:13	46820/46820	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:11%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-appoints-finance-and-pharmaceutical-leaders-fred-hassan-andrea-ellis-and-douglas-dachille-to-its-board-of-directors/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-appoints-finance-and-pharmaceutical-leaders-fred-hassan-andrea-ellis-and-douglas-dachille-to-its-board-of-directors/index.html	(from https://bridgebio.com/news/page/8/)
02:55:13	57459/57459	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:11%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/index.html	(from https://bridgebio.com/news/page/8/)
02:55:13	41192/41192	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:11%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-20/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-20/index.html	(from https://bridgebio.com/news/page/8/)
02:55:13	48542/48542	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:13%20GMT	https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-bristol-myers-squibb-to-study-bbp-398/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-bristol-myers-squibb-to-study-bbp-398/index.html	(from https://bridgebio.com/news/page/8/)
02:55:14	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734505020	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style1178.css	(from https://bridgebio.com/news/page/13/)
02:55:14	41172/41172	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:14%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-19/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-19/index.html	(from https://bridgebio.com/news/page/8/)
02:55:14	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734505020	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css1178.css	(from https://bridgebio.com/news/page/13/)
02:55:14	47630/47630	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:14%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-three-academic-research-institutions/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-three-academic-research-institutions/index.html	(from https://bridgebio.com/news/page/8/)
02:55:15	66137/66137	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:14%20GMT	https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-partner-helsinn-group-announce-fda-approval-of-truseltiq-infigratinib-for-patients-with-cholangiocarcinoma/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-an/index.html	(from https://bridgebio.com/news/page/8/)
02:55:15	41189/41189	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:14%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-18/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-18/index.html	(from https://bridgebio.com/news/page/8/)
02:55:15	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734505020	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust1178.css	(from https://bridgebio.com/news/page/13/)
02:55:15	41090/41090	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:15%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-17/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-17/index.html	(from https://bridgebio.com/news/page/8/)
02:55:15	50810/50810	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:15%20GMT	https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-gene-therapy-for-congenital-adrenal-hyperplasia/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-gene-therapy-for-congenital-adrenal-hyperplasia/index.html	(from https://bridgebio.com/news/page/8/)
02:55:15	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734505020	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts1178.js	(from https://bridgebio.com/news/page/13/)
02:55:16	55392/55392	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:16%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2021-financial-results-and-business-update/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2021-financial-results-and-business-update/index.html	(from https://bridgebio.com/news/page/8/)
02:55:16	47108/47108	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:16%20GMT	https://bridgebio.com/news/bridgebio-pharma-and-the-university-of-california-san-diego-announce-collaboration-to-advance-treatments-for-genetically-driven-conditions/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-the-university-of-california-san-diego-announce-collaboration-to-advance-treatments-for-genetically-driven-conditions/index.html	(from https://bridgebio.com/news/page/9/)
02:55:16	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734505020	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal1178.js	(from https://bridgebio.com/news/page/13/)
02:55:17	46876/46876	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:16%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-and-uc-davis-establish-collaboration-to-transform-research-into-potential-therapies-for-genetically-driven-diseases/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-and-uc-davis-establish-collaboration-to-transform-research-into-potential-therapies-for-genetically-driven-diseases/index.html	(from https://bridgebio.com/news/page/9/)
02:55:17	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.325.delayed	(from https://bridgebio.com/news/page/13/)
02:55:17	47828/47828	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:17%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-and-roswell-park-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-cancers/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-and-roswell-park-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-cancers/index.html	(from https://bridgebio.com/news/page/9/)
02:55:17	47474/47474	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:17%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-and-oregon-health-science-university-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-diseases/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-and-oregon-health-science-/index.html	(from https://bridgebio.com/news/page/9/)
02:55:18	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:55:17%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/page/13/)
02:55:20	47636/47636	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:18%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-and-glyconet-initiate-collaboration-to-discover-potential-treatments-for-genetic-diseases-through-glycomics-research/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-and-glyconet-initiate-collaboration-to-discover-potential-treatments-for-genetic-diseases-through-glycomics-research/index.html	(from https://bridgebio.com/news/page/9/)
02:55:20	47930/47930	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:18%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-and-the-lundquist-institute-collaborate-to-advance-treatments-for-genetically-driven-conditions-and-cancers/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-and-the-lundquist-institute-collaborate-to-advance-treatments-for-genetically-driven-conditions-and-cancers/index.html	(from https://bridgebio.com/news/page/9/)
02:55:20	46918/46918	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:18%20GMT	https://bridgebio.com/news/bridgebio-pharma-and-brown-university-announce-partnership/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-brown-university-announce-partnership/index.html	(from https://bridgebio.com/news/page/9/)
02:55:21	41075/41075	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:18%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-16/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-16/index.html	(from https://bridgebio.com/news/page/9/)
02:55:21	54272/54272	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:20%20GMT	https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-helsinn-group-announce-strategic-collaboration-to-co-develop-and-commercialize-infigratinib-in-oncology/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-an/index-2.html	(from https://bridgebio.com/news/page/9/)
02:55:21	59251/59251	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:21%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-reports-fourth-quarter-and-full-year-2020-financial-results-and-business-update/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-reports-fourth-quarter-and-full-year-2020-financial-results-and-business-update/index.html	(from https://bridgebio.com/news/page/9/)
02:55:21	61881/61881	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:21%20GMT	https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announce-fda-approval-of-nulibry-fosdenopterin/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announce-fda-approval-of-nulibry-fosdenopterin/index.html	(from https://bridgebio.com/news/page/9/)
02:55:22	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734510240	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style66b5.css	(from https://bridgebio.com/news/page/14/)
02:55:22	41028/41028	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:21%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-15/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-15/index.html	(from https://bridgebio.com/news/page/9/)
02:55:22	44671/44671	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:22%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock/index.html	(from https://bridgebio.com/news/page/9/)
02:55:22	49122/49122	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:22%20GMT	https://bridgebio.com/news/bridgebio-pharma-and-affiliate-ml-bio-solutions-announce-dosing-of-first-patient-in-phase-2-trial-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-affiliate-ml-bio-solutions/index.html	(from https://bridgebio.com/news/page/9/)
02:55:22	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734510240	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css66b5.css	(from https://bridgebio.com/news/page/14/)
02:55:23	40875/40875	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:23%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14/index.html	(from https://bridgebio.com/news/page/9/)
02:55:23	44399/44399	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:23%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-announces-launch-of-secondary-offering-of-common-stock/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-announces-launch-of-secondary-offering-of-common-stock/index.html	(from https://bridgebio.com/news/page/9/)
02:55:23	48281/48281	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:23%20GMT	https://bridgebio.com/news/bridgebio-pharma-and-affiliate-venthera-announce-dosing-of-first-patient-in-phase-1-2-clinical-trial-of-bbp-681/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-affiliate-venthera-announce-dosing-of-first-patient-in-phase-1-2-clinical-trial-of-bbp-681/index.html	(from https://bridgebio.com/news/page/9/)
02:55:23	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734510240	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust66b5.css	(from https://bridgebio.com/news/page/14/)
02:55:24	50982/50982	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:24%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc/index.html	(from https://bridgebio.com/news/page/9/)
02:55:24	53617/53617	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:24%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes/index.html	(from https://bridgebio.com/news/page/10/)
02:55:24	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734510240	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts66b5.js	(from https://bridgebio.com/news/page/14/)
02:55:24	52266/52266	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:24%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-400-million-convertible-senior-notes/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-400-million-convertible-senior-notes/index.html	(from https://bridgebio.com/news/page/10/)
02:55:25	52574/52574	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:24%20GMT	https://bridgebio.com/news/stockholders-of-bridgebio-pharma-inc-and-eidos-therapeutics-inc-approve-bridgebio-pharma-inc-acquisition-of-eidos-therapeutics-inc/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/stockholders-of-bridgebio-pharma-inc-and-eidos-therapeutics-inc-approve-bridgebio-pharma-inc-acquisition-of-eidos-therapeutics-inc/index.html	(from https://bridgebio.com/news/page/10/)
02:55:25	55860/55860	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:24%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-and-eidos-therapeutics-inc-announce-january-21-2021-election-deadline-for-merger/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-and-eidos-therapeutics-inc-announce-january-21-2021-election-deadline-for-merger/index.html	(from https://bridgebio.com/news/page/10/)
02:55:25	41406/41406	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:25%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-13/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-13/index.html	(from https://bridgebio.com/news/page/10/)
02:55:25	54511/54511	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:25%20GMT	https://bridgebio.com/news/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/index.html	(from https://bridgebio.com/news/page/10/)
02:55:26	46638/46638	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:26%20GMT	https://bridgebio.com/news/ucsf-and-bridgebio-pharma-collaborate-to-accelerate-the-development-of-therapies-for-genetic-diseases/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/ucsf-and-bridgebio-pharma-collaborate-to-accelerate-the-development-of-therapies-for-genetic-diseases/index.html	(from https://bridgebio.com/news/page/10/)
02:55:26	49632/49632	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:26%20GMT	https://bridgebio.com/news/bridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease/index.html	(from https://bridgebio.com/news/page/10/)
02:55:26	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734510240	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal66b5.js	(from https://bridgebio.com/news/page/14/)
02:55:26	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.32c.delayed	(from https://bridgebio.com/news/page/14/)
02:55:27	41512/41512	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:26%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-12/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-12/index.html	(from https://bridgebio.com/news/page/10/)
02:55:27	47968/47968	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:26%20GMT	https://bridgebio.com/news/bridgebio-pharma-and-affiliate-qed-therapeutics-announce-fda-acceptance-of-new-drug-application-for-infigratinib-for-the-treatment-of-cholangiocarcinoma/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-affiliate-qed-therapeutics/index.html	(from https://bridgebio.com/news/page/10/)
02:55:27	57143/57143	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:27%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2020-financial-results-and-business-update/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2020-financial-results-and-business-update/index.html	(from https://bridgebio.com/news/page/10/)
02:55:27	47937/47937	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:27%20GMT	https://bridgebio.com/news/bridgebio-pharma-and-affiliate-navire-pharma-announce-dosing-of-first-patient-in-phase-1-clinical-trial-of-shp2-inhibitor-bbp-398/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-affiliate-navire-pharma-announce-dosing-of-first-patient-in-phase-1-clinical-trial-of-shp2-inhibitor-bbp-398/index.html	(from https://bridgebio.com/news/page/10/)
02:55:28	41422/41422	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:27%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-11/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-11/index.html	(from https://bridgebio.com/news/page/10/)
02:55:28	49437/49437	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:28%20GMT	https://bridgebio.com/news/bridgebio-pharma-and-affiliate-phoenix-tissue-repair-announce-first-patient-dosing-in-phase-2-trial-of-protein-replacement-therapy/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-affiliate-phoenix-tissue-repair-announce-first-patient-dosing-in-phase-2-trial-of-protein-replacement-therapy/index.html	(from https://bridgebio.com/news/page/10/)
02:55:28	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:55:27%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/page/14/)
02:55:30	48245/48245	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:28%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-and-the-university-of-colorado-anschutz-medical-campus-collaborate-to-advance-medicines-for-genetically-driven-diseases/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-and-the-university-of-colorado-anschutz-medical-campus-collaborate-to-advance-medicines-for-genetically-driven-diseases/index.html	(from https://bridgebio.com/news/page/10/)
02:55:30	47956/47956	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:29%20GMT	https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a-2/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-bioscienc/index.html	(from https://bridgebio.com/news/page/10/)
02:55:30	47517/47517	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:28%20GMT	https://bridgebio.com/news/salk-institute-and-bridgebio-pharma-collaborate-to-advance-therapies-for-genetically-driven-disease/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/salk-institute-and-bridgebio-pharma-collaborate-to-advance-therapies-for-genetically-driven-disease/index.html	(from https://bridgebio.com/news/page/10/)
02:55:31	60493/60493	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:29%20GMT	https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-announce-merger-agreement/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-announce-merger-agreement/index.html	(from https://bridgebio.com/news/page/10/)
02:55:31	47965/47965	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:30%20GMT	https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-bioscienc/index-2.html	(from https://bridgebio.com/news/page/10/)
02:55:31	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734504840	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/stylec41a.css	(from https://bridgebio.com/news/page/15/)
02:55:31	43178/43178	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:31%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020-2/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020-2/index.html	(from https://bridgebio.com/news/page/10/)
02:55:32	43255/43255	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:31%20GMT	https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020/index.html	(from https://bridgebio.com/news/page/11/)
02:55:32	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734504840	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-cssc41a.css	(from https://bridgebio.com/news/page/15/)
02:55:32	48519/48519	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:32%20GMT	https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1/index.html	(from https://bridgebio.com/news/page/11/)
02:55:32	41544/41544	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:32%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10/index.html	(from https://bridgebio.com/news/page/11/)
02:55:32	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734504840	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrustc41a.css	(from https://bridgebio.com/news/page/15/)
02:55:33	41439/41439	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:33%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10-2/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10-2/index.html	(from https://bridgebio.com/news/page/11/)
02:55:33	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734504840	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptsc41a.js	(from https://bridgebio.com/news/page/15/)
02:55:33	41542/41542	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:33%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-9/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-9/index.html	(from https://bridgebio.com/news/page/11/)
02:55:34	57820/57820	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:33%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2020-financial-results-and-business-update/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2020-financial-results-and-business-update/index.html	(from https://bridgebio.com/news/page/11/)
02:55:34	51214/51214	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:33%20GMT	https://bridgebio.com/news/bridgebio-pharma-expands-reach-into-china-and-other-major-asian-markets-through-strategic-collaboration-with-perceptive-advisors-founded-company-lianbio/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-expands-reach-into-china-and-o/index.html	(from https://bridgebio.com/news/page/11/)
02:55:34	50252/50252	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:34%20GMT	https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-pharmas-qed-therapeutics-announce-dosing-of-first-patient-in-investigator-initiated-phase-0-2-clinical-trial-of-infigratinib/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-pharmas-qe/index.html	(from https://bridgebio.com/news/page/11/)
02:55:34	48898/48898	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:34%20GMT	https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-doses-first-child-in-phase-2-clinical-trial-of-the-investigational-medicine-infigratinib-in-achondroplasia/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-doses-first-child-in-phase-2-clinical-trial-of-the-investigational-medicine-infigratinib-in-achondroplasia/index.html	(from https://bridgebio.com/news/page/11/)
02:55:35	46992/46992	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:34%20GMT	https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-to-highlight-interim-phase-1-2-study-data-in-a-presentation-at-the-society-for-pediatric-dermatologys-45th-annual-meeting/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-to-high/index.html	(from https://bridgebio.com/news/page/11/)
02:55:35	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734504840	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modalc41a.js	(from https://bridgebio.com/news/page/15/)
02:55:35	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.333.delayed	(from https://bridgebio.com/news/page/15/)
02:55:35	41513/41513	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:35%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-8/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-8/index.html	(from https://bridgebio.com/news/page/11/)
02:55:35	47985/47985	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:35%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-appoints-biotech-trailblazers-brent-saunders-and-randy-scott-and-renowned-economist-andrew-lo-to-board-of-directors/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-appoints-biotech-trailblazers-brent-saunders-and-randy-scott-and-renowned-economist-andrew-lo-to-board-of-directors/index.html	(from https://bridgebio.com/news/page/11/)
02:55:36	46931/46931	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:35%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-and-university-of-florida-establish-collaboration-to-advance-therapies-for-genetically-driven-diseases/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-and-university-of-florida-establish-collaboration-to-advance-therapies-for-genetically-driven-diseases/index.html	(from https://bridgebio.com/news/page/11/)
02:55:36	46740/46740	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:36%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-enters-into-collaboration-agreement-with-johns-hopkins-university-to-accelerate-development-of-new-medicines-in-genetically-driven-diseases/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-enters-into-collaboration-/index.html	(from https://bridgebio.com/news/page/11/)
02:55:36	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:55:36%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/page/15/)
02:55:37	50999/50999	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:36%20GMT	https://bridgebio.com/news/bridgebio-pharmas-ml-bio-solutions-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-bbp-418-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-ml-bio-solutions-announces-do/index.html	(from https://bridgebio.com/news/page/11/)
02:55:37	41511/41511	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:36%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-7/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-7/index.html	(from https://bridgebio.com/news/page/11/)
02:55:38	48891/48891	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:37%20GMT	https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-presents-data-on-infigratinib-in-cholangiocarcinoma-and-urothelial-carcinoma/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-presents-data-on-infigratinib-in-cholangiocarcinoma-and-urothelial-carcinoma/index.html	(from https://bridgebio.com/news/page/11/)
02:55:38	49957/49957	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:37%20GMT	https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-provides-updates-to-its-recessive-dystrophic-epidermolysis-bullosa-rdeb-program-and-announces-new-leadership-appointments/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-provide/index.html	(from https://bridgebio.com/news/page/11/)
02:55:38	49442/49442	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:38%20GMT	https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-preclinical-data-demonstrating-potential-of-low-dose-infigratinib-in-achondroplasia/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-preclinical-data-demonstrating-potential-of-low-dose-infigratinib-in-achondroplasia/index.html	(from https://bridgebio.com/news/page/12/)
02:55:38	58669/58669	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:38%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2020-financial-results-and-business-update/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2020-financial-results-and-business-update/index.html	(from https://bridgebio.com/news/page/11/)
02:55:38	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734504300	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style8b9e.css	(from https://bridgebio.com/news/page/16/)
02:55:39	40831/40831	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:38%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2/index.html	(from https://bridgebio.com/news/page/12/)
02:55:39	41107/41107	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:39%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6/index.html	(from https://bridgebio.com/news/page/12/)
02:55:39	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734504300	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css8b9e.css	(from https://bridgebio.com/news/page/16/)
02:55:40	49435/49435	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:39%20GMT	https://bridgebio.com/news/a-letter-to-our-shareholders-from-ceo-neil-kumar/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/a-letter-to-our-shareholders-from-ceo-neil-kumar/index.html	(from https://bridgebio.com/news/page/12/)
02:55:40	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734504300	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust8b9e.css	(from https://bridgebio.com/news/page/16/)
02:55:40	41479/41479	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:40%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-5/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-5/index.html	(from https://bridgebio.com/news/page/12/)
02:55:40	40917/40917	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:40%20GMT	https://bridgebio.com/news/an-open-letter-to-patients-and-their-families-from-bridgebio-pharma-ceo-neil-kumar/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/an-open-letter-to-patients-and-their-families-from-bridgebio-pharma-ceo-neil-kumar/index.html	(from https://bridgebio.com/news/page/12/)
02:55:41	48431/48431	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:40%20GMT	https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-dosing-of-first-patients-in-phase-3-and-phase-2-clinical-trials-of-infigratinib/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-dosing-of-first-patients-in-phase-3-and-phase-2-clinical-trials-of-infigratinib/index.html	(from https://bridgebio.com/news/page/12/)
02:55:41	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734504300	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts8b9e.js	(from https://bridgebio.com/news/page/16/)
02:55:41	51761/51761	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:41%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-475-million-convertible-senior-notes/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-475-million-convertible-senior-notes/index.html	(from https://bridgebio.com/news/page/12/)
02:55:41	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734504300	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal8b9e.js	(from https://bridgebio.com/news/page/16/)
02:55:41	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.33a.delayed	(from https://bridgebio.com/news/page/16/)
02:55:41	51110/51110	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:41%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-350-million-convertible-senior-notes/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-350-million-convertible-senior-notes/index.html	(from https://bridgebio.com/news/page/12/)
02:55:42	60150/60150	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:42%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2019-financial-results-and-highlights-portfolio-progress/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2019-financial-results-and-highlights-portfolio-progress/index.html	(from https://bridgebio.com/news/page/12/)
02:55:42	41056/41056	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:42%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-4/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-4/index.html	(from https://bridgebio.com/news/page/12/)
02:55:42	43846/43846	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:42%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-appoints-ronald-j-daniels-to-its-board-of-directors/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-appoints-ronald-j-daniels-to-its-board-of-directors/index.html	(from https://bridgebio.com/news/page/12/)
02:55:43	41742/41742	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:42%20GMT	https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-to-present-at-upcoming-investor-conferences/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-to-present-at-upcoming-investor-conferences/index.html	(from https://bridgebio.com/news/page/12/)
02:55:43	41278/41278	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:42%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-3/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-3/index.html	(from https://bridgebio.com/news/page/12/)
02:55:43	48985/48985	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:43%20GMT	https://bridgebio.com/news/bridgebio-pharmas-gene-therapy-subsidiaries-enter-strategic-partnership-with-catalent-for-dedicated-gene-therapy-development-and-manufacturing-capacity/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-gene-therapy-subsidiaries-ent/index.html	(from https://bridgebio.com/news/page/12/)
02:55:43	50711/50711	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:43%20GMT	https://bridgebio.com/news/pellepharm-initiates-phase-2-clinical-trial-of-patidegib-topical-gel-for-people-with-high-frequency-basal-cell-carcinoma/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/pellepharm-initiates-phase-2-clinical-trial-of-patidegib-topical-gel-for-people-with-high-frequency-basal-cell-carcinoma/index.html	(from https://bridgebio.com/news/page/12/)
02:55:44	50552/50552	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:43%20GMT	https://bridgebio.com/news/bridgebio-pharma-grows-pipeline-to-20-genetic-medicines-with-four-assets-focused-on-treating-genetically-driven-diseases-at-their-source/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-grows-pipeline-to-20-genetic-medicines-with-four-assets-focused-on-treating-genetically-driven-diseases-at-their-source/index.html	(from https://bridgebio.com/news/page/12/)
02:55:44	49922/49922	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:43%20GMT	https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-receives-fast-track-designation-for-infigratinib/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-receives-fast-track-designation-for-infigratinib/index.html	(from https://bridgebio.com/news/page/12/)
02:55:44	49281/49281	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:44%20GMT	https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-enters-partnership-with-medison-to-commercialize-bbp-870-in-israel-for-mocd-type-a/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-origin-biosciences-enters-partnership-with-medison-to-commercialize-bbp-870-in-israel-for-mocd-type-a/index.html	(from https://bridgebio.com/news/page/12/)
02:55:44	41026/41026	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:44%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference/index.html	(from https://bridgebio.com/news/page/12/)
02:55:45	43184/43184	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:44%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-appoints-industry-leader-jennifer-cook-as-new-board-member/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-appoints-industry-leader-jennifer-cook-as-new-board-member/index.html	(from https://bridgebio.com/news/page/13/)
02:55:45	44355/44355	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:44%20GMT	https://bridgebio.com/news/bridgebio-pharma-inc-appoints-eli-wallace-as-chief-scientific-officer-in-residence-for-oncology-programs/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-appoints-eli-wallace-as-chief-scientific-officer-in-residence-for-oncology-programs/index.html	(from https://bridgebio.com/news/page/13/)
02:55:45	40923/40923	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:45%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2/index.html	(from https://bridgebio.com/news/page/13/)
02:55:45	49581/49581	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:45%20GMT	https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-initiates-rolling-submission-of-new-drug-application-with-the-u-s-fda-for-bbp-870-for-the-treatment-of-mocd-type-a/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-origin-biosciences-initiates-/index.html	(from https://bridgebio.com/news/page/13/)
02:55:46	48715/48715	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:45%20GMT	https://bridgebio.com/news/pellepharm-completes-enrollment-of-pivotal-phase-3-clinical-trial-of-patidegib-topical-gel-in-patients-with-gorlin-syndrome/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/pellepharm-completes-enrollment-of-pivotal-phase-3-clinical-trial-of-patidegib-topical-gel-in-patients-with-gorlin-syndrome/index.html	(from https://bridgebio.com/news/page/13/)
02:55:46	51571/51571	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:46%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2019-financial-results-and-highlights-portfolio-progress/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2019-financial-results-and-highlights-portfolio-progress/index.html	(from https://bridgebio.com/news/page/13/)
02:55:46	43261/43261	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:46%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/index.html	(from https://bridgebio.com/news/page/13/)
02:55:47	49231/49231	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:46%20GMT	https://bridgebio.com/news/bridgebio-pharma-gene-therapy-subsidiaries-present-data-demonstrating-potential-in-two-rare-disease-indications/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-gene-therapy-subsidiaries-present-data-demonstrating-potential-in-two-rare-disease-indications/index.html	(from https://bridgebio.com/news/page/13/)
02:55:47	51295/51295	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:46%20GMT	https://bridgebio.com/news/qed-and-parent-company-bridgebio-announce-preclinical-data-supporting-tolerability-and-activity-of-low-dose-infigratinib-in-treating-achondroplasia/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/qed-and-parent-company-bridgebio-announce-preclinical-data-supporting-tolerability-and-activity-of-low-dose-infigratinib-in-treating-achondroplasia/index.html	(from https://bridgebio.com/news/page/13/)
02:55:47	47844/47844	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:47%20GMT	https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-subsidiary-qed-therapeutics-announce-collaboration-to-advance-cancer-research-and-treatment-options/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-subsidiary-qed-therapeutics-announce-collaboration-to-advance-cancer-research-and-treatment-options/index.html	(from https://bridgebio.com/news/page/13/)
02:55:47	43517/43517	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:47%20GMT	https://bridgebio.com/news/bridgebio-pharma-terminates-merger-process-with-its-subsidiary-eidos-therapeutics/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-terminates-merger-process-with-its-subsidiary-eidos-therapeutics/index.html	(from https://bridgebio.com/news/page/13/)
02:55:48	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:55:42%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/page/16/)
02:55:49	52638/52638	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:47%20GMT	https://bridgebio.com/news/alexion-and-bridgebio-announce-japanese-license-agreement-for-eidos-transthyretin-amyloidosis-attr-investigational-medicine/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/alexion-and-bridgebio-announce-japanese-license-agreement-for-eidos-transthyretin-amyloidosis-attr-investigational-medicine/index.html	(from https://bridgebio.com/news/page/13/)
02:55:49	50525/50525	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:48%20GMT	https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-presents-new-data-on-the-natural-history-of-molybdenum-cofactor-deficiency-mocd-type-a/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-origin-biosciences-presents-new-data-on-the-natural-history-of-molybdenum-cofactor-deficiency-mocd-type-a/index.html	(from https://bridgebio.com/news/page/13/)
02:55:50	42741/42741	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:48%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-its-initial-public-offering/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-pricing-of-its-initial-public-offering/index.html	(from https://bridgebio.com/news/page/13/)
02:55:50	47310/47310	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:49%20GMT	https://bridgebio.com/news/bridgebio-pharma-expands-its-research-into-neuromuscular-disease-to-include-limb-girdle-muscular-dystrophy-type-2-lgmd2i-with-new-subsidiary-ml-bio-solutions/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-expands-its-research-into-neur/index.html	(from https://bridgebio.com/news/page/13/)
02:55:50	44278/44278	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:50%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-filing-of-registration-statement-for-proposed-initial-public-offering/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-filing-of-registration-statement-for-proposed-initial-public-offering/index.html	(from https://bridgebio.com/news/page/13/)
02:55:50	9577/9577	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:55:50%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/3419	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/3419.json	(from https://bridgebio.com/news/archive/)
02:55:51	50438/50438	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:50%20GMT	https://bridgebio.com/news/eidos-therapeutics-initiates-attribute-cm-a-phase-3-study-of-ag10-in-attr-cm-with-registrational-12-month-endpoint/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-initiates-attribute-cm-a-phase-3-study-of-ag10-in-attr-cm-with-registrational-12-month-endpoint/index.html	(from https://bridgebio.com/news/page/13/)
02:55:51	47815/47815	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:50%20GMT	https://bridgebio.com/news/phoenix-tissue-repair-doses-first-patient-in-phase-1-2-clinical-trial-of-ptr-01-bbp-589-for-treatment-of-recessive-dystrophic-epidermolysis-bullosa-rdeb/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/phoenix-tissue-repair-doses-first-patient-in-ph/index.html	(from https://bridgebio.com/news/page/13/)
02:55:51	44895/44895	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:51%20GMT	https://bridgebio.com/news/bridgebio-pharma-closes-299-2-million-financing-round-to-support-its-efforts-to-target-genetic-disease-at-the-source/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-closes-299-2-million-financing-round-to-support-its-efforts-to-target-genetic-disease-at-the-source/index.html	(from https://bridgebio.com/news/page/13/)
02:55:53	41244/41244	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:51%20GMT	https://bridgebio.com/news/qed-therapeutics-announces-a-collaboration-with-foundation-medicine-to-develop-companion-diagnostics-for-infigratinib/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/qed-therapeutics-announces-a-collaboration-with-foundation-medicine-to-develop-companion-diagnostics-for-infigratinib/index.html	(from https://bridgebio.com/news/page/14/)
02:55:53	2254/2254	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:55:51%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Farchive%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb50b.json	(from https://bridgebio.com/news/archive/)
02:55:53	49506/49506	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:52%20GMT	https://bridgebio.com/news/eidos-therapeutics-appoints-william-lis-to-board-of-directors/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-appoints-william-lis-to-board-of-directors/index.html	(from https://bridgebio.com/news/page/14/)
02:55:53	49926/49926	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:52%20GMT	https://bridgebio.com/news/leo-pharma-and-pellepharm-announce-760-million-collaboration-to-advance-innovative-therapies-for-rare-skin-diseases/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/leo-pharma-and-pellepharm-announce-760-million-collaboration-to-advance-innovative-therapies-for-rare-skin-diseases/index.html	(from https://bridgebio.com/news/page/14/)
02:55:54	50640/50640	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:53%20GMT	https://bridgebio.com/news/eidos-therapeutics-announces-positive-phase-2-data-for-ag10-in-symptomatic-patients-with-mutant-or-wild-type-ttr-amyloid-cardiomyopathy/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-announces-positive-phase-2-data-for-ag10-in-symptomatic-patients-with-mutant-or-wild-type-ttr-amyloid-cardiomyopathy/index.html	(from https://bridgebio.com/news/page/14/)
02:55:54	42803/42803	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:53%20GMT	https://bridgebio.com/news/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics/index.html	(from https://bridgebio.com/news/page/14/)
02:55:54	2443/2443	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:55:54%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Farchive%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed375f	(from https://bridgebio.com/news/archive/)
02:55:54	46726/46726	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:54%20GMT	https://bridgebio.com/news/eidos-therapeutics-receives-positive-opinion-for-orphan-designation/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-receives-positive-opinion-for-orphan-designation/index.html	(from https://bridgebio.com/news/page/14/)
02:55:54	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.33f.delayed	(from https://bridgebio.com/news/archive/)
02:55:54	43936/43936	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:54%20GMT	https://bridgebio.com/news/qed-therapeutics-presents-data-for-infigratinib-in-cholangiocarcinoma-in-late-breaking-abstract-at-the-european-society-of-medical-oncology-2018-congress/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/qed-therapeutics-presents-data-for-infigratinib/index.html	(from https://bridgebio.com/news/page/14/)
02:55:55	44492/44492	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:54%20GMT	https://bridgebio.com/news/data-published-in-nature-communications-demonstrates-coa-therapeutics-potential-to-treat-genetically-driven-pantothenate-kinase-associated-neurodegeneration-pkan/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/data-published-in-nature-communications-demonst/index.html	(from https://bridgebio.com/news/page/14/)
02:55:55	46234/46234	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:55%20GMT	https://bridgebio.com/news/pellepharm-presents-updated-data-from-two-phase-2-studies/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/pellepharm-presents-updated-data-from-two-phase-2-studies/index.html	(from https://bridgebio.com/news/page/14/)
02:55:55	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:55:55%20GMT	https://bridgebio.com/news/archive/page/2	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/archive/page/2	(from https://bridgebio.com/news/archive/)
02:55:55	42412/42412	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:55%20GMT	https://bridgebio.com/news/eidos-therapeutics-to-present-phase-2-data-for-ag10-in-ttr-amyloidosis-cardiomyopathy/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-to-present-phase-2-data-for-ag10-in-ttr-amyloidosis-cardiomyopathy/index.html	(from https://bridgebio.com/news/page/14/)
02:55:56	46697/46697	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:55%20GMT	https://bridgebio.com/news/fda-grants-orphan-drug-designation-to-eidos-therapeutics-product-candidate-ag10-for-treatment-of-transthyretin-amyloidosis/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/fda-grants-orphan-drug-designation-to-eidos-therapeutics-product-candidate-ag10-for-treatment-of-transthyretin-amyloidosis/index.html	(from https://bridgebio.com/news/page/14/)
02:55:56	48032/48032	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:56%20GMT	https://bridgebio.com/news/eidos-therapeutics-presents-data-from-its-phase-1-clinical-trial-of-ag10-at-the-22nd-annual-scientific-meeting-of-the-heart-failure-society-of-america/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-presents-data-from-its-phase/index.html	(from https://bridgebio.com/news/page/14/)
02:55:56	47087/47087	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:56%20GMT	https://bridgebio.com/news/eidos-therapeutics-announces-publication-of-ag10-molecular-design-in-journal-of-medicinal-chemistry/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-announces-publication-of-ag10-molecular-design-in-journal-of-medicinal-chemistry/index.html	(from https://bridgebio.com/news/page/14/)
02:55:56	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:55:56%20GMT	https://bridgebio.com/news/archive/page/3	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/archive/page/3	(from https://bridgebio.com/news/archive/)
02:55:57	43302/43302	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:56%20GMT	https://bridgebio.com/news/eidos-therapeutics-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares/index.html	(from https://bridgebio.com/news/page/14/)
02:55:58	42172/42172	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:57%20GMT	https://bridgebio.com/news/eidos-therapeutics-announces-pricing-of-initial-public-offering/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-announces-pricing-of-initial-public-offering/index.html	(from https://bridgebio.com/news/page/14/)
02:55:58	45479/45479	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:57%20GMT	https://bridgebio.com/news/neurovive-out-licenses-targeted-lhon-therapy-to-bridgebio-pharmas-new-subsidiary-fortify-therapeutics/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/neurovive-out-licenses-targeted-lhon-therapy-to-bridgebio-pharmas-new-subsidiary-fortify-therapeutics/index.html	(from https://bridgebio.com/news/page/14/)
02:55:58	43713/43713	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:58%20GMT	https://bridgebio.com/news/bridgebio-pharma-launches-coa-therapeutics-to-target-coenzyme-a-for-rare-genetic-disorders/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-launches-coa-therapeutics-to-target-coenzyme-a-for-rare-genetic-disorders/index.html	(from https://bridgebio.com/news/page/14/)
02:55:59	43836/43836	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:58%20GMT	https://bridgebio.com/news/bridgebio-pharma-enters-into-agreement-to-acquire-late-stage-therapy-for-ultra-rare-disorder-from-alexion/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-enters-into-agreement-to-acquire-late-stage-therapy-for-ultra-rare-disorder-from-alexion/index.html	(from https://bridgebio.com/news/page/15/)
02:55:59	47794/47794	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:59%20GMT	https://bridgebio.com/news/pellepharm-to-present-topical-patidegib-and-skin-cancer-epidemiological-data-at-the-7th-international-investigative-dermatology-meeting/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/pellepharm-to-present-topical-patidegib-and-skin-cancer-epidemiological-data-at-the-7th-international-investigative-dermatology-meeting/index.html	(from https://bridgebio.com/news/page/15/)
02:55:59	47676/47676	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:59%20GMT	https://bridgebio.com/news/eidos-therapeutics-initiates-phase-2-clinical-trial-for-ag10-targeting-transthyretin-amyloidosis-cardiomyopathy/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-initiates-phase-2-clinical-trial-for-ag10-targeting-transthyretin-amyloidosis-cardiomyopathy/index.html	(from https://bridgebio.com/news/page/15/)
02:55:59	44563/44563	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:59%20GMT	https://bridgebio.com/news/eidos-therapeutics-completes-64m-series-b-financing/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-completes-64m-series-b-financing/index.html	(from https://bridgebio.com/news/page/15/)
02:56:00	42781/42781	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:55:59%20GMT	https://bridgebio.com/news/eidos-therapeutics-to-host-symposium-on-ttr-stabilization-at-the-16th-international-symposium-on-amyloidosis/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-to-host-symposium-on-ttr-stabilization-at-the-16th-international-symposium-on-amyloidosis/index.html	(from https://bridgebio.com/news/page/15/)
02:56:00	44457/44457	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:56:00%20GMT	https://bridgebio.com/news/bridgebio-pharma-licenses-late-stage-oncology-drug-infigratinib/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-licenses-late-stage-oncology-drug-infigratinib/index.html	(from https://bridgebio.com/news/page/15/)
02:56:00	42924/42924	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:56:00%20GMT	https://bridgebio.com/news/bridgebio-pharma-appoints-sanuj-ravindran-m-d-and-eric-michael-david-m-d-as-ceos-in-residence-to-lead-dermatology-and-gene-therapy-programs/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-appoints-sanuj-ravindran-m-d-and-eric-michael-david-m-d-as-ceos-in-residence-to-lead-dermatology-and-gene-therapy-programs/index.html	(from https://bridgebio.com/news/page/15/)
02:56:00	45773/45773	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:56:00%20GMT	https://bridgebio.com/news/pellepharm-appoints-sanuj-k-ravindran-m-d-as-president-and-chief-executive-officer/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/pellepharm-appoints-sanuj-k-ravindran-m-d-as-president-and-chief-executive-officer/index.html	(from https://bridgebio.com/news/page/15/)
02:56:01	46196/46196	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:56:00%20GMT	https://bridgebio.com/news/fda-grants-breakthrough-therapy-designation-and-orphan-drug-designation-to-pellepharm-for-topical-patidegib-in-gorlin-syndrome/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/fda-grants-breakthrough-therapy-designation-and-orphan-drug-designation-to-pellepharm-for-topical-patidegib-in-gorlin-syndrome/index.html	(from https://bridgebio.com/news/page/15/)
02:56:01	45342/45342	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:56:01%20GMT	https://bridgebio.com/news/preclinical-data-demonstrates-potential-of-eidos-therapeutics-lead-compound-for-the-treatment-for-transythyretin-amyloidosis/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/preclinical-data-demonstrates-potential-of-eidos-therapeutics-lead-compound-for-the-treatment-for-transythyretin-amyloidosis/index.html	(from https://bridgebio.com/news/page/15/)
02:56:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:55:57%20GMT	https://bridgebio.com/news/archive/page/4	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/archive/page/4	(from https://bridgebio.com/news/archive/)
02:56:01	47782/47782	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:56:01%20GMT	https://bridgebio.com/news/eidos-therapeutics-initiates-first-clinical-study-for-ag10-targeting-transthyretin-amyloidosis-appoints-camille-landis-as-chief-business-officer/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-initiates-first-clinical-study-for-ag10-targeting-transthyretin-amyloidosis-appoints-camille-landis-as-chief-business-officer/index.html	(from https://bridgebio.com/news/page/15/)
02:56:02	46972/46972	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:56:01%20GMT	https://bridgebio.com/news/md-anderson-and-bridgebio-pharma-launch-navire-pharma-to-develop-targeted-therapy-for-patients-with-difficult-to-treat-cancer/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/md-anderson-and-bridgebio-pharma-launch-navire-pharma-to-develop-targeted-therapy-for-patients-with-difficult-to-treat-cancer/index.html	(from https://bridgebio.com/news/page/15/)
02:56:02	46924/46924	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:56:02%20GMT	https://bridgebio.com/news/pellepharm-announces-topline-results-from-phase-2-study-of-topical-patidegib/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/pellepharm-announces-topline-results-from-phase-2-study-of-topical-patidegib/index.html	(from https://bridgebio.com/news/page/15/)
02:56:02	44219/44219	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:56:01%20GMT	https://bridgebio.com/news/bridgebio-pharma-expands-investor-base-raising-an-additional-135-million-and-discloses-genetic-disease-pipeline-programs/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-expands-investor-base-raising-an-additional-135-million-and-discloses-genetic-disease-pipeline-programs/index.html	(from https://bridgebio.com/news/page/15/)
02:56:02	43802/43802	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:56:02%20GMT	https://bridgebio.com/news/bridgebio-pharma-launches-eidos-therapeutics-to-develop-targeted-therapy-for-fatal-heart-disease/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-launches-eidos-therapeutics-to-develop-targeted-therapy-for-fatal-heart-disease/index.html	(from https://bridgebio.com/news/page/15/)
02:56:03	42771/42771	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:56:02%20GMT	https://bridgebio.com/news/bridgebio-pharma-launches-with-a-focus-on-precision-medicines-for-genetic-diseases/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-launches-with-a-focus-on-precision-medicines-for-genetic-diseases/index.html	(from https://bridgebio.com/news/page/15/)
02:56:03	48254/48254	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:56:03%20GMT	https://bridgebio.com/news/pellepharm-launches-with-financing-from-bridgebio-pharma-to-develop-topical-therapy-for-basal-cell-carcinomas-and-gorlin-syndrome/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/pellepharm-launches-with-financing-from-bridgebio-pharma-to-develop-topical-therapy-for-basal-cell-carcinomas-and-gorlin-syndrome/index.html	(from https://bridgebio.com/news/page/16/)
02:56:03	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:01%20GMT	https://bridgebio.com/news/archive/page/5	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/archive/page/5	(from https://bridgebio.com/news/archive/)
02:56:04	49090/49090	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:56:03%20GMT	https://bridgebio.com/news/archive/page/2/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/archive/page/2/index.html	(from https://bridgebio.com/news/archive/)
02:56:04	48680/48680	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:56:04%20GMT	https://bridgebio.com/news/archive/page/3/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/archive/page/3/index.html	(from https://bridgebio.com/news/archive/)
02:56:04	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:03%20GMT	https://bridgebio.com/?p=3419	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index3c39.html	(from https://bridgebio.com/news/archive/)
02:56:04	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:03%20GMT	https://bridgebio.com/news/archive/page/6	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/archive/page/6	(from https://bridgebio.com/news/archive/)
02:56:04	48942/48942	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:56:04%20GMT	https://bridgebio.com/news/archive/page/4/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/archive/page/4/index.html	(from https://bridgebio.com/news/archive/)
02:56:04	48628/48628	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:56:04%20GMT	https://bridgebio.com/news/archive/page/5/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/archive/page/5/index.html	(from https://bridgebio.com/news/archive/)
02:56:05	48919/48919	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:56:04%20GMT	https://bridgebio.com/news/archive/page/6/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/archive/page/6/index.html	(from https://bridgebio.com/news/archive/)
02:56:05	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:04%20GMT	https://bridgebio.com/news/archive/page/7	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/archive/page/7	(from https://bridgebio.com/news/archive/)
02:56:05	49342/49342	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:56:05%20GMT	https://bridgebio.com/news/archive/page/7/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/archive/page/7/index.html	(from https://bridgebio.com/news/archive/)
02:56:05	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:05%20GMT	https://bridgebio.com/news/archive/page/8	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/archive/page/8	(from https://bridgebio.com/news/archive/)
02:56:06	48692/48692	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:56:06%20GMT	https://bridgebio.com/news/archive/page/8/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/archive/page/8/index.html	(from https://bridgebio.com/news/archive/)
02:56:06	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:06%20GMT	https://bridgebio.com/news/archive/page/9	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/archive/page/9	(from https://bridgebio.com/news/archive/)
02:56:06	44177/44177	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:56:06%20GMT	https://bridgebio.com/news/archive/page/9/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/archive/page/9/index.html	(from https://bridgebio.com/news/archive/)
02:56:06	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:06%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/archive/)
02:56:07	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:07%20GMT	https://bridgebio.com/bridgebio-hcp-privacy-notice/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/bridgebio-hcp-privacy-notice/index.html	(from https://bridgebio.com/bridgebio-hcp-privacy-notice)
02:56:07	21549/21549	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:07%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/5775	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/5775.json	(from https://bridgebio.com/bridgebio-hcp-privacy-notice)
02:56:08	2454/2454	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:08%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fbridgebio-hcp-privacy-notice	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8492.json	(from https://bridgebio.com/bridgebio-hcp-privacy-notice)
02:56:08	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:08%20GMT	https://bridgebio.com/?p=5775	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index30cc.html	(from https://bridgebio.com/bridgebio-hcp-privacy-notice)
02:56:08	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.34c.delayed	(from https://bridgebio.com/bridgebio-hcp-privacy-notice)
02:56:08	2646/2646	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:56:08%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fbridgebio-hcp-privacy-notice&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8e4e	(from https://bridgebio.com/bridgebio-hcp-privacy-notice)
02:56:09	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:09%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/bridgebio-hcp-privacy-notice)
02:56:09	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734509700	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style82c3.css	(from https://bridgebio.com/bridgebio-eea-swiss-and-uk-candidate-privacy-notice/)
02:56:09	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734509700	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css82c3.css	(from https://bridgebio.com/bridgebio-eea-swiss-and-uk-candidate-privacy-notice/)
02:56:09	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734509700	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust82c3.css	(from https://bridgebio.com/bridgebio-eea-swiss-and-uk-candidate-privacy-notice/)
02:56:10	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734509700	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts82c3.js	(from https://bridgebio.com/bridgebio-eea-swiss-and-uk-candidate-privacy-notice/)
02:56:10	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734509700	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal82c3.js	(from https://bridgebio.com/bridgebio-eea-swiss-and-uk-candidate-privacy-notice/)
02:56:10	36924/36924	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:10%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/5776	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/5776.json	(from https://bridgebio.com/bridgebio-eea-swiss-and-uk-candidate-privacy-notice/)
02:56:11	2552/2552	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:11%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fbridgebio-eea-swiss-and-uk-candidate-privacy-notice%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb8cf.json	(from https://bridgebio.com/bridgebio-eea-swiss-and-uk-candidate-privacy-notice/)
02:56:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:11%20GMT	https://bridgebio.com/?p=5776	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index05bf.html	(from https://bridgebio.com/bridgebio-eea-swiss-and-uk-candidate-privacy-notice/)
02:56:11	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.356.delayed	(from https://bridgebio.com/bridgebio-eea-swiss-and-uk-candidate-privacy-notice/)
02:56:11	2743/2743	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:56:11%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fbridgebio-eea-swiss-and-uk-candidate-privacy-notice%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedfdfb	(from https://bridgebio.com/bridgebio-eea-swiss-and-uk-candidate-privacy-notice/)
02:56:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:12%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/bridgebio-eea-swiss-and-uk-candidate-privacy-notice/)
02:56:13	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:13%20GMT	https://bridgebio.com/?p=6812	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexe643.html	(from https://bridgebio.com/careers/vp-regulatory-affairs/)
02:56:13	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734515280	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style634d.css	(from https://bridgebio.com/what-is-adh1/encaleret/)
02:56:14	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734515280	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css634d.css	(from https://bridgebio.com/what-is-adh1/encaleret/)
02:56:14	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734515280	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust634d.css	(from https://bridgebio.com/what-is-adh1/encaleret/)
02:56:14	30604/30604	---MCZ	200	added ('OK')	text/css	etag:W/%2266e85bb7-778c%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/affiliates.css?ver=1734515280	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/affiliates634d.css	(from https://bridgebio.com/what-is-adh1/encaleret/)
02:56:14	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734515280	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts634d.js	(from https://bridgebio.com/what-is-adh1/encaleret/)
02:56:14	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734515280	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal634d.js	(from https://bridgebio.com/what-is-adh1/encaleret/)
02:56:15	3058/3058	---MCZ	200	added ('OK')	application/javascript	etag:W/%2266e85bb7-bf2%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/affiliates.js?ver=1734515280	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/affiliates634d.js	(from https://bridgebio.com/what-is-adh1/encaleret/)
02:56:15	280030/280030	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:15%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/6250	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/6250.json	(from https://bridgebio.com/what-is-adh1/encaleret/)
02:56:16	2414/2414	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:16%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fwhat-is-adh1%2Fencaleret%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc0fc.json	(from https://bridgebio.com/what-is-adh1/encaleret/)
02:56:16	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:16%20GMT	https://bridgebio.com/?p=6250	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index789f.html	(from https://bridgebio.com/what-is-adh1/encaleret/)
02:56:16	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.362.delayed	(from https://bridgebio.com/what-is-adh1/encaleret/)
02:56:16	2603/2603	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:56:16%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fwhat-is-adh1%2Fencaleret%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedbca9	(from https://bridgebio.com/what-is-adh1/encaleret/)
02:56:17	96568/96568	---MCZ	200	added ('OK')	image/svg+xml	etag:W/%2266829bf7-17938%22	https://bridgebio.com/wp-content/uploads/2024/02/our-approach.svg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/02/our-approach.svg	(from https://bridgebio.com/what-is-adh1/encaleret/)
02:56:17	1053672/1053672	---M--	200	added ('OK')	image/png	etag:%2266829bf7-13b9e1%22	https://bridgebio.com/wp-content/uploads/2024/02/encaleret-header.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/02/encaleret-header.png	(from https://bridgebio.com/what-is-adh1/encaleret/)
02:56:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:17%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/what-is-adh1/encaleret/)
02:56:17	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734519060	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/stylea23e.css	(from https://bridgebio.com/what-is-adh1/patient-resources/)
02:56:18	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734519060	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-cssa23e.css	(from https://bridgebio.com/what-is-adh1/patient-resources/)
02:56:18	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734519060	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrusta23e.css	(from https://bridgebio.com/what-is-adh1/patient-resources/)
02:56:18	30604/30604	---MCZ	200	added ('OK')	text/css	etag:W/%2266e85bb7-778c%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/affiliates.css?ver=1734519060	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/affiliatesa23e.css	(from https://bridgebio.com/what-is-adh1/patient-resources/)
02:56:18	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734519060	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptsa23e.js	(from https://bridgebio.com/what-is-adh1/patient-resources/)
02:56:19	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734519060	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modala23e.js	(from https://bridgebio.com/what-is-adh1/patient-resources/)
02:56:19	3058/3058	---MCZ	200	added ('OK')	application/javascript	etag:W/%2266e85bb7-bf2%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/affiliates.js?ver=1734519060	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/affiliatesa23e.js	(from https://bridgebio.com/what-is-adh1/patient-resources/)
02:56:19	27225/27225	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:20%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/6331	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/6331.json	(from https://bridgebio.com/what-is-adh1/patient-resources/)
02:56:20	2412/2412	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:20%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fwhat-is-adh1%2Fpatient-resources%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb03a.json	(from https://bridgebio.com/what-is-adh1/patient-resources/)
02:56:20	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:20%20GMT	https://bridgebio.com/?p=6331	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexc75b.html	(from https://bridgebio.com/what-is-adh1/patient-resources/)
02:56:20	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.370.delayed	(from https://bridgebio.com/what-is-adh1/patient-resources/)
02:56:20	2601/2601	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:56:20%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fwhat-is-adh1%2Fpatient-resources%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeda32f	(from https://bridgebio.com/what-is-adh1/patient-resources/)
02:56:21	1167727/1167727	---M--	200	added ('OK')	image/png	etag:%2266829bfa-163a16%22	https://bridgebio.com/wp-content/uploads/2024/02/resources-header.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/02/resources-header.png	(from https://bridgebio.com/what-is-adh1/patient-resources/)
02:56:21	81979/81979	---M--	200	added ('OK')	image/png	etag:%2266829c00-1dbe5%22	https://bridgebio.com/wp-content/uploads/2024/02/adh1-unmet-needs.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/02/adh1-unmet-needs.png	(from https://bridgebio.com/what-is-adh1/patient-resources/)
02:56:21	49163/49163	---M--	200	added ('OK')	image/png	etag:%2266829bf8-131a3%22	https://bridgebio.com/wp-content/uploads/2024/02/photo-sm-alexis.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/02/photo-sm-alexis.png	(from https://bridgebio.com/what-is-adh1/patient-resources/)
02:56:21	51267/51267	---M--	200	added ('OK')	image/png	etag:%2266829bf7-cac4%22	https://bridgebio.com/wp-content/uploads/2024/02/photo-alexis-300x300.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/02/photo-alexis-300x300.png	(from https://bridgebio.com/what-is-adh1/patient-resources/)
02:56:22	52108/52108	---M--	200	added ('OK')	image/png	etag:%2266829bf9-15653%22	https://bridgebio.com/wp-content/uploads/2024/02/photo-sm-jackson.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/02/photo-sm-jackson.png	(from https://bridgebio.com/what-is-adh1/patient-resources/)
02:56:22	53736/53736	---M--	200	added ('OK')	image/png	etag:%2266829bf8-d1f4%22	https://bridgebio.com/wp-content/uploads/2024/02/photo-jackson-300x300.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/02/photo-jackson-300x300.png	(from https://bridgebio.com/what-is-adh1/patient-resources/)
02:56:22	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:22%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/what-is-adh1/patient-resources/)
02:56:23	26780/26780	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:23%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6106	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6106.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-new-england-journal-of-medicine-publication-of-positive-encaleret-proof-of-concept-phase-2b-results-in-patients-with-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:23	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-new-england-journal-of-medicine-publication-of-positive-encaleret-proof-of-concept-phase-2b-results-in-patients-with-autosomal-dominant-hypocalcemia-type-1-adh1/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-new-england-journal-/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-new-england-journal-of-medicine-publication-of-positive-encaleret-proof-of-concept-phase-2b-results-in-patients-with-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:23	3537/3537	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:23%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-new-england-journal-of-medicine-publication-of-positive-encaleret-proof-of-concept-phase-2b-results-in-patients-with-autosomal-dominant-hypocalcemia-type-1-adh1%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1d7a.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-new-england-journal-of-medicine-publication-of-positive-encaleret-proof-of-concept-phase-2b-results-in-patients-with-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:24	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:24%20GMT	https://bridgebio.com/?p=6106	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index43f5.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-new-england-journal-of-medicine-publication-of-positive-encaleret-proof-of-concept-phase-2b-results-in-patients-with-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:24	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.37b.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-new-england-journal-of-medicine-publication-of-positive-encaleret-proof-of-concept-phase-2b-results-in-patients-with-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:24	3729/3729	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:56:24%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-new-england-journal-of-medicine-publication-of-positive-encaleret-proof-of-concept-phase-2b-results-in-patients-with-autosomal-dominant-hypocalcemia-type-1-adh1%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3a15	(from https://bridgebio.com/news/bridgebio-pharma-announces-new-england-journal-of-medicine-publication-of-positive-encaleret-proof-of-concept-phase-2b-results-in-patients-with-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:24	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:24%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-announces-new-england-journal-of-medicine-publication-of-positive-encaleret-proof-of-concept-phase-2b-results-in-patients-with-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:24	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:24%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-new-england-journal-of-medicine-publication-of-positive-encaleret-proof-of-concept-phase-2b-results-in-patients-with-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:25	25893/25893	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:25%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5797	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5797.json	(from https://bridgebio.com/news/bridgebio-pharma-initiates-calibrate-a-pivotal-phase-3-study-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1/)
02:56:25	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-initiates-calibrate-a-pivotal-phase-3-study-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-initiates-calibrate-a-pivotal-phase-3-study-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-initiates-calibrate-a-pivotal-phase-3-study-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1/)
02:56:25	2820/2820	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:25%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-initiates-calibrate-a-pivotal-phase-3-study-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed490b.json	(from https://bridgebio.com/news/bridgebio-pharma-initiates-calibrate-a-pivotal-phase-3-study-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1/)
02:56:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:26%20GMT	https://bridgebio.com/?p=5797	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexda83.html	(from https://bridgebio.com/news/bridgebio-pharma-initiates-calibrate-a-pivotal-phase-3-study-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1/)
02:56:26	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.381.delayed	(from https://bridgebio.com/news/bridgebio-pharma-initiates-calibrate-a-pivotal-phase-3-study-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1/)
02:56:26	3009/3009	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:56:26%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-initiates-calibrate-a-pivotal-phase-3-study-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb14b	(from https://bridgebio.com/news/bridgebio-pharma-initiates-calibrate-a-pivotal-phase-3-study-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1/)
02:56:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:26%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-initiates-calibrate-a-pivotal-phase-3-study-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1/)
02:56:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:27%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-initiates-calibrate-a-pivotal-phase-3-study-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1/)
02:56:29	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734517800	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/styleb503.css	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:29	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734517800	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-cssb503.css	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:29	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:30	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734517800	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrustb503.css	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:30	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734517800	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptsb503.js	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:33	147176/147176	---M--	200	added ('OK')	image/jpeg	etag:%2266829bfe-26fa2%22	http://bridgebio.com/wp-content/uploads/2022/06/Capture123.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2022/06/Capture123.jpg	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:33	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734517800	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modalb503.js	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:34	30855/30855	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:34%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5529	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5529.json	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:34	2932/2932	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:34%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3648.json	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:34	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:34%20GMT	https://bridgebio.com/?p=5529	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index2d38.html	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:34	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.38d.delayed	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:35	3088/3088	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:56:35%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0546	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:35	162/162	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:35%20GMT	http://bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:35	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:35%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:35	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:35%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:36	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:36%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-phase-2b-data-and-announces-pivotal-study-design-for-phase-3-trial-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1/)
02:56:36	25744/25744	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:36%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5517	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5517.json	(from https://bridgebio.com/news/bridgebio-pharma-to-present-phase-2b-data-and-pivotal-phase-3-study-design-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-at-the-endocrine-society-endo-2022-annual-conference/)
02:56:37	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-present-phase-2b-data-and-pivotal-phase-3-study-design-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-at-the-endocrine-society-endo-2022-annual-conference/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-present-phase-2b-data-and-p/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-present-phase-2b-data-and-pivotal-phase-3-study-design-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-at-the-endocrine-society-endo-2022-annual-conference/)
02:56:37	3117/3117	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-present-phase-2b-data-and-pivotal-phase-3-study-design-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-at-the-endocrine-society-endo-2022-annual-conference%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd031.json	(from https://bridgebio.com/news/bridgebio-pharma-to-present-phase-2b-data-and-pivotal-phase-3-study-design-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-at-the-endocrine-society-endo-2022-annual-conference/)
02:56:37	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:37%20GMT	https://bridgebio.com/?p=5517	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index2a99.html	(from https://bridgebio.com/news/bridgebio-pharma-to-present-phase-2b-data-and-pivotal-phase-3-study-design-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-at-the-endocrine-society-endo-2022-annual-conference/)
02:56:37	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.395.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-present-phase-2b-data-and-pivotal-phase-3-study-design-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-at-the-endocrine-society-endo-2022-annual-conference/)
02:56:37	3306/3306	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:56:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-present-phase-2b-data-and-pivotal-phase-3-study-design-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-at-the-endocrine-society-endo-2022-annual-conference%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1391	(from https://bridgebio.com/news/bridgebio-pharma-to-present-phase-2b-data-and-pivotal-phase-3-study-design-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-at-the-endocrine-society-endo-2022-annual-conference/)
02:56:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:38%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-to-present-phase-2b-data-and-pivotal-phase-3-study-design-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-at-the-endocrine-society-endo-2022-annual-conference/)
02:56:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:38%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-present-phase-2b-data-and-pivotal-phase-3-study-design-of-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-at-the-endocrine-society-endo-2022-annual-conference/)
02:56:39	28452/28452	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:39%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5202	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5202.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data/)
02:56:39	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data/)
02:56:39	2825/2825	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:39%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-updated-phase-2b-data%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed12ff.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data/)
02:56:39	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:39%20GMT	https://bridgebio.com/?p=5202	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index9459.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data/)
02:56:39	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.39b.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data/)
02:56:40	162/162	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:40%20GMT	http://bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting	(from https://bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data/)
02:56:40	3014/3014	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:56:40%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-updated-phase-2b-data%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf77a	(from https://bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data/)
02:56:40	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:40%20GMT	https://bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting	(from https://bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data/)
02:56:40	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:40%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data/)
02:56:41	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:41%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data/)
02:56:41	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734509160	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style1394.css	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1/)
02:56:42	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1/)
02:56:42	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734509160	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css1394.css	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1/)
02:56:42	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734509160	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust1394.css	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1/)
02:56:42	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734509160	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts1394.js	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1/)
02:56:42	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734509160	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal1394.js	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1/)
02:56:43	22653/22653	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:43%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3834	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3834.json	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1/)
02:56:43	2856/2856	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:43%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7130.json	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1/)
02:56:43	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:43%20GMT	https://bridgebio.com/?p=3834	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index4d24.html	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1/)
02:56:44	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.3a8.delayed	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1/)
02:56:44	3045/3045	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:56:44%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedad2c	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1/)
02:56:44	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:44%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1/)
02:56:44	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:44%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-encaleret-for-the-treatment-of-autosomal-dominant-hypocalcemia-type-1/)
02:56:45	26594/26594	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:45%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3486	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3486.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting/)
02:56:45	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting/)
02:56:45	2827/2827	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:45%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5e58.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting/)
02:56:46	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:46%20GMT	https://bridgebio.com/?p=3486	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index444b.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting/)
02:56:46	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.3ae.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting/)
02:56:46	3020/3020	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:56:46%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8d0c	(from https://bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting/)
02:56:46	30515/30515	---M--	200	added ('OK')	image/png	etag:%2266829bfa-9c8e%22	https://bridgebio.com/wp-content/uploads/2021/03/image.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/03/image.png	(from https://bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting/)
02:56:46	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:47%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting/)
02:56:47	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:47%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-proof-of-concept-data-of-encaleret-in-adh1-at-the-endocrine-societys-2021-annual-meeting/)
02:56:47	22624/22624	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:47%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3302	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3302.json	(from https://bridgebio.com/news/bridgebio-pharma-to-announce-proof-of-concept-data-from-adh1-at-the-endocrine-societys-2021-annual-meeting/)
02:56:48	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-announce-proof-of-concept-data-from-adh1-at-the-endocrine-societys-2021-annual-meeting/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-announce-proof-of-concept-data-from-adh1-at-the-endocrine-societys-2021-annual-meeting/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-announce-proof-of-concept-data-from-adh1-at-the-endocrine-societys-2021-annual-meeting/)
02:56:48	2782/2782	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:48%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-announce-proof-of-concept-data-from-adh1-at-the-endocrine-societys-2021-annual-meeting%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede65f.json	(from https://bridgebio.com/news/bridgebio-pharma-to-announce-proof-of-concept-data-from-adh1-at-the-endocrine-societys-2021-annual-meeting/)
02:56:48	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:48%20GMT	https://bridgebio.com/?p=3302	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index8a86.html	(from https://bridgebio.com/news/bridgebio-pharma-to-announce-proof-of-concept-data-from-adh1-at-the-endocrine-societys-2021-annual-meeting/)
02:56:48	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.3b5.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-announce-proof-of-concept-data-from-adh1-at-the-endocrine-societys-2021-annual-meeting/)
02:56:48	2975/2975	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:56:48%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-announce-proof-of-concept-data-from-adh1-at-the-endocrine-societys-2021-annual-meeting%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb92e	(from https://bridgebio.com/news/bridgebio-pharma-to-announce-proof-of-concept-data-from-adh1-at-the-endocrine-societys-2021-annual-meeting/)
02:56:48	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:49%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-to-announce-proof-of-concept-data-from-adh1-at-the-endocrine-societys-2021-annual-meeting/)
02:56:49	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:49%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-announce-proof-of-concept-data-from-adh1-at-the-endocrine-societys-2021-annual-meeting/)
02:56:49	21134/21134	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:49%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/4118	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/4118.json	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1-2/)
02:56:50	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1-2/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1-2/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1-2/)
02:56:50	2893/2893	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:50%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1-2%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5be4.json	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1-2/)
02:56:50	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:50%20GMT	https://bridgebio.com/?p=4118	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index9a40.html	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1-2/)
02:56:50	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.3bb.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1-2/)
02:56:50	3086/3086	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:56:50%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1-2%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedfe86	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1-2/)
02:56:51	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:51%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1-2/)
02:56:51	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:51%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1-2/)
02:56:52	160/160	---MCZ	200	added ('OK')	text/plain	etag:W/%2266829be9-c2%22	http://bridgebio.com/robots.txt		(from https://bridgebio.com/what-is-adh1/)
02:56:52	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734483600	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/styleb360.css	(from https://bridgebio.com/lgmd2i-r9/bbp-418/)
02:56:52	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734483600	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-cssb360.css	(from https://bridgebio.com/lgmd2i-r9/bbp-418/)
02:56:52	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734483600	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrustb360.css	(from https://bridgebio.com/lgmd2i-r9/bbp-418/)
02:56:53	30604/30604	---MCZ	200	added ('OK')	text/css	etag:W/%2266e85bb7-778c%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/affiliates.css?ver=1734483600	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/affiliatesb360.css	(from https://bridgebio.com/lgmd2i-r9/bbp-418/)
02:56:53	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734483600	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptsb360.js	(from https://bridgebio.com/lgmd2i-r9/bbp-418/)
02:56:54	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734483600	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modalb360.js	(from https://bridgebio.com/lgmd2i-r9/bbp-418/)
02:56:54	3058/3058	---MCZ	200	added ('OK')	application/javascript	etag:W/%2266e85bb7-bf2%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/affiliates.js?ver=1734483600	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/affiliatesb360.js	(from https://bridgebio.com/lgmd2i-r9/bbp-418/)
02:56:54	27211/27211	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:54%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/6799	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/6799.json	(from https://bridgebio.com/lgmd2i-r9/bbp-418/)
02:56:55	2386/2386	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:55%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Flgmd2i-r9%2Fbbp-418%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed983d.json	(from https://bridgebio.com/lgmd2i-r9/bbp-418/)
02:56:55	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:55%20GMT	https://bridgebio.com/?p=6799	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index0d19.html	(from https://bridgebio.com/lgmd2i-r9/bbp-418/)
02:56:55	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.3c8.delayed	(from https://bridgebio.com/lgmd2i-r9/bbp-418/)
02:56:55	2573/2573	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:56:55%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Flgmd2i-r9%2Fbbp-418%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed378b	(from https://bridgebio.com/lgmd2i-r9/bbp-418/)
02:56:55	389828/389828	---M--	200	added ('OK')	image/webp	etag:%2266e85bb5-5f2c4%22	https://bridgebio.com/wp-content/uploads/2024/09/patient_resources_hero_family_full.webp	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/patient_resources_hero_family_full.webp	(from https://bridgebio.com/lgmd2i-r9/bbp-418/)
02:56:56	80290/80290	---M--	200	added ('OK')	image/webp	etag:%2266e85bb5-139a2%22	https://bridgebio.com/wp-content/uploads/2024/09/patient-resources-hero-family-mobile.webp	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/patient-resources-hero-family-mobile.webp	(from https://bridgebio.com/lgmd2i-r9/bbp-418/)
02:56:56	183393/183393	---MCZ	200	added ('OK')	image/svg+xml	etag:W/%2266e85bb5-2cc61%22	https://bridgebio.com/wp-content/uploads/2024/09/BBP%e2%80%91418-chart-2-Desktop.svg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/BBP%e2%80%91418-chart-2-Desktop.svg	(from https://bridgebio.com/lgmd2i-r9/bbp-418/)
02:56:56	200603/200603	---MCZ	200	added ('OK')	image/svg+xml	etag:W/%2266e85bb5-30f9b%22	https://bridgebio.com/wp-content/uploads/2024/09/BBP%e2%80%91418-chart-2-Mobile.svg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/BBP%e2%80%91418-chart-2-Mobile.svg	(from https://bridgebio.com/lgmd2i-r9/bbp-418/)
02:56:56	2219/2219	---MCZ	200	added ('OK')	image/svg+xml	etag:W/%2266e85bb5-8ab%22	https://bridgebio.com/wp-content/uploads/2024/09/fortify-logo.svg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/fortify-logo.svg	(from https://bridgebio.com/lgmd2i-r9/bbp-418/)
02:56:57	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:57%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/lgmd2i-r9/bbp-418/)
02:56:57	58817/58817	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:57%20GMT	https://bridgebio.com/wp-json/wp/v2/pages/6797	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/pages/6797.json	(from https://bridgebio.com/lgmd2i-r9/patient-resources/)
02:56:58	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:56:58%20GMT	https://bridgebio.com/?p=6797	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index9852.html	(from https://bridgebio.com/lgmd2i-r9/patient-resources/)
02:56:59	2421/2421	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:56:59%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Flgmd2i-r9%2Fpatient-resources%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5907.json	(from https://bridgebio.com/lgmd2i-r9/patient-resources/)
02:56:59	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.3d2.delayed	(from https://bridgebio.com/lgmd2i-r9/patient-resources/)
02:56:59	2608/2608	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:57:00%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Flgmd2i-r9%2Fpatient-resources%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed93f9	(from https://bridgebio.com/lgmd2i-r9/patient-resources/)
02:57:00	334550/334550	---M--	200	added ('OK')	image/webp	etag:%2266e85bb5-51ad6%22	https://bridgebio.com/wp-content/uploads/2024/09/BBP-418-hero.webp	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/BBP-418-hero.webp	(from https://bridgebio.com/lgmd2i-r9/patient-resources/)
02:57:06	34401/34401	---M--	200	added ('OK')	image/jpeg	etag:%2266e85bb5-87f7%22	https://bridgebio.com/wp-content/uploads/2024/09/MLBio_Julie_Indiv.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/MLBio_Julie_Indiv.jpg	(from https://bridgebio.com/lgmd2i-r9/patient-resources/)
02:57:07	24484/24484	---M--	200	added ('OK')	image/jpeg	etag:%2266e85bb5-5fa4%22	https://bridgebio.com/wp-content/uploads/2024/09/MLBio_Julie_Group-300x300.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/MLBio_Julie_Group-300x300.jpg	(from https://bridgebio.com/lgmd2i-r9/patient-resources/)
02:57:10	20202/20202	---M--	200	added ('OK')	image/jpeg	etag:%2266e85bb5-5339%22	https://bridgebio.com/wp-content/uploads/2024/09/cyndy-family-bw-300x300.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/cyndy-family-bw-300x300.jpg	(from https://bridgebio.com/lgmd2i-r9/patient-resources/)
02:57:11	33136/33136	---M--	200	added ('OK')	image/jpeg	etag:%2266e85bb5-897d%22	https://bridgebio.com/wp-content/uploads/2024/09/cyndy-thumbnail-bw.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/cyndy-thumbnail-bw.jpg	(from https://bridgebio.com/lgmd2i-r9/patient-resources/)
02:57:14	139066/139066	---M--	200	added ('OK')	image/webp	etag:%2266e85bb5-21f3a%22	https://bridgebio.com/wp-content/uploads/2024/09/BBP-418-hero-mobile.webp	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/BBP-418-hero-mobile.webp	(from https://bridgebio.com/lgmd2i-r9/patient-resources/)
02:57:14	25466/25466	---M--	200	added ('OK')	image/jpeg	etag:%2266e85bb5-6bad%22	https://bridgebio.com/wp-content/uploads/2024/09/seamus-icon-bw.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/seamus-icon-bw.jpg	(from https://bridgebio.com/lgmd2i-r9/patient-resources/)
02:57:15	26325/26325	---M--	200	added ('OK')	image/jpeg	etag:%2266e85bb5-6da3%22	https://bridgebio.com/wp-content/uploads/2024/09/seamus-trail-bw-300x300.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/seamus-trail-bw-300x300.jpg	(from https://bridgebio.com/lgmd2i-r9/patient-resources/)
02:57:17	162976/162976	---M--	200	added ('OK')	application/pdf	etag:%2266fa99bc-27ca0%22	http://bridgebio.com/wp-content/uploads/2024/09/BBP-418-ML-Bio-Last-Patient-In-Fortify-BridgeBio_MED-US-BBP418-0005-V1.pdf?fbclid=IwY2xjawFnyQBleHRuA2FlbQIxMAABHQ58-9jkYcXYG-v4NX641to7CpOUegEuoyWNVoANIzkbh3Eurr0X_ZfSjQ_aem_8EZz1Uy6LIQBv3B21JImjQ	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/09/BBP-418-ML-Bio-Last-Patient-In-Fortify-BridgeBio_MED-US-BBP418-0005-V17e0d.pdf	(from https://bridgebio.com/lgmd2i-r9/patient-resources/)
02:57:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:14%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/lgmd2i-r9/patient-resources/)
02:57:20	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-39/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-39/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-39/)
02:57:20	13570/13570	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:20%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6574	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6574.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-39/)
02:57:20	2976/2976	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:20%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-39%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed6ff8.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-39/)
02:57:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:21%20GMT	https://bridgebio.com/?p=6574	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index2e88.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-39/)
02:57:21	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.3e0.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-39/)
02:57:21	3176/3176	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:57:21%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-39%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed73f5	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-39/)
02:57:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:21%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-39/)
02:57:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:21%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-39/)
02:57:22	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734512400	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/styled115.css	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference/)
02:57:22	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference/)
02:57:22	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734512400	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-cssd115.css	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference/)
02:57:22	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734512400	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrustd115.css	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference/)
02:57:23	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734512400	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptsd115.js	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference/)
02:57:23	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734512400	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modald115.js	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference/)
02:57:23	15365/15365	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:24%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6549	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6549.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference/)
02:57:24	3049/3049	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:24%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2033.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference/)
02:57:24	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:24%20GMT	https://bridgebio.com/?p=6549	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index7ecb.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference/)
02:57:24	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.3eb.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference/)
02:57:24	3250/3250	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:57:24%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede6bc	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference/)
02:57:25	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:25%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference/)
02:57:25	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:25%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-45th-annual-goldman-sachs-global-healthcare-conference/)
02:57:25	34137/34137	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:26%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6545	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6545.json	(from https://bridgebio.com/news/bridgebio-announces-durable-month-12-and-18-phase-2-cohort-5-results-of-oral-infigratinib-in-achondroplasia-and-first-participant-consented-in-accel-for-hypochondroplasia/)
02:57:26	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-announces-durable-month-12-and-18-phase-2-cohort-5-results-of-oral-infigratinib-in-achondroplasia-and-first-participant-consented-in-accel-for-hypochondroplasia/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-announces-durable-month-12-and-18-pha/feed/index.html	(from https://bridgebio.com/news/bridgebio-announces-durable-month-12-and-18-phase-2-cohort-5-results-of-oral-infigratinib-in-achondroplasia-and-first-participant-consented-in-accel-for-hypochondroplasia/)
02:57:26	3385/3385	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:26%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-announces-durable-month-12-and-18-phase-2-cohort-5-results-of-oral-infigratinib-in-achondroplasia-and-first-participant-consented-in-accel-for-hypochondroplasia%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1649.json	(from https://bridgebio.com/news/bridgebio-announces-durable-month-12-and-18-phase-2-cohort-5-results-of-oral-infigratinib-in-achondroplasia-and-first-participant-consented-in-accel-for-hypochondroplasia/)
02:57:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:26%20GMT	https://bridgebio.com/?p=6545	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexb82c.html	(from https://bridgebio.com/news/bridgebio-announces-durable-month-12-and-18-phase-2-cohort-5-results-of-oral-infigratinib-in-achondroplasia-and-first-participant-consented-in-accel-for-hypochondroplasia/)
02:57:26	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.3f1.delayed	(from https://bridgebio.com/news/bridgebio-announces-durable-month-12-and-18-phase-2-cohort-5-results-of-oral-infigratinib-in-achondroplasia-and-first-participant-consented-in-accel-for-hypochondroplasia/)
02:57:26	3572/3572	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:57:27%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-announces-durable-month-12-and-18-phase-2-cohort-5-results-of-oral-infigratinib-in-achondroplasia-and-first-participant-consented-in-accel-for-hypochondroplasia%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedce23	(from https://bridgebio.com/news/bridgebio-announces-durable-month-12-and-18-phase-2-cohort-5-results-of-oral-infigratinib-in-achondroplasia-and-first-participant-consented-in-accel-for-hypochondroplasia/)
02:57:27	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:27%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-announces-durable-month-12-and-18-phase-2-cohort-5-results-of-oral-infigratinib-in-achondroplasia-and-first-participant-consented-in-accel-for-hypochondroplasia/)
02:57:27	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:27%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-announces-durable-month-12-and-18-phase-2-cohort-5-results-of-oral-infigratinib-in-achondroplasia-and-first-participant-consented-in-accel-for-hypochondroplasia/)
02:57:28	14160/14160	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:28%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6544	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6544.json	(from https://bridgebio.com/news/achondroplasia-investor-call/)
02:57:28	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/achondroplasia-investor-call/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/achondroplasia-investor-call/feed/index.html	(from https://bridgebio.com/news/achondroplasia-investor-call/)
02:57:28	2982/2982	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:28%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fachondroplasia-investor-call%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed4a8a.json	(from https://bridgebio.com/news/achondroplasia-investor-call/)
02:57:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:29%20GMT	https://bridgebio.com/?p=6544	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index5857.html	(from https://bridgebio.com/news/achondroplasia-investor-call/)
02:57:29	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.3f7.delayed	(from https://bridgebio.com/news/achondroplasia-investor-call/)
02:57:29	3177/3177	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:57:29%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fachondroplasia-investor-call%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedfd4e	(from https://bridgebio.com/news/achondroplasia-investor-call/)
02:57:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:29%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/achondroplasia-investor-call/)
02:57:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:29%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/achondroplasia-investor-call/)
02:57:30	30555/30555	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:30%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6532	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6532.json	(from https://bridgebio.com/news/additional-data-showing-acoramidis-increases-serum-transthyretin-which-is-associated-with-improved-cardiovascular-outcomes-presented-at-isa-from-bridgebio-pharmas-phase-3-attribute-cm-study-i/)
02:57:31	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/additional-data-showing-acoramidis-increases-serum-transthyretin-which-is-associated-with-improved-cardiovascular-outcomes-presented-at-isa-from-bridgebio-pharmas-phase-3-attribute-cm-study-i/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/additional-data-showing-acoramidis-increases-se/feed/index.html	(from https://bridgebio.com/news/additional-data-showing-acoramidis-increases-serum-transthyretin-which-is-associated-with-improved-cardiovascular-outcomes-presented-at-isa-from-bridgebio-pharmas-phase-3-attribute-cm-study-i/)
02:57:31	3708/3708	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:31%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fadditional-data-showing-acoramidis-increases-serum-transthyretin-which-is-associated-with-improved-cardiovascular-outcomes-presented-at-isa-from-bridgebio-pharmas-phase-3-attribute-cm-study-i%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed82bd.json	(from https://bridgebio.com/news/additional-data-showing-acoramidis-increases-serum-transthyretin-which-is-associated-with-improved-cardiovascular-outcomes-presented-at-isa-from-bridgebio-pharmas-phase-3-attribute-cm-study-i/)
02:57:31	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:31%20GMT	https://bridgebio.com/?p=6532	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexb382.html	(from https://bridgebio.com/news/additional-data-showing-acoramidis-increases-serum-transthyretin-which-is-associated-with-improved-cardiovascular-outcomes-presented-at-isa-from-bridgebio-pharmas-phase-3-attribute-cm-study-i/)
02:57:31	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.3fd.delayed	(from https://bridgebio.com/news/additional-data-showing-acoramidis-increases-serum-transthyretin-which-is-associated-with-improved-cardiovascular-outcomes-presented-at-isa-from-bridgebio-pharmas-phase-3-attribute-cm-study-i/)
02:57:32	3905/3905	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:57:31%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fadditional-data-showing-acoramidis-increases-serum-transthyretin-which-is-associated-with-improved-cardiovascular-outcomes-presented-at-isa-from-bridgebio-pharmas-phase-3-attribute-cm-study-i%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3a13	(from https://bridgebio.com/news/additional-data-showing-acoramidis-increases-serum-transthyretin-which-is-associated-with-improved-cardiovascular-outcomes-presented-at-isa-from-bridgebio-pharmas-phase-3-attribute-cm-study-i/)
02:57:32	162/162	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:32%20GMT	http://bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-aha	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-aha.3fe.delayed	(from https://bridgebio.com/news/additional-data-showing-acoramidis-increases-serum-transthyretin-which-is-associated-with-improved-cardiovascular-outcomes-presented-at-isa-from-bridgebio-pharmas-phase-3-attribute-cm-study-i/)
02:57:32	50612/50612	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:57:32%20GMT	https://bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-aha	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-aha.html	(from https://bridgebio.com/news/additional-data-showing-acoramidis-increases-serum-transthyretin-which-is-associated-with-improved-cardiovascular-outcomes-presented-at-isa-from-bridgebio-pharmas-phase-3-attribute-cm-study-i/)
02:57:33	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:33%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/additional-data-showing-acoramidis-increases-serum-transthyretin-which-is-associated-with-improved-cardiovascular-outcomes-presented-at-isa-from-bridgebio-pharmas-phase-3-attribute-cm-study-i/)
02:57:33	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:33%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/additional-data-showing-acoramidis-increases-serum-transthyretin-which-is-associated-with-improved-cardiovascular-outcomes-presented-at-isa-from-bridgebio-pharmas-phase-3-attribute-cm-study-i/)
02:57:34	29942/29942	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:34%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6521	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6521.json	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-analyses-from-the-phase-3-attribute-cm-study-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-2024-isa-meeting/)
02:57:34	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-present-additional-analyses-from-the-phase-3-attribute-cm-study-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-2024-isa-meeting/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-present-additional-analyses/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-analyses-from-the-phase-3-attribute-cm-study-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-2024-isa-meeting/)
02:57:34	3516/3516	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:34%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-present-additional-analyses-from-the-phase-3-attribute-cm-study-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-2024-isa-meeting%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8370.json	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-analyses-from-the-phase-3-attribute-cm-study-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-2024-isa-meeting/)
02:57:34	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:35%20GMT	https://bridgebio.com/?p=6521	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index8242.html	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-analyses-from-the-phase-3-attribute-cm-study-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-2024-isa-meeting/)
02:57:35	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.405.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-analyses-from-the-phase-3-attribute-cm-study-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-2024-isa-meeting/)
02:57:35	3708/3708	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:57:35%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-present-additional-analyses-from-the-phase-3-attribute-cm-study-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-2024-isa-meeting%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5be1	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-analyses-from-the-phase-3-attribute-cm-study-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-2024-isa-meeting/)
02:57:35	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:35%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-analyses-from-the-phase-3-attribute-cm-study-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-2024-isa-meeting/)
02:57:35	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:35%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-analyses-from-the-phase-3-attribute-cm-study-of-acoramidis-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-2024-isa-meeting/)
02:57:36	13944/13944	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:36%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6509	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6509.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-38/)
02:57:36	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-38/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-38/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-38/)
02:57:36	2974/2974	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:36%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-38%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0c66.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-38/)
02:57:37	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:37%20GMT	https://bridgebio.com/?p=6509	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index526f.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-38/)
02:57:37	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.40b.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-38/)
02:57:37	3174/3174	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:57:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-38%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedeacb	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-38/)
02:57:37	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:37%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-38/)
02:57:37	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:37%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-38/)
02:57:38	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734516000	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style099b.css	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024/)
02:57:38	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024/)
02:57:38	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734516000	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css099b.css	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024/)
02:57:39	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734516000	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust099b.css	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024/)
02:57:39	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734516000	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts099b.js	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024/)
02:57:39	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734516000	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal099b.js	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024/)
02:57:39	13949/13949	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:40%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6507	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6507.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024/)
02:57:40	3090/3090	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:40%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedbac0.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024/)
02:57:40	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:40%20GMT	https://bridgebio.com/?p=6507	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index9077.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024/)
02:57:40	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.416.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024/)
02:57:40	3289/3289	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:57:40%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5198	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024/)
02:57:41	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:41%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024/)
02:57:41	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:41%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference-2024/)
02:57:42	28878/28878	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:42%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6500	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6500.json	(from https://bridgebio.com/news/bridgebio-pharma-presents-additional-data-and-analyses-from-its-phase-3-attribute-cm-study-in-transthyretin-amyloid-cardiomyopathy-attr-cm-at-esc-hf-including-that-acoramidis-treatment-significantl/)
02:57:42	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-presents-additional-data-and-analyses-from-its-phase-3-attribute-cm-study-in-transthyretin-amyloid-cardiomyopathy-attr-cm-at-esc-hf-including-that-acoramidis-treatment-significantl/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-presents-additional-data-and-a/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-presents-additional-data-and-analyses-from-its-phase-3-attribute-cm-study-in-transthyretin-amyloid-cardiomyopathy-attr-cm-at-esc-hf-including-that-acoramidis-treatment-significantl/)
02:57:42	3916/3916	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:42%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-presents-additional-data-and-analyses-from-its-phase-3-attribute-cm-study-in-transthyretin-amyloid-cardiomyopathy-attr-cm-at-esc-hf-including-that-acoramidis-treatment-significantl%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede04e.json	(from https://bridgebio.com/news/bridgebio-pharma-presents-additional-data-and-analyses-from-its-phase-3-attribute-cm-study-in-transthyretin-amyloid-cardiomyopathy-attr-cm-at-esc-hf-including-that-acoramidis-treatment-significantl/)
02:57:42	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:42%20GMT	https://bridgebio.com/?p=6500	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexc5c8.html	(from https://bridgebio.com/news/bridgebio-pharma-presents-additional-data-and-analyses-from-its-phase-3-attribute-cm-study-in-transthyretin-amyloid-cardiomyopathy-attr-cm-at-esc-hf-including-that-acoramidis-treatment-significantl/)
02:57:42	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.41c.delayed	(from https://bridgebio.com/news/bridgebio-pharma-presents-additional-data-and-analyses-from-its-phase-3-attribute-cm-study-in-transthyretin-amyloid-cardiomyopathy-attr-cm-at-esc-hf-including-that-acoramidis-treatment-significantl/)
02:57:42	4107/4107	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:57:43%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-presents-additional-data-and-analyses-from-its-phase-3-attribute-cm-study-in-transthyretin-amyloid-cardiomyopathy-attr-cm-at-esc-hf-including-that-acoramidis-treatment-significantl%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8293	(from https://bridgebio.com/news/bridgebio-pharma-presents-additional-data-and-analyses-from-its-phase-3-attribute-cm-study-in-transthyretin-amyloid-cardiomyopathy-attr-cm-at-esc-hf-including-that-acoramidis-treatment-significantl/)
02:57:43	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:43%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-presents-additional-data-and-analyses-from-its-phase-3-attribute-cm-study-in-transthyretin-amyloid-cardiomyopathy-attr-cm-at-esc-hf-including-that-acoramidis-treatment-significantl/)
02:57:43	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:43%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-presents-additional-data-and-analyses-from-its-phase-3-attribute-cm-study-in-transthyretin-amyloid-cardiomyopathy-attr-cm-at-esc-hf-including-that-acoramidis-treatment-significantl/)
02:57:43	146/146	---MCZ	404	error ('Not%20Found')	text/html	date:Wed,%2018%20Dec%202024%2010:57:43%20GMT	http://bridgebio.com/wp-content/uploads/2024/05/2024-Financial-Results-tables-5.1.24_Page_1.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/05/2024-Financial-Results-tables-5.1.24_Page_1.png	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/)
02:57:44	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734510060	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/styled56f.css	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/)
02:57:44	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/)
02:57:44	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734510060	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-cssd56f.css	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/)
02:57:44	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734510060	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrustd56f.css	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/)
02:57:45	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734510060	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptsd56f.js	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/)
02:57:45	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734510060	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modald56f.js	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/)
02:57:45	33093/33093	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:46%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6472	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6472.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/)
02:57:46	2989/2989	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:46%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9a2c.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/)
02:57:46	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:46%20GMT	https://bridgebio.com/?p=6472	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index1579.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/)
02:57:46	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.428.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/)
02:57:47	3146/3146	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:57:46%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedbf02	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/)
02:57:47	146/146	---MCZ	404	error ('Not%20Found')	text/html	date:Wed,%2018%20Dec%202024%2010:57:47%20GMT	http://bridgebio.com/wp-content/uploads/2024/05/2024-Financial-Results-tables-5.1.24_Page_2.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/05/2024-Financial-Results-tables-5.1.24_Page_2.png	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/)
02:57:47	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:47%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/)
02:57:47	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:47%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2024-financial-results-and-business-update/)
02:57:48	23817/23817	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:48%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6473	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6473.json	(from https://bridgebio.com/news/bridgebio-launches-bridgebio-oncology-therapeutics-bbot-with-200m-of-private-external-capital-to-accelerate-the-development-of-its-novel-precision-oncology-pipeline/)
02:57:48	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-launches-bridgebio-oncology-therapeutics-bbot-with-200m-of-private-external-capital-to-accelerate-the-development-of-its-novel-precision-oncology-pipeline/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-launches-bridgebio-oncology-therapeut/feed/index.html	(from https://bridgebio.com/news/bridgebio-launches-bridgebio-oncology-therapeutics-bbot-with-200m-of-private-external-capital-to-accelerate-the-development-of-its-novel-precision-oncology-pipeline/)
02:57:48	3416/3416	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:48%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-launches-bridgebio-oncology-therapeutics-bbot-with-200m-of-private-external-capital-to-accelerate-the-development-of-its-novel-precision-oncology-pipeline%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeda9d6.json	(from https://bridgebio.com/news/bridgebio-launches-bridgebio-oncology-therapeutics-bbot-with-200m-of-private-external-capital-to-accelerate-the-development-of-its-novel-precision-oncology-pipeline/)
02:57:49	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:49%20GMT	https://bridgebio.com/?p=6473	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index9572.html	(from https://bridgebio.com/news/bridgebio-launches-bridgebio-oncology-therapeutics-bbot-with-200m-of-private-external-capital-to-accelerate-the-development-of-its-novel-precision-oncology-pipeline/)
02:57:49	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.42f.delayed	(from https://bridgebio.com/news/bridgebio-launches-bridgebio-oncology-therapeutics-bbot-with-200m-of-private-external-capital-to-accelerate-the-development-of-its-novel-precision-oncology-pipeline/)
02:57:49	3605/3605	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:57:49%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-launches-bridgebio-oncology-therapeutics-bbot-with-200m-of-private-external-capital-to-accelerate-the-development-of-its-novel-precision-oncology-pipeline%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc7ba	(from https://bridgebio.com/news/bridgebio-launches-bridgebio-oncology-therapeutics-bbot-with-200m-of-private-external-capital-to-accelerate-the-development-of-its-novel-precision-oncology-pipeline/)
02:57:49	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:49%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-launches-bridgebio-oncology-therapeutics-bbot-with-200m-of-private-external-capital-to-accelerate-the-development-of-its-novel-precision-oncology-pipeline/)
02:57:49	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:49%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-launches-bridgebio-oncology-therapeutics-bbot-with-200m-of-private-external-capital-to-accelerate-the-development-of-its-novel-precision-oncology-pipeline/)
02:57:50	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734514380	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style81cb.css	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37/)
02:57:50	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37/)
02:57:50	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734514380	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css81cb.css	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37/)
02:57:51	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734514380	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust81cb.css	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37/)
02:57:51	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734514380	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts81cb.js	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37/)
02:57:51	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734514380	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal81cb.js	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37/)
02:57:52	13928/13928	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:52%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6407	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6407.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37/)
02:57:52	2978/2978	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:52%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb2e7.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37/)
02:57:52	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:52%20GMT	https://bridgebio.com/?p=6407	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexa59c.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37/)
02:57:52	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.43a.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37/)
02:57:52	3178/3178	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:57:52%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd73a	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37/)
02:57:53	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:53%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37/)
02:57:53	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:53%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-37/)
02:57:54	26464/26464	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:54%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6405	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6405.json	(from https://bridgebio.com/news/bridgebio-pharma-presents-cardiac-magnetic-resonance-cmr-imaging-evidence-consistent-with-clinical-improvement-observed-in-the-attribute-cm-phase-3-study-in-patients-with-transthyretin-amyloid-cardi/)
02:57:54	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-presents-cardiac-magnetic-resonance-cmr-imaging-evidence-consistent-with-clinical-improvement-observed-in-the-attribute-cm-phase-3-study-in-patients-with-transthyretin-amyloid-cardi/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-presents-cardiac-magnetic-reso/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-presents-cardiac-magnetic-resonance-cmr-imaging-evidence-consistent-with-clinical-improvement-observed-in-the-attribute-cm-phase-3-study-in-patients-with-transthyretin-amyloid-cardi/)
02:57:54	3665/3665	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:54%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-presents-cardiac-magnetic-resonance-cmr-imaging-evidence-consistent-with-clinical-improvement-observed-in-the-attribute-cm-phase-3-study-in-patients-with-transthyretin-amyloid-cardi%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc995.json	(from https://bridgebio.com/news/bridgebio-pharma-presents-cardiac-magnetic-resonance-cmr-imaging-evidence-consistent-with-clinical-improvement-observed-in-the-attribute-cm-phase-3-study-in-patients-with-transthyretin-amyloid-cardi/)
02:57:54	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:54%20GMT	https://bridgebio.com/?p=6405	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index4b0b.html	(from https://bridgebio.com/news/bridgebio-pharma-presents-cardiac-magnetic-resonance-cmr-imaging-evidence-consistent-with-clinical-improvement-observed-in-the-attribute-cm-phase-3-study-in-patients-with-transthyretin-amyloid-cardi/)
02:57:54	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.440.delayed	(from https://bridgebio.com/news/bridgebio-pharma-presents-cardiac-magnetic-resonance-cmr-imaging-evidence-consistent-with-clinical-improvement-observed-in-the-attribute-cm-phase-3-study-in-patients-with-transthyretin-amyloid-cardi/)
02:57:54	3857/3857	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:57:55%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-presents-cardiac-magnetic-resonance-cmr-imaging-evidence-consistent-with-clinical-improvement-observed-in-the-attribute-cm-phase-3-study-in-patients-with-transthyretin-amyloid-cardi%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1268	(from https://bridgebio.com/news/bridgebio-pharma-presents-cardiac-magnetic-resonance-cmr-imaging-evidence-consistent-with-clinical-improvement-observed-in-the-attribute-cm-phase-3-study-in-patients-with-transthyretin-amyloid-cardi/)
02:57:55	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:55%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-presents-cardiac-magnetic-resonance-cmr-imaging-evidence-consistent-with-clinical-improvement-observed-in-the-attribute-cm-phase-3-study-in-patients-with-transthyretin-amyloid-cardi/)
02:57:55	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:55%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-presents-cardiac-magnetic-resonance-cmr-imaging-evidence-consistent-with-clinical-improvement-observed-in-the-attribute-cm-phase-3-study-in-patients-with-transthyretin-amyloid-cardi/)
02:57:56	41800/41800	---MCZ	200	added ('OK')	text/html	date:Wed,%2018%20Dec%202024%2010:57:56%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36/)
02:57:56	16799/16799	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:56%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6379	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6379.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock-2/)
02:57:56	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock-2/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock-2/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock-2/)
02:57:56	2904/2904	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:56%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-pricing-of-public-offering-of-common-stock-2%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8b8b.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock-2/)
02:57:56	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:56%20GMT	https://bridgebio.com/?p=6379	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index2928.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock-2/)
02:57:56	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.446.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock-2/)
02:57:56	3098/3098	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:57:57%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-pricing-of-public-offering-of-common-stock-2%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf570	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock-2/)
02:57:57	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:57%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock-2/)
02:57:57	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:57%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock-2/)
02:57:58	17000/17000	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:58%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6373	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6373.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock-2/)
02:57:58	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock-2/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock-2/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock-2/)
02:57:58	2904/2904	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:57:58%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-proposed-public-offering-of-common-stock-2%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed084e.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock-2/)
02:57:58	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:58%20GMT	https://bridgebio.com/?p=6373	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index7349.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock-2/)
02:57:58	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.44c.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock-2/)
02:57:58	3098/3098	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:57:59%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-proposed-public-offering-of-common-stock-2%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9487	(from https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock-2/)
02:57:59	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:59%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock-2/)
02:57:59	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:57:59%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock-2/)
02:58:00	22369/22369	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:00%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6369	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6369.json	(from https://bridgebio.com/news/bridgebio-pharma-and-bayer-announce-european-licensing-agreement-for-acoramidis-in-attr-cm/)
02:58:00	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-and-bayer-announce-european-licensing-agreement-for-acoramidis-in-attr-cm/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-bayer-announce-european-licensing-agreement-for-acoramidis-in-attr-cm/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-and-bayer-announce-european-licensing-agreement-for-acoramidis-in-attr-cm/)
02:58:00	3035/3035	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:00%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-bayer-announce-european-licensing-agreement-for-acoramidis-in-attr-cm%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed390d.json	(from https://bridgebio.com/news/bridgebio-pharma-and-bayer-announce-european-licensing-agreement-for-acoramidis-in-attr-cm/)
02:58:00	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:00%20GMT	https://bridgebio.com/?p=6369	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index72f0.html	(from https://bridgebio.com/news/bridgebio-pharma-and-bayer-announce-european-licensing-agreement-for-acoramidis-in-attr-cm/)
02:58:00	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.452.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-bayer-announce-european-licensing-agreement-for-acoramidis-in-attr-cm/)
02:58:01	3227/3227	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:58:01%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-bayer-announce-european-licensing-agreement-for-acoramidis-in-attr-cm%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed83de	(from https://bridgebio.com/news/bridgebio-pharma-and-bayer-announce-european-licensing-agreement-for-acoramidis-in-attr-cm/)
02:58:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:01%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-and-bayer-announce-european-licensing-agreement-for-acoramidis-in-attr-cm/)
02:58:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:01%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-and-bayer-announce-european-licensing-agreement-for-acoramidis-in-attr-cm/)
02:58:04	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734514200	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/stylef29a.css	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/)
02:58:04	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734514200	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-cssf29a.css	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/)
02:58:04	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/)
02:58:04	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734514200	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrustf29a.css	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/)
02:58:05	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734514200	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptsf29a.js	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/)
02:58:10	201407/201407	---M--	200	added ('OK')	image/jpeg	etag:%2266829c01-407a4%22	http://bridgebio.com/wp-content/uploads/2024/02/bbio-er-Q4-2023_2.21.2024_Page_1.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/02/bbio-er-Q4-2023_2.21.2024_Page_1.jpg	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/)
02:58:10	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734514200	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modalf29a.js	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/)
02:58:11	38290/38290	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:11%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6343	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6343.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/)
02:58:11	2976/2976	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:11%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedeeba.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/)
02:58:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:11%20GMT	https://bridgebio.com/?p=6343	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index954f.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/)
02:58:12	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.45e.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/)
02:58:12	3133/3133	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:58:12%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed4bb5	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/)
02:58:26	103380/103380	---M--	200	added ('OK')	image/jpeg	etag:%2266829bfd-274d7%22	https://bridgebio.com/wp-content/uploads/2024/02/bbio-er-Q4-2023_2.21.2024_Page_4.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/02/bbio-er-Q4-2023_2.21.2024_Page_4.jpg	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/)
02:58:26	141750/141750	---M--	200	added ('OK')	image/jpeg	etag:%2266829bfb-30920%22	http://bridgebio.com/wp-content/uploads/2024/02/bbio-er-Q4-2023_2.21.2024_Page_2.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/02/bbio-er-Q4-2023_2.21.2024_Page_2.jpg	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/)
02:58:26	275422/275422	---M--	200	added ('OK')	image/jpeg	etag:%2266829bfc-52453%22	https://bridgebio.com/wp-content/uploads/2024/02/bbio-er-Q4-2023_2.21.2024_Page_3.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2024/02/bbio-er-Q4-2023_2.21.2024_Page_3.jpg	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/)
02:58:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:13%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/)
02:58:27	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:27%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and-business-update/)
02:58:28	26825/26825	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:27%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6285	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6285.json	(from https://bridgebio.com/news/bridgebio-pharma-and-kyowa-kirin-announce-partnership-with-an-upfront-payment-of-100-million-for-an-exclusive-license-on-infigratinib-in-skeletal-dysplasias-in-japan/)
02:58:28	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-and-kyowa-kirin-announce-partnership-with-an-upfront-payment-of-100-million-for-an-exclusive-license-on-infigratinib-in-skeletal-dysplasias-in-japan/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-kyowa-kirin-announce-partn/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-and-kyowa-kirin-announce-partnership-with-an-upfront-payment-of-100-million-for-an-exclusive-license-on-infigratinib-in-skeletal-dysplasias-in-japan/)
02:58:28	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:28%20GMT	https://bridgebio.com/?p=6285	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index76a7.html	(from https://bridgebio.com/news/bridgebio-pharma-and-kyowa-kirin-announce-partnership-with-an-upfront-payment-of-100-million-for-an-exclusive-license-on-infigratinib-in-skeletal-dysplasias-in-japan/)
02:58:28	3409/3409	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:29%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-kyowa-kirin-announce-partnership-with-an-upfront-payment-of-100-million-for-an-exclusive-license-on-infigratinib-in-skeletal-dysplasias-in-japan%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeddfb6.json	(from https://bridgebio.com/news/bridgebio-pharma-and-kyowa-kirin-announce-partnership-with-an-upfront-payment-of-100-million-for-an-exclusive-license-on-infigratinib-in-skeletal-dysplasias-in-japan/)
02:58:29	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.467.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-kyowa-kirin-announce-partnership-with-an-upfront-payment-of-100-million-for-an-exclusive-license-on-infigratinib-in-skeletal-dysplasias-in-japan/)
02:58:29	3601/3601	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:58:29%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-kyowa-kirin-announce-partnership-with-an-upfront-payment-of-100-million-for-an-exclusive-license-on-infigratinib-in-skeletal-dysplasias-in-japan%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd7c1	(from https://bridgebio.com/news/bridgebio-pharma-and-kyowa-kirin-announce-partnership-with-an-upfront-payment-of-100-million-for-an-exclusive-license-on-infigratinib-in-skeletal-dysplasias-in-japan/)
02:58:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:29%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-and-kyowa-kirin-announce-partnership-with-an-upfront-payment-of-100-million-for-an-exclusive-license-on-infigratinib-in-skeletal-dysplasias-in-japan/)
02:58:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:29%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-and-kyowa-kirin-announce-partnership-with-an-upfront-payment-of-100-million-for-an-exclusive-license-on-infigratinib-in-skeletal-dysplasias-in-japan/)
02:58:30	13970/13970	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:30%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6282	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6282.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-35/)
02:58:30	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-35/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-35/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-35/)
02:58:31	2993/2993	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:31%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-35%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed62f1.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-35/)
02:58:31	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:31%20GMT	https://bridgebio.com/?p=6282	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index29e8.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-35/)
02:58:31	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.46d.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-35/)
02:58:31	3193/3193	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:58:31%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-35%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd2ab	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-35/)
02:58:31	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:31%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-35/)
02:58:32	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:32%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-35/)
02:58:32	24175/24175	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:32%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6281	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6281.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-u-s-food-and-drug-administration-fda-acceptance-of-new-drug-application-nda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-attr/)
02:58:33	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-u-s-food-and-drug-administration-fda-acceptance-of-new-drug-application-nda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-attr/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-u-s-food-and-drug-ad/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-u-s-food-and-drug-administration-fda-acceptance-of-new-drug-application-nda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-attr/)
02:58:33	3591/3591	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:33%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-u-s-food-and-drug-administration-fda-acceptance-of-new-drug-application-nda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-attr%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf449.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-u-s-food-and-drug-administration-fda-acceptance-of-new-drug-application-nda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-attr/)
02:58:33	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:33%20GMT	https://bridgebio.com/?p=6281	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index0368.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-u-s-food-and-drug-administration-fda-acceptance-of-new-drug-application-nda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-attr/)
02:58:33	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.473.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-u-s-food-and-drug-administration-fda-acceptance-of-new-drug-application-nda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-attr/)
02:58:33	3783/3783	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:58:33%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-u-s-food-and-drug-administration-fda-acceptance-of-new-drug-application-nda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-attr%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeda5e9	(from https://bridgebio.com/news/bridgebio-pharma-announces-u-s-food-and-drug-administration-fda-acceptance-of-new-drug-application-nda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-attr/)
02:58:33	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:33%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-announces-u-s-food-and-drug-administration-fda-acceptance-of-new-drug-application-nda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-attr/)
02:58:34	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:34%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-u-s-food-and-drug-administration-fda-acceptance-of-new-drug-application-nda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-attr/)
02:58:34	22300/22300	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:34%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6277	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6277.json	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-results-of-single-arm-phase-3-study-of-acoramidis-in-japanese-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-including-no-mortality-reported-in-the-trial/)
02:58:35	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-shares-positive-results-of-single-arm-phase-3-study-of-acoramidis-in-japanese-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-including-no-mortality-reported-in-the-trial/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-shares-positive-results-of-sin/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-results-of-single-arm-phase-3-study-of-acoramidis-in-japanese-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-including-no-mortality-reported-in-the-trial/)
02:58:35	3631/3631	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:35%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-shares-positive-results-of-single-arm-phase-3-study-of-acoramidis-in-japanese-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-including-no-mortality-reported-in-the-trial%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedaacd.json	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-results-of-single-arm-phase-3-study-of-acoramidis-in-japanese-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-including-no-mortality-reported-in-the-trial/)
02:58:35	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:35%20GMT	https://bridgebio.com/?p=6277	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index3abd.html	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-results-of-single-arm-phase-3-study-of-acoramidis-in-japanese-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-including-no-mortality-reported-in-the-trial/)
02:58:35	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.479.delayed	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-results-of-single-arm-phase-3-study-of-acoramidis-in-japanese-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-including-no-mortality-reported-in-the-trial/)
02:58:35	3824/3824	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:58:35%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-shares-positive-results-of-single-arm-phase-3-study-of-acoramidis-in-japanese-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-including-no-mortality-reported-in-the-trial%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5462	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-results-of-single-arm-phase-3-study-of-acoramidis-in-japanese-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-including-no-mortality-reported-in-the-trial/)
02:58:36	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:36%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-results-of-single-arm-phase-3-study-of-acoramidis-in-japanese-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-including-no-mortality-reported-in-the-trial/)
02:58:36	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:36%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-results-of-single-arm-phase-3-study-of-acoramidis-in-japanese-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-including-no-mortality-reported-in-the-trial/)
02:58:36	25865/25865	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:37%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6259	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6259.json	(from https://bridgebio.com/news/bridgebio-pharma-secures-up-to-1-25-billion-of-capital-from-blue-owl-and-cpp-investments-to-accelerate-the-development-and-launch-of-genetic-medicines/)
02:58:37	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-secures-up-to-1-25-billion-of-capital-from-blue-owl-and-cpp-investments-to-accelerate-the-development-and-launch-of-genetic-medicines/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-secures-up-to-1-25-billion-of-/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-secures-up-to-1-25-billion-of-capital-from-blue-owl-and-cpp-investments-to-accelerate-the-development-and-launch-of-genetic-medicines/)
02:58:37	3258/3258	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-secures-up-to-1-25-billion-of-capital-from-blue-owl-and-cpp-investments-to-accelerate-the-development-and-launch-of-genetic-medicines%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed617e.json	(from https://bridgebio.com/news/bridgebio-pharma-secures-up-to-1-25-billion-of-capital-from-blue-owl-and-cpp-investments-to-accelerate-the-development-and-launch-of-genetic-medicines/)
02:58:37	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:37%20GMT	https://bridgebio.com/?p=6259	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index5fe6.html	(from https://bridgebio.com/news/bridgebio-pharma-secures-up-to-1-25-billion-of-capital-from-blue-owl-and-cpp-investments-to-accelerate-the-development-and-launch-of-genetic-medicines/)
02:58:37	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.47f.delayed	(from https://bridgebio.com/news/bridgebio-pharma-secures-up-to-1-25-billion-of-capital-from-blue-owl-and-cpp-investments-to-accelerate-the-development-and-launch-of-genetic-medicines/)
02:58:37	3449/3449	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:58:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-secures-up-to-1-25-billion-of-capital-from-blue-owl-and-cpp-investments-to-accelerate-the-development-and-launch-of-genetic-medicines%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedeb7c	(from https://bridgebio.com/news/bridgebio-pharma-secures-up-to-1-25-billion-of-capital-from-blue-owl-and-cpp-investments-to-accelerate-the-development-and-launch-of-genetic-medicines/)
02:58:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:38%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-secures-up-to-1-25-billion-of-capital-from-blue-owl-and-cpp-investments-to-accelerate-the-development-and-launch-of-genetic-medicines/)
02:58:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:38%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-secures-up-to-1-25-billion-of-capital-from-blue-owl-and-cpp-investments-to-accelerate-the-development-and-launch-of-genetic-medicines/)
02:58:38	23573/23573	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:39%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6240	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6240.json	(from https://bridgebio.com/news/nejm-pr-post/)
02:58:39	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/nejm-pr-post/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/nejm-pr-post/feed/index.html	(from https://bridgebio.com/news/nejm-pr-post/)
02:58:39	3229/3229	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:39%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fnejm-pr-post%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3b8a.json	(from https://bridgebio.com/news/nejm-pr-post/)
02:58:39	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:39%20GMT	https://bridgebio.com/?p=6240	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index2ee7.html	(from https://bridgebio.com/news/nejm-pr-post/)
02:58:39	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.485.delayed	(from https://bridgebio.com/news/nejm-pr-post/)
02:58:39	3420/3420	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:58:40%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fnejm-pr-post%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeddc3b	(from https://bridgebio.com/news/nejm-pr-post/)
02:58:40	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:40%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/nejm-pr-post/)
02:58:40	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:40%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/nejm-pr-post/)
02:58:41	13941/13941	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:41%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6241	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6241.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-34/)
02:58:41	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-34/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-34/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-34/)
02:58:41	2984/2984	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:41%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-34%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0717.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-34/)
02:58:41	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:41%20GMT	https://bridgebio.com/?p=6241	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index8769.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-34/)
02:58:42	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.48b.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-34/)
02:58:42	3184/3184	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:58:42%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-34%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed975e	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-34/)
02:58:42	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:42%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-34/)
02:58:42	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:42%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-34/)
02:58:43	13435/13435	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:43%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6166	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6166.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference-2/)
02:58:43	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference-2/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference-2/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference-2/)
02:58:43	2941/2941	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:43%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference-2%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed33e6.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference-2/)
02:58:44	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:44%20GMT	https://bridgebio.com/?p=6166	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index70cf.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference-2/)
02:58:44	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.491.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference-2/)
02:58:44	3139/3139	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:58:44%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference-2%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8870	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference-2/)
02:58:44	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:44%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference-2/)
02:58:44	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:44%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference-2/)
02:58:45	21227/21227	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:45%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6168	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6168.json	(from https://bridgebio.com/news/bridgebio-announces-fda-clearance-of-ind-application-for-bbo-8520-a-first-in-class-direct-inhibitor-of-krasg12c-on/)
02:58:45	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-announces-fda-clearance-of-ind-application-for-bbo-8520-a-first-in-class-direct-inhibitor-of-krasg12c-on/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-announces-fda-clearance-of-ind-application-for-bbo-8520-a-first-in-class-direct-inhibitor-of-krasg12c-on/feed/index.html	(from https://bridgebio.com/news/bridgebio-announces-fda-clearance-of-ind-application-for-bbo-8520-a-first-in-class-direct-inhibitor-of-krasg12c-on/)
02:58:45	3145/3145	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:45%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-announces-fda-clearance-of-ind-application-for-bbo-8520-a-first-in-class-direct-inhibitor-of-krasg12c-on%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embededfc.json	(from https://bridgebio.com/news/bridgebio-announces-fda-clearance-of-ind-application-for-bbo-8520-a-first-in-class-direct-inhibitor-of-krasg12c-on/)
02:58:46	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:46%20GMT	https://bridgebio.com/?p=6168	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexfe96.html	(from https://bridgebio.com/news/bridgebio-announces-fda-clearance-of-ind-application-for-bbo-8520-a-first-in-class-direct-inhibitor-of-krasg12c-on/)
02:58:46	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.497.delayed	(from https://bridgebio.com/news/bridgebio-announces-fda-clearance-of-ind-application-for-bbo-8520-a-first-in-class-direct-inhibitor-of-krasg12c-on/)
02:58:46	3334/3334	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:58:46%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-announces-fda-clearance-of-ind-application-for-bbo-8520-a-first-in-class-direct-inhibitor-of-krasg12c-on%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedbeca	(from https://bridgebio.com/news/bridgebio-announces-fda-clearance-of-ind-application-for-bbo-8520-a-first-in-class-direct-inhibitor-of-krasg12c-on/)
02:58:46	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:46%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-announces-fda-clearance-of-ind-application-for-bbo-8520-a-first-in-class-direct-inhibitor-of-krasg12c-on/)
02:58:46	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:46%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-announces-fda-clearance-of-ind-application-for-bbo-8520-a-first-in-class-direct-inhibitor-of-krasg12c-on/)
02:58:47	25614/25614	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:47%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6148	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6148.json	(from https://bridgebio.com/news/bridgebio-announces-first-child-dosed-with-infigratinib-in-propel-3-its-phase-3-clinical-trial-in-children-with-achondroplasia/)
02:58:47	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-announces-first-child-dosed-with-infigratinib-in-propel-3-its-phase-3-clinical-trial-in-children-with-achondroplasia/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-announces-first-child-dosed-with-infigratinib-in-propel-3-its-phase-3-clinical-trial-in-children-with-achondroplasia/feed/index.html	(from https://bridgebio.com/news/bridgebio-announces-first-child-dosed-with-infigratinib-in-propel-3-its-phase-3-clinical-trial-in-children-with-achondroplasia/)
02:58:47	3192/3192	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:48%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-announces-first-child-dosed-with-infigratinib-in-propel-3-its-phase-3-clinical-trial-in-children-with-achondroplasia%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedefa9.json	(from https://bridgebio.com/news/bridgebio-announces-first-child-dosed-with-infigratinib-in-propel-3-its-phase-3-clinical-trial-in-children-with-achondroplasia/)
02:58:48	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:48%20GMT	https://bridgebio.com/?p=6148	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexb139.html	(from https://bridgebio.com/news/bridgebio-announces-first-child-dosed-with-infigratinib-in-propel-3-its-phase-3-clinical-trial-in-children-with-achondroplasia/)
02:58:48	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.49d.delayed	(from https://bridgebio.com/news/bridgebio-announces-first-child-dosed-with-infigratinib-in-propel-3-its-phase-3-clinical-trial-in-children-with-achondroplasia/)
02:58:48	3383/3383	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:58:48%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-announces-first-child-dosed-with-infigratinib-in-propel-3-its-phase-3-clinical-trial-in-children-with-achondroplasia%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1407	(from https://bridgebio.com/news/bridgebio-announces-first-child-dosed-with-infigratinib-in-propel-3-its-phase-3-clinical-trial-in-children-with-achondroplasia/)
02:58:48	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:48%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-announces-first-child-dosed-with-infigratinib-in-propel-3-its-phase-3-clinical-trial-in-children-with-achondroplasia/)
02:58:48	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:49%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-announces-first-child-dosed-with-infigratinib-in-propel-3-its-phase-3-clinical-trial-in-children-with-achondroplasia/)
02:58:49	13933/13933	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:49%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6149	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6149.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-33/)
02:58:49	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-33/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-33/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-33/)
02:58:49	2988/2988	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:50%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-33%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedacc1.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-33/)
02:58:50	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:50%20GMT	https://bridgebio.com/?p=6149	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index848b.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-33/)
02:58:50	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.4a3.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-33/)
02:58:50	3188/3188	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:58:50%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-33%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeddff0	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-33/)
02:58:50	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:50%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-33/)
02:58:50	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:51%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-33/)
02:58:51	24093/24093	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:51%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6146	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6146.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-submission-of-new-drug-application-nda-to-u-s-food-and-drug-administration-fda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-a/)
02:58:51	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-submission-of-new-drug-application-nda-to-u-s-food-and-drug-administration-fda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-a/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-submission-of-new-dr/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-submission-of-new-drug-application-nda-to-u-s-food-and-drug-administration-fda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-a/)
02:58:51	3591/3591	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:52%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-submission-of-new-drug-application-nda-to-u-s-food-and-drug-administration-fda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-a%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8aa1.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-submission-of-new-drug-application-nda-to-u-s-food-and-drug-administration-fda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-a/)
02:58:52	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:52%20GMT	https://bridgebio.com/?p=6146	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index77d4.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-submission-of-new-drug-application-nda-to-u-s-food-and-drug-administration-fda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-a/)
02:58:52	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.4a9.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-submission-of-new-drug-application-nda-to-u-s-food-and-drug-administration-fda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-a/)
02:58:52	3781/3781	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:58:52%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-submission-of-new-drug-application-nda-to-u-s-food-and-drug-administration-fda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-a%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed203f	(from https://bridgebio.com/news/bridgebio-pharma-announces-submission-of-new-drug-application-nda-to-u-s-food-and-drug-administration-fda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-a/)
02:58:52	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:52%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-announces-submission-of-new-drug-application-nda-to-u-s-food-and-drug-administration-fda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-a/)
02:58:53	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:53%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-submission-of-new-drug-application-nda-to-u-s-food-and-drug-administration-fda-for-acoramidis-for-the-treatment-of-patients-with-transthyretin-amyloid-cardiomyopathy-a/)
02:58:53	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734510780	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/stylee000.css	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-data-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-american-heart-association-aha-scientific-sessi/)
02:58:54	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-present-additional-data-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-american-heart-association-aha-scientific-sessi/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-present-additional-data-fro/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-data-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-american-heart-association-aha-scientific-sessi/)
02:58:54	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734510780	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-csse000.css	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-data-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-american-heart-association-aha-scientific-sessi/)
02:58:54	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734510780	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetruste000.css	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-data-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-american-heart-association-aha-scientific-sessi/)
02:58:54	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734510780	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptse000.js	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-data-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-american-heart-association-aha-scientific-sessi/)
02:58:54	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734510780	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modale000.js	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-data-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-american-heart-association-aha-scientific-sessi/)
02:58:55	18038/18038	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:55%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6134	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6134.json	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-data-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-american-heart-association-aha-scientific-sessi/)
02:58:55	3609/3609	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:55%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-present-additional-data-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-american-heart-association-aha-scientific-sessi%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1f69.json	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-data-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-american-heart-association-aha-scientific-sessi/)
02:58:55	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:55%20GMT	https://bridgebio.com/?p=6134	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index76a7-2.html	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-data-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-american-heart-association-aha-scientific-sessi/)
02:58:55	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.4b4.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-data-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-american-heart-association-aha-scientific-sessi/)
02:58:56	3807/3807	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:58:56%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-present-additional-data-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-american-heart-association-aha-scientific-sessi%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2adf	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-data-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-american-heart-association-aha-scientific-sessi/)
02:58:56	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:56%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-data-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-american-heart-association-aha-scientific-sessi/)
02:58:56	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:56%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-present-additional-data-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-the-american-heart-association-aha-scientific-sessi/)
02:58:57	13975/13975	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:57%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6131	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6131.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-32/)
02:58:57	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-32/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-32/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-32/)
02:58:57	2994/2994	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:57%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-32%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed81e8.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-32/)
02:58:57	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:57%20GMT	https://bridgebio.com/?p=6131	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexdff3.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-32/)
02:58:58	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.4ba.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-32/)
02:58:58	3194/3194	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:58:58%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-32%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed019c	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-32/)
02:58:58	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:58%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-32/)
02:58:58	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:58:58%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-32/)
02:59:02	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update/)
02:59:02	2946/2946	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:00%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9f47.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update/)
02:59:03	42687/42687	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:58:59%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6119	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6119.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update/)
02:59:03	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.4c1.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update/)
02:59:03	3105/3105	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:59:03%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf27b	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update/)
02:59:09	44931/44931	---M--	200	added ('OK')	image/png	etag:%2266829bf5-16a1f%22	https://bridgebio.com/wp-content/uploads/2023/11/Q3-Graph-2.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2023/11/Q3-Graph-2.png	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update/)
02:59:12	24157/24157	---M--	200	added ('OK')	image/png	etag:%2266829bf8-c554%22	https://bridgebio.com/wp-content/uploads/2023/11/Q3-Graph-4-1.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2023/11/Q3-Graph-4-1.png	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update/)
02:59:17	229534/229534	---M--	200	added ('OK')	image/jpeg	etag:%2266829bfb-44f9f%22	http://bridgebio.com/wp-content/uploads/2023/11/Q3-Graph-1.jpeg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2023/11/Q3-Graph-1.jpg	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update/)
02:59:17	272306/272306	---M--	200	added ('OK')	image/jpeg	etag:%2266829bfa-51f21%22	https://bridgebio.com/wp-content/uploads/2023/11/Q3-third.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2023/11/Q3-third.jpg	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update/)
02:59:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:13%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update/)
02:59:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:03%20GMT	https://bridgebio.com/?p=6119	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index02b4.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update/)
02:59:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:17%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2023-financial-results-and-business-update/)
02:59:18	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-31/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-31/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-31/)
02:59:18	14678/14678	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:18%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6107	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6107.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-31/)
02:59:19	2989/2989	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:18%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-31%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd064.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-31/)
02:59:19	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:19%20GMT	https://bridgebio.com/?p=6107	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index803c.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-31/)
02:59:19	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.4ca.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-31/)
02:59:19	3189/3189	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:59:19%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-31%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed96ec	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-31/)
02:59:20	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:20%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-31/)
02:59:20	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:20%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-31/)
02:59:21	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734519240	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/stylef147.css	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-long-term-data-from-an-ongoing-phase-2-study-which-support-the-potential-use-of-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-as-a-surrogate-endpoint-in-limb-g/)
02:59:21	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734519240	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-cssf147.css	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-long-term-data-from-an-ongoing-phase-2-study-which-support-the-potential-use-of-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-as-a-surrogate-endpoint-in-limb-g/)
02:59:21	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-shares-positive-long-term-data-from-an-ongoing-phase-2-study-which-support-the-potential-use-of-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-as-a-surrogate-endpoint-in-limb-g/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-shares-positive-long-term-data/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-long-term-data-from-an-ongoing-phase-2-study-which-support-the-potential-use-of-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-as-a-surrogate-endpoint-in-limb-g/)
02:59:21	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734519240	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrustf147.css	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-long-term-data-from-an-ongoing-phase-2-study-which-support-the-potential-use-of-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-as-a-surrogate-endpoint-in-limb-g/)
02:59:21	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734519240	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptsf147.js	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-long-term-data-from-an-ongoing-phase-2-study-which-support-the-potential-use-of-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-as-a-surrogate-endpoint-in-limb-g/)
02:59:21	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734519240	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modalf147.js	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-long-term-data-from-an-ongoing-phase-2-study-which-support-the-potential-use-of-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-as-a-surrogate-endpoint-in-limb-g/)
02:59:22	26285/26285	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:22%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6101	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6101.json	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-long-term-data-from-an-ongoing-phase-2-study-which-support-the-potential-use-of-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-as-a-surrogate-endpoint-in-limb-g/)
02:59:22	3690/3690	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:22%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-shares-positive-long-term-data-from-an-ongoing-phase-2-study-which-support-the-potential-use-of-glycosylated-alpha-dystroglycan-%25e2%258d%25badg-levels-as-a-surrogate-endpoint-in-limb-g%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd2a3.json	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-long-term-data-from-an-ongoing-phase-2-study-which-support-the-potential-use-of-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-as-a-surrogate-endpoint-in-limb-g/)
02:59:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:23%20GMT	https://bridgebio.com/?p=6101	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexaf56.html	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-long-term-data-from-an-ongoing-phase-2-study-which-support-the-potential-use-of-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-as-a-surrogate-endpoint-in-limb-g/)
02:59:23	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.4d5.delayed	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-long-term-data-from-an-ongoing-phase-2-study-which-support-the-potential-use-of-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-as-a-surrogate-endpoint-in-limb-g/)
02:59:23	3883/3883	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:59:23%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-shares-positive-long-term-data-from-an-ongoing-phase-2-study-which-support-the-potential-use-of-glycosylated-alpha-dystroglycan-%25e2%258d%25badg-levels-as-a-surrogate-endpoint-in-limb-g%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed95b3	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-long-term-data-from-an-ongoing-phase-2-study-which-support-the-potential-use-of-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-as-a-surrogate-endpoint-in-limb-g/)
02:59:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:23%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-long-term-data-from-an-ongoing-phase-2-study-which-support-the-potential-use-of-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-as-a-surrogate-endpoint-in-limb-g/)
02:59:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:23%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-shares-positive-long-term-data-from-an-ongoing-phase-2-study-which-support-the-potential-use-of-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-as-a-surrogate-endpoint-in-limb-g/)
02:59:24	25451/25451	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:24%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6098	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6098.json	(from https://bridgebio.com/news/bridgebio-and-resilience-announce-strategic-multi-year-partnership-to-advance-bbp-631-bbp-812-and-future-gene-therapy-treatments/)
02:59:24	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-and-resilience-announce-strategic-multi-year-partnership-to-advance-bbp-631-bbp-812-and-future-gene-therapy-treatments/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-and-resilience-announce-strategic-multi-year-partnership-to-advance-bbp-631-bbp-812-and-future-gene-therapy-treatments/feed/index.html	(from https://bridgebio.com/news/bridgebio-and-resilience-announce-strategic-multi-year-partnership-to-advance-bbp-631-bbp-812-and-future-gene-therapy-treatments/)
02:59:25	3282/3282	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:25%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-and-resilience-announce-strategic-multi-year-partnership-to-advance-bbp-631-bbp-812-and-future-gene-therapy-treatments%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedeb5b.json	(from https://bridgebio.com/news/bridgebio-and-resilience-announce-strategic-multi-year-partnership-to-advance-bbp-631-bbp-812-and-future-gene-therapy-treatments/)
02:59:25	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:25%20GMT	https://bridgebio.com/?p=6098	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index359c.html	(from https://bridgebio.com/news/bridgebio-and-resilience-announce-strategic-multi-year-partnership-to-advance-bbp-631-bbp-812-and-future-gene-therapy-treatments/)
02:59:25	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.4db.delayed	(from https://bridgebio.com/news/bridgebio-and-resilience-announce-strategic-multi-year-partnership-to-advance-bbp-631-bbp-812-and-future-gene-therapy-treatments/)
02:59:25	3474/3474	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:59:25%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-and-resilience-announce-strategic-multi-year-partnership-to-advance-bbp-631-bbp-812-and-future-gene-therapy-treatments%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf828	(from https://bridgebio.com/news/bridgebio-and-resilience-announce-strategic-multi-year-partnership-to-advance-bbp-631-bbp-812-and-future-gene-therapy-treatments/)
02:59:25	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:25%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-and-resilience-announce-strategic-multi-year-partnership-to-advance-bbp-631-bbp-812-and-future-gene-therapy-treatments/)
02:59:25	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:26%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-and-resilience-announce-strategic-multi-year-partnership-to-advance-bbp-631-bbp-812-and-future-gene-therapy-treatments/)
02:59:26	18188/18188	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:26%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6096	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6096.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-250-million-private-placement-equity-financing/)
02:59:26	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-250-million-private-placement-equity-financing/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-250-million-private-placement-equity-financing/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-250-million-private-placement-equity-financing/)
02:59:27	2935/2935	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:27%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-250-million-private-placement-equity-financing%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8687.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-250-million-private-placement-equity-financing/)
02:59:27	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:27%20GMT	https://bridgebio.com/?p=6096	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index4958.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-250-million-private-placement-equity-financing/)
02:59:27	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.4e1.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-250-million-private-placement-equity-financing/)
02:59:27	3127/3127	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:59:27%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-250-million-private-placement-equity-financing%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb88d	(from https://bridgebio.com/news/bridgebio-pharma-announces-250-million-private-placement-equity-financing/)
02:59:27	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:27%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-announces-250-million-private-placement-equity-financing/)
02:59:28	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:28%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-250-million-private-placement-equity-financing/)
02:59:28	13950/13950	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:29%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6084	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6084.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-30/)
02:59:29	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-30/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-30/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-30/)
02:59:29	2995/2995	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:29%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-30%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0238.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-30/)
02:59:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:29%20GMT	https://bridgebio.com/?p=6084	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexdccb.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-30/)
02:59:29	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.4e7.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-30/)
02:59:29	3195/3195	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:59:30%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-30%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed577c	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-30/)
02:59:30	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:30%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-30/)
02:59:30	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:30%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-30/)
02:59:31	13899/13899	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:31%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6078	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6078.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-morgan-stanley-21st-annual-global-healthcare-conference/)
02:59:31	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-morgan-stanley-21st-annual-global-healthcare-conference/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-the-morgan-stanley-21st-annual-global-healthcare-conference/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-morgan-stanley-21st-annual-global-healthcare-conference/)
02:59:31	3046/3046	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:31%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-the-morgan-stanley-21st-annual-global-healthcare-conference%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc8e6.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-morgan-stanley-21st-annual-global-healthcare-conference/)
02:59:31	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:31%20GMT	https://bridgebio.com/?p=6078	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index304e.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-morgan-stanley-21st-annual-global-healthcare-conference/)
02:59:32	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.4ed.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-morgan-stanley-21st-annual-global-healthcare-conference/)
02:59:32	3244/3244	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:59:32%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-the-morgan-stanley-21st-annual-global-healthcare-conference%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeda6b9	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-morgan-stanley-21st-annual-global-healthcare-conference/)
02:59:32	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:32%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-morgan-stanley-21st-annual-global-healthcare-conference/)
02:59:32	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:32%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-morgan-stanley-21st-annual-global-healthcare-conference/)
02:59:33	25231/25231	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:33%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6081	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6081.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-feedback-from-the-u-s-fda-and-eu-ema-on-the-regulatory-path-for-a-pivotal-phase-3-trial-of-infigratinib-in-children-with-achondroplasia/)
02:59:33	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-positive-feedback-from-the-u-s-fda-and-eu-ema-on-the-regulatory-path-for-a-pivotal-phase-3-trial-of-infigratinib-in-children-with-achondroplasia/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-positive-feedback-fr/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-feedback-from-the-u-s-fda-and-eu-ema-on-the-regulatory-path-for-a-pivotal-phase-3-trial-of-infigratinib-in-children-with-achondroplasia/)
02:59:33	3400/3400	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:33%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-positive-feedback-from-the-u-s-fda-and-eu-ema-on-the-regulatory-path-for-a-pivotal-phase-3-trial-of-infigratinib-in-children-with-achondroplasia%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2230.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-feedback-from-the-u-s-fda-and-eu-ema-on-the-regulatory-path-for-a-pivotal-phase-3-trial-of-infigratinib-in-children-with-achondroplasia/)
02:59:33	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:34%20GMT	https://bridgebio.com/?p=6081	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexf724.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-feedback-from-the-u-s-fda-and-eu-ema-on-the-regulatory-path-for-a-pivotal-phase-3-trial-of-infigratinib-in-children-with-achondroplasia/)
02:59:34	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.4f3.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-feedback-from-the-u-s-fda-and-eu-ema-on-the-regulatory-path-for-a-pivotal-phase-3-trial-of-infigratinib-in-children-with-achondroplasia/)
02:59:34	3591/3591	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:59:34%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-positive-feedback-from-the-u-s-fda-and-eu-ema-on-the-regulatory-path-for-a-pivotal-phase-3-trial-of-infigratinib-in-children-with-achondroplasia%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed78d4	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-feedback-from-the-u-s-fda-and-eu-ema-on-the-regulatory-path-for-a-pivotal-phase-3-trial-of-infigratinib-in-children-with-achondroplasia/)
02:59:34	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:34%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-feedback-from-the-u-s-fda-and-eu-ema-on-the-regulatory-path-for-a-pivotal-phase-3-trial-of-infigratinib-in-children-with-achondroplasia/)
02:59:34	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:34%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-feedback-from-the-u-s-fda-and-eu-ema-on-the-regulatory-path-for-a-pivotal-phase-3-trial-of-infigratinib-in-children-with-achondroplasia/)
02:59:35	30208/30208	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:35%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6068	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6068.json	(from https://bridgebio.com/news/bridgebio-presents-detailed-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-european-society-of-cardiology-congress-2/)
02:59:35	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-presents-detailed-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-european-society-of-cardiology-congress-2/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-presents-detailed-positive-results-fr/feed/index.html	(from https://bridgebio.com/news/bridgebio-presents-detailed-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-european-society-of-cardiology-congress-2/)
02:59:35	3578/3578	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:35%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-presents-detailed-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-european-society-of-cardiology-congress-2%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7918.json	(from https://bridgebio.com/news/bridgebio-presents-detailed-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-european-society-of-cardiology-congress-2/)
02:59:36	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:36%20GMT	https://bridgebio.com/?p=6068	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index6053.html	(from https://bridgebio.com/news/bridgebio-presents-detailed-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-european-society-of-cardiology-congress-2/)
02:59:36	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.4f9.delayed	(from https://bridgebio.com/news/bridgebio-presents-detailed-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-european-society-of-cardiology-congress-2/)
02:59:36	3768/3768	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:59:36%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-presents-detailed-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-european-society-of-cardiology-congress-2%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed55d2	(from https://bridgebio.com/news/bridgebio-presents-detailed-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-european-society-of-cardiology-congress-2/)
02:59:36	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:36%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-presents-detailed-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-european-society-of-cardiology-congress-2/)
02:59:36	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:36%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-presents-detailed-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm-at-european-society-of-cardiology-congress-2/)
02:59:37	19962/19962	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:37%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6066	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6066.json	(from https://bridgebio.com/news/bridgebio-pharma-to-present-detailed-results-from-the-phase-3-attribute-study-in-patients-with-transthyretin-amyloidosis-cardiomyopathy-attr-cm-at-european-society-of-cardiology-esc-congress-2023/)
02:59:37	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-present-detailed-results-from-the-phase-3-attribute-study-in-patients-with-transthyretin-amyloidosis-cardiomyopathy-attr-cm-at-european-society-of-cardiology-esc-congress-2023/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-present-detailed-results-fr/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-present-detailed-results-from-the-phase-3-attribute-study-in-patients-with-transthyretin-amyloidosis-cardiomyopathy-attr-cm-at-european-society-of-cardiology-esc-congress-2023/)
02:59:37	3596/3596	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-present-detailed-results-from-the-phase-3-attribute-study-in-patients-with-transthyretin-amyloidosis-cardiomyopathy-attr-cm-at-european-society-of-cardiology-esc-congress-2023%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed614b.json	(from https://bridgebio.com/news/bridgebio-pharma-to-present-detailed-results-from-the-phase-3-attribute-study-in-patients-with-transthyretin-amyloidosis-cardiomyopathy-attr-cm-at-european-society-of-cardiology-esc-congress-2023/)
02:59:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:38%20GMT	https://bridgebio.com/?p=6066	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index7c50.html	(from https://bridgebio.com/news/bridgebio-pharma-to-present-detailed-results-from-the-phase-3-attribute-study-in-patients-with-transthyretin-amyloidosis-cardiomyopathy-attr-cm-at-european-society-of-cardiology-esc-congress-2023/)
02:59:38	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.4ff.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-present-detailed-results-from-the-phase-3-attribute-study-in-patients-with-transthyretin-amyloidosis-cardiomyopathy-attr-cm-at-european-society-of-cardiology-esc-congress-2023/)
02:59:38	3794/3794	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:59:38%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-present-detailed-results-from-the-phase-3-attribute-study-in-patients-with-transthyretin-amyloidosis-cardiomyopathy-attr-cm-at-european-society-of-cardiology-esc-congress-2023%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed408c	(from https://bridgebio.com/news/bridgebio-pharma-to-present-detailed-results-from-the-phase-3-attribute-study-in-patients-with-transthyretin-amyloidosis-cardiomyopathy-attr-cm-at-european-society-of-cardiology-esc-congress-2023/)
02:59:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:38%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-to-present-detailed-results-from-the-phase-3-attribute-study-in-patients-with-transthyretin-amyloidosis-cardiomyopathy-attr-cm-at-european-society-of-cardiology-esc-congress-2023/)
02:59:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:39%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-present-detailed-results-from-the-phase-3-attribute-study-in-patients-with-transthyretin-amyloidosis-cardiomyopathy-attr-cm-at-european-society-of-cardiology-esc-congress-2023/)
02:59:39	13930/13930	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:39%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5977	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5977.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-29/)
02:59:40	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-29/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-29/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-29/)
02:59:40	2984/2984	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:40%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-29%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeddf43.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-29/)
02:59:40	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:40%20GMT	https://bridgebio.com/?p=5977	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexb0dd.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-29/)
02:59:40	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.505.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-29/)
02:59:40	3184/3184	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:59:40%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-29%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1c15	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-29/)
02:59:40	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:40%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-29/)
02:59:41	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:41%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-29/)
02:59:41	36563/36563	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:41%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5968	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5968.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2023-financial-results-and-business-update/)
02:59:42	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2023-financial-results-and-business-update/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2023-financial-results-and-business-update/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2023-financial-results-and-business-update/)
02:59:42	2997/2997	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:42%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-second-quarter-2023-financial-results-and-business-update%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3773.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2023-financial-results-and-business-update/)
02:59:42	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:42%20GMT	https://bridgebio.com/?p=5968	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexd369.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2023-financial-results-and-business-update/)
02:59:42	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.50b.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2023-financial-results-and-business-update/)
02:59:42	3187/3187	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:59:42%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-second-quarter-2023-financial-results-and-business-update%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0cb9	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2023-financial-results-and-business-update/)
02:59:42	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:43%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2023-financial-results-and-business-update/)
02:59:43	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:43%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-second-quarter-2023-financial-results-and-business-update/)
02:59:43	28500/28500	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:43%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5964	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5964.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-opportunity-for-accelerated-approval-pathway-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i-r9-based-on-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-and-announ/)
02:59:44	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-opportunity-for-accelerated-approval-pathway-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i-r9-based-on-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-and-announ/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-opportunity-for-acce/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-opportunity-for-accelerated-approval-pathway-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i-r9-based-on-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-and-announ/)
02:59:44	3642/3642	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:44%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-opportunity-for-accelerated-approval-pathway-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i-r9-based-on-glycosylated-alpha-dystroglycan-%25e2%258d%25badg-levels-and-announ%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed6f3a.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-opportunity-for-accelerated-approval-pathway-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i-r9-based-on-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-and-announ/)
02:59:44	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:44%20GMT	https://bridgebio.com/?p=5964	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index0895.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-opportunity-for-accelerated-approval-pathway-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i-r9-based-on-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-and-announ/)
02:59:44	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.511.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-opportunity-for-accelerated-approval-pathway-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i-r9-based-on-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-and-announ/)
02:59:44	3837/3837	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:59:44%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-opportunity-for-accelerated-approval-pathway-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i-r9-based-on-glycosylated-alpha-dystroglycan-%25e2%258d%25badg-levels-and-announ%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed4849	(from https://bridgebio.com/news/bridgebio-pharma-announces-opportunity-for-accelerated-approval-pathway-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i-r9-based-on-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-and-announ/)
02:59:45	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:45%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-announces-opportunity-for-accelerated-approval-pathway-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i-r9-based-on-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-and-announ/)
02:59:45	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:45%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-opportunity-for-accelerated-approval-pathway-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i-r9-based-on-glycosylated-alpha-dystroglycan-%e2%8d%badg-levels-and-announ/)
02:59:46	14058/14058	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:46%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5956	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5956.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-28/)
02:59:46	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-28/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-28/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-28/)
02:59:46	2982/2982	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:46%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-28%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb6ed.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-28/)
02:59:46	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:47%20GMT	https://bridgebio.com/?p=5956	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexdd4f.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-28/)
02:59:47	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.517.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-28/)
02:59:47	3182/3182	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:59:47%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-28%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5d74	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-28/)
02:59:47	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:47%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-28/)
02:59:47	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:47%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-28/)
02:59:48	27856/27856	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:48%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5958	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5958.json	(from https://bridgebio.com/news/bridgebio-announces-consistently-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm/)
02:59:48	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-announces-consistently-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-announces-consistently-positive-resul/feed/index.html	(from https://bridgebio.com/news/bridgebio-announces-consistently-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm/)
02:59:48	3437/3437	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:49%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-announces-consistently-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2789.json	(from https://bridgebio.com/news/bridgebio-announces-consistently-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm/)
02:59:49	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:49%20GMT	https://bridgebio.com/?p=5958	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index2f19.html	(from https://bridgebio.com/news/bridgebio-announces-consistently-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm/)
02:59:49	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.51d.delayed	(from https://bridgebio.com/news/bridgebio-announces-consistently-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm/)
02:59:49	3629/3629	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:59:49%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-announces-consistently-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5275	(from https://bridgebio.com/news/bridgebio-announces-consistently-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm/)
02:59:49	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:49%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-announces-consistently-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm/)
02:59:50	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:50%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-announces-consistently-positive-results-from-phase-3-attribute-cm-study-of-acoramidis-for-patients-with-transthyretin-amyloid-cardiomyopathy-attr-cm/)
02:59:50	15784/15784	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:50%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5954	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5954.json	(from https://bridgebio.com/news/bridgebio-to-host-investor-call-to-share-topline-30-month-results-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-on-july-17-2023/)
02:59:51	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-to-host-investor-call-to-share-topline-30-month-results-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-on-july-17-2023/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-to-host-investor-call-to-share-toplin/feed/index.html	(from https://bridgebio.com/news/bridgebio-to-host-investor-call-to-share-topline-30-month-results-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-on-july-17-2023/)
02:59:51	3392/3392	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:51%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-to-host-investor-call-to-share-topline-30-month-results-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-on-july-17-2023%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeddc8d.json	(from https://bridgebio.com/news/bridgebio-to-host-investor-call-to-share-topline-30-month-results-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-on-july-17-2023/)
02:59:51	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:51%20GMT	https://bridgebio.com/?p=5954	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexe123.html	(from https://bridgebio.com/news/bridgebio-to-host-investor-call-to-share-topline-30-month-results-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-on-july-17-2023/)
02:59:51	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.523.delayed	(from https://bridgebio.com/news/bridgebio-to-host-investor-call-to-share-topline-30-month-results-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-on-july-17-2023/)
02:59:51	3582/3582	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:59:51%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-to-host-investor-call-to-share-topline-30-month-results-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-on-july-17-2023%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed43dc	(from https://bridgebio.com/news/bridgebio-to-host-investor-call-to-share-topline-30-month-results-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-on-july-17-2023/)
02:59:51	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:51%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-to-host-investor-call-to-share-topline-30-month-results-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-on-july-17-2023/)
02:59:52	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:52%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-to-host-investor-call-to-share-topline-30-month-results-from-the-phase-3-attribute-cm-study-in-patients-with-transthyretin-amyloid-cardiomyopathy-on-july-17-2023/)
02:59:53	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/burjeel-holdings-to-launch-rare-disease-research-development-project-nader-in-partnership-with-us-based-bridgebio-pharma/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/burjeel-holdings-to-launch-rare-disease-research-development-project-nader-in-partnership-with-us-based-bridgebio-pharma/feed/index.html	(from https://bridgebio.com/news/burjeel-holdings-to-launch-rare-disease-research-development-project-nader-in-partnership-with-us-based-bridgebio-pharma/)
02:59:53	26270/26270	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:53%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5951	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5951.json	(from https://bridgebio.com/news/burjeel-holdings-to-launch-rare-disease-research-development-project-nader-in-partnership-with-us-based-bridgebio-pharma/)
02:59:53	3227/3227	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:53%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fburjeel-holdings-to-launch-rare-disease-research-development-project-nader-in-partnership-with-us-based-bridgebio-pharma%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed146c.json	(from https://bridgebio.com/news/burjeel-holdings-to-launch-rare-disease-research-development-project-nader-in-partnership-with-us-based-bridgebio-pharma/)
02:59:53	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:53%20GMT	https://bridgebio.com/?p=5951	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexb6e7.html	(from https://bridgebio.com/news/burjeel-holdings-to-launch-rare-disease-research-development-project-nader-in-partnership-with-us-based-bridgebio-pharma/)
02:59:53	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.529.delayed	(from https://bridgebio.com/news/burjeel-holdings-to-launch-rare-disease-research-development-project-nader-in-partnership-with-us-based-bridgebio-pharma/)
02:59:53	3437/3437	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:59:54%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fburjeel-holdings-to-launch-rare-disease-research-development-project-nader-in-partnership-with-us-based-bridgebio-pharma%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8170	(from https://bridgebio.com/news/burjeel-holdings-to-launch-rare-disease-research-development-project-nader-in-partnership-with-us-based-bridgebio-pharma/)
02:59:54	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:54%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/burjeel-holdings-to-launch-rare-disease-research-development-project-nader-in-partnership-with-us-based-bridgebio-pharma/)
02:59:54	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:54%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/burjeel-holdings-to-launch-rare-disease-research-development-project-nader-in-partnership-with-us-based-bridgebio-pharma/)
02:59:55	24986/24986	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:55%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5945	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5945.json	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-six-month-results-from-its-phase-2-cohort-5-trial-of-infigratinib-in-achondroplasia-at-the-endocrine-society-endo-2023-annual-conference/)
02:59:55	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-presents-updated-six-month-results-from-its-phase-2-cohort-5-trial-of-infigratinib-in-achondroplasia-at-the-endocrine-society-endo-2023-annual-conference/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-presents-updated-six-month-res/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-six-month-results-from-its-phase-2-cohort-5-trial-of-infigratinib-in-achondroplasia-at-the-endocrine-society-endo-2023-annual-conference/)
02:59:55	3374/3374	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:55%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-presents-updated-six-month-results-from-its-phase-2-cohort-5-trial-of-infigratinib-in-achondroplasia-at-the-endocrine-society-endo-2023-annual-conference%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed28e9.json	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-six-month-results-from-its-phase-2-cohort-5-trial-of-infigratinib-in-achondroplasia-at-the-endocrine-society-endo-2023-annual-conference/)
02:59:55	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:55%20GMT	https://bridgebio.com/?p=5945	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index89fe.html	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-six-month-results-from-its-phase-2-cohort-5-trial-of-infigratinib-in-achondroplasia-at-the-endocrine-society-endo-2023-annual-conference/)
02:59:55	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.52f.delayed	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-six-month-results-from-its-phase-2-cohort-5-trial-of-infigratinib-in-achondroplasia-at-the-endocrine-society-endo-2023-annual-conference/)
02:59:56	3566/3566	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:59:56%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-presents-updated-six-month-results-from-its-phase-2-cohort-5-trial-of-infigratinib-in-achondroplasia-at-the-endocrine-society-endo-2023-annual-conference%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed6279	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-six-month-results-from-its-phase-2-cohort-5-trial-of-infigratinib-in-achondroplasia-at-the-endocrine-society-endo-2023-annual-conference/)
02:59:56	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:56%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-six-month-results-from-its-phase-2-cohort-5-trial-of-infigratinib-in-achondroplasia-at-the-endocrine-society-endo-2023-annual-conference/)
02:59:56	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:56%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-six-month-results-from-its-phase-2-cohort-5-trial-of-infigratinib-in-achondroplasia-at-the-endocrine-society-endo-2023-annual-conference/)
02:59:57	14049/14049	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:57%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5938	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5938.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-27/)
02:59:57	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-27/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-27/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-27/)
02:59:57	2990/2990	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:57%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-27%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed4df0.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-27/)
02:59:57	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:58%20GMT	https://bridgebio.com/?p=5938	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index4e66.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-27/)
02:59:58	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.535.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-27/)
02:59:58	3191/3191	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2010:59:58%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-27%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed50f7	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-27/)
02:59:58	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:58%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-27/)
02:59:58	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2010:59:58%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-27/)
02:59:59	21160/21160	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:59%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5935	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5935.json	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-six-month-results-from-its-phase-2-cohort-5-study-of-infigratinib-in-achondroplasia-in-a-late-breaker-oral-presentation-at-the-endocrine-society-endo-2023-annual/)
02:59:59	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-present-updated-six-month-results-from-its-phase-2-cohort-5-study-of-infigratinib-in-achondroplasia-in-a-late-breaker-oral-presentation-at-the-endocrine-society-endo-2023-annual/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-present-updated-six-month-r/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-six-month-results-from-its-phase-2-cohort-5-study-of-infigratinib-in-achondroplasia-in-a-late-breaker-oral-presentation-at-the-endocrine-society-endo-2023-annual/)
02:59:59	3626/3626	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2010:59:59%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-present-updated-six-month-results-from-its-phase-2-cohort-5-study-of-infigratinib-in-achondroplasia-in-a-late-breaker-oral-presentation-at-the-endocrine-society-endo-2023-annual%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeda070.json	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-six-month-results-from-its-phase-2-cohort-5-study-of-infigratinib-in-achondroplasia-in-a-late-breaker-oral-presentation-at-the-endocrine-society-endo-2023-annual/)
03:00:00	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:00%20GMT	https://bridgebio.com/?p=5935	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index8cc6.html	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-six-month-results-from-its-phase-2-cohort-5-study-of-infigratinib-in-achondroplasia-in-a-late-breaker-oral-presentation-at-the-endocrine-society-endo-2023-annual/)
03:00:00	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.53b.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-six-month-results-from-its-phase-2-cohort-5-study-of-infigratinib-in-achondroplasia-in-a-late-breaker-oral-presentation-at-the-endocrine-society-endo-2023-annual/)
03:00:00	3825/3825	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:00:00%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-present-updated-six-month-results-from-its-phase-2-cohort-5-study-of-infigratinib-in-achondroplasia-in-a-late-breaker-oral-presentation-at-the-endocrine-society-endo-2023-annual%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeda118	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-six-month-results-from-its-phase-2-cohort-5-study-of-infigratinib-in-achondroplasia-in-a-late-breaker-oral-presentation-at-the-endocrine-society-endo-2023-annual/)
03:00:00	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:00%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-six-month-results-from-its-phase-2-cohort-5-study-of-infigratinib-in-achondroplasia-in-a-late-breaker-oral-presentation-at-the-endocrine-society-endo-2023-annual/)
03:00:00	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:01%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-six-month-results-from-its-phase-2-cohort-5-study-of-infigratinib-in-achondroplasia-in-a-late-breaker-oral-presentation-at-the-endocrine-society-endo-2023-annual/)
03:00:01	29018/29018	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:01%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5881	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5881.json	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-encouraging-clinical-and-biomarker-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-mee/)
03:00:01	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-presents-updated-encouraging-clinical-and-biomarker-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-mee/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-presents-updated-encouraging-c/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-encouraging-clinical-and-biomarker-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-mee/)
03:00:02	3575/3575	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:02%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-presents-updated-encouraging-clinical-and-biomarker-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-mee%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed383b.json	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-encouraging-clinical-and-biomarker-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-mee/)
03:00:02	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:02%20GMT	https://bridgebio.com/?p=5881	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexd799.html	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-encouraging-clinical-and-biomarker-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-mee/)
03:00:02	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.541.delayed	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-encouraging-clinical-and-biomarker-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-mee/)
03:00:02	3768/3768	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:00:02%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-presents-updated-encouraging-clinical-and-biomarker-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-mee%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0711	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-encouraging-clinical-and-biomarker-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-mee/)
03:00:02	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:02%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-encouraging-clinical-and-biomarker-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-mee/)
03:00:03	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:03%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-encouraging-clinical-and-biomarker-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-mee/)
03:00:03	24477/24477	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:03%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5877	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5877.json	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-meeting/)
03:00:04	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-present-updated-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-meeting/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-present-updated-data-from-i/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-meeting/)
03:00:04	3461/3461	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:04%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-present-updated-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-meeting%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc698.json	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-meeting/)
03:00:04	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:04%20GMT	https://bridgebio.com/?p=5877	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexe802.html	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-meeting/)
03:00:04	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.547.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-meeting/)
03:00:04	3665/3665	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:00:04%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-present-updated-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-meeting%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc86b	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-meeting/)
03:00:05	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:05%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-meeting/)
03:00:05	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:05%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-2023-american-society-of-gene-and-cell-therapy-asgct-annual-meeting/)
03:00:06	14029/14029	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:06%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5875	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5875.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-26/)
03:00:06	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-26/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-26/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-26/)
03:00:06	2977/2977	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:06%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-26%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed08b2.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-26/)
03:00:06	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:06%20GMT	https://bridgebio.com/?p=5875	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index452f.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-26/)
03:00:06	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.54d.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-26/)
03:00:06	3177/3177	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:00:07%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-26%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf5a3	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-26/)
03:00:07	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:07%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-26/)
03:00:07	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:07%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-26/)
03:00:08	31302/31302	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:08%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5873	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5873.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2023-financial-results-and-business-update/)
03:00:08	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2023-financial-results-and-business-update/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2023-financial-results-and-business-update/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2023-financial-results-and-business-update/)
03:00:08	2673/2673	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:08%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-first-quarter-2023-financial-results-and-business-update%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5c6c.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2023-financial-results-and-business-update/)
03:00:09	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:09%20GMT	https://bridgebio.com/?p=5873	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index93ab.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2023-financial-results-and-business-update/)
03:00:09	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.553.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2023-financial-results-and-business-update/)
03:00:09	2864/2864	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:00:09%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-first-quarter-2023-financial-results-and-business-update%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedde88	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2023-financial-results-and-business-update/)
03:00:09	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:09%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2023-financial-results-and-business-update/)
03:00:09	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:09%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2023-financial-results-and-business-update/)
03:00:10	13899/13899	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:10%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5870	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5870.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference/)
03:00:10	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference/)
03:00:11	2751/2751	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:11%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9916.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference/)
03:00:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:11%20GMT	https://bridgebio.com/?p=5870	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexcfc0.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference/)
03:00:11	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.559.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference/)
03:00:11	2940/2940	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:00:11%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8a53	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference/)
03:00:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:11%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference/)
03:00:12	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:12%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-merrill-lynch-global-healthcare-conference/)
03:00:13	13411/13411	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:13%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5866	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5866.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-25/)
03:00:13	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-25/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-25/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-25/)
03:00:13	2641/2641	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:13%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-25%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede464.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-25/)
03:00:13	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:13%20GMT	https://bridgebio.com/?p=5866	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexe935.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-25/)
03:00:13	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.55f.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-25/)
03:00:13	2830/2830	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:00:14%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-25%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb528	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-25/)
03:00:14	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:14%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-25/)
03:00:14	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:14%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-25/)
03:00:15	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-trial-for-shp2-inhibitor-bbp-398-in-combination-with-bristol-myers-squibbs-opdivo-nivolumab/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-pa/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-trial-for-shp2-inhibitor-bbp-398-in-combination-with-bristol-myers-squibbs-opdivo-nivolumab/)
03:00:15	24070/24070	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:15%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5861	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5861.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-trial-for-shp2-inhibitor-bbp-398-in-combination-with-bristol-myers-squibbs-opdivo-nivolumab/)
03:00:15	3038/3038	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:15%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-trial-for-shp2-inhibitor-bbp-398-in-combination-with-bristol-myers-squibbs-opdivo-nivolumab%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8a6f.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-trial-for-shp2-inhibitor-bbp-398-in-combination-with-bristol-myers-squibbs-opdivo-nivolumab/)
03:00:16	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:16%20GMT	https://bridgebio.com/?p=5861	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index73ec.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-trial-for-shp2-inhibitor-bbp-398-in-combination-with-bristol-myers-squibbs-opdivo-nivolumab/)
03:00:16	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.565.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-trial-for-shp2-inhibitor-bbp-398-in-combination-with-bristol-myers-squibbs-opdivo-nivolumab/)
03:00:16	3232/3232	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:00:16%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-trial-for-shp2-inhibitor-bbp-398-in-combination-with-bristol-myers-squibbs-opdivo-nivolumab%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed10d1	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-trial-for-shp2-inhibitor-bbp-398-in-combination-with-bristol-myers-squibbs-opdivo-nivolumab/)
03:00:16	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:16%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-trial-for-shp2-inhibitor-bbp-398-in-combination-with-bristol-myers-squibbs-opdivo-nivolumab/)
03:00:16	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:16%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-trial-for-shp2-inhibitor-bbp-398-in-combination-with-bristol-myers-squibbs-opdivo-nivolumab/)
03:00:17	26699/26699	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:17%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5860	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5860.json	(from https://bridgebio.com/news/bridgebio-pharma-shares-preliminary-findings-on-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:00:17	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-shares-preliminary-findings-on-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-shares-preliminary-findings-on/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-shares-preliminary-findings-on-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:00:17	3096/3096	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:17%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-shares-preliminary-findings-on-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%25e2%258d%25badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedadae.json	(from https://bridgebio.com/news/bridgebio-pharma-shares-preliminary-findings-on-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:00:18	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:18%20GMT	https://bridgebio.com/?p=5860	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index901b.html	(from https://bridgebio.com/news/bridgebio-pharma-shares-preliminary-findings-on-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:00:18	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.56b.delayed	(from https://bridgebio.com/news/bridgebio-pharma-shares-preliminary-findings-on-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:00:18	3295/3295	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:00:18%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-shares-preliminary-findings-on-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%25e2%258d%25badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf732	(from https://bridgebio.com/news/bridgebio-pharma-shares-preliminary-findings-on-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:00:18	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:18%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-shares-preliminary-findings-on-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:00:19	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:19%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-shares-preliminary-findings-on-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:00:19	23498/23498	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:19%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5854	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5854.json	(from https://bridgebio.com/news/bridgebio-pharma-to-present-preliminary-findings-on-its-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:00:20	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-present-preliminary-findings-on-its-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-present-preliminary-finding/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-present-preliminary-findings-on-its-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:00:20	3098/3098	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:20%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-present-preliminary-findings-on-its-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%25e2%258d%25badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9349.json	(from https://bridgebio.com/news/bridgebio-pharma-to-present-preliminary-findings-on-its-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:00:20	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:20%20GMT	https://bridgebio.com/?p=5854	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index422e.html	(from https://bridgebio.com/news/bridgebio-pharma-to-present-preliminary-findings-on-its-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:00:20	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.571.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-present-preliminary-findings-on-its-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:00:20	3295/3295	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:00:20%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-present-preliminary-findings-on-its-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%25e2%258d%25badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5a80	(from https://bridgebio.com/news/bridgebio-pharma-to-present-preliminary-findings-on-its-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:00:20	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:21%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-to-present-preliminary-findings-on-its-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:00:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:21%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-present-preliminary-findings-on-its-novel-bioassay-measuring-glycosylated-alpha-dystroglycan-%e2%8d%badg-in-patients-with-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:00:21	17323/17323	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:21%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5850	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5850.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock/)
03:00:22	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock/)
03:00:22	2631/2631	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:22%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-pricing-of-public-offering-of-common-stock%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeda0ee.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock/)
03:00:22	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:22%20GMT	https://bridgebio.com/?p=5850	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index5f8b.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock/)
03:00:22	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.577.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock/)
03:00:22	2820/2820	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:00:22%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-pricing-of-public-offering-of-common-stock%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedcc62	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock/)
03:00:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:23%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock/)
03:00:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:23%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-public-offering-of-common-stock/)
03:00:24	16813/16813	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:24%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5847	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5847.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock/)
03:00:24	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock/)
03:00:24	2614/2614	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:24%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-proposed-public-offering-of-common-stock%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1e6f.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock/)
03:00:24	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:24%20GMT	https://bridgebio.com/?p=5847	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index9ede.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock/)
03:00:24	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.57d.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock/)
03:00:24	2803/2803	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:00:24%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-proposed-public-offering-of-common-stock%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedaec5	(from https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock/)
03:00:25	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:25%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock/)
03:00:25	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:25%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-proposed-public-offering-of-common-stock/)
03:00:26	55617/55617	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:26%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5841	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5841.json	(from https://bridgebio.com/news/bridgebio-announces-positive-phase-2-cohort-5-results-of-infigratinib-in-achondroplasia/)
03:00:26	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-announces-positive-phase-2-cohort-5-results-of-infigratinib-in-achondroplasia/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-announces-positive-phase-2-cohort-5-results-of-infigratinib-in-achondroplasia/feed/index.html	(from https://bridgebio.com/news/bridgebio-announces-positive-phase-2-cohort-5-results-of-infigratinib-in-achondroplasia/)
03:00:26	2933/2933	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:26%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-announces-positive-phase-2-cohort-5-results-of-infigratinib-in-achondroplasia%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5dce.json	(from https://bridgebio.com/news/bridgebio-announces-positive-phase-2-cohort-5-results-of-infigratinib-in-achondroplasia/)
03:00:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:26%20GMT	https://bridgebio.com/?p=5841	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index19ea.html	(from https://bridgebio.com/news/bridgebio-announces-positive-phase-2-cohort-5-results-of-infigratinib-in-achondroplasia/)
03:00:27	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.583.delayed	(from https://bridgebio.com/news/bridgebio-announces-positive-phase-2-cohort-5-results-of-infigratinib-in-achondroplasia/)
03:00:27	3120/3120	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:00:27%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-announces-positive-phase-2-cohort-5-results-of-infigratinib-in-achondroplasia%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf707	(from https://bridgebio.com/news/bridgebio-announces-positive-phase-2-cohort-5-results-of-infigratinib-in-achondroplasia/)
03:00:27	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:27%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-announces-positive-phase-2-cohort-5-results-of-infigratinib-in-achondroplasia/)
03:00:27	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:27%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-announces-positive-phase-2-cohort-5-results-of-infigratinib-in-achondroplasia/)
03:00:28	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-to-host-investor-call-to-discuss-phase-2-cohort-5-data-for-achondroplasia-on-march-6-2023/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-to-host-investor-call-to-discuss-phase-2-cohort-5-data-for-achondroplasia-on-march-6-2023/feed/index.html	(from https://bridgebio.com/news/bridgebio-to-host-investor-call-to-discuss-phase-2-cohort-5-data-for-achondroplasia-on-march-6-2023/)
03:00:28	14656/14656	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:28%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5842	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5842.json	(from https://bridgebio.com/news/bridgebio-to-host-investor-call-to-discuss-phase-2-cohort-5-data-for-achondroplasia-on-march-6-2023/)
03:00:28	2754/2754	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:29%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-to-host-investor-call-to-discuss-phase-2-cohort-5-data-for-achondroplasia-on-march-6-2023%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedaf65.json	(from https://bridgebio.com/news/bridgebio-to-host-investor-call-to-discuss-phase-2-cohort-5-data-for-achondroplasia-on-march-6-2023/)
03:00:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:29%20GMT	https://bridgebio.com/?p=5842	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexb43a.html	(from https://bridgebio.com/news/bridgebio-to-host-investor-call-to-discuss-phase-2-cohort-5-data-for-achondroplasia-on-march-6-2023/)
03:00:29	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.589.delayed	(from https://bridgebio.com/news/bridgebio-to-host-investor-call-to-discuss-phase-2-cohort-5-data-for-achondroplasia-on-march-6-2023/)
03:00:29	2943/2943	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:00:29%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-to-host-investor-call-to-discuss-phase-2-cohort-5-data-for-achondroplasia-on-march-6-2023%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed10c5	(from https://bridgebio.com/news/bridgebio-to-host-investor-call-to-discuss-phase-2-cohort-5-data-for-achondroplasia-on-march-6-2023/)
03:00:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:29%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us	(from https://bridgebio.com/news/bridgebio-to-host-investor-call-to-discuss-phase-2-cohort-5-data-for-achondroplasia-on-march-6-2023/)
03:00:30	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:30%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-to-host-investor-call-to-discuss-phase-2-cohort-5-data-for-achondroplasia-on-march-6-2023/)
03:00:34	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update/)
03:00:34	38865/38865	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:31%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5832	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5832.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update/)
03:00:34	2719/2719	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:00:31%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedaf0a.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update/)
03:00:35	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.590.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update/)
03:00:35	2877/2877	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:00:35%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedae06	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update/)
03:01:01	313882/313882	---M--	200	added ('OK')	image/jpeg	etag:%2266829bf6-68567%22	http://bridgebio.com/wp-content/uploads/2023/02/BRIDGEBIO-PHARMA_final_Page_1.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2023/02/BRIDGEBIO-PHARMA_final_Page_1.jpg	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update/)
03:01:05	251877/251877	---M--	200	added ('OK')	image/jpeg	etag:%2266829bf6-5545e%22	https://bridgebio.com/wp-content/uploads/2023/02/BRIDGEBIO-PHARMA_final_Page_2.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2023/02/BRIDGEBIO-PHARMA_final_Page_2.jpg	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update/)
03:01:07	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:00:34%20GMT	https://bridgebio.com/?p=5832	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index3db6.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update/)
03:01:19	194415/194415	---M--	200	added ('OK')	image/jpeg	etag:%2266829bf9-43434%22	http://bridgebio.com/wp-content/uploads/2023/02/BRIDGEBIO-PHARMA_final_Page_4.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2023/02/BRIDGEBIO-PHARMA_final_Page_4.jpg	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update/)
03:01:19	480269/480269	---M--	200	added ('OK')	image/jpeg	etag:%2266829bf8-9ccf9%22	https://bridgebio.com/wp-content/uploads/2023/02/BRIDGEBIO-PHARMA_final_Page_3.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2023/02/BRIDGEBIO-PHARMA_final_Page_3.jpg	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update/)
03:01:19	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:06%20GMT	https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.594.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update/)
03:01:19	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:20%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2022-financial-results-and-business-update/)
03:01:20	13433/13433	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:20%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5826	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5826.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-23/)
03:01:21	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-23/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-23/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-23/)
03:01:21	2644/2644	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:21%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-23%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed4a56.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-23/)
03:01:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:21%20GMT	https://bridgebio.com/?p=5826	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index112c.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-23/)
03:01:22	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.599.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-23/)
03:01:22	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.59a.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-23/)
03:01:22	2833/2833	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:01:22%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-23%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9ace	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-23/)
03:01:22	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:22%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-23/)
03:01:23	14598/14598	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:23%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5823	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5823.json	(from https://bridgebio.com/news/bridgebio-pharma-to-host-educational-roundtable-with-esteemed-achondroplasia-expert-on-february-16-2023/)
03:01:23	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-host-educational-roundtable-with-esteemed-achondroplasia-expert-on-february-16-2023/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-host-educational-roundtable-with-esteemed-achondroplasia-expert-on-february-16-2023/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-host-educational-roundtable-with-esteemed-achondroplasia-expert-on-february-16-2023/)
03:01:23	2769/2769	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:23%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-host-educational-roundtable-with-esteemed-achondroplasia-expert-on-february-16-2023%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedee8c.json	(from https://bridgebio.com/news/bridgebio-pharma-to-host-educational-roundtable-with-esteemed-achondroplasia-expert-on-february-16-2023/)
03:01:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:23%20GMT	https://bridgebio.com/?p=5823	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexbb33.html	(from https://bridgebio.com/news/bridgebio-pharma-to-host-educational-roundtable-with-esteemed-achondroplasia-expert-on-february-16-2023/)
03:01:23	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.59f.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-host-educational-roundtable-with-esteemed-achondroplasia-expert-on-february-16-2023/)
03:01:23	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.5a0.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-host-educational-roundtable-with-esteemed-achondroplasia-expert-on-february-16-2023/)
03:01:23	2958/2958	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:01:24%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-host-educational-roundtable-with-esteemed-achondroplasia-expert-on-february-16-2023%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf847	(from https://bridgebio.com/news/bridgebio-pharma-to-host-educational-roundtable-with-esteemed-achondroplasia-expert-on-february-16-2023/)
03:01:24	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:24%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-host-educational-roundtable-with-esteemed-achondroplasia-expert-on-february-16-2023/)
03:01:24	13768/13768	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:24%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5820	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5820.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-february-and-march-investor-events/)
03:01:25	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-february-and-march-investor-events/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-february-and-march-investor-events/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-february-and-march-investor-events/)
03:01:25	2642/2642	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:25%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-february-and-march-investor-events%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed974e.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-february-and-march-investor-events/)
03:01:25	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:25%20GMT	https://bridgebio.com/?p=5820	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index7781.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-february-and-march-investor-events/)
03:01:25	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.5a5.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-february-and-march-investor-events/)
03:01:25	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.5a6.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-february-and-march-investor-events/)
03:01:25	2831/2831	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:01:26%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-february-and-march-investor-events%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede1c6	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-february-and-march-investor-events/)
03:01:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:26%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-february-and-march-investor-events/)
03:01:27	13345/13345	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:26%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5801	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5801.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference/)
03:01:27	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference/)
03:01:27	2632/2632	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:27%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed90c4.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference/)
03:01:27	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:27%20GMT	https://bridgebio.com/?p=5801	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index3ad1.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference/)
03:01:27	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.5ab.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference/)
03:01:27	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.5ac.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference/)
03:01:27	2821/2821	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:01:27%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedcdc1	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference/)
03:01:28	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:28%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-j-p-morgan-healthcare-conference/)
03:01:29	13235/13235	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:29%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5771	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5771.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-november-investor-events/)
03:01:29	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-november-investor-events/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-november-investor-events/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-november-investor-events/)
03:01:29	2580/2580	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:29%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-november-investor-events%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0b61.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-november-investor-events/)
03:01:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:29%20GMT	https://bridgebio.com/?p=5771	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index2ef2.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-november-investor-events/)
03:01:30	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.5b1.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-november-investor-events/)
03:01:30	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.5b2.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-november-investor-events/)
03:01:30	2769/2769	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:01:30%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-november-investor-events%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb547	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-november-investor-events/)
03:01:30	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:30%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-november-investor-events/)
03:01:31	67505/67505	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:31%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5769	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5769.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2022-financial-results-and-business-update/)
03:01:31	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2022-financial-results-and-business-update/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2022-financial-results-and-business-update/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2022-financial-results-and-business-update/)
03:01:31	2698/2698	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:31%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-reports-third-quarter-2022-financial-results-and-business-update%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3cba.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2022-financial-results-and-business-update/)
03:01:31	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:31%20GMT	https://bridgebio.com/?p=5769	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexe1aa.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2022-financial-results-and-business-update/)
03:01:32	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.5b7.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2022-financial-results-and-business-update/)
03:01:32	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.5b8.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2022-financial-results-and-business-update/)
03:01:32	2889/2889	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:01:32%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-reports-third-quarter-2022-financial-results-and-business-update%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb748	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2022-financial-results-and-business-update/)
03:01:32	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:32%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2022-financial-results-and-business-update/)
03:01:32	27685/27685	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:33%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5767	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5767.json	(from https://bridgebio.com/news/bridgebio-pharma-highlights-its-ras-precision-oncology-portfolio-and-shares-compelling-data-from-next-generation-g12c-inhibitor-and-novel-pi3k%ce%b1ras-breaker-mechanism-at-the-fourth-ras-initiative/)
03:01:33	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-highlights-its-ras-precision-oncology-portfolio-and-shares-compelling-data-from-next-generation-g12c-inhibitor-and-novel-pi3k%ce%b1ras-breaker-mechanism-at-the-fourth-ras-initiative/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-highlights-its-ras-precision-o/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-highlights-its-ras-precision-oncology-portfolio-and-shares-compelling-data-from-next-generation-g12c-inhibitor-and-novel-pi3k%ce%b1ras-breaker-mechanism-at-the-fourth-ras-initiative/)
03:01:33	3155/3155	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:33%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-highlights-its-ras-precision-oncology-portfolio-and-shares-compelling-data-from-next-generation-g12c-inhibitor-and-novel-pi3k%25ce%25b1ras-breaker-mechanism-at-the-fourth-ras-initiative%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeda04a.json	(from https://bridgebio.com/news/bridgebio-pharma-highlights-its-ras-precision-oncology-portfolio-and-shares-compelling-data-from-next-generation-g12c-inhibitor-and-novel-pi3k%ce%b1ras-breaker-mechanism-at-the-fourth-ras-initiative/)
03:01:33	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:33%20GMT	https://bridgebio.com/?p=5767	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexda6c.html	(from https://bridgebio.com/news/bridgebio-pharma-highlights-its-ras-precision-oncology-portfolio-and-shares-compelling-data-from-next-generation-g12c-inhibitor-and-novel-pi3k%ce%b1ras-breaker-mechanism-at-the-fourth-ras-initiative/)
03:01:33	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.5bd.delayed	(from https://bridgebio.com/news/bridgebio-pharma-highlights-its-ras-precision-oncology-portfolio-and-shares-compelling-data-from-next-generation-g12c-inhibitor-and-novel-pi3k%ce%b1ras-breaker-mechanism-at-the-fourth-ras-initiative/)
03:01:33	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.5be.delayed	(from https://bridgebio.com/news/bridgebio-pharma-highlights-its-ras-precision-oncology-portfolio-and-shares-compelling-data-from-next-generation-g12c-inhibitor-and-novel-pi3k%ce%b1ras-breaker-mechanism-at-the-fourth-ras-initiative/)
03:01:34	3346/3346	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:01:34%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-highlights-its-ras-precision-oncology-portfolio-and-shares-compelling-data-from-next-generation-g12c-inhibitor-and-novel-pi3k%25ce%25b1ras-breaker-mechanism-at-the-fourth-ras-initiative%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf3f0	(from https://bridgebio.com/news/bridgebio-pharma-highlights-its-ras-precision-oncology-portfolio-and-shares-compelling-data-from-next-generation-g12c-inhibitor-and-novel-pi3k%ce%b1ras-breaker-mechanism-at-the-fourth-ras-initiative/)
03:01:34	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:34%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-highlights-its-ras-precision-oncology-portfolio-and-shares-compelling-data-from-next-generation-g12c-inhibitor-and-novel-pi3k%ce%b1ras-breaker-mechanism-at-the-fourth-ras-initiative/)
03:01:34	24308/24308	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:34%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5766	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5766.json	(from https://bridgebio.com/news/bridgebio-pharma-presents-12-month-results-from-phase-2-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:01:35	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-presents-12-month-results-from-phase-2-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-presents-12-month-results-from-phase-2-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-presents-12-month-results-from-phase-2-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:01:35	2840/2840	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:35%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-presents-12-month-results-from-phase-2-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd401.json	(from https://bridgebio.com/news/bridgebio-pharma-presents-12-month-results-from-phase-2-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:01:35	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:35%20GMT	https://bridgebio.com/?p=5766	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index49b5.html	(from https://bridgebio.com/news/bridgebio-pharma-presents-12-month-results-from-phase-2-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:01:35	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.5c3.delayed	(from https://bridgebio.com/news/bridgebio-pharma-presents-12-month-results-from-phase-2-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:01:35	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.5c4.delayed	(from https://bridgebio.com/news/bridgebio-pharma-presents-12-month-results-from-phase-2-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:01:35	3029/3029	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:01:36%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-presents-12-month-results-from-phase-2-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed39ac	(from https://bridgebio.com/news/bridgebio-pharma-presents-12-month-results-from-phase-2-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:01:36	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:36%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-presents-12-month-results-from-phase-2-study-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:01:36	27288/27288	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:36%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5765	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5765.json	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-positive-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-51st-annual-meeting-of-the-child-neurology-society/)
03:01:37	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-presents-updated-positive-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-51st-annual-meeting-of-the-child-neurology-society/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-presents-updated-positive-data/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-positive-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-51st-annual-meeting-of-the-child-neurology-society/)
03:01:37	2986/2986	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-presents-updated-positive-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-51st-annual-meeting-of-the-child-neurology-society%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed4925.json	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-positive-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-51st-annual-meeting-of-the-child-neurology-society/)
03:01:37	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:37%20GMT	https://bridgebio.com/?p=5765	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index4ad3.html	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-positive-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-51st-annual-meeting-of-the-child-neurology-society/)
03:01:37	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.5c9.delayed	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-positive-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-51st-annual-meeting-of-the-child-neurology-society/)
03:01:37	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.5ca.delayed	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-positive-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-51st-annual-meeting-of-the-child-neurology-society/)
03:01:37	3175/3175	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:01:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-presents-updated-positive-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-51st-annual-meeting-of-the-child-neurology-society%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedaeb5	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-positive-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-51st-annual-meeting-of-the-child-neurology-society/)
03:01:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:38%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-positive-data-from-its-bbp-812-canavan-disease-gene-therapy-program-at-the-51st-annual-meeting-of-the-child-neurology-society/)
03:01:38	27079/27079	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:38%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5761	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5761.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-2-trial-and-us-fda-fast-track-designation-for-shp2-inhibitor-bbp-398-in-combination-with-amgens-lumakras-sotorasib/)
03:01:39	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-2-trial-and-us-fda-fast-track-designation-for-shp2-inhibitor-bbp-398-in-combination-with-amgens-lumakras-sotorasib/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-pa/feed/index-2.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-2-trial-and-us-fda-fast-track-designation-for-shp2-inhibitor-bbp-398-in-combination-with-amgens-lumakras-sotorasib/)
03:01:39	3121/3121	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:39%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-2-trial-and-us-fda-fast-track-designation-for-shp2-inhibitor-bbp-398-in-combination-with-amgens-lumakras-sotorasib%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7df0.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-2-trial-and-us-fda-fast-track-designation-for-shp2-inhibitor-bbp-398-in-combination-with-amgens-lumakras-sotorasib/)
03:01:39	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:39%20GMT	https://bridgebio.com/?p=5761	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index491c.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-2-trial-and-us-fda-fast-track-designation-for-shp2-inhibitor-bbp-398-in-combination-with-amgens-lumakras-sotorasib/)
03:01:39	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.5cf.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-2-trial-and-us-fda-fast-track-designation-for-shp2-inhibitor-bbp-398-in-combination-with-amgens-lumakras-sotorasib/)
03:01:39	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.5d0.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-2-trial-and-us-fda-fast-track-designation-for-shp2-inhibitor-bbp-398-in-combination-with-amgens-lumakras-sotorasib/)
03:01:39	3310/3310	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:01:39%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-2-trial-and-us-fda-fast-track-designation-for-shp2-inhibitor-bbp-398-in-combination-with-amgens-lumakras-sotorasib%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede733	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-2-trial-and-us-fda-fast-track-designation-for-shp2-inhibitor-bbp-398-in-combination-with-amgens-lumakras-sotorasib/)
03:01:40	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:40%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-lung-cancer-patient-dosed-in-phase-1-2-trial-and-us-fda-fast-track-designation-for-shp2-inhibitor-bbp-398-in-combination-with-amgens-lumakras-sotorasib/)
03:01:40	22211/22211	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:40%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5759	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5759.json	(from https://bridgebio.com/news/bridgebio-pharma-to-present-new-data-on-its-novel-approaches-to-ras-driven-cancers-at-the-fourth-ras-initiative-symposium/)
03:01:41	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-present-new-data-on-its-novel-approaches-to-ras-driven-cancers-at-the-fourth-ras-initiative-symposium/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-present-new-data-on-its-novel-approaches-to-ras-driven-cancers-at-the-fourth-ras-initiative-symposium/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-present-new-data-on-its-novel-approaches-to-ras-driven-cancers-at-the-fourth-ras-initiative-symposium/)
03:01:41	2840/2840	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:41%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-present-new-data-on-its-novel-approaches-to-ras-driven-cancers-at-the-fourth-ras-initiative-symposium%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3084.json	(from https://bridgebio.com/news/bridgebio-pharma-to-present-new-data-on-its-novel-approaches-to-ras-driven-cancers-at-the-fourth-ras-initiative-symposium/)
03:01:41	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:41%20GMT	https://bridgebio.com/?p=5759	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index324e.html	(from https://bridgebio.com/news/bridgebio-pharma-to-present-new-data-on-its-novel-approaches-to-ras-driven-cancers-at-the-fourth-ras-initiative-symposium/)
03:01:41	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.5d5.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-present-new-data-on-its-novel-approaches-to-ras-driven-cancers-at-the-fourth-ras-initiative-symposium/)
03:01:41	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.5d6.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-present-new-data-on-its-novel-approaches-to-ras-driven-cancers-at-the-fourth-ras-initiative-symposium/)
03:01:41	3029/3029	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:01:41%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-present-new-data-on-its-novel-approaches-to-ras-driven-cancers-at-the-fourth-ras-initiative-symposium%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedbf39	(from https://bridgebio.com/news/bridgebio-pharma-to-present-new-data-on-its-novel-approaches-to-ras-driven-cancers-at-the-fourth-ras-initiative-symposium/)
03:01:42	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:42%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-present-new-data-on-its-novel-approaches-to-ras-driven-cancers-at-the-fourth-ras-initiative-symposium/)
03:01:42	26314/26314	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:42%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5755	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5755.json	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-marketing-authorization-in-the-eu-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:01:43	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-marketing-authorization-in-the-eu-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-marketing-authorization-in-the-eu-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-marketing-authorization-in-the-eu-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:01:43	2934/2934	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:43%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-sentynl-therapeutics-receive-marketing-authorization-in-the-eu-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd5be.json	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-marketing-authorization-in-the-eu-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:01:43	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:43%20GMT	https://bridgebio.com/?p=5755	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index83d5.html	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-marketing-authorization-in-the-eu-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:01:43	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.5db.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-marketing-authorization-in-the-eu-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:01:43	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.5dc.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-marketing-authorization-in-the-eu-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:01:43	3123/3123	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:01:43%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-sentynl-therapeutics-receive-marketing-authorization-in-the-eu-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed48fa	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-marketing-authorization-in-the-eu-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:01:43	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:43%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-marketing-authorization-in-the-eu-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:01:44	13976/13976	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:44%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5751	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5751.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events/)
03:01:45	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events/)
03:01:45	2588/2588	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:45%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-september-investor-events%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7ed4.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events/)
03:01:45	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:45%20GMT	https://bridgebio.com/?p=5751	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index725b.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events/)
03:01:45	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.5e1.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events/)
03:01:45	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.5e2.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events/)
03:01:45	2777/2777	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:01:45%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-september-investor-events%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed34d9	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events/)
03:01:45	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:46%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-september-investor-events/)
03:01:46	23518/23518	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:46%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5748	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5748.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-trial-of-bbp-671-a-potential-best-in-class-treatment-for-propionic-acidemia-pa-and-methylmalonic-acidemia-mma/)
03:01:46	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-trial-of-bbp-671-a-potential-best-in-class-treatment-for-propionic-acidemia-pa-and-methylmalonic-acidemia-mma/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-pati/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-trial-of-bbp-671-a-potential-best-in-class-treatment-for-propionic-acidemia-pa-and-methylmalonic-acidemia-mma/)
03:01:47	3024/3024	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:47%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-trial-of-bbp-671-a-potential-best-in-class-treatment-for-propionic-acidemia-pa-and-methylmalonic-acidemia-mma%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed40ef.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-trial-of-bbp-671-a-potential-best-in-class-treatment-for-propionic-acidemia-pa-and-methylmalonic-acidemia-mma/)
03:01:47	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:47%20GMT	https://bridgebio.com/?p=5748	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index1868.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-trial-of-bbp-671-a-potential-best-in-class-treatment-for-propionic-acidemia-pa-and-methylmalonic-acidemia-mma/)
03:01:47	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.5e7.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-trial-of-bbp-671-a-potential-best-in-class-treatment-for-propionic-acidemia-pa-and-methylmalonic-acidemia-mma/)
03:01:47	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.5e8.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-trial-of-bbp-671-a-potential-best-in-class-treatment-for-propionic-acidemia-pa-and-methylmalonic-acidemia-mma/)
03:01:47	3213/3213	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:01:47%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-trial-of-bbp-671-a-potential-best-in-class-treatment-for-propionic-acidemia-pa-and-methylmalonic-acidemia-mma%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7d07	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-trial-of-bbp-671-a-potential-best-in-class-treatment-for-propionic-acidemia-pa-and-methylmalonic-acidemia-mma/)
03:01:47	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:47%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-trial-of-bbp-671-a-potential-best-in-class-treatment-for-propionic-acidemia-pa-and-methylmalonic-acidemia-mma/)
03:01:48	28039/28039	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:48%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5743	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5743.json	(from https://bridgebio.com/news/bridgebio-pharma-sentynl-therapeutics-and-medison-pharma-announce-approval-in-israel-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:01:48	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-sentynl-therapeutics-and-medison-pharma-announce-approval-in-israel-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-sentynl-therapeutics-and-medison-pharma-announce-approval-in-israel-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-sentynl-therapeutics-and-medison-pharma-announce-approval-in-israel-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:01:48	2939/2939	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:49%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-sentynl-therapeutics-and-medison-pharma-announce-approval-in-israel-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed546c.json	(from https://bridgebio.com/news/bridgebio-pharma-sentynl-therapeutics-and-medison-pharma-announce-approval-in-israel-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:01:49	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:49%20GMT	https://bridgebio.com/?p=5743	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index7bde.html	(from https://bridgebio.com/news/bridgebio-pharma-sentynl-therapeutics-and-medison-pharma-announce-approval-in-israel-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:01:49	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.5ed.delayed	(from https://bridgebio.com/news/bridgebio-pharma-sentynl-therapeutics-and-medison-pharma-announce-approval-in-israel-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:01:49	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.5ee.delayed	(from https://bridgebio.com/news/bridgebio-pharma-sentynl-therapeutics-and-medison-pharma-announce-approval-in-israel-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:01:49	3128/3128	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:01:49%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-sentynl-therapeutics-and-medison-pharma-announce-approval-in-israel-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf294	(from https://bridgebio.com/news/bridgebio-pharma-sentynl-therapeutics-and-medison-pharma-announce-approval-in-israel-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:01:49	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:49%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-sentynl-therapeutics-and-medison-pharma-announce-approval-in-israel-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:01:52	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update/)
03:01:52	2659/2659	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:51%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedcdb5.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update/)
03:01:52	46517/46517	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:01:51%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5713	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5713.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update/)
03:01:53	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.5f4.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update/)
03:01:53	2821/2821	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:01:53%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed713a	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update/)
03:01:59	135043/135043	---M--	200	added ('OK')	image/png	etag:%2266829c06-25722%22	http://bridgebio.com/wp-content/uploads/2022/08/BBIO_Q2_1.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2022/08/BBIO_Q2_1.png	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update/)
03:01:59	101455/101455	---M--	200	added ('OK')	image/png	etag:%2266829c06-1b962%22	https://bridgebio.com/wp-content/uploads/2022/08/BBIO_Q2_2.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2022/08/BBIO_Q2_2.png	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update/)
03:01:59	164594/164594	---M--	200	added ('OK')	image/png	etag:%2266829bf5-3cfe8%22	https://bridgebio.com/wp-content/uploads/2022/08/BBIO_Q2_3-e1659614511302.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2022/08/BBIO_Q2_3-e1659614511302.png	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update/)
03:01:59	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:01:53%20GMT	https://bridgebio.com/?p=5713	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexefd9.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update/)
03:02:00	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.5f8.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update/)
03:02:00	12718/12718	---M--	200	added ('OK')	image/png	etag:%2266829c04-4dc1%22	https://bridgebio.com/wp-content/uploads/2022/08/earningspr-300x101.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2022/08/earningspr-300x101.png	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update/)
03:02:00	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:00%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2022-financial-results-and-business-update/)
03:02:01	23481/23481	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:01%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5706	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5706.json	(from https://bridgebio.com/news/5706-2/)
03:02:01	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/5706-2/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/5706-2/feed/index.html	(from https://bridgebio.com/news/5706-2/)
03:02:01	2878/2878	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:01%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2F5706-2%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb257.json	(from https://bridgebio.com/news/5706-2/)
03:02:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:02%20GMT	https://bridgebio.com/?p=5706	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index97c4.html	(from https://bridgebio.com/news/5706-2/)
03:02:02	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.5fd.delayed	(from https://bridgebio.com/news/5706-2/)
03:02:02	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.5fe.delayed	(from https://bridgebio.com/news/5706-2/)
03:02:02	3065/3065	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:02%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2F5706-2%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc92b	(from https://bridgebio.com/news/5706-2/)
03:02:02	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:02%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/5706-2/)
03:02:02	24932/24932	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:03%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5705	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5705.json	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-positive-chmp-opinion-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:02:03	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-positive-chmp-opinion-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-positive-chmp-opinion-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-positive-chmp-opinion-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:02:03	2866/2866	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:03%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-sentynl-therapeutics-receive-positive-chmp-opinion-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed106f.json	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-positive-chmp-opinion-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:02:04	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:04%20GMT	https://bridgebio.com/?p=5705	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index8080.html	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-positive-chmp-opinion-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:02:04	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.603.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-positive-chmp-opinion-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:02:04	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.604.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-positive-chmp-opinion-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:02:04	3055/3055	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:04%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-sentynl-therapeutics-receive-positive-chmp-opinion-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc3ad	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-positive-chmp-opinion-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:02:04	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:04%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-receive-positive-chmp-opinion-for-nulibry-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:02:05	19295/19295	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:05%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5702	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5702.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-founding-affiliation-with-bakar-labs-incubator-at-uc-berkeleys-bakar-bioenginuity-hub/)
03:02:05	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-founding-affiliation-with-bakar-labs-incubator-at-uc-berkeleys-bakar-bioenginuity-hub/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-founding-affiliation-with-bakar-labs-incubator-at-uc-berkeleys-bakar-bioenginuity-hub/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-founding-affiliation-with-bakar-labs-incubator-at-uc-berkeleys-bakar-bioenginuity-hub/)
03:02:05	2793/2793	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:05%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-founding-affiliation-with-bakar-labs-incubator-at-uc-berkeleys-bakar-bioenginuity-hub%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed223b.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-founding-affiliation-with-bakar-labs-incubator-at-uc-berkeleys-bakar-bioenginuity-hub/)
03:02:05	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:05%20GMT	https://bridgebio.com/?p=5702	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexdcc4.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-founding-affiliation-with-bakar-labs-incubator-at-uc-berkeleys-bakar-bioenginuity-hub/)
03:02:06	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.609.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-founding-affiliation-with-bakar-labs-incubator-at-uc-berkeleys-bakar-bioenginuity-hub/)
03:02:06	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.60a.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-founding-affiliation-with-bakar-labs-incubator-at-uc-berkeleys-bakar-bioenginuity-hub/)
03:02:06	2988/2988	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:06%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-founding-affiliation-with-bakar-labs-incubator-at-uc-berkeleys-bakar-bioenginuity-hub%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8523	(from https://bridgebio.com/news/bridgebio-pharma-announces-founding-affiliation-with-bakar-labs-incubator-at-uc-berkeleys-bakar-bioenginuity-hub/)
03:02:06	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:06%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-founding-affiliation-with-bakar-labs-incubator-at-uc-berkeleys-bakar-bioenginuity-hub/)
03:02:07	19058/19058	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:07%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5701	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5701.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-academic-collaboration-with-baylor-college-of-medicine-to-advance-potential-therapies-to-treat-genetic-diseases/)
03:02:07	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-academic-collaboration-with-baylor-college-of-medicine-to-advance-potential-therapies-to-treat-genetic-diseases/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-academic-collaboration-with-baylor-college-of-medicine-to-advance-potential-therapies-to-treat-genetic-diseases/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-academic-collaboration-with-baylor-college-of-medicine-to-advance-potential-therapies-to-treat-genetic-diseases/)
03:02:07	2916/2916	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:07%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-academic-collaboration-with-baylor-college-of-medicine-to-advance-potential-therapies-to-treat-genetic-diseases%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed6378.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-academic-collaboration-with-baylor-college-of-medicine-to-advance-potential-therapies-to-treat-genetic-diseases/)
03:02:07	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:07%20GMT	https://bridgebio.com/?p=5701	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index3755.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-academic-collaboration-with-baylor-college-of-medicine-to-advance-potential-therapies-to-treat-genetic-diseases/)
03:02:07	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.60f.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-academic-collaboration-with-baylor-college-of-medicine-to-advance-potential-therapies-to-treat-genetic-diseases/)
03:02:08	3105/3105	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:08%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-academic-collaboration-with-baylor-college-of-medicine-to-advance-potential-therapies-to-treat-genetic-diseases%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed99d5	(from https://bridgebio.com/news/bridgebio-pharma-announces-academic-collaboration-with-baylor-college-of-medicine-to-advance-potential-therapies-to-treat-genetic-diseases/)
03:02:08	162/162	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:08%20GMT	http://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners.610.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-academic-collaboration-with-baylor-college-of-medicine-to-advance-potential-therapies-to-treat-genetic-diseases/)
03:02:08	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:08%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/news/bridgebio-pharma-announces-academic-collaboration-with-baylor-college-of-medicine-to-advance-potential-therapies-to-treat-genetic-diseases/)
03:02:08	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.612.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-academic-collaboration-with-baylor-college-of-medicine-to-advance-potential-therapies-to-treat-genetic-diseases/)
03:02:09	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:09%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-academic-collaboration-with-baylor-college-of-medicine-to-advance-potential-therapies-to-treat-genetic-diseases/)
03:02:09	24047/24047	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:09%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5696	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5696.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-1-data-and-phase-2-3-trial-design-for-bbp-711-a-potentially-best-in-class-go-inhibitor-for-primary-hyperoxaluria-type-1-ph1-and-recurrent-kidney-stone-form/)
03:02:10	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-1-data-and-phase-2-3-trial-design-for-bbp-711-a-potentially-best-in-class-go-inhibitor-for-primary-hyperoxaluria-type-1-ph1-and-recurrent-kidney-stone-form/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-positive-phase-1-dat/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-1-data-and-phase-2-3-trial-design-for-bbp-711-a-potentially-best-in-class-go-inhibitor-for-primary-hyperoxaluria-type-1-ph1-and-recurrent-kidney-stone-form/)
03:02:10	3171/3171	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:10%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-positive-phase-1-data-and-phase-2-3-trial-design-for-bbp-711-a-potentially-best-in-class-go-inhibitor-for-primary-hyperoxaluria-type-1-ph1-and-recurrent-kidney-stone-form%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedff31.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-1-data-and-phase-2-3-trial-design-for-bbp-711-a-potentially-best-in-class-go-inhibitor-for-primary-hyperoxaluria-type-1-ph1-and-recurrent-kidney-stone-form/)
03:02:10	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:10%20GMT	https://bridgebio.com/?p=5696	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexb041.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-1-data-and-phase-2-3-trial-design-for-bbp-711-a-potentially-best-in-class-go-inhibitor-for-primary-hyperoxaluria-type-1-ph1-and-recurrent-kidney-stone-form/)
03:02:10	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.617.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-1-data-and-phase-2-3-trial-design-for-bbp-711-a-potentially-best-in-class-go-inhibitor-for-primary-hyperoxaluria-type-1-ph1-and-recurrent-kidney-stone-form/)
03:02:10	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.618.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-1-data-and-phase-2-3-trial-design-for-bbp-711-a-potentially-best-in-class-go-inhibitor-for-primary-hyperoxaluria-type-1-ph1-and-recurrent-kidney-stone-form/)
03:02:10	3361/3361	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:10%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-positive-phase-1-data-and-phase-2-3-trial-design-for-bbp-711-a-potentially-best-in-class-go-inhibitor-for-primary-hyperoxaluria-type-1-ph1-and-recurrent-kidney-stone-form%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed122c-2	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-1-data-and-phase-2-3-trial-design-for-bbp-711-a-potentially-best-in-class-go-inhibitor-for-primary-hyperoxaluria-type-1-ph1-and-recurrent-kidney-stone-form/)
03:02:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:11%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-1-data-and-phase-2-3-trial-design-for-bbp-711-a-potentially-best-in-class-go-inhibitor-for-primary-hyperoxaluria-type-1-ph1-and-recurrent-kidney-stone-form/)
03:02:11	24776/24776	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:11%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5541	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5541.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-early-positive-data-for-bbp-812-its-investigational-aav9-gene-therapy-for-canavan-disease/)
03:02:12	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-early-positive-data-for-bbp-812-its-investigational-aav9-gene-therapy-for-canavan-disease/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-early-positive-data-for-bbp-812-its-investigational-aav9-gene-therapy-for-canavan-disease/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-early-positive-data-for-bbp-812-its-investigational-aav9-gene-therapy-for-canavan-disease/)
03:02:12	2791/2791	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:12%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-early-positive-data-for-bbp-812-its-investigational-aav9-gene-therapy-for-canavan-disease%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed444b.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-early-positive-data-for-bbp-812-its-investigational-aav9-gene-therapy-for-canavan-disease/)
03:02:12	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:12%20GMT	https://bridgebio.com/?p=5541	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index6dbb.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-early-positive-data-for-bbp-812-its-investigational-aav9-gene-therapy-for-canavan-disease/)
03:02:12	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.61d.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-early-positive-data-for-bbp-812-its-investigational-aav9-gene-therapy-for-canavan-disease/)
03:02:12	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.61e.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-early-positive-data-for-bbp-812-its-investigational-aav9-gene-therapy-for-canavan-disease/)
03:02:12	2982/2982	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:12%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-early-positive-data-for-bbp-812-its-investigational-aav9-gene-therapy-for-canavan-disease%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed45c7	(from https://bridgebio.com/news/bridgebio-pharma-announces-early-positive-data-for-bbp-812-its-investigational-aav9-gene-therapy-for-canavan-disease/)
03:02:13	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:13%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-early-positive-data-for-bbp-812-its-investigational-aav9-gene-therapy-for-canavan-disease/)
03:02:13	20354/20354	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:13%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5522	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5522.json	(from https://bridgebio.com/news/bridgebio-pharma-affiliate-venthera-presents-preliminary-results-from-clinical-trial-of-vt30-bbp-681-for-venous-lymphatic-and-venolymphatic-malformations/)
03:02:14	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-affiliate-venthera-presents-preliminary-results-from-clinical-trial-of-vt30-bbp-681-for-venous-lymphatic-and-venolymphatic-malformations/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-affiliate-venthera-presents-pr/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-affiliate-venthera-presents-preliminary-results-from-clinical-trial-of-vt30-bbp-681-for-venous-lymphatic-and-venolymphatic-malformations/)
03:02:14	2944/2944	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:14%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-affiliate-venthera-presents-preliminary-results-from-clinical-trial-of-vt30-bbp-681-for-venous-lymphatic-and-venolymphatic-malformations%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb950.json	(from https://bridgebio.com/news/bridgebio-pharma-affiliate-venthera-presents-preliminary-results-from-clinical-trial-of-vt30-bbp-681-for-venous-lymphatic-and-venolymphatic-malformations/)
03:02:14	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:14%20GMT	https://bridgebio.com/?p=5522	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index0d4c.html	(from https://bridgebio.com/news/bridgebio-pharma-affiliate-venthera-presents-preliminary-results-from-clinical-trial-of-vt30-bbp-681-for-venous-lymphatic-and-venolymphatic-malformations/)
03:02:14	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.623.delayed	(from https://bridgebio.com/news/bridgebio-pharma-affiliate-venthera-presents-preliminary-results-from-clinical-trial-of-vt30-bbp-681-for-venous-lymphatic-and-venolymphatic-malformations/)
03:02:14	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.624.delayed	(from https://bridgebio.com/news/bridgebio-pharma-affiliate-venthera-presents-preliminary-results-from-clinical-trial-of-vt30-bbp-681-for-venous-lymphatic-and-venolymphatic-malformations/)
03:02:14	3133/3133	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:14%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-affiliate-venthera-presents-preliminary-results-from-clinical-trial-of-vt30-bbp-681-for-venous-lymphatic-and-venolymphatic-malformations%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed27c6	(from https://bridgebio.com/news/bridgebio-pharma-affiliate-venthera-presents-preliminary-results-from-clinical-trial-of-vt30-bbp-681-for-venous-lymphatic-and-venolymphatic-malformations/)
03:02:15	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:15%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-affiliate-venthera-presents-preliminary-results-from-clinical-trial-of-vt30-bbp-681-for-venous-lymphatic-and-venolymphatic-malformations/)
03:02:15	15436/15436	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:15%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5497	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5497.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-june-investor-events/)
03:02:16	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-june-investor-events/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-june-investor-events/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-june-investor-events/)
03:02:16	2563/2563	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:16%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-june-investor-events%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed092d.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-june-investor-events/)
03:02:16	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:16%20GMT	https://bridgebio.com/?p=5497	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index7705.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-june-investor-events/)
03:02:16	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.629.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-june-investor-events/)
03:02:16	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.62a.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-june-investor-events/)
03:02:16	2752/2752	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:16%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-june-investor-events%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeda354	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-june-investor-events/)
03:02:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:17%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-june-investor-events/)
03:02:18	22797/22797	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:18%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5486	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5486.json	(from https://bridgebio.com/news/bridgebio-pharma-presents-positive-phase-1-data-in-healthy-volunteers-advancing-development-of-bbp-671-for-pantothenate-kinase-associated-neurodegeneration-pkan-and-organic-acidemias/)
03:02:18	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-presents-positive-phase-1-data-in-healthy-volunteers-advancing-development-of-bbp-671-for-pantothenate-kinase-associated-neurodegeneration-pkan-and-organic-acidemias/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-presents-positive-phase-1-data/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-presents-positive-phase-1-data-in-healthy-volunteers-advancing-development-of-bbp-671-for-pantothenate-kinase-associated-neurodegeneration-pkan-and-organic-acidemias/)
03:02:18	3059/3059	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:18%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-presents-positive-phase-1-data-in-healthy-volunteers-advancing-development-of-bbp-671-for-pantothenate-kinase-associated-neurodegeneration-pkan-and-organic-acidemias%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed4776.json	(from https://bridgebio.com/news/bridgebio-pharma-presents-positive-phase-1-data-in-healthy-volunteers-advancing-development-of-bbp-671-for-pantothenate-kinase-associated-neurodegeneration-pkan-and-organic-acidemias/)
03:02:19	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:19%20GMT	https://bridgebio.com/?p=5486	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index480a.html	(from https://bridgebio.com/news/bridgebio-pharma-presents-positive-phase-1-data-in-healthy-volunteers-advancing-development-of-bbp-671-for-pantothenate-kinase-associated-neurodegeneration-pkan-and-organic-acidemias/)
03:02:19	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.62f.delayed	(from https://bridgebio.com/news/bridgebio-pharma-presents-positive-phase-1-data-in-healthy-volunteers-advancing-development-of-bbp-671-for-pantothenate-kinase-associated-neurodegeneration-pkan-and-organic-acidemias/)
03:02:19	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.630.delayed	(from https://bridgebio.com/news/bridgebio-pharma-presents-positive-phase-1-data-in-healthy-volunteers-advancing-development-of-bbp-671-for-pantothenate-kinase-associated-neurodegeneration-pkan-and-organic-acidemias/)
03:02:19	3248/3248	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:19%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-presents-positive-phase-1-data-in-healthy-volunteers-advancing-development-of-bbp-671-for-pantothenate-kinase-associated-neurodegeneration-pkan-and-organic-acidemias%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb862	(from https://bridgebio.com/news/bridgebio-pharma-presents-positive-phase-1-data-in-healthy-volunteers-advancing-development-of-bbp-671-for-pantothenate-kinase-associated-neurodegeneration-pkan-and-organic-acidemias/)
03:02:19	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:19%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-presents-positive-phase-1-data-in-healthy-volunteers-advancing-development-of-bbp-671-for-pantothenate-kinase-associated-neurodegeneration-pkan-and-organic-acidemias/)
03:02:20	25548/25548	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:20%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5484	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5484.json	(from https://bridgebio.com/news/bridgebio-pharma-affiliate-phoenix-tissue-repair-announces-positive-results-from-phase-2-trial-of-ptr-01-a-protein-replacement-therapy-for-the-treatment-of-recessive-dystrophic-epidermolysis-bullosa/)
03:02:20	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-affiliate-phoenix-tissue-repair-announces-positive-results-from-phase-2-trial-of-ptr-01-a-protein-replacement-therapy-for-the-treatment-of-recessive-dystrophic-epidermolysis-bullosa/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-affiliate-phoenix-tissue-repai/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-affiliate-phoenix-tissue-repair-announces-positive-results-from-phase-2-trial-of-ptr-01-a-protein-replacement-therapy-for-the-treatment-of-recessive-dystrophic-epidermolysis-bullosa/)
03:02:20	3166/3166	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:20%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-affiliate-phoenix-tissue-repair-announces-positive-results-from-phase-2-trial-of-ptr-01-a-protein-replacement-therapy-for-the-treatment-of-recessive-dystrophic-epidermolysis-bullosa%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed44f2.json	(from https://bridgebio.com/news/bridgebio-pharma-affiliate-phoenix-tissue-repair-announces-positive-results-from-phase-2-trial-of-ptr-01-a-protein-replacement-therapy-for-the-treatment-of-recessive-dystrophic-epidermolysis-bullosa/)
03:02:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:21%20GMT	https://bridgebio.com/?p=5484	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index9269.html	(from https://bridgebio.com/news/bridgebio-pharma-affiliate-phoenix-tissue-repair-announces-positive-results-from-phase-2-trial-of-ptr-01-a-protein-replacement-therapy-for-the-treatment-of-recessive-dystrophic-epidermolysis-bullosa/)
03:02:21	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.635.delayed	(from https://bridgebio.com/news/bridgebio-pharma-affiliate-phoenix-tissue-repair-announces-positive-results-from-phase-2-trial-of-ptr-01-a-protein-replacement-therapy-for-the-treatment-of-recessive-dystrophic-epidermolysis-bullosa/)
03:02:21	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.636.delayed	(from https://bridgebio.com/news/bridgebio-pharma-affiliate-phoenix-tissue-repair-announces-positive-results-from-phase-2-trial-of-ptr-01-a-protein-replacement-therapy-for-the-treatment-of-recessive-dystrophic-epidermolysis-bullosa/)
03:02:21	3355/3355	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:21%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-affiliate-phoenix-tissue-repair-announces-positive-results-from-phase-2-trial-of-ptr-01-a-protein-replacement-therapy-for-the-treatment-of-recessive-dystrophic-epidermolysis-bullosa%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9267	(from https://bridgebio.com/news/bridgebio-pharma-affiliate-phoenix-tissue-repair-announces-positive-results-from-phase-2-trial-of-ptr-01-a-protein-replacement-therapy-for-the-treatment-of-recessive-dystrophic-epidermolysis-bullosa/)
03:02:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:21%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-affiliate-phoenix-tissue-repair-announces-positive-results-from-phase-2-trial-of-ptr-01-a-protein-replacement-therapy-for-the-treatment-of-recessive-dystrophic-epidermolysis-bullosa/)
03:02:22	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/5481-2/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/5481-2/feed/index.html	(from https://bridgebio.com/news/5481-2/)
03:02:22	12321/12321	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:22%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5481	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5481.json	(from https://bridgebio.com/news/5481-2/)
03:02:22	2466/2466	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:23%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2F5481-2%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed4b8f.json	(from https://bridgebio.com/news/5481-2/)
03:02:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:23%20GMT	https://bridgebio.com/?p=5481	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index258d.html	(from https://bridgebio.com/news/5481-2/)
03:02:23	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.63b.delayed	(from https://bridgebio.com/news/5481-2/)
03:02:23	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.63c.delayed	(from https://bridgebio.com/news/5481-2/)
03:02:23	2655/2655	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:23%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2F5481-2%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3e96	(from https://bridgebio.com/news/5481-2/)
03:02:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:23%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/5481-2/)
03:02:24	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734511860	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style14ad.css	(from https://bridgebio.com/news/bridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years/)
03:02:24	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years/)
03:02:24	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734511860	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css14ad.css	(from https://bridgebio.com/news/bridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years/)
03:02:25	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734511860	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust14ad.css	(from https://bridgebio.com/news/bridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years/)
03:02:25	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734511860	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts14ad.js	(from https://bridgebio.com/news/bridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years/)
03:02:25	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734511860	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal14ad.js	(from https://bridgebio.com/news/bridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years/)
03:02:26	19633/19633	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:26%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5479	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5479.json	(from https://bridgebio.com/news/bridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years/)
03:02:26	2913/2913	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:26%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7a32.json	(from https://bridgebio.com/news/bridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years/)
03:02:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:26%20GMT	https://bridgebio.com/?p=5479	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index5423.html	(from https://bridgebio.com/news/bridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years/)
03:02:26	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.646.delayed	(from https://bridgebio.com/news/bridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years/)
03:02:26	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.647.delayed	(from https://bridgebio.com/news/bridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years/)
03:02:26	3102/3102	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:26%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5699	(from https://bridgebio.com/news/bridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years/)
03:02:27	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:27%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-sells-rare-pediatric-disease-priority-review-voucher-for-110-million-and-defers-principal-payment-on-senior-debt-by-two-years/)
03:02:27	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-announces-exclusive-license-agreement-with-bristol-myers-squibb-to-develop-and-commercialize-bbp-398-a-potentially-best-in-class-shp2-inhibitor-in-oncology/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-announces-exclusive-license-agreement/feed/index.html	(from https://bridgebio.com/news/bridgebio-announces-exclusive-license-agreement-with-bristol-myers-squibb-to-develop-and-commercialize-bbp-398-a-potentially-best-in-class-shp2-inhibitor-in-oncology/)
03:02:27	22370/22370	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:27%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5468	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5468.json	(from https://bridgebio.com/news/bridgebio-announces-exclusive-license-agreement-with-bristol-myers-squibb-to-develop-and-commercialize-bbp-398-a-potentially-best-in-class-shp2-inhibitor-in-oncology/)
03:02:28	2987/2987	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:28%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-announces-exclusive-license-agreement-with-bristol-myers-squibb-to-develop-and-commercialize-bbp-398-a-potentially-best-in-class-shp2-inhibitor-in-oncology%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede662.json	(from https://bridgebio.com/news/bridgebio-announces-exclusive-license-agreement-with-bristol-myers-squibb-to-develop-and-commercialize-bbp-398-a-potentially-best-in-class-shp2-inhibitor-in-oncology/)
03:02:28	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:28%20GMT	https://bridgebio.com/?p=5468	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexe1db.html	(from https://bridgebio.com/news/bridgebio-announces-exclusive-license-agreement-with-bristol-myers-squibb-to-develop-and-commercialize-bbp-398-a-potentially-best-in-class-shp2-inhibitor-in-oncology/)
03:02:28	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.64c.delayed	(from https://bridgebio.com/news/bridgebio-announces-exclusive-license-agreement-with-bristol-myers-squibb-to-develop-and-commercialize-bbp-398-a-potentially-best-in-class-shp2-inhibitor-in-oncology/)
03:02:28	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.64d.delayed	(from https://bridgebio.com/news/bridgebio-announces-exclusive-license-agreement-with-bristol-myers-squibb-to-develop-and-commercialize-bbp-398-a-potentially-best-in-class-shp2-inhibitor-in-oncology/)
03:02:28	3176/3176	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:28%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-announces-exclusive-license-agreement-with-bristol-myers-squibb-to-develop-and-commercialize-bbp-398-a-potentially-best-in-class-shp2-inhibitor-in-oncology%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedcd4a	(from https://bridgebio.com/news/bridgebio-announces-exclusive-license-agreement-with-bristol-myers-squibb-to-develop-and-commercialize-bbp-398-a-potentially-best-in-class-shp2-inhibitor-in-oncology/)
03:02:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:29%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-announces-exclusive-license-agreement-with-bristol-myers-squibb-to-develop-and-commercialize-bbp-398-a-potentially-best-in-class-shp2-inhibitor-in-oncology/)
03:02:29	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734509880	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/stylee1ae.css	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference/)
03:02:30	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference/)
03:02:30	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734509880	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-csse1ae.css	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference/)
03:02:30	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734509880	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetruste1ae.css	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference/)
03:02:30	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734509880	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptse1ae.js	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference/)
03:02:31	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734509880	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modale1ae.js	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference/)
03:02:31	14219/14219	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:31%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5456	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5456.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference/)
03:02:32	2704/2704	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:32%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedff44.json	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference/)
03:02:32	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:32%20GMT	https://bridgebio.com/?p=5456	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index720c.html	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference/)
03:02:32	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.657.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference/)
03:02:32	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.658.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference/)
03:02:32	2893/2893	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:32%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedfbc7	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference/)
03:02:32	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:33%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-participate-in-the-bank-of-america-securities-healthcare-conference/)
03:02:33	21056/21056	---M--	200	added ('OK')	image/png	etag:%2266829bf5-d3a8%22	http://bridgebio.com/wp-content/uploads/2022/05/Q1-2022-image-1.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2022/05/Q1-2022-image-1.png	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2022-financial-results-and-business-update/)
03:02:34	36974/36974	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:34%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5464	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5464.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2022-financial-results-and-business-update/)
03:02:34	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2022-financial-results-and-business-update/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2022-financial-results-and-business-update/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2022-financial-results-and-business-update/)
03:02:34	2615/2615	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:34%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-first-quarter-2022-financial-results-and-business-update%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedbaa6.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2022-financial-results-and-business-update/)
03:02:34	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:34%20GMT	https://bridgebio.com/?p=5464	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexaf23.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2022-financial-results-and-business-update/)
03:02:34	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.65e.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2022-financial-results-and-business-update/)
03:02:34	2773/2773	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:35%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-first-quarter-2022-financial-results-and-business-update%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeddfbf	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2022-financial-results-and-business-update/)
03:02:35	4663/4663	---M--	200	added ('OK')	image/png	etag:%2266829bf6-2d3c%22	https://bridgebio.com/wp-content/uploads/2022/05/Q1-2022-image-2.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2022/05/Q1-2022-image-2.png	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2022-financial-results-and-business-update/)
03:02:35	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.661.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2022-financial-results-and-business-update/)
03:02:35	22795/22795	---M--	200	added ('OK')	image/png	etag:%2266829bf6-e977%22	https://bridgebio.com/wp-content/uploads/2022/05/Q1-2022-image-3.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2022/05/Q1-2022-image-3.png	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2022-financial-results-and-business-update/)
03:02:35	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:35%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-first-quarter-2022-financial-results-and-business-update/)
03:02:36	24431/24431	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:36%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5407	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5407.json	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/)
03:02:36	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-presents-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-presents-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/)
03:02:36	2919/2919	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-presents-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1144.json	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/)
03:02:37	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:37%20GMT	https://bridgebio.com/?p=5407	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index5852.html	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/)
03:02:37	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.666.delayed	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/)
03:02:37	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.667.delayed	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/)
03:02:37	3108/3108	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-presents-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed00bd	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/)
03:02:37	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:37%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-presents-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/)
03:02:38	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-present-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-present-updated-results-fro/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/)
03:02:38	21726/21726	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:38%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5404	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5404.json	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/)
03:02:38	3109/3109	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:39%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-present-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0edd.json	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/)
03:02:39	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:39%20GMT	https://bridgebio.com/?p=5404	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexfbdb.html	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/)
03:02:39	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.66c.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/)
03:02:39	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.66d.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/)
03:02:39	3300/3300	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:39%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-present-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2215	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/)
03:02:39	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:39%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-present-updated-results-from-phase-2-open-label-extension-study-of-acoramidis-in-transthyretin-amyloid-cardiomyopathy-attr-cm/)
03:02:40	25439/25439	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:40%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5373	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5373.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:02:40	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-positive-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:02:40	2743/2743	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:40%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-positive-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5766.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:02:41	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:41%20GMT	https://bridgebio.com/?p=5373	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index984a.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:02:41	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.672.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:02:41	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.673.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:02:41	2932/2932	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:41%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-positive-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd680	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:02:41	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:41%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-positive-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:02:42	20799/20799	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:42%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5362	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5362.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-host-investor-call-to-discuss-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:02:42	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-to-host-investor-call-to-discuss-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-to-host-investor-call-to-discuss-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-host-investor-call-to-discuss-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:02:42	2836/2836	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:42%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-to-host-investor-call-to-discuss-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeded09.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-host-investor-call-to-discuss-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:02:42	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:42%20GMT	https://bridgebio.com/?p=5362	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index7da3.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-host-investor-call-to-discuss-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:02:43	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.678.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-host-investor-call-to-discuss-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:02:43	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.679.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-host-investor-call-to-discuss-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:02:43	3025/3025	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:43%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-to-host-investor-call-to-discuss-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedfdf1	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-host-investor-call-to-discuss-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:02:43	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:43%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-host-investor-call-to-discuss-phase-2-data-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:02:43	25567/25567	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:44%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5353	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5353.json	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-announce-asset-purchase-agreement-for-bridgebio-pharmas-nulibry-fosdenopterin/)
03:02:44	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-announce-asset-purchase-agreement-for-bridgebio-pharmas-nulibry-fosdenopterin/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-announce-asset-purchase-agreement-for-bridgebio-pharmas-nulibry-fosdenopterin/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-announce-asset-purchase-agreement-for-bridgebio-pharmas-nulibry-fosdenopterin/)
03:02:44	2875/2875	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:44%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-sentynl-therapeutics-announce-asset-purchase-agreement-for-bridgebio-pharmas-nulibry-fosdenopterin%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf213.json	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-announce-asset-purchase-agreement-for-bridgebio-pharmas-nulibry-fosdenopterin/)
03:02:44	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:44%20GMT	https://bridgebio.com/?p=5353	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index1365.html	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-announce-asset-purchase-agreement-for-bridgebio-pharmas-nulibry-fosdenopterin/)
03:02:44	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.67e.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-announce-asset-purchase-agreement-for-bridgebio-pharmas-nulibry-fosdenopterin/)
03:02:44	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.67f.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-announce-asset-purchase-agreement-for-bridgebio-pharmas-nulibry-fosdenopterin/)
03:02:44	3080/3080	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:44%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-sentynl-therapeutics-announce-asset-purchase-agreement-for-bridgebio-pharmas-nulibry-fosdenopterin%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2950	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-announce-asset-purchase-agreement-for-bridgebio-pharmas-nulibry-fosdenopterin/)
03:02:45	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:45%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-and-sentynl-therapeutics-announce-asset-purchase-agreement-for-bridgebio-pharmas-nulibry-fosdenopterin/)
03:02:45	33348/33348	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:45%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5346	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5346.json	(from https://bridgebio.com/news/helsinn-group-and-bridgebio-pharma-announce-update-to-strategic-collaboration/)
03:02:45	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/helsinn-group-and-bridgebio-pharma-announce-update-to-strategic-collaboration/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/helsinn-group-and-bridgebio-pharma-announce-update-to-strategic-collaboration/feed/index.html	(from https://bridgebio.com/news/helsinn-group-and-bridgebio-pharma-announce-update-to-strategic-collaboration/)
03:02:46	2854/2854	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:46%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fhelsinn-group-and-bridgebio-pharma-announce-update-to-strategic-collaboration%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1aa2.json	(from https://bridgebio.com/news/helsinn-group-and-bridgebio-pharma-announce-update-to-strategic-collaboration/)
03:02:46	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:46%20GMT	https://bridgebio.com/?p=5346	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index010a.html	(from https://bridgebio.com/news/helsinn-group-and-bridgebio-pharma-announce-update-to-strategic-collaboration/)
03:02:46	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.684.delayed	(from https://bridgebio.com/news/helsinn-group-and-bridgebio-pharma-announce-update-to-strategic-collaboration/)
03:02:46	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.685.delayed	(from https://bridgebio.com/news/helsinn-group-and-bridgebio-pharma-announce-update-to-strategic-collaboration/)
03:02:46	3043/3043	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:46%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fhelsinn-group-and-bridgebio-pharma-announce-update-to-strategic-collaboration%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2aa7	(from https://bridgebio.com/news/helsinn-group-and-bridgebio-pharma-announce-update-to-strategic-collaboration/)
03:02:46	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:47%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/helsinn-group-and-bridgebio-pharma-announce-update-to-strategic-collaboration/)
03:02:47	36699/36699	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:47%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5343	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5343.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2021-financial-results-and-business-update/)
03:02:47	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2021-financial-results-and-business-update/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2021-financial-results-and-business-update/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2021-financial-results-and-business-update/)
03:02:47	2747/2747	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:48%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-fourth-quarter-and-full-year-2021-financial-results-and-business-update%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9c69.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2021-financial-results-and-business-update/)
03:02:48	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:48%20GMT	https://bridgebio.com/?p=5343	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexbaa4.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2021-financial-results-and-business-update/)
03:02:48	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.68a.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2021-financial-results-and-business-update/)
03:02:48	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.68b.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2021-financial-results-and-business-update/)
03:02:48	2938/2938	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:48%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-fourth-quarter-and-full-year-2021-financial-results-and-business-update%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3e1d	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2021-financial-results-and-business-update/)
03:02:48	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:48%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2021-financial-results-and-business-update/)
03:02:49	25738/25738	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:49%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5257	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5257.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/)
03:02:49	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/)
03:02:49	2933/2933	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:49%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9f99.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/)
03:02:49	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:49%20GMT	https://bridgebio.com/?p=5257	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexa3b7.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/)
03:02:50	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.690.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/)
03:02:50	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.691.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/)
03:02:50	3118/3118	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:50%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed601a	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/)
03:02:50	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:50%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-congenital-adrenal-hyperplasia-cah/)
03:02:50	21170/21170	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:51%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5256	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5256.json	(from https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-amgen-to-study-bbp-398/)
03:02:51	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-amgen-to-study-bbp-398/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-amgen-to-study-bbp-398/feed/index.html	(from https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-amgen-to-study-bbp-398/)
03:02:51	2931/2931	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:51%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-announces-clinical-collaboration-with-amgen-to-study-bbp-398%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeda40d.json	(from https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-amgen-to-study-bbp-398/)
03:02:51	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:51%20GMT	https://bridgebio.com/?p=5256	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexce00.html	(from https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-amgen-to-study-bbp-398/)
03:02:51	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.696.delayed	(from https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-amgen-to-study-bbp-398/)
03:02:51	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.697.delayed	(from https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-amgen-to-study-bbp-398/)
03:02:51	3120/3120	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:51%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-announces-clinical-collaboration-with-amgen-to-study-bbp-398%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed396a	(from https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-amgen-to-study-bbp-398/)
03:02:52	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:52%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-amgen-to-study-bbp-398/)
03:02:52	26408/26408	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:52%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5249	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5249.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-month-12-topline-results-from-phase-3-attribute-cm-study/)
03:02:53	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-month-12-topline-results-from-phase-3-attribute-cm-study/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-month-12-topline-results-from-phase-3-attribute-cm-study/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-month-12-topline-results-from-phase-3-attribute-cm-study/)
03:02:53	2676/2676	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:53%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-month-12-topline-results-from-phase-3-attribute-cm-study%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed59f2.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-month-12-topline-results-from-phase-3-attribute-cm-study/)
03:02:53	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:53%20GMT	https://bridgebio.com/?p=5249	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index0f7a.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-month-12-topline-results-from-phase-3-attribute-cm-study/)
03:02:53	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.69c.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-month-12-topline-results-from-phase-3-attribute-cm-study/)
03:02:53	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.69d.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-month-12-topline-results-from-phase-3-attribute-cm-study/)
03:02:53	2865/2865	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:53%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-month-12-topline-results-from-phase-3-attribute-cm-study%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb47d	(from https://bridgebio.com/news/bridgebio-pharma-reports-month-12-topline-results-from-phase-3-attribute-cm-study/)
03:02:53	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:54%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-month-12-topline-results-from-phase-3-attribute-cm-study/)
03:02:54	13675/13675	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:54%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5248	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5248.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-22/)
03:02:54	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-22/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-22/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-22/)
03:02:55	2658/2658	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:55%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-22%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7b2a.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-22/)
03:02:55	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:55%20GMT	https://bridgebio.com/?p=5248	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index6bdb.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-22/)
03:02:55	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.6a2.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-22/)
03:02:55	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.6a3.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-22/)
03:02:55	2845/2845	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:55%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-22%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed4e3c	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-22/)
03:02:55	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:55%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-22/)
03:02:56	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-and-helsinn-group-announce-strategic-collaboration/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-helsinn-group-announce-strategic-collaboration/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-and-helsinn-group-announce-strategic-collaboration/)
03:02:56	26021/26021	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:56%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5234	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5234.json	(from https://bridgebio.com/news/bridgebio-pharma-and-helsinn-group-announce-strategic-collaboration/)
03:02:56	2837/2837	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:57%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-helsinn-group-announce-strategic-collaboration%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedaef3.json	(from https://bridgebio.com/news/bridgebio-pharma-and-helsinn-group-announce-strategic-collaboration/)
03:02:57	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:57%20GMT	https://bridgebio.com/?p=5234	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexa560.html	(from https://bridgebio.com/news/bridgebio-pharma-and-helsinn-group-announce-strategic-collaboration/)
03:02:57	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.6a8.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-helsinn-group-announce-strategic-collaboration/)
03:02:57	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.6a9.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-helsinn-group-announce-strategic-collaboration/)
03:02:57	3038/3038	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:57%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-helsinn-group-announce-strategic-collaboration%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5293	(from https://bridgebio.com/news/bridgebio-pharma-and-helsinn-group-announce-strategic-collaboration/)
03:02:57	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:57%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-and-helsinn-group-announce-strategic-collaboration/)
03:02:58	22158/22158	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:58%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5233	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5233.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-secures-up-to-750-million-in-non-dilutive-debt-financing/)
03:02:58	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-secures-up-to-750-million-in-non-dilutive-debt-financing/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-secures-up-to-750-million-in-non-dilutive-debt-financing/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-secures-up-to-750-million-in-non-dilutive-debt-financing/)
03:02:58	2677/2677	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:02:58%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-secures-up-to-750-million-in-non-dilutive-debt-financing%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5837.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-secures-up-to-750-million-in-non-dilutive-debt-financing/)
03:02:59	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:59%20GMT	https://bridgebio.com/?p=5233	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexdca4.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-secures-up-to-750-million-in-non-dilutive-debt-financing/)
03:02:59	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.6ae.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-secures-up-to-750-million-in-non-dilutive-debt-financing/)
03:02:59	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.6af.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-secures-up-to-750-million-in-non-dilutive-debt-financing/)
03:02:59	2866/2866	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:02:59%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-secures-up-to-750-million-in-non-dilutive-debt-financing%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedee89	(from https://bridgebio.com/news/bridgebio-pharma-inc-secures-up-to-750-million-in-non-dilutive-debt-financing/)
03:02:59	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:02:59%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-secures-up-to-750-million-in-non-dilutive-debt-financing/)
03:03:00	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2021-financial-results-and-business-update/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2021-financial-results-and-business-update/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2021-financial-results-and-business-update/)
03:03:00	36174/36174	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:00%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5232	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5232.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2021-financial-results-and-business-update/)
03:03:00	2678/2678	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:00%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-third-quarter-2021-financial-results-and-business-update%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed31e1.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2021-financial-results-and-business-update/)
03:03:00	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:01%20GMT	https://bridgebio.com/?p=5232	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index3322.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2021-financial-results-and-business-update/)
03:03:01	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.6b4.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2021-financial-results-and-business-update/)
03:03:01	2869/2869	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:01%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-third-quarter-2021-financial-results-and-business-update%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2a7c	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2021-financial-results-and-business-update/)
03:03:01	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.6b7.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2021-financial-results-and-business-update/)
03:03:01	404547/404547	---M--	200	added ('OK')	image/png	etag:%2266829bf5-7e561%22	https://bridgebio.com/wp-content/uploads/2021/11/BBIO_Earnings_1.1-1024x603.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/11/BBIO_Earnings_1.1-1024x603.png	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2021-financial-results-and-business-update/)
03:03:02	368829/368829	---M--	200	added ('OK')	image/png	etag:%2266829bf6-6e580%22	https://bridgebio.com/wp-content/uploads/2021/11/BBIO_Earnings_2.1-1024x692.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/11/BBIO_Earnings_2.1-1024x692.png	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2021-financial-results-and-business-update/)
03:03:02	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:02%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2021-financial-results-and-business-update/)
03:03:02	24422/24422	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:02%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5228	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5228.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-canavan-disease/)
03:03:03	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-canavan-disease/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-canavan-disease/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-canavan-disease/)
03:03:03	2851/2851	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:03%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-canavan-disease%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed76ec.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-canavan-disease/)
03:03:03	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:03%20GMT	https://bridgebio.com/?p=5228	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index1230.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-canavan-disease/)
03:03:03	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.6bc.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-canavan-disease/)
03:03:03	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.6bd.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-canavan-disease/)
03:03:03	3037/3037	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:03%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-canavan-disease%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7eb4	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-canavan-disease/)
03:03:03	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:04%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-dosing-of-first-patient-in-phase-1-2-trial-of-investigational-gene-therapy-for-canavan-disease/)
03:03:04	23307/23307	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:04%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5224	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5224.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-columbia-university-and-mount-sinai-to-develop-potential-therapies-for-genetic-diseases-and-cancers/)
03:03:04	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-columbia-university-and-mount-sinai-to-develop-potential-therapies-for-genetic-diseases-and-cancers/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-columbia-university-and-mount-sinai-to-develop-potential-therapies-for-genetic-diseases-and-cancers/)
03:03:04	2942/2942	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:05%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-collaborations-with-columbia-university-and-mount-sinai-to-develop-potential-therapies-for-genetic-diseases-and-cancers%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd35c.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-columbia-university-and-mount-sinai-to-develop-potential-therapies-for-genetic-diseases-and-cancers/)
03:03:05	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:05%20GMT	https://bridgebio.com/?p=5224	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index16d3.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-columbia-university-and-mount-sinai-to-develop-potential-therapies-for-genetic-diseases-and-cancers/)
03:03:05	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.6c2.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-columbia-university-and-mount-sinai-to-develop-potential-therapies-for-genetic-diseases-and-cancers/)
03:03:05	0/-1	---M--	301	error ('')			http://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners.6c3.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-columbia-university-and-mount-sinai-to-develop-potential-therapies-for-genetic-diseases-and-cancers/)
03:03:05	3135/3135	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:05%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-collaborations-with-columbia-university-and-mount-sinai-to-develop-potential-therapies-for-genetic-diseases-and-cancers%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3416	(from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-columbia-university-and-mount-sinai-to-develop-potential-therapies-for-genetic-diseases-and-cancers/)
03:03:05	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:05%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-columbia-university-and-mount-sinai-to-develop-potential-therapies-for-genetic-diseases-and-cancers/)
03:03:05	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.6c5.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-columbia-university-and-mount-sinai-to-develop-potential-therapies-for-genetic-diseases-and-cancers/)
03:03:06	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:06%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-columbia-university-and-mount-sinai-to-develop-potential-therapies-for-genetic-diseases-and-cancers/)
03:03:06	17036/17036	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:06%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5220	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5220.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-pioneering-national-leader-in-genomics-and-workforce-diversity-hannah-valantine-to-its-board-of-directors/)
03:03:06	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-appoints-pioneering-national-leader-in-genomics-and-workforce-diversity-hannah-valantine-to-its-board-of-directors/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-appoints-pioneering-national-leader-in-genomics-and-workforce-diversity-hannah-valantine-to-its-board-of-directors/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-pioneering-national-leader-in-genomics-and-workforce-diversity-hannah-valantine-to-its-board-of-directors/)
03:03:07	2911/2911	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:07%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-appoints-pioneering-national-leader-in-genomics-and-workforce-diversity-hannah-valantine-to-its-board-of-directors%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3cf3.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-pioneering-national-leader-in-genomics-and-workforce-diversity-hannah-valantine-to-its-board-of-directors/)
03:03:07	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:07%20GMT	https://bridgebio.com/?p=5220	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index453c.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-pioneering-national-leader-in-genomics-and-workforce-diversity-hannah-valantine-to-its-board-of-directors/)
03:03:07	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.6ca.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-pioneering-national-leader-in-genomics-and-workforce-diversity-hannah-valantine-to-its-board-of-directors/)
03:03:07	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.6cb.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-pioneering-national-leader-in-genomics-and-workforce-diversity-hannah-valantine-to-its-board-of-directors/)
03:03:07	3100/3100	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:07%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-appoints-pioneering-national-leader-in-genomics-and-workforce-diversity-hannah-valantine-to-its-board-of-directors%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed89e3	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-pioneering-national-leader-in-genomics-and-workforce-diversity-hannah-valantine-to-its-board-of-directors/)
03:03:07	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:08%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-pioneering-national-leader-in-genomics-and-workforce-diversity-hannah-valantine-to-its-board-of-directors/)
03:03:08	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734495840	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style00cc.css	(from https://bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/)
03:03:08	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/)
03:03:09	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734495840	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css00cc.css	(from https://bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/)
03:03:09	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734495840	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust00cc.css	(from https://bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/)
03:03:09	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734495840	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts00cc.js	(from https://bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/)
03:03:09	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734495840	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal00cc.js	(from https://bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/)
03:03:10	32056/32056	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:10%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5217	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5217.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/)
03:03:10	2883/2883	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:10%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedbb31.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/)
03:03:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:11%20GMT	https://bridgebio.com/?p=5217	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexe79c.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/)
03:03:11	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.6d5.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/)
03:03:11	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.6d7.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/)
03:03:11	3078/3078	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:11%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2e93	(from https://bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/)
03:03:11	162/162	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:11%20GMT	http://bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data-for-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-demonstrating-blood-and-urine-calcium-normalization-in-trial-participants	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-updated-phase-2b-data-for-encaleret-in-autosomal-dominant-hypocalcemia-type-1-adh1-demonstrating-blood-and-urine-calcium-normalizatio	(from https://bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/)
03:03:12	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:11%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-progress-in-its-kras-portfolio-new-gene-therapy-programs/)
03:03:12	25056/25056	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:12%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5214	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5214.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-publication-of-preclinical-data/)
03:03:13	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-first-publication-of-preclinical-data/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-first-publication-of-preclinical-data/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-publication-of-preclinical-data/)
03:03:13	2915/2915	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:13%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-first-publication-of-preclinical-data%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed4d62.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-publication-of-preclinical-data/)
03:03:13	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:13%20GMT	https://bridgebio.com/?p=5214	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexfa9e.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-publication-of-preclinical-data/)
03:03:13	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.6dc.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-publication-of-preclinical-data/)
03:03:13	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.6dd.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-publication-of-preclinical-data/)
03:03:13	3104/3104	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:13%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-first-publication-of-preclinical-data%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed17da	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-publication-of-preclinical-data/)
03:03:14	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:14%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-first-publication-of-preclinical-data/)
03:03:14	17332/17332	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:14%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5211	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5211.json	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-october-12-2021/)
03:03:15	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-october-12-2021/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-october-12-2021/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-october-12-2021/)
03:03:15	2589/2589	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:15%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-host-virtual-rd-day-on-october-12-2021%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed535d.json	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-october-12-2021/)
03:03:15	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:15%20GMT	https://bridgebio.com/?p=5211	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index11b5.html	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-october-12-2021/)
03:03:15	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.6e2.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-october-12-2021/)
03:03:15	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.6e3.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-october-12-2021/)
03:03:15	2784/2784	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:15%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-host-virtual-rd-day-on-october-12-2021%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedcbf9	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-october-12-2021/)
03:03:16	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:16%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-october-12-2021/)
03:03:16	29662/29662	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:16%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5199	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5199.json	(from https://bridgebio.com/news/helsinn-group-and-bridgebio-pharmas-affiliate-qed-therapeutics-announce-health-canada-conditional-approval-of-truseltiq-infigratinib/)
03:03:17	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/helsinn-group-and-bridgebio-pharmas-affiliate-qed-therapeutics-announce-health-canada-conditional-approval-of-truseltiq-infigratinib/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/helsinn-group-and-bridgebio-pharmas-affiliate-qed-therapeutics-announce-health-canada-conditional-approval-of-truseltiq-infigratinib/feed/index.html	(from https://bridgebio.com/news/helsinn-group-and-bridgebio-pharmas-affiliate-qed-therapeutics-announce-health-canada-conditional-approval-of-truseltiq-infigratinib/)
03:03:17	2999/2999	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:17%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fhelsinn-group-and-bridgebio-pharmas-affiliate-qed-therapeutics-announce-health-canada-conditional-approval-of-truseltiq-infigratinib%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5fa4.json	(from https://bridgebio.com/news/helsinn-group-and-bridgebio-pharmas-affiliate-qed-therapeutics-announce-health-canada-conditional-approval-of-truseltiq-infigratinib/)
03:03:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:17%20GMT	https://bridgebio.com/?p=5199	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index53c3.html	(from https://bridgebio.com/news/helsinn-group-and-bridgebio-pharmas-affiliate-qed-therapeutics-announce-health-canada-conditional-approval-of-truseltiq-infigratinib/)
03:03:17	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.6e8.delayed	(from https://bridgebio.com/news/helsinn-group-and-bridgebio-pharmas-affiliate-qed-therapeutics-announce-health-canada-conditional-approval-of-truseltiq-infigratinib/)
03:03:17	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.6e9.delayed	(from https://bridgebio.com/news/helsinn-group-and-bridgebio-pharmas-affiliate-qed-therapeutics-announce-health-canada-conditional-approval-of-truseltiq-infigratinib/)
03:03:17	3200/3200	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:17%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fhelsinn-group-and-bridgebio-pharmas-affiliate-qed-therapeutics-announce-health-canada-conditional-approval-of-truseltiq-infigratinib%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed87f7	(from https://bridgebio.com/news/helsinn-group-and-bridgebio-pharmas-affiliate-qed-therapeutics-announce-health-canada-conditional-approval-of-truseltiq-infigratinib/)
03:03:18	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:18%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/helsinn-group-and-bridgebio-pharmas-affiliate-qed-therapeutics-announce-health-canada-conditional-approval-of-truseltiq-infigratinib/)
03:03:18	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-therapy-for-the-treatment-of-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-design/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-therapy-for-the-treatment-of-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:03:19	24075/24075	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:19%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5195	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5195.json	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-therapy-for-the-treatment-of-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:03:19	2951/2951	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:19%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-receives-fda-fast-track-designation-for-investigational-therapy-for-the-treatment-of-limb-girdle-muscular-dystrophy-type-2i-lgmd2i%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7242.json	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-therapy-for-the-treatment-of-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:03:19	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.6ee.delayed	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-therapy-for-the-treatment-of-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:03:19	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.6ef.delayed	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-therapy-for-the-treatment-of-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:03:19	3140/3140	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:19%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-receives-fda-fast-track-designation-for-investigational-therapy-for-the-treatment-of-limb-girdle-muscular-dystrophy-type-2i-lgmd2i%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0e3a	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-therapy-for-the-treatment-of-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:03:19	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:19%20GMT	https://bridgebio.com/?p=5195	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexc4a5.html	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-therapy-for-the-treatment-of-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:03:20	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:20%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-therapy-for-the-treatment-of-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:03:20	13543/13543	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:21%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/5192	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/5192.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-21/)
03:03:21	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-21/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-21/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-21/)
03:03:21	2660/2660	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:21%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-21%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2cee.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-21/)
03:03:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:21%20GMT	https://bridgebio.com/?p=5192	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexbe69.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-21/)
03:03:21	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.6f4.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-21/)
03:03:21	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.6f5.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-21/)
03:03:21	2847/2847	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:21%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-21%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0848	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-21/)
03:03:22	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:22%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-21/)
03:03:22	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734504120	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style6813.css	(from https://bridgebio.com/news/bridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib-in-patients-with-gastric-cancer-and-other-advanced-solid-tumors/)
03:03:23	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib-in-patients-with-gastric-cancer-and-other-advanced-solid-tumors/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-lianbio-announce-first-pat/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib-in-patients-with-gastric-cancer-and-other-advanced-solid-tumors/)
03:03:23	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734504120	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css6813.css	(from https://bridgebio.com/news/bridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib-in-patients-with-gastric-cancer-and-other-advanced-solid-tumors/)
03:03:23	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734504120	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust6813.css	(from https://bridgebio.com/news/bridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib-in-patients-with-gastric-cancer-and-other-advanced-solid-tumors/)
03:03:23	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734504120	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts6813.js	(from https://bridgebio.com/news/bridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib-in-patients-with-gastric-cancer-and-other-advanced-solid-tumors/)
03:03:24	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734504120	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal6813.js	(from https://bridgebio.com/news/bridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib-in-patients-with-gastric-cancer-and-other-advanced-solid-tumors/)
03:03:24	25833/25833	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:24%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/4876	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/4876.json	(from https://bridgebio.com/news/bridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib-in-patients-with-gastric-cancer-and-other-advanced-solid-tumors/)
03:03:24	2973/2973	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:25%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib-in-patients-with-gastric-cancer-and-other-advanced-solid-tumors%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2fc1.json	(from https://bridgebio.com/news/bridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib-in-patients-with-gastric-cancer-and-other-advanced-solid-tumors/)
03:03:25	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:25%20GMT	https://bridgebio.com/?p=4876	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index33a1.html	(from https://bridgebio.com/news/bridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib-in-patients-with-gastric-cancer-and-other-advanced-solid-tumors/)
03:03:25	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.6ff.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib-in-patients-with-gastric-cancer-and-other-advanced-solid-tumors/)
03:03:25	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.700.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib-in-patients-with-gastric-cancer-and-other-advanced-solid-tumors/)
03:03:25	3162/3162	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:25%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib-in-patients-with-gastric-cancer-and-other-advanced-solid-tumors%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb764	(from https://bridgebio.com/news/bridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib-in-patients-with-gastric-cancer-and-other-advanced-solid-tumors/)
03:03:25	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:25%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-and-lianbio-announce-first-patient-treated-in-phase-2a-trial-of-infigratinib-in-patients-with-gastric-cancer-and-other-advanced-solid-tumors/)
03:03:26	19738/19738	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:26%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/4875	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/4875.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-finance-and-pharmaceutical-leaders-fred-hassan-andrea-ellis-and-douglas-dachille-to-its-board-of-directors/)
03:03:26	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-appoints-finance-and-pharmaceutical-leaders-fred-hassan-andrea-ellis-and-douglas-dachille-to-its-board-of-directors/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-appoints-finance-and-pharmaceutical-leaders-fred-hassan-andrea-ellis-and-douglas-dachille-to-its-board-of-directors/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-finance-and-pharmaceutical-leaders-fred-hassan-andrea-ellis-and-douglas-dachille-to-its-board-of-directors/)
03:03:26	2905/2905	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:26%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-appoints-finance-and-pharmaceutical-leaders-fred-hassan-andrea-ellis-and-douglas-dachille-to-its-board-of-directors%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed205c.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-finance-and-pharmaceutical-leaders-fred-hassan-andrea-ellis-and-douglas-dachille-to-its-board-of-directors/)
03:03:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:27%20GMT	https://bridgebio.com/?p=4875	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index0f61.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-finance-and-pharmaceutical-leaders-fred-hassan-andrea-ellis-and-douglas-dachille-to-its-board-of-directors/)
03:03:27	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.705.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-finance-and-pharmaceutical-leaders-fred-hassan-andrea-ellis-and-douglas-dachille-to-its-board-of-directors/)
03:03:27	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.706.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-finance-and-pharmaceutical-leaders-fred-hassan-andrea-ellis-and-douglas-dachille-to-its-board-of-directors/)
03:03:27	3094/3094	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:27%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-appoints-finance-and-pharmaceutical-leaders-fred-hassan-andrea-ellis-and-douglas-dachille-to-its-board-of-directors%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed6e44	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-finance-and-pharmaceutical-leaders-fred-hassan-andrea-ellis-and-douglas-dachille-to-its-board-of-directors/)
03:03:27	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:27%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-finance-and-pharmaceutical-leaders-fred-hassan-andrea-ellis-and-douglas-dachille-to-its-board-of-directors/)
03:03:28	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734516360	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/styleeaf0.css	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/)
03:03:28	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/)
03:03:28	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734516360	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-csseaf0.css	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/)
03:03:28	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734516360	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrusteaf0.css	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/)
03:03:29	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734516360	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptseaf0.js	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/)
03:03:29	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734516360	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modaleaf0.js	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/)
03:03:30	30399/30399	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:30%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/4874	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/4874.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/)
03:03:30	2705/2705	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:30%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0b72.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/)
03:03:30	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:30%20GMT	https://bridgebio.com/?p=4874	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index443f.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/)
03:03:31	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.710.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/)
03:03:31	2896/2896	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:31%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed517f	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/)
03:03:31	105108/105108	---M--	200	added ('OK')	image/jpeg	etag:%2266829c0b-1ef4a%22	https://bridgebio.com/wp-content/uploads/2021/08/Q2-PR_Screenshot-2021-08-04-180927-1.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/08/Q2-PR_Screenshot-2021-08-04-180927-1.jpg	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/)
03:03:31	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.713.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/)
03:03:31	99437/99437	---M--	200	added ('OK')	image/jpeg	etag:%2266829c11-1da25%22	https://bridgebio.com/wp-content/uploads/2021/08/bbio-q2-2021-earning-report-image_Screenshot-2021-08-04-181115-1.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/08/bbio-q2-2021-earning-report-image_Screenshot-2021-08-04-181115-1.jpg	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/)
03:03:32	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:32%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2021-financial-results-and-business-update/)
03:03:33	13507/13507	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:33%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/4873	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/4873.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-20/)
03:03:33	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-20/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-20/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-20/)
03:03:33	2656/2656	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:33%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-20%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf8fe.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-20/)
03:03:33	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:33%20GMT	https://bridgebio.com/?p=4873	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index632f.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-20/)
03:03:33	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.718.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-20/)
03:03:33	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.719.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-20/)
03:03:34	2843/2843	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:34%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-20%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeda479	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-20/)
03:03:34	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:34%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-20/)
03:03:34	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-bristol-myers-squibb-to-study-bbp-398/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-bristol-myers-squibb-to-study-bbp-398/feed/index.html	(from https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-bristol-myers-squibb-to-study-bbp-398/)
03:03:35	21143/21143	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:35%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/4960	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/4960.json	(from https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-bristol-myers-squibb-to-study-bbp-398/)
03:03:35	2969/2969	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:35%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-announces-clinical-collaboration-with-bristol-myers-squibb-to-study-bbp-398%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedbad2.json	(from https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-bristol-myers-squibb-to-study-bbp-398/)
03:03:36	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:36%20GMT	https://bridgebio.com/?p=4960	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index18de.html	(from https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-bristol-myers-squibb-to-study-bbp-398/)
03:03:36	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.71e.delayed	(from https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-bristol-myers-squibb-to-study-bbp-398/)
03:03:36	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.71f.delayed	(from https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-bristol-myers-squibb-to-study-bbp-398/)
03:03:36	3158/3158	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:36%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-announces-clinical-collaboration-with-bristol-myers-squibb-to-study-bbp-398%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedade5	(from https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-bristol-myers-squibb-to-study-bbp-398/)
03:03:36	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:36%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-announces-clinical-collaboration-with-bristol-myers-squibb-to-study-bbp-398/)
03:03:37	13477/13477	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:37%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3872	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3872.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-19/)
03:03:37	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-19/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-19/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-19/)
03:03:37	2656/2656	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-19%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8232.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-19/)
03:03:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:38%20GMT	https://bridgebio.com/?p=3872	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index8608.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-19/)
03:03:38	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.724.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-19/)
03:03:38	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.725.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-19/)
03:03:38	2843/2843	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:38%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-19%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb625	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-19/)
03:03:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:38%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-19/)
03:03:39	20253/20253	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:39%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3863	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3863.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-three-academic-research-institutions/)
03:03:39	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-three-academic-research-institutions/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-three-academic-research-institutions/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-three-academic-research-institutions/)
03:03:39	2694/2694	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:39%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-collaborations-with-three-academic-research-institutions%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd778.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-three-academic-research-institutions/)
03:03:40	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:40%20GMT	https://bridgebio.com/?p=3863	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexcc64.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-three-academic-research-institutions/)
03:03:40	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.72a.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-three-academic-research-institutions/)
03:03:40	0/-1	---M--	301	error ('')			http://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners.72b.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-three-academic-research-institutions/)
03:03:40	2883/2883	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:40%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-collaborations-with-three-academic-research-institutions%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7efc	(from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-three-academic-research-institutions/)
03:03:40	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:40%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-three-academic-research-institutions/)
03:03:40	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.72d.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-three-academic-research-institutions/)
03:03:40	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:41%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-collaborations-with-three-academic-research-institutions/)
03:03:41	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-18/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-18/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-18/)
03:03:41	13416/13416	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:41%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3844	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3844.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-18/)
03:03:42	2656/2656	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:42%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-18%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeda179.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-18/)
03:03:42	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:42%20GMT	https://bridgebio.com/?p=3844	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index096f.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-18/)
03:03:42	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.732.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-18/)
03:03:42	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.733.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-18/)
03:03:42	2843/2843	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:42%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-18%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc158	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-18/)
03:03:42	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:43%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-18/)
03:03:43	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734509340	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/styleef61.css	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-partner-helsinn-group-announce-fda-approval-of-truseltiq-infigratinib-for-patients-with-cholangiocarcinoma/)
03:03:43	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734509340	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-cssef61.css	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-partner-helsinn-group-announce-fda-approval-of-truseltiq-infigratinib-for-patients-with-cholangiocarcinoma/)
03:03:44	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-partner-helsinn-group-announce-fda-approval-of-truseltiq-infigratinib-for-patients-with-cholangiocarcinoma/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-an/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-partner-helsinn-group-announce-fda-approval-of-truseltiq-infigratinib-for-patients-with-cholangiocarcinoma/)
03:03:44	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734509340	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrustef61.css	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-partner-helsinn-group-announce-fda-approval-of-truseltiq-infigratinib-for-patients-with-cholangiocarcinoma/)
03:03:44	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734509340	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptsef61.js	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-partner-helsinn-group-announce-fda-approval-of-truseltiq-infigratinib-for-patients-with-cholangiocarcinoma/)
03:03:44	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734509340	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modalef61.js	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-partner-helsinn-group-announce-fda-approval-of-truseltiq-infigratinib-for-patients-with-cholangiocarcinoma/)
03:03:45	39600/39600	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:45%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3823	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3823.json	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-partner-helsinn-group-announce-fda-approval-of-truseltiq-infigratinib-for-patients-with-cholangiocarcinoma/)
03:03:45	2993/2993	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:45%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-affiliate-qed-therapeutics-and-partner-helsinn-group-announce-fda-approval-of-truseltiq-infigratinib-for-patients-with-cholangiocarcinoma%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf75b.json	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-partner-helsinn-group-announce-fda-approval-of-truseltiq-infigratinib-for-patients-with-cholangiocarcinoma/)
03:03:45	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:45%20GMT	https://bridgebio.com/?p=3823	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexd745.html	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-partner-helsinn-group-announce-fda-approval-of-truseltiq-infigratinib-for-patients-with-cholangiocarcinoma/)
03:03:46	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.73d.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-partner-helsinn-group-announce-fda-approval-of-truseltiq-infigratinib-for-patients-with-cholangiocarcinoma/)
03:03:46	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.73e.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-partner-helsinn-group-announce-fda-approval-of-truseltiq-infigratinib-for-patients-with-cholangiocarcinoma/)
03:03:46	3194/3194	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:46%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-affiliate-qed-therapeutics-and-partner-helsinn-group-announce-fda-approval-of-truseltiq-infigratinib-for-patients-with-cholangiocarcinoma%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed21e9	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-partner-helsinn-group-announce-fda-approval-of-truseltiq-infigratinib-for-patients-with-cholangiocarcinoma/)
03:03:46	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:46%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-partner-helsinn-group-announce-fda-approval-of-truseltiq-infigratinib-for-patients-with-cholangiocarcinoma/)
03:03:47	13306/13306	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:47%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3800	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3800.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-17/)
03:03:47	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-17/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-17/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-17/)
03:03:47	2655/2655	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:47%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-17%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0b83.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-17/)
03:03:47	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:47%20GMT	https://bridgebio.com/?p=3800	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexcc6f.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-17/)
03:03:48	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.743.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-17/)
03:03:48	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.744.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-17/)
03:03:48	2842/2842	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:48%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-17%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc167	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-17/)
03:03:48	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:48%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-17/)
03:03:49	23775/23775	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:49%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3793	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3793.json	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-gene-therapy-for-congenital-adrenal-hyperplasia/)
03:03:49	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-gene-therapy-for-congenital-adrenal-hyperplasia/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-gene-therapy-for-congenital-adrenal-hyperplasia/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-gene-therapy-for-congenital-adrenal-hyperplasia/)
03:03:49	2835/2835	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:49%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-receives-fda-fast-track-designation-for-investigational-gene-therapy-for-congenital-adrenal-hyperplasia%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf0cb.json	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-gene-therapy-for-congenital-adrenal-hyperplasia/)
03:03:49	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:49%20GMT	https://bridgebio.com/?p=3793	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexffdc.html	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-gene-therapy-for-congenital-adrenal-hyperplasia/)
03:03:49	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.749.delayed	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-gene-therapy-for-congenital-adrenal-hyperplasia/)
03:03:49	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.74a.delayed	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-gene-therapy-for-congenital-adrenal-hyperplasia/)
03:03:49	3024/3024	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:49%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-receives-fda-fast-track-designation-for-investigational-gene-therapy-for-congenital-adrenal-hyperplasia%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf3b9	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-gene-therapy-for-congenital-adrenal-hyperplasia/)
03:03:50	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:50%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-receives-fda-fast-track-designation-for-investigational-gene-therapy-for-congenital-adrenal-hyperplasia/)
03:03:50	28554/28554	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:50%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3751	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3751.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2021-financial-results-and-business-update/)
03:03:51	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2021-financial-results-and-business-update/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2021-financial-results-and-business-update/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2021-financial-results-and-business-update/)
03:03:51	2700/2700	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:51%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-reports-first-quarter-2021-financial-results-and-business-update%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed18ef.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2021-financial-results-and-business-update/)
03:03:51	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:51%20GMT	https://bridgebio.com/?p=3751	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index176d.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2021-financial-results-and-business-update/)
03:03:51	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.74f.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2021-financial-results-and-business-update/)
03:03:51	2891/2891	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:51%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-reports-first-quarter-2021-financial-results-and-business-update%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd0db	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2021-financial-results-and-business-update/)
03:03:52	129198/129198	---M--	200	added ('OK')	image/jpeg	etag:%2266829bfc-26b3b%22	https://bridgebio.com/wp-content/uploads/2021/05/bbio-q1-2021-earning-report-image-1.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/05/bbio-q1-2021-earning-report-image-1.jpg	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2021-financial-results-and-business-update/)
03:03:52	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.752.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2021-financial-results-and-business-update/)
03:03:52	133295/133295	---M--	200	added ('OK')	image/jpeg	etag:%2266829bfc-284c2%22	https://bridgebio.com/wp-content/uploads/2021/05/bbio-q1-2021-earning-report-image-2.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/05/bbio-q1-2021-earning-report-image-2.jpg	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2021-financial-results-and-business-update/)
03:03:52	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:52%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2021-financial-results-and-business-update/)
03:03:53	19762/19762	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:53%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3646	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3646.json	(from https://bridgebio.com/news/bridgebio-pharma-and-the-university-of-california-san-diego-announce-collaboration-to-advance-treatments-for-genetically-driven-conditions/)
03:03:53	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-and-the-university-of-california-san-diego-announce-collaboration-to-advance-treatments-for-genetically-driven-conditions/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-the-university-of-california-san-diego-announce-collaboration-to-advance-treatments-for-genetically-driven-conditions/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-and-the-university-of-california-san-diego-announce-collaboration-to-advance-treatments-for-genetically-driven-conditions/)
03:03:53	2924/2924	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:53%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-the-university-of-california-san-diego-announce-collaboration-to-advance-treatments-for-genetically-driven-conditions%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc428.json	(from https://bridgebio.com/news/bridgebio-pharma-and-the-university-of-california-san-diego-announce-collaboration-to-advance-treatments-for-genetically-driven-conditions/)
03:03:54	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:54%20GMT	https://bridgebio.com/?p=3646	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index3234.html	(from https://bridgebio.com/news/bridgebio-pharma-and-the-university-of-california-san-diego-announce-collaboration-to-advance-treatments-for-genetically-driven-conditions/)
03:03:54	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.757.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-the-university-of-california-san-diego-announce-collaboration-to-advance-treatments-for-genetically-driven-conditions/)
03:03:54	0/-1	---M--	301	error ('')			http://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners.758.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-the-university-of-california-san-diego-announce-collaboration-to-advance-treatments-for-genetically-driven-conditions/)
03:03:54	3113/3113	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:54%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-the-university-of-california-san-diego-announce-collaboration-to-advance-treatments-for-genetically-driven-conditions%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed342b	(from https://bridgebio.com/news/bridgebio-pharma-and-the-university-of-california-san-diego-announce-collaboration-to-advance-treatments-for-genetically-driven-conditions/)
03:03:54	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:54%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/news/bridgebio-pharma-and-the-university-of-california-san-diego-announce-collaboration-to-advance-treatments-for-genetically-driven-conditions/)
03:03:54	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.75a.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-the-university-of-california-san-diego-announce-collaboration-to-advance-treatments-for-genetically-driven-conditions/)
03:03:54	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:54%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-and-the-university-of-california-san-diego-announce-collaboration-to-advance-treatments-for-genetically-driven-conditions/)
03:03:55	19639/19639	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:55%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3643	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3643.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-uc-davis-establish-collaboration-to-transform-research-into-potential-therapies-for-genetically-driven-diseases/)
03:03:55	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-and-uc-davis-establish-collaboration-to-transform-research-into-potential-therapies-for-genetically-driven-diseases/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-and-uc-davis-establish-collaboration-to-transform-research-into-potential-therapies-for-genetically-driven-diseases/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-uc-davis-establish-collaboration-to-transform-research-into-potential-therapies-for-genetically-driven-diseases/)
03:03:56	2907/2907	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:56%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-and-uc-davis-establish-collaboration-to-transform-research-into-potential-therapies-for-genetically-driven-diseases%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf59f.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-uc-davis-establish-collaboration-to-transform-research-into-potential-therapies-for-genetically-driven-diseases/)
03:03:56	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:56%20GMT	https://bridgebio.com/?p=3643	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexdc9d.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-uc-davis-establish-collaboration-to-transform-research-into-potential-therapies-for-genetically-driven-diseases/)
03:03:56	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.75f.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-uc-davis-establish-collaboration-to-transform-research-into-potential-therapies-for-genetically-driven-diseases/)
03:03:56	0/-1	---M--	301	error ('')			http://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners.760.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-uc-davis-establish-collaboration-to-transform-research-into-potential-therapies-for-genetically-driven-diseases/)
03:03:56	3096/3096	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:56%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-and-uc-davis-establish-collaboration-to-transform-research-into-potential-therapies-for-genetically-driven-diseases%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc30e	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-uc-davis-establish-collaboration-to-transform-research-into-potential-therapies-for-genetically-driven-diseases/)
03:03:56	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:56%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-uc-davis-establish-collaboration-to-transform-research-into-potential-therapies-for-genetically-driven-diseases/)
03:03:56	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.762.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-uc-davis-establish-collaboration-to-transform-research-into-potential-therapies-for-genetically-driven-diseases/)
03:03:57	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:57%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-uc-davis-establish-collaboration-to-transform-research-into-potential-therapies-for-genetically-driven-diseases/)
03:03:57	20528/20528	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:57%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3640	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3640.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-roswell-park-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-cancers/)
03:03:58	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-and-roswell-park-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-cancers/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-and-roswell-park-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-cancers/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-roswell-park-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-cancers/)
03:03:58	2917/2917	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:03:58%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-and-roswell-park-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-cancers%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedbeee.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-roswell-park-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-cancers/)
03:03:58	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:58%20GMT	https://bridgebio.com/?p=3640	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index5d33.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-roswell-park-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-cancers/)
03:03:58	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.767.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-roswell-park-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-cancers/)
03:03:58	0/-1	---M--	301	error ('')			http://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners.768.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-roswell-park-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-cancers/)
03:03:59	3106/3106	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:03:59%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-and-roswell-park-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-cancers%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede230	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-roswell-park-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-cancers/)
03:03:59	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:59%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-roswell-park-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-cancers/)
03:03:59	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.76a.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-roswell-park-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-cancers/)
03:03:59	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:03:59%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-roswell-park-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-cancers/)
03:04:00	20273/20273	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:00%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3637	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3637.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-oregon-health-science-university-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-diseases/)
03:04:00	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-and-oregon-health-science-university-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-diseases/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-and-oregon-health-science-/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-oregon-health-science-university-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-diseases/)
03:04:00	3019/3019	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:00%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-and-oregon-health-science-university-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-diseases%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb3f6.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-oregon-health-science-university-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-diseases/)
03:04:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:01%20GMT	https://bridgebio.com/?p=3637	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexd114.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-oregon-health-science-university-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-diseases/)
03:04:01	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.76f.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-oregon-health-science-university-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-diseases/)
03:04:01	0/-1	---M--	301	error ('')			http://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners.770.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-oregon-health-science-university-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-diseases/)
03:04:01	3214/3214	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:01%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-and-oregon-health-science-university-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-diseases%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0cd2	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-oregon-health-science-university-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-diseases/)
03:04:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:01%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-oregon-health-science-university-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-diseases/)
03:04:01	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.772.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-oregon-health-science-university-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-diseases/)
03:04:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:01%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-oregon-health-science-university-establish-collaboration-to-translate-pioneering-research-into-therapies-for-genetically-driven-diseases/)
03:04:02	20566/20566	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:02%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3634	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3634.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-the-lundquist-institute-collaborate-to-advance-treatments-for-genetically-driven-conditions-and-cancers/)
03:04:02	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-and-the-lundquist-institute-collaborate-to-advance-treatments-for-genetically-driven-conditions-and-cancers/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-and-the-lundquist-institute-collaborate-to-advance-treatments-for-genetically-driven-conditions-and-cancers/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-the-lundquist-institute-collaborate-to-advance-treatments-for-genetically-driven-conditions-and-cancers/)
03:04:02	2880/2880	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:03%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-and-the-lundquist-institute-collaborate-to-advance-treatments-for-genetically-driven-conditions-and-cancers%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed544b.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-the-lundquist-institute-collaborate-to-advance-treatments-for-genetically-driven-conditions-and-cancers/)
03:04:03	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:03%20GMT	https://bridgebio.com/?p=3634	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index2253.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-the-lundquist-institute-collaborate-to-advance-treatments-for-genetically-driven-conditions-and-cancers/)
03:04:03	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.777.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-the-lundquist-institute-collaborate-to-advance-treatments-for-genetically-driven-conditions-and-cancers/)
03:04:03	0/-1	---M--	301	error ('')			http://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners.778.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-the-lundquist-institute-collaborate-to-advance-treatments-for-genetically-driven-conditions-and-cancers/)
03:04:03	3073/3073	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:03%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-and-the-lundquist-institute-collaborate-to-advance-treatments-for-genetically-driven-conditions-and-cancers%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed806d	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-the-lundquist-institute-collaborate-to-advance-treatments-for-genetically-driven-conditions-and-cancers/)
03:04:03	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:03%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-the-lundquist-institute-collaborate-to-advance-treatments-for-genetically-driven-conditions-and-cancers/)
03:04:03	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.77a.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-the-lundquist-institute-collaborate-to-advance-treatments-for-genetically-driven-conditions-and-cancers/)
03:04:03	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:04%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-the-lundquist-institute-collaborate-to-advance-treatments-for-genetically-driven-conditions-and-cancers/)
03:04:04	20474/20474	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:04%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3629	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3629.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-glyconet-initiate-collaboration-to-discover-potential-treatments-for-genetic-diseases-through-glycomics-research/)
03:04:04	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-and-glyconet-initiate-collaboration-to-discover-potential-treatments-for-genetic-diseases-through-glycomics-research/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-and-glyconet-initiate-collaboration-to-discover-potential-treatments-for-genetic-diseases-through-glycomics-research/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-glyconet-initiate-collaboration-to-discover-potential-treatments-for-genetic-diseases-through-glycomics-research/)
03:04:05	2908/2908	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:05%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-and-glyconet-initiate-collaboration-to-discover-potential-treatments-for-genetic-diseases-through-glycomics-research%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8a91.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-glyconet-initiate-collaboration-to-discover-potential-treatments-for-genetic-diseases-through-glycomics-research/)
03:04:05	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:05%20GMT	https://bridgebio.com/?p=3629	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexa474.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-glyconet-initiate-collaboration-to-discover-potential-treatments-for-genetic-diseases-through-glycomics-research/)
03:04:05	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.77f.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-glyconet-initiate-collaboration-to-discover-potential-treatments-for-genetic-diseases-through-glycomics-research/)
03:04:05	0/-1	---M--	301	error ('')			http://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners.780.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-glyconet-initiate-collaboration-to-discover-potential-treatments-for-genetic-diseases-through-glycomics-research/)
03:04:05	3097/3097	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:05%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-and-glyconet-initiate-collaboration-to-discover-potential-treatments-for-genetic-diseases-through-glycomics-research%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3995	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-glyconet-initiate-collaboration-to-discover-potential-treatments-for-genetic-diseases-through-glycomics-research/)
03:04:05	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:05%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-glyconet-initiate-collaboration-to-discover-potential-treatments-for-genetic-diseases-through-glycomics-research/)
03:04:05	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.782.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-glyconet-initiate-collaboration-to-discover-potential-treatments-for-genetic-diseases-through-glycomics-research/)
03:04:06	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:06%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-glyconet-initiate-collaboration-to-discover-potential-treatments-for-genetic-diseases-through-glycomics-research/)
03:04:06	19123/19123	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:06%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3626	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3626.json	(from https://bridgebio.com/news/bridgebio-pharma-and-brown-university-announce-partnership/)
03:04:07	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-and-brown-university-announce-partnership/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-brown-university-announce-partnership/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-and-brown-university-announce-partnership/)
03:04:07	2832/2832	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:07%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-brown-university-announce-partnership%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedbad5.json	(from https://bridgebio.com/news/bridgebio-pharma-and-brown-university-announce-partnership/)
03:04:07	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:07%20GMT	https://bridgebio.com/?p=3626	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexc060.html	(from https://bridgebio.com/news/bridgebio-pharma-and-brown-university-announce-partnership/)
03:04:07	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.787.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-brown-university-announce-partnership/)
03:04:07	0/-1	---M--	301	error ('')			http://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners.788.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-brown-university-announce-partnership/)
03:04:07	3025/3025	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:07%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-brown-university-announce-partnership%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd543	(from https://bridgebio.com/news/bridgebio-pharma-and-brown-university-announce-partnership/)
03:04:08	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:08%20GMT	https://bridgebio.com/partners	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/partners	(from https://bridgebio.com/news/bridgebio-pharma-and-brown-university-announce-partnership/)
03:04:08	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.78a.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-brown-university-announce-partnership/)
03:04:08	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:08%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-and-brown-university-announce-partnership/)
03:04:09	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-16/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-16/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-16/)
03:04:09	13378/13378	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:09%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3600	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3600.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-16/)
03:04:09	2656/2656	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:09%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-16%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed60ec.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-16/)
03:04:09	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:09%20GMT	https://bridgebio.com/?p=3600	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index7999.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-16/)
03:04:09	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.78f.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-16/)
03:04:09	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.790.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-16/)
03:04:09	2843/2843	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:09%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-16%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1ade	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-16/)
03:04:10	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:10%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-16/)
03:04:10	27468/27468	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:10%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3519	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3519.json	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-helsinn-group-announce-strategic-collaboration-to-co-develop-and-commercialize-infigratinib-in-oncology/)
03:04:11	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-helsinn-group-announce-strategic-collaboration-to-co-develop-and-commercialize-infigratinib-in-oncology/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-an/feed/index-2.html	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-helsinn-group-announce-strategic-collaboration-to-co-develop-and-commercialize-infigratinib-in-oncology/)
03:04:11	2980/2980	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:11%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-affiliate-qed-therapeutics-and-helsinn-group-announce-strategic-collaboration-to-co-develop-and-commercialize-infigratinib-in-oncology%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9ecc.json	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-helsinn-group-announce-strategic-collaboration-to-co-develop-and-commercialize-infigratinib-in-oncology/)
03:04:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:11%20GMT	https://bridgebio.com/?p=3519	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index3e0b.html	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-helsinn-group-announce-strategic-collaboration-to-co-develop-and-commercialize-infigratinib-in-oncology/)
03:04:11	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.795.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-helsinn-group-announce-strategic-collaboration-to-co-develop-and-commercialize-infigratinib-in-oncology/)
03:04:11	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.796.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-helsinn-group-announce-strategic-collaboration-to-co-develop-and-commercialize-infigratinib-in-oncology/)
03:04:11	3173/3173	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:11%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-affiliate-qed-therapeutics-and-helsinn-group-announce-strategic-collaboration-to-co-develop-and-commercialize-infigratinib-in-oncology%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd938	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-helsinn-group-announce-strategic-collaboration-to-co-develop-and-commercialize-infigratinib-in-oncology/)
03:04:12	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:12%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharmas-affiliate-qed-therapeutics-and-helsinn-group-announce-strategic-collaboration-to-co-develop-and-commercialize-infigratinib-in-oncology/)
03:04:12	13321/13321	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:12%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3390	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3390.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-15/)
03:04:13	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-15/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-15/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-15/)
03:04:13	2656/2656	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:13%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-15%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed4e0a.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-15/)
03:04:13	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:13%20GMT	https://bridgebio.com/?p=3390	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index1714.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-15/)
03:04:13	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.79b.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-15/)
03:04:13	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.79c.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-15/)
03:04:13	2843/2843	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:13%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-15%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed076c	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-15/)
03:04:14	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:14%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-15/)
03:04:14	34978/34978	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:14%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3364	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3364.json	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announce-fda-approval-of-nulibry-fosdenopterin/)
03:04:15	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announce-fda-approval-of-nulibry-fosdenopterin/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announce-fda-approval-of-nulibry-fosdenopterin/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announce-fda-approval-of-nulibry-fosdenopterin/)
03:04:15	2939/2939	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:15%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-affiliate-origin-biosciences-announce-fda-approval-of-nulibry-fosdenopterin%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed839a.json	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announce-fda-approval-of-nulibry-fosdenopterin/)
03:04:15	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:15%20GMT	https://bridgebio.com/?p=3364	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index9e5d.html	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announce-fda-approval-of-nulibry-fosdenopterin/)
03:04:15	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.7a1.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announce-fda-approval-of-nulibry-fosdenopterin/)
03:04:15	3134/3134	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:15%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-affiliate-origin-biosciences-announce-fda-approval-of-nulibry-fosdenopterin%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed060f	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announce-fda-approval-of-nulibry-fosdenopterin/)
03:04:15	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.7a3.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announce-fda-approval-of-nulibry-fosdenopterin/)
03:04:15	101380/101380	---M--	200	added ('OK')	image/png	etag:%2266829bf8-2cc71%22	https://bridgebio.com/wp-content/uploads/2021/02/Nulibry-Chart_Rev022421--1024x576.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/02/Nulibry-Chart_Rev022421--1024x576.png	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announce-fda-approval-of-nulibry-fosdenopterin/)
03:04:16	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:16%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announce-fda-approval-of-nulibry-fosdenopterin/)
03:04:16	32536/32536	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:16%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3317	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3317.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-fourth-quarter-and-full-year-2020-financial-results-and-business-update/)
03:04:17	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-reports-fourth-quarter-and-full-year-2020-financial-results-and-business-update/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-reports-fourth-quarter-and-full-year-2020-financial-results-and-business-update/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-fourth-quarter-and-full-year-2020-financial-results-and-business-update/)
03:04:17	2775/2775	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:17%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-reports-fourth-quarter-and-full-year-2020-financial-results-and-business-update%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf0ca.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-fourth-quarter-and-full-year-2020-financial-results-and-business-update/)
03:04:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:17%20GMT	https://bridgebio.com/?p=3317	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index14a5.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-fourth-quarter-and-full-year-2020-financial-results-and-business-update/)
03:04:17	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.7a8.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-fourth-quarter-and-full-year-2020-financial-results-and-business-update/)
03:04:17	2966/2966	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:17%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-reports-fourth-quarter-and-full-year-2020-financial-results-and-business-update%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedfe16	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-fourth-quarter-and-full-year-2020-financial-results-and-business-update/)
03:04:18	112610/112610	---M--	200	added ('OK')	image/jpeg	etag:%2266829c00-2041c%22	https://bridgebio.com/wp-content/uploads/2021/02/Q4-Chart-1.2-1-1024x776.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/02/Q4-Chart-1.2-1-1024x776.jpg	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-fourth-quarter-and-full-year-2020-financial-results-and-business-update/)
03:04:18	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.7ab.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-fourth-quarter-and-full-year-2020-financial-results-and-business-update/)
03:04:18	113859/113859	---M--	200	added ('OK')	image/jpeg	etag:%2266829c01-20972%22	https://bridgebio.com/wp-content/uploads/2021/02/Q4-Chart-2.2-1-1024x839.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2021/02/Q4-Chart-2.2-1-1024x839.jpg	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-fourth-quarter-and-full-year-2020-financial-results-and-business-update/)
03:04:18	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:18%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-fourth-quarter-and-full-year-2020-financial-results-and-business-update/)
03:04:19	23357/23357	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:19%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3282	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3282.json	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-ml-bio-solutions-announce-dosing-of-first-patient-in-phase-2-trial-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:04:20	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-and-affiliate-ml-bio-solutions-announce-dosing-of-first-patient-in-phase-2-trial-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-affiliate-ml-bio-solutions/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-ml-bio-solutions-announce-dosing-of-first-patient-in-phase-2-trial-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:04:20	3006/3006	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:19%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-affiliate-ml-bio-solutions-announce-dosing-of-first-patient-in-phase-2-trial-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed14f1.json	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-ml-bio-solutions-announce-dosing-of-first-patient-in-phase-2-trial-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:04:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:21%20GMT	https://bridgebio.com/?p=3282	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index6d8d.html	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-ml-bio-solutions-announce-dosing-of-first-patient-in-phase-2-trial-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:04:21	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.7b0.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-ml-bio-solutions-announce-dosing-of-first-patient-in-phase-2-trial-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:04:21	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.7b1.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-ml-bio-solutions-announce-dosing-of-first-patient-in-phase-2-trial-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:04:21	3197/3197	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:21%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-affiliate-ml-bio-solutions-announce-dosing-of-first-patient-in-phase-2-trial-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed277a	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-ml-bio-solutions-announce-dosing-of-first-patient-in-phase-2-trial-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:04:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:21%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-ml-bio-solutions-announce-dosing-of-first-patient-in-phase-2-trial-of-bbp-418-in-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:04:22	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734502320	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style1746.css	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock/)
03:04:22	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock/)
03:04:22	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734502320	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css1746.css	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock/)
03:04:23	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734502320	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust1746.css	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock/)
03:04:23	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734502320	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts1746.js	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock/)
03:04:23	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734502320	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal1746.js	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock/)
03:04:24	16914/16914	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:24%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3244	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3244.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock/)
03:04:24	2667/2667	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:24%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf0a3.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock/)
03:04:24	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:24%20GMT	https://bridgebio.com/?p=3244	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexb0ef.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock/)
03:04:24	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.7bb.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock/)
03:04:24	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.7bc.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock/)
03:04:24	2856/2856	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:25%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9b6e	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock/)
03:04:25	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:25%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-pricing-of-secondary-offering-of-common-stock/)
03:04:26	16722/16722	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:26%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3236	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3236.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-launch-of-secondary-offering-of-common-stock/)
03:04:26	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-announces-launch-of-secondary-offering-of-common-stock/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-announces-launch-of-secondary-offering-of-common-stock/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-launch-of-secondary-offering-of-common-stock/)
03:04:26	2660/2660	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:26%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-announces-launch-of-secondary-offering-of-common-stock%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede638.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-launch-of-secondary-offering-of-common-stock/)
03:04:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:26%20GMT	https://bridgebio.com/?p=3236	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexaa10.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-launch-of-secondary-offering-of-common-stock/)
03:04:27	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.7c1.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-launch-of-secondary-offering-of-common-stock/)
03:04:27	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.7c2.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-launch-of-secondary-offering-of-common-stock/)
03:04:27	2849/2849	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:27%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-announces-launch-of-secondary-offering-of-common-stock%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf796	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-launch-of-secondary-offering-of-common-stock/)
03:04:27	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:27%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-launch-of-secondary-offering-of-common-stock/)
03:04:28	13075/13075	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:28%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3219	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3219.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14/)
03:04:28	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14/)
03:04:28	2654/2654	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:28%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeda97a.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14/)
03:04:28	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:28%20GMT	https://bridgebio.com/?p=3219	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index1e0d.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14/)
03:04:28	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.7c7.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14/)
03:04:28	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.7c8.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14/)
03:04:28	2841/2841	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:29%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb675	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14/)
03:04:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:29%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-14/)
03:04:30	20989/20989	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:30%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3183	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3183.json	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-venthera-announce-dosing-of-first-patient-in-phase-1-2-clinical-trial-of-bbp-681/)
03:04:30	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-and-affiliate-venthera-announce-dosing-of-first-patient-in-phase-1-2-clinical-trial-of-bbp-681/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-affiliate-venthera-announce-dosing-of-first-patient-in-phase-1-2-clinical-trial-of-bbp-681/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-venthera-announce-dosing-of-first-patient-in-phase-1-2-clinical-trial-of-bbp-681/)
03:04:30	2920/2920	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:30%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-affiliate-venthera-announce-dosing-of-first-patient-in-phase-1-2-clinical-trial-of-bbp-681%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd2e0.json	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-venthera-announce-dosing-of-first-patient-in-phase-1-2-clinical-trial-of-bbp-681/)
03:04:30	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:30%20GMT	https://bridgebio.com/?p=3183	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexae92.html	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-venthera-announce-dosing-of-first-patient-in-phase-1-2-clinical-trial-of-bbp-681/)
03:04:31	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.7cd.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-venthera-announce-dosing-of-first-patient-in-phase-1-2-clinical-trial-of-bbp-681/)
03:04:31	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.7ce.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-venthera-announce-dosing-of-first-patient-in-phase-1-2-clinical-trial-of-bbp-681/)
03:04:31	3106/3106	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:31%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-affiliate-venthera-announce-dosing-of-first-patient-in-phase-1-2-clinical-trial-of-bbp-681%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeddb54	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-venthera-announce-dosing-of-first-patient-in-phase-1-2-clinical-trial-of-bbp-681/)
03:04:31	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:31%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-venthera-announce-dosing-of-first-patient-in-phase-1-2-clinical-trial-of-bbp-681/)
03:04:32	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734515820	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/styleb596.css	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc/)
03:04:32	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734515820	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-cssb596.css	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc/)
03:04:32	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc/)
03:04:32	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734515820	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrustb596.css	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc/)
03:04:32	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734515820	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scriptsb596.js	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc/)
03:04:33	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734515820	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modalb596.js	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc/)
03:04:33	23635/23635	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:33%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3168	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3168.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc/)
03:04:33	2671/2671	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:34%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed013f.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc/)
03:04:34	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:34%20GMT	https://bridgebio.com/?p=3168	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index9a18.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc/)
03:04:34	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.7d8.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc/)
03:04:34	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.7d9.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc/)
03:04:34	2860/2860	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:34%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed6788	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc/)
03:04:34	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:34%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-completion-of-merger-with-eidos-therapeutics-inc/)
03:04:35	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734509520	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style6881.css	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes/)
03:04:35	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes/)
03:04:35	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734509520	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css6881.css	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes/)
03:04:35	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734509520	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust6881.css	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes/)
03:04:36	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734509520	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts6881.js	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes/)
03:04:36	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734509520	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal6881.js	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes/)
03:04:36	26322/26322	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:36%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3171	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3171.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes/)
03:04:37	2689/2689	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2b4d.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes/)
03:04:37	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:37%20GMT	https://bridgebio.com/?p=3171	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexacff.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes/)
03:04:37	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.7e3.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes/)
03:04:37	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.7e4.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes/)
03:04:37	2878/2878	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9cc5	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes/)
03:04:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:38%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-650-million-convertible-senior-notes/)
03:04:38	24985/24985	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:38%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3164	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3164.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-400-million-convertible-senior-notes/)
03:04:39	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-400-million-convertible-senior-notes/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-400-million-convertible-senior-notes/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-400-million-convertible-senior-notes/)
03:04:39	2703/2703	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:39%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-announces-proposed-offering-of-400-million-convertible-senior-notes%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9e33.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-400-million-convertible-senior-notes/)
03:04:39	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:39%20GMT	https://bridgebio.com/?p=3164	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexfd6e.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-400-million-convertible-senior-notes/)
03:04:40	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.7e9.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-400-million-convertible-senior-notes/)
03:04:40	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.7ea.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-400-million-convertible-senior-notes/)
03:04:40	2892/2892	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:40%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-announces-proposed-offering-of-400-million-convertible-senior-notes%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8184	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-400-million-convertible-senior-notes/)
03:04:40	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:40%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-400-million-convertible-senior-notes/)
03:04:41	25552/25552	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:41%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3154	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3154.json	(from https://bridgebio.com/news/stockholders-of-bridgebio-pharma-inc-and-eidos-therapeutics-inc-approve-bridgebio-pharma-inc-acquisition-of-eidos-therapeutics-inc/)
03:04:41	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/stockholders-of-bridgebio-pharma-inc-and-eidos-therapeutics-inc-approve-bridgebio-pharma-inc-acquisition-of-eidos-therapeutics-inc/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/stockholders-of-bridgebio-pharma-inc-and-eidos-therapeutics-inc-approve-bridgebio-pharma-inc-acquisition-of-eidos-therapeutics-inc/feed/index.html	(from https://bridgebio.com/news/stockholders-of-bridgebio-pharma-inc-and-eidos-therapeutics-inc-approve-bridgebio-pharma-inc-acquisition-of-eidos-therapeutics-inc/)
03:04:41	2907/2907	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:41%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fstockholders-of-bridgebio-pharma-inc-and-eidos-therapeutics-inc-approve-bridgebio-pharma-inc-acquisition-of-eidos-therapeutics-inc%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8af7.json	(from https://bridgebio.com/news/stockholders-of-bridgebio-pharma-inc-and-eidos-therapeutics-inc-approve-bridgebio-pharma-inc-acquisition-of-eidos-therapeutics-inc/)
03:04:42	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:42%20GMT	https://bridgebio.com/?p=3154	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexdf72.html	(from https://bridgebio.com/news/stockholders-of-bridgebio-pharma-inc-and-eidos-therapeutics-inc-approve-bridgebio-pharma-inc-acquisition-of-eidos-therapeutics-inc/)
03:04:42	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.7ef.delayed	(from https://bridgebio.com/news/stockholders-of-bridgebio-pharma-inc-and-eidos-therapeutics-inc-approve-bridgebio-pharma-inc-acquisition-of-eidos-therapeutics-inc/)
03:04:42	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.7f0.delayed	(from https://bridgebio.com/news/stockholders-of-bridgebio-pharma-inc-and-eidos-therapeutics-inc-approve-bridgebio-pharma-inc-acquisition-of-eidos-therapeutics-inc/)
03:04:42	3102/3102	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:42%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fstockholders-of-bridgebio-pharma-inc-and-eidos-therapeutics-inc-approve-bridgebio-pharma-inc-acquisition-of-eidos-therapeutics-inc%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb050	(from https://bridgebio.com/news/stockholders-of-bridgebio-pharma-inc-and-eidos-therapeutics-inc-approve-bridgebio-pharma-inc-acquisition-of-eidos-therapeutics-inc/)
03:04:42	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:42%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/stockholders-of-bridgebio-pharma-inc-and-eidos-therapeutics-inc-approve-bridgebio-pharma-inc-acquisition-of-eidos-therapeutics-inc/)
03:04:43	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-and-eidos-therapeutics-inc-announce-january-21-2021-election-deadline-for-merger/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-and-eidos-therapeutics-inc-announce-january-21-2021-election-deadline-for-merger/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-eidos-therapeutics-inc-announce-january-21-2021-election-deadline-for-merger/)
03:04:43	28831/28831	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:43%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3141	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3141.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-eidos-therapeutics-inc-announce-january-21-2021-election-deadline-for-merger/)
03:04:44	2777/2777	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:44%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-and-eidos-therapeutics-inc-announce-january-21-2021-election-deadline-for-merger%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed90b4.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-eidos-therapeutics-inc-announce-january-21-2021-election-deadline-for-merger/)
03:04:44	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:44%20GMT	https://bridgebio.com/?p=3141	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index4730.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-eidos-therapeutics-inc-announce-january-21-2021-election-deadline-for-merger/)
03:04:44	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.7f5.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-eidos-therapeutics-inc-announce-january-21-2021-election-deadline-for-merger/)
03:04:44	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.7f6.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-eidos-therapeutics-inc-announce-january-21-2021-election-deadline-for-merger/)
03:04:44	2965/2965	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:44%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-and-eidos-therapeutics-inc-announce-january-21-2021-election-deadline-for-merger%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed25e8	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-eidos-therapeutics-inc-announce-january-21-2021-election-deadline-for-merger/)
03:04:45	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:45%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-eidos-therapeutics-inc-announce-january-21-2021-election-deadline-for-merger/)
03:04:46	13634/13634	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:46%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3118	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3118.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-13/)
03:04:46	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-13/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-13/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-13/)
03:04:46	2658/2658	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:46%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-13%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedec04.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-13/)
03:04:47	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:46%20GMT	https://bridgebio.com/?p=3118	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index039c.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-13/)
03:04:47	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.7fb.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-13/)
03:04:47	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.7fc.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-13/)
03:04:47	2845/2845	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:47%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-13%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed6847	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-13/)
03:04:47	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:47%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-13/)
03:04:48	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734511500	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style6189.css	(from https://bridgebio.com/news/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/)
03:04:48	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/feed/index.html	(from https://bridgebio.com/news/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/)
03:04:49	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734511500	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css6189.css	(from https://bridgebio.com/news/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/)
03:04:49	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734511500	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust6189.css	(from https://bridgebio.com/news/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/)
03:04:49	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734511500	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts6189.js	(from https://bridgebio.com/news/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/)
03:04:49	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734511500	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal6189.js	(from https://bridgebio.com/news/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/)
03:04:50	27722/27722	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:50%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3106	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3106.json	(from https://bridgebio.com/news/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/)
03:04:50	2930/2930	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:50%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fleading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf5a4.json	(from https://bridgebio.com/news/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/)
03:04:51	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:51%20GMT	https://bridgebio.com/?p=3106	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexdb05.html	(from https://bridgebio.com/news/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/)
03:04:51	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.806.delayed	(from https://bridgebio.com/news/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/)
03:04:51	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.807.delayed	(from https://bridgebio.com/news/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/)
03:04:51	3137/3137	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:51%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fleading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb996	(from https://bridgebio.com/news/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/)
03:04:51	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:51%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/leading-independent-proxy-advisory-firm-iss-recommends-bridgebio-pharma-and-eidos-therapeutics-stockholders-vote-for-proposed-merger/)
03:04:52	19203/19203	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:52%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3099	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3099.json	(from https://bridgebio.com/news/ucsf-and-bridgebio-pharma-collaborate-to-accelerate-the-development-of-therapies-for-genetic-diseases/)
03:04:52	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/ucsf-and-bridgebio-pharma-collaborate-to-accelerate-the-development-of-therapies-for-genetic-diseases/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/ucsf-and-bridgebio-pharma-collaborate-to-accelerate-the-development-of-therapies-for-genetic-diseases/feed/index.html	(from https://bridgebio.com/news/ucsf-and-bridgebio-pharma-collaborate-to-accelerate-the-development-of-therapies-for-genetic-diseases/)
03:04:52	2753/2753	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:52%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fucsf-and-bridgebio-pharma-collaborate-to-accelerate-the-development-of-therapies-for-genetic-diseases%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeddc3a.json	(from https://bridgebio.com/news/ucsf-and-bridgebio-pharma-collaborate-to-accelerate-the-development-of-therapies-for-genetic-diseases/)
03:04:53	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:53%20GMT	https://bridgebio.com/?p=3099	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index09f3.html	(from https://bridgebio.com/news/ucsf-and-bridgebio-pharma-collaborate-to-accelerate-the-development-of-therapies-for-genetic-diseases/)
03:04:53	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.80c.delayed	(from https://bridgebio.com/news/ucsf-and-bridgebio-pharma-collaborate-to-accelerate-the-development-of-therapies-for-genetic-diseases/)
03:04:53	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.80d.delayed	(from https://bridgebio.com/news/ucsf-and-bridgebio-pharma-collaborate-to-accelerate-the-development-of-therapies-for-genetic-diseases/)
03:04:53	2946/2946	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:53%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fucsf-and-bridgebio-pharma-collaborate-to-accelerate-the-development-of-therapies-for-genetic-diseases%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed936c	(from https://bridgebio.com/news/ucsf-and-bridgebio-pharma-collaborate-to-accelerate-the-development-of-therapies-for-genetic-diseases/)
03:04:53	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:53%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/ucsf-and-bridgebio-pharma-collaborate-to-accelerate-the-development-of-therapies-for-genetic-diseases/)
03:04:54	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734510960	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style2ba9.css	(from https://bridgebio.com/news/bridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease/)
03:04:54	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease/)
03:04:54	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734510960	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css2ba9.css	(from https://bridgebio.com/news/bridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease/)
03:04:55	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734510960	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust2ba9.css	(from https://bridgebio.com/news/bridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease/)
03:04:55	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734510960	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts2ba9.js	(from https://bridgebio.com/news/bridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease/)
03:04:55	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734510960	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal2ba9.js	(from https://bridgebio.com/news/bridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease/)
03:04:56	22414/22414	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:56%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3061	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3061.json	(from https://bridgebio.com/news/bridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease/)
03:04:56	2865/2865	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:56%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc83c.json	(from https://bridgebio.com/news/bridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease/)
03:04:56	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:56%20GMT	https://bridgebio.com/?p=3061	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index7ab0.html	(from https://bridgebio.com/news/bridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease/)
03:04:56	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.817.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease/)
03:04:56	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.818.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease/)
03:04:56	3062/3062	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:57%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7dc9	(from https://bridgebio.com/news/bridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease/)
03:04:57	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:57%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-and-maze-therapeutics-establish-joint-venture-to-advance-precision-medicine-to-treat-cardiovascular-disease/)
03:04:57	13658/13658	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:58%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3057	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3057.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-12/)
03:04:58	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-12/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-12/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-12/)
03:04:58	2650/2650	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:04:58%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-12%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed670e.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-12/)
03:04:58	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:58%20GMT	https://bridgebio.com/?p=3057	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index5bb8.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-12/)
03:04:58	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.81d.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-12/)
03:04:58	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.81e.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-12/)
03:04:58	2837/2837	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:04:59%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-12%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed219c	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-12/)
03:04:59	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:04:59%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-12/)
03:05:00	20899/20899	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:00%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/3039	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/3039.json	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-qed-therapeutics-announce-fda-acceptance-of-new-drug-application-for-infigratinib-for-the-treatment-of-cholangiocarcinoma/)
03:05:00	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-and-affiliate-qed-therapeutics-announce-fda-acceptance-of-new-drug-application-for-infigratinib-for-the-treatment-of-cholangiocarcinoma/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-affiliate-qed-therapeutics/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-qed-therapeutics-announce-fda-acceptance-of-new-drug-application-for-infigratinib-for-the-treatment-of-cholangiocarcinoma/)
03:05:00	2963/2963	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:00%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-affiliate-qed-therapeutics-announce-fda-acceptance-of-new-drug-application-for-infigratinib-for-the-treatment-of-cholangiocarcinoma%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2caa.json	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-qed-therapeutics-announce-fda-acceptance-of-new-drug-application-for-infigratinib-for-the-treatment-of-cholangiocarcinoma/)
03:05:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:00%20GMT	https://bridgebio.com/?p=3039	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index89e3.html	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-qed-therapeutics-announce-fda-acceptance-of-new-drug-application-for-infigratinib-for-the-treatment-of-cholangiocarcinoma/)
03:05:01	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.823.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-qed-therapeutics-announce-fda-acceptance-of-new-drug-application-for-infigratinib-for-the-treatment-of-cholangiocarcinoma/)
03:05:01	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.824.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-qed-therapeutics-announce-fda-acceptance-of-new-drug-application-for-infigratinib-for-the-treatment-of-cholangiocarcinoma/)
03:05:01	3152/3152	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:05:01%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-affiliate-qed-therapeutics-announce-fda-acceptance-of-new-drug-application-for-infigratinib-for-the-treatment-of-cholangiocarcinoma%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed33b3	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-qed-therapeutics-announce-fda-acceptance-of-new-drug-application-for-infigratinib-for-the-treatment-of-cholangiocarcinoma/)
03:05:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:01%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-qed-therapeutics-announce-fda-acceptance-of-new-drug-application-for-infigratinib-for-the-treatment-of-cholangiocarcinoma/)
03:05:02	20731/20731	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:02%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2930	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2930.json	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-navire-pharma-announce-dosing-of-first-patient-in-phase-1-clinical-trial-of-shp2-inhibitor-bbp-398/)
03:05:02	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-and-affiliate-navire-pharma-announce-dosing-of-first-patient-in-phase-1-clinical-trial-of-shp2-inhibitor-bbp-398/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-affiliate-navire-pharma-announce-dosing-of-first-patient-in-phase-1-clinical-trial-of-shp2-inhibitor-bbp-398/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-navire-pharma-announce-dosing-of-first-patient-in-phase-1-clinical-trial-of-shp2-inhibitor-bbp-398/)
03:05:02	3006/3006	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:02%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-affiliate-navire-pharma-announce-dosing-of-first-patient-in-phase-1-clinical-trial-of-shp2-inhibitor-bbp-398%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8115.json	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-navire-pharma-announce-dosing-of-first-patient-in-phase-1-clinical-trial-of-shp2-inhibitor-bbp-398/)
03:05:03	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:03%20GMT	https://bridgebio.com/?p=2930	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index4611.html	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-navire-pharma-announce-dosing-of-first-patient-in-phase-1-clinical-trial-of-shp2-inhibitor-bbp-398/)
03:05:03	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.829.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-navire-pharma-announce-dosing-of-first-patient-in-phase-1-clinical-trial-of-shp2-inhibitor-bbp-398/)
03:05:03	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.82a.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-navire-pharma-announce-dosing-of-first-patient-in-phase-1-clinical-trial-of-shp2-inhibitor-bbp-398/)
03:05:03	3195/3195	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:05:03%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-affiliate-navire-pharma-announce-dosing-of-first-patient-in-phase-1-clinical-trial-of-shp2-inhibitor-bbp-398%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed055e	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-navire-pharma-announce-dosing-of-first-patient-in-phase-1-clinical-trial-of-shp2-inhibitor-bbp-398/)
03:05:03	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:03%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-navire-pharma-announce-dosing-of-first-patient-in-phase-1-clinical-trial-of-shp2-inhibitor-bbp-398/)
03:05:04	30089/30089	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:04%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2898	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2898.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2020-financial-results-and-business-update/)
03:05:04	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2020-financial-results-and-business-update/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2020-financial-results-and-business-update/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2020-financial-results-and-business-update/)
03:05:04	2699/2699	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:05%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-reports-third-quarter-2020-financial-results-and-business-update%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedbf63.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2020-financial-results-and-business-update/)
03:05:05	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:05%20GMT	https://bridgebio.com/?p=2898	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexb7df.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2020-financial-results-and-business-update/)
03:05:05	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.82f.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2020-financial-results-and-business-update/)
03:05:05	2890/2890	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:05:05%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-reports-third-quarter-2020-financial-results-and-business-update%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7063	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2020-financial-results-and-business-update/)
03:05:05	104779/104779	---M--	200	added ('OK')	image/jpeg	etag:%2266829bf9-3450d%22	https://bridgebio.com/wp-content/uploads/2020/11/Q3-image-1-1.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2020/11/Q3-image-1-1.jpg	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2020-financial-results-and-business-update/)
03:05:06	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.832.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2020-financial-results-and-business-update/)
03:05:06	106253/106253	---M--	200	added ('OK')	image/jpeg	etag:%2266829bfa-1f328%22	https://bridgebio.com/wp-content/uploads/2020/11/Q3-image-2.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2020/11/Q3-image-2.jpg	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2020-financial-results-and-business-update/)
03:05:06	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:06%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-third-quarter-2020-financial-results-and-business-update/)
03:05:07	13583/13583	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:07%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2892	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2892.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-11/)
03:05:07	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-11/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-11/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-11/)
03:05:07	2661/2661	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:07%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-11%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede810.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-11/)
03:05:08	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:07%20GMT	https://bridgebio.com/?p=2892	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexe027.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-11/)
03:05:08	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.837.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-11/)
03:05:08	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.838.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-11/)
03:05:08	2848/2848	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:05:08%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-11%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed78f0	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-11/)
03:05:08	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:08%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-11/)
03:05:09	22274/22274	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:09%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2879	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2879.json	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-phoenix-tissue-repair-announce-first-patient-dosing-in-phase-2-trial-of-protein-replacement-therapy/)
03:05:09	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-and-affiliate-phoenix-tissue-repair-announce-first-patient-dosing-in-phase-2-trial-of-protein-replacement-therapy/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-affiliate-phoenix-tissue-repair-announce-first-patient-dosing-in-phase-2-trial-of-protein-replacement-therapy/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-phoenix-tissue-repair-announce-first-patient-dosing-in-phase-2-trial-of-protein-replacement-therapy/)
03:05:10	3018/3018	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:10%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-affiliate-phoenix-tissue-repair-announce-first-patient-dosing-in-phase-2-trial-of-protein-replacement-therapy%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedef09.json	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-phoenix-tissue-repair-announce-first-patient-dosing-in-phase-2-trial-of-protein-replacement-therapy/)
03:05:10	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:10%20GMT	https://bridgebio.com/?p=2879	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index071b.html	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-phoenix-tissue-repair-announce-first-patient-dosing-in-phase-2-trial-of-protein-replacement-therapy/)
03:05:10	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.83d.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-phoenix-tissue-repair-announce-first-patient-dosing-in-phase-2-trial-of-protein-replacement-therapy/)
03:05:10	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.83e.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-phoenix-tissue-repair-announce-first-patient-dosing-in-phase-2-trial-of-protein-replacement-therapy/)
03:05:10	3207/3207	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:05:10%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-affiliate-phoenix-tissue-repair-announce-first-patient-dosing-in-phase-2-trial-of-protein-replacement-therapy%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf92d	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-phoenix-tissue-repair-announce-first-patient-dosing-in-phase-2-trial-of-protein-replacement-therapy/)
03:05:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:11%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-phoenix-tissue-repair-announce-first-patient-dosing-in-phase-2-trial-of-protein-replacement-therapy/)
03:05:11	20986/20986	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:12%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2852	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2852.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-the-university-of-colorado-anschutz-medical-campus-collaborate-to-advance-medicines-for-genetically-driven-diseases/)
03:05:12	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-and-the-university-of-colorado-anschutz-medical-campus-collaborate-to-advance-medicines-for-genetically-driven-diseases/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-and-the-university-of-colorado-anschutz-medical-campus-collaborate-to-advance-medicines-for-genetically-driven-diseases/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-the-university-of-colorado-anschutz-medical-campus-collaborate-to-advance-medicines-for-genetically-driven-diseases/)
03:05:12	2916/2916	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:12%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-and-the-university-of-colorado-anschutz-medical-campus-collaborate-to-advance-medicines-for-genetically-driven-diseases%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeda2e0.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-the-university-of-colorado-anschutz-medical-campus-collaborate-to-advance-medicines-for-genetically-driven-diseases/)
03:05:12	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:12%20GMT	https://bridgebio.com/?p=2852	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index0b9d.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-the-university-of-colorado-anschutz-medical-campus-collaborate-to-advance-medicines-for-genetically-driven-diseases/)
03:05:13	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.843.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-the-university-of-colorado-anschutz-medical-campus-collaborate-to-advance-medicines-for-genetically-driven-diseases/)
03:05:13	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.844.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-the-university-of-colorado-anschutz-medical-campus-collaborate-to-advance-medicines-for-genetically-driven-diseases/)
03:05:13	3105/3105	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:05:13%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-and-the-university-of-colorado-anschutz-medical-campus-collaborate-to-advance-medicines-for-genetically-driven-diseases%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed4dd2	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-the-university-of-colorado-anschutz-medical-campus-collaborate-to-advance-medicines-for-genetically-driven-diseases/)
03:05:13	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:13%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-the-university-of-colorado-anschutz-medical-campus-collaborate-to-advance-medicines-for-genetically-driven-diseases/)
03:05:14	20016/20016	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:14%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2855	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2855.json	(from https://bridgebio.com/news/salk-institute-and-bridgebio-pharma-collaborate-to-advance-therapies-for-genetically-driven-disease/)
03:05:14	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/salk-institute-and-bridgebio-pharma-collaborate-to-advance-therapies-for-genetically-driven-disease/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/salk-institute-and-bridgebio-pharma-collaborate-to-advance-therapies-for-genetically-driven-disease/feed/index.html	(from https://bridgebio.com/news/salk-institute-and-bridgebio-pharma-collaborate-to-advance-therapies-for-genetically-driven-disease/)
03:05:14	2756/2756	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:14%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fsalk-institute-and-bridgebio-pharma-collaborate-to-advance-therapies-for-genetically-driven-disease%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb68c.json	(from https://bridgebio.com/news/salk-institute-and-bridgebio-pharma-collaborate-to-advance-therapies-for-genetically-driven-disease/)
03:05:14	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:15%20GMT	https://bridgebio.com/?p=2855	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index7a2c.html	(from https://bridgebio.com/news/salk-institute-and-bridgebio-pharma-collaborate-to-advance-therapies-for-genetically-driven-disease/)
03:05:15	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.849.delayed	(from https://bridgebio.com/news/salk-institute-and-bridgebio-pharma-collaborate-to-advance-therapies-for-genetically-driven-disease/)
03:05:15	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.84a.delayed	(from https://bridgebio.com/news/salk-institute-and-bridgebio-pharma-collaborate-to-advance-therapies-for-genetically-driven-disease/)
03:05:15	2945/2945	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:05:15%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fsalk-institute-and-bridgebio-pharma-collaborate-to-advance-therapies-for-genetically-driven-disease%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1f70	(from https://bridgebio.com/news/salk-institute-and-bridgebio-pharma-collaborate-to-advance-therapies-for-genetically-driven-disease/)
03:05:15	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:15%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/salk-institute-and-bridgebio-pharma-collaborate-to-advance-therapies-for-genetically-driven-disease/)
03:05:16	33326/33326	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:16%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2792	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2792.json	(from https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-announce-merger-agreement/)
03:05:16	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-announce-merger-agreement/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-announce-merger-agreement/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-announce-merger-agreement/)
03:05:16	2613/2613	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:16%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-eidos-therapeutics-announce-merger-agreement%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2259.json	(from https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-announce-merger-agreement/)
03:05:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:17%20GMT	https://bridgebio.com/?p=2792	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index5343.html	(from https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-announce-merger-agreement/)
03:05:17	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.84f.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-announce-merger-agreement/)
03:05:17	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.850.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-announce-merger-agreement/)
03:05:17	2806/2806	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:05:17%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-eidos-therapeutics-announce-merger-agreement%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5e95	(from https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-announce-merger-agreement/)
03:05:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:17%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-announce-merger-agreement/)
03:05:18	20847/20847	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:18%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/4120	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/4120.json	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a-2/)
03:05:18	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a-2/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-bioscienc/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a-2/)
03:05:18	2979/2979	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:18%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a-2%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd3eb.json	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a-2/)
03:05:19	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:19%20GMT	https://bridgebio.com/?p=4120	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index7dfd.html	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a-2/)
03:05:19	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.855.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a-2/)
03:05:19	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.856.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a-2/)
03:05:19	3168/3168	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:05:19%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a-2%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed054a	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a-2/)
03:05:19	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:19%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a-2/)
03:05:20	20866/20866	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:20%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2774	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2774.json	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:05:20	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-bioscienc/feed/index-2.html	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:05:20	2967/2967	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:21%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed00df.json	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:05:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:21%20GMT	https://bridgebio.com/?p=2774	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index5649.html	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:05:21	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.85b.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:05:21	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.85c.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:05:21	3156/3156	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:05:21%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc753	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:05:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:21%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-and-affiliate-origin-biosciences-announces-fda-acceptance-of-its-new-drug-application-for-fosdenopterin-for-the-treatment-of-mocd-type-a/)
03:05:22	15322/15322	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:22%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/4119	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/4119.json	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020-2/)
03:05:22	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020-2/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020-2/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020-2/)
03:05:22	2575/2575	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:23%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020-2%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedaaa3.json	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020-2/)
03:05:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:23%20GMT	https://bridgebio.com/?p=4119	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexb6cf.html	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020-2/)
03:05:23	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.861.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020-2/)
03:05:23	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.862.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020-2/)
03:05:23	2770/2770	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:05:23%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020-2%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1cd0	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020-2/)
03:05:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:23%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020-2/)
03:05:24	15434/15434	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:24%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2761	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2761.json	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020/)
03:05:24	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020/)
03:05:24	2582/2582	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:25%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedcce9.json	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020/)
03:05:25	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:25%20GMT	https://bridgebio.com/?p=2761	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index75b9.html	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020/)
03:05:25	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.867.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020/)
03:05:25	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.868.delayed	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020/)
03:05:25	2777/2777	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:05:25%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2002	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020/)
03:05:25	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:25%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-to-host-virtual-rd-day-on-september-29-2020/)
03:05:26	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734506460	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style6ff1.css	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1/)
03:05:26	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1/)
03:05:26	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734506460	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css6ff1.css	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1/)
03:05:26	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734506460	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust6ff1.css	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1/)
03:05:27	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734506460	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts6ff1.js	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1/)
03:05:27	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734506460	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal6ff1.js	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1/)
03:05:28	21435/21435	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:28%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2748	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2748.json	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1/)
03:05:28	2887/2887	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:28%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed461b.json	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1/)
03:05:28	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:28%20GMT	https://bridgebio.com/?p=2748	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index21a5.html	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1/)
03:05:28	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.872.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1/)
03:05:28	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.873.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1/)
03:05:29	3080/3080	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:05:29%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1f92	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1/)
03:05:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:29%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharmas-calcilytix-therapeutics-initiates-phase-2-study-of-encaleret-for-autosomal-dominant-hypocalcemia-type-1-adh1/)
03:05:29	13739/13739	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:30%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2733	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2733.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10/)
03:05:30	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10/)
03:05:30	2662/2662	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:30%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc558.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10/)
03:05:30	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:30%20GMT	https://bridgebio.com/?p=2733	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index0e86.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10/)
03:05:30	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.878.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10/)
03:05:30	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.879.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10/)
03:05:30	2851/2851	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:05:30%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc6ba	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10/)
03:05:30	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:31%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10/)
03:05:31	13544/13544	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:31%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2846	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2846.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10-2/)
03:05:32	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10-2/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10-2/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10-2/)
03:05:32	2653/2653	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:32%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10-2%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed60e6.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10-2/)
03:05:32	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:32%20GMT	https://bridgebio.com/?p=2846	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index689a.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10-2/)
03:05:32	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.87e.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10-2/)
03:05:32	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.87f.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10-2/)
03:05:32	2840/2840	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:05:32%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10-2%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede426	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10-2/)
03:05:33	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:33%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-10-2/)
03:05:33	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-9/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-9/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-9/)
03:05:33	13716/13716	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:34%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2659	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2659.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-9/)
03:05:34	2653/2653	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:34%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-9%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8120.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-9/)
03:05:34	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:34%20GMT	https://bridgebio.com/?p=2659	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexbf56.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-9/)
03:05:34	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.884.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-9/)
03:05:34	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.885.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-9/)
03:05:34	2840/2840	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:05:34%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-9%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedddf3	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-9/)
03:05:35	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:35%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-9/)
03:05:35	30239/30239	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:35%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2614	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2614.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2020-financial-results-and-business-update/)
03:05:36	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2020-financial-results-and-business-update/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2020-financial-results-and-business-update/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2020-financial-results-and-business-update/)
03:05:36	2706/2706	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:36%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-reports-second-quarter-2020-financial-results-and-business-update%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed43f2.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2020-financial-results-and-business-update/)
03:05:36	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:36%20GMT	https://bridgebio.com/?p=2614	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index1697.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2020-financial-results-and-business-update/)
03:05:36	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.88a.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2020-financial-results-and-business-update/)
03:05:36	2897/2897	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:05:36%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-reports-second-quarter-2020-financial-results-and-business-update%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed041d	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2020-financial-results-and-business-update/)
03:05:36	118906/118906	---M--	200	added ('OK')	image/jpeg	etag:%2266829bfa-23742%22	https://bridgebio.com/wp-content/uploads/2020/08/Annotation-2020-08-10-203552_image-1.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2020/08/Annotation-2020-08-10-203552_image-1.jpg	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2020-financial-results-and-business-update/)
03:05:37	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.88d.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2020-financial-results-and-business-update/)
03:05:37	111317/111317	---M--	200	added ('OK')	image/jpeg	etag:%2266829bfa-21d12%22	https://bridgebio.com/wp-content/uploads/2020/08/Annotation-2020-08-10-203850_image-2-1.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2020/08/Annotation-2020-08-10-203850_image-2-1.jpg	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2020-financial-results-and-business-update/)
03:05:37	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:37%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-second-quarter-2020-financial-results-and-business-update/)
03:05:38	24313/24313	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:38%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2594	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2594.json	(from https://bridgebio.com/news/bridgebio-pharma-expands-reach-into-china-and-other-major-asian-markets-through-strategic-collaboration-with-perceptive-advisors-founded-company-lianbio/)
03:05:38	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-expands-reach-into-china-and-other-major-asian-markets-through-strategic-collaboration-with-perceptive-advisors-founded-company-lianbio/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-expands-reach-into-china-and-o/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-expands-reach-into-china-and-other-major-asian-markets-through-strategic-collaboration-with-perceptive-advisors-founded-company-lianbio/)
03:05:38	2962/2962	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:38%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-expands-reach-into-china-and-other-major-asian-markets-through-strategic-collaboration-with-perceptive-advisors-founded-company-lianbio%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9827.json	(from https://bridgebio.com/news/bridgebio-pharma-expands-reach-into-china-and-other-major-asian-markets-through-strategic-collaboration-with-perceptive-advisors-founded-company-lianbio/)
03:05:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:38%20GMT	https://bridgebio.com/?p=2594	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index79da.html	(from https://bridgebio.com/news/bridgebio-pharma-expands-reach-into-china-and-other-major-asian-markets-through-strategic-collaboration-with-perceptive-advisors-founded-company-lianbio/)
03:05:38	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.892.delayed	(from https://bridgebio.com/news/bridgebio-pharma-expands-reach-into-china-and-other-major-asian-markets-through-strategic-collaboration-with-perceptive-advisors-founded-company-lianbio/)
03:05:39	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.894.delayed	(from https://bridgebio.com/news/bridgebio-pharma-expands-reach-into-china-and-other-major-asian-markets-through-strategic-collaboration-with-perceptive-advisors-founded-company-lianbio/)
03:05:39	3151/3151	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:05:39%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-expands-reach-into-china-and-other-major-asian-markets-through-strategic-collaboration-with-perceptive-advisors-founded-company-lianbio%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed55c1	(from https://bridgebio.com/news/bridgebio-pharma-expands-reach-into-china-and-other-major-asian-markets-through-strategic-collaboration-with-perceptive-advisors-founded-company-lianbio/)
03:05:49	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:39%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-expands-reach-into-china-and-other-major-asian-markets-through-strategic-collaboration-with-perceptive-advisors-founded-company-lianbio/)
03:05:51	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-pharmas-qed-therapeutics-announce-dosing-of-first-patient-in-investigator-initiated-phase-0-2-clinical-trial-of-infigratinib/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-pharmas-qe/feed/index.html	(from https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-pharmas-qed-therapeutics-announce-dosing-of-first-patient-in-investigator-initiated-phase-0-2-clinical-trial-of-infigratinib/)
03:05:51	23191/23191	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:50%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2564	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2564.json	(from https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-pharmas-qed-therapeutics-announce-dosing-of-first-patient-in-investigator-initiated-phase-0-2-clinical-trial-of-infigratinib/)
03:05:51	3069/3069	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:05:50%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fivy-brain-tumor-center-and-bridgebio-pharmas-qed-therapeutics-announce-dosing-of-first-patient-in-investigator-initiated-phase-0-2-clinical-trial-of-infigratinib%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeda96b.json	(from https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-pharmas-qed-therapeutics-announce-dosing-of-first-patient-in-investigator-initiated-phase-0-2-clinical-trial-of-infigratinib/)
03:05:52	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.899.delayed	(from https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-pharmas-qed-therapeutics-announce-dosing-of-first-patient-in-investigator-initiated-phase-0-2-clinical-trial-of-infigratinib/)
03:05:52	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.89a.delayed	(from https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-pharmas-qed-therapeutics-announce-dosing-of-first-patient-in-investigator-initiated-phase-0-2-clinical-trial-of-infigratinib/)
03:05:53	3258/3258	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:05:52%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fivy-brain-tumor-center-and-bridgebio-pharmas-qed-therapeutics-announce-dosing-of-first-patient-in-investigator-initiated-phase-0-2-clinical-trial-of-infigratinib%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedadc5	(from https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-pharmas-qed-therapeutics-announce-dosing-of-first-patient-in-investigator-initiated-phase-0-2-clinical-trial-of-infigratinib/)
03:06:02	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:53%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-pharmas-qed-therapeutics-announce-dosing-of-first-patient-in-investigator-initiated-phase-0-2-clinical-trial-of-infigratinib/)
03:06:05	21850/21850	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:03%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2543	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2543.json	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-doses-first-child-in-phase-2-clinical-trial-of-the-investigational-medicine-infigratinib-in-achondroplasia/)
03:06:05	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-doses-first-child-in-phase-2-clinical-trial-of-the-investigational-medicine-infigratinib-in-achondroplasia/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-doses-first-child-in-phase-2-clinical-trial-of-the-investigational-medicine-infigratinib-in-achondroplasia/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-doses-first-child-in-phase-2-clinical-trial-of-the-investigational-medicine-infigratinib-in-achondroplasia/)
03:06:06	2938/2938	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:05%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-qed-therapeutics-doses-first-child-in-phase-2-clinical-trial-of-the-investigational-medicine-infigratinib-in-achondroplasia%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede76b.json	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-doses-first-child-in-phase-2-clinical-trial-of-the-investigational-medicine-infigratinib-in-achondroplasia/)
03:06:08	3131/3131	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:06:07%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-qed-therapeutics-doses-first-child-in-phase-2-clinical-trial-of-the-investigational-medicine-infigratinib-in-achondroplasia%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7e27	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-doses-first-child-in-phase-2-clinical-trial-of-the-investigational-medicine-infigratinib-in-achondroplasia/)
03:06:08	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.89f.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-doses-first-child-in-phase-2-clinical-trial-of-the-investigational-medicine-infigratinib-in-achondroplasia/)
03:06:08	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.8a0.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-doses-first-child-in-phase-2-clinical-trial-of-the-investigational-medicine-infigratinib-in-achondroplasia/)
03:06:09	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:05:52%20GMT	https://bridgebio.com/?p=2564	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexb0e3.html	(from https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-pharmas-qed-therapeutics-announce-dosing-of-first-patient-in-investigator-initiated-phase-0-2-clinical-trial-of-infigratinib/)
03:06:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:08%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-doses-first-child-in-phase-2-clinical-trial-of-the-investigational-medicine-infigratinib-in-achondroplasia/)
03:06:19	19742/19742	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:18%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2523	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2523.json	(from https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-to-highlight-interim-phase-1-2-study-data-in-a-presentation-at-the-society-for-pediatric-dermatologys-45th-annual-meeting/)
03:06:20	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-to-highlight-interim-phase-1-2-study-data-in-a-presentation-at-the-society-for-pediatric-dermatologys-45th-annual-meeting/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-to-high/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-to-highlight-interim-phase-1-2-study-data-in-a-presentation-at-the-society-for-pediatric-dermatologys-45th-annual-meeting/)
03:06:21	3020/3020	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:20%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-phoenix-tissue-repair-to-highlight-interim-phase-1-2-study-data-in-a-presentation-at-the-society-for-pediatric-dermatologys-45th-annual-meeting%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7fba.json	(from https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-to-highlight-interim-phase-1-2-study-data-in-a-presentation-at-the-society-for-pediatric-dermatologys-45th-annual-meeting/)
03:06:22	3213/3213	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:06:21%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-phoenix-tissue-repair-to-highlight-interim-phase-1-2-study-data-in-a-presentation-at-the-society-for-pediatric-dermatologys-45th-annual-meeting%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed4e8a	(from https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-to-highlight-interim-phase-1-2-study-data-in-a-presentation-at-the-society-for-pediatric-dermatologys-45th-annual-meeting/)
03:06:23	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.8a5.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-to-highlight-interim-phase-1-2-study-data-in-a-presentation-at-the-society-for-pediatric-dermatologys-45th-annual-meeting/)
03:06:23	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.8a6.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-to-highlight-interim-phase-1-2-study-data-in-a-presentation-at-the-society-for-pediatric-dermatologys-45th-annual-meeting/)
03:06:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:06%20GMT	https://bridgebio.com/?p=2543	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexe1b8.html	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-doses-first-child-in-phase-2-clinical-trial-of-the-investigational-medicine-infigratinib-in-achondroplasia/)
03:06:32	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:23%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-to-highlight-interim-phase-1-2-study-data-in-a-presentation-at-the-society-for-pediatric-dermatologys-45th-annual-meeting/)
03:06:34	13637/13637	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:33%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2519	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2519.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-8/)
03:06:35	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-8/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-8/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-8/)
03:06:35	2644/2644	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:34%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-8%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed54b8.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-8/)
03:06:37	2831/2831	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:06:36%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-8%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7dd2	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-8/)
03:06:37	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.8ab.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-8/)
03:06:37	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.8ac.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-8/)
03:06:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:21%20GMT	https://bridgebio.com/?p=2523	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index8268.html	(from https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-to-highlight-interim-phase-1-2-study-data-in-a-presentation-at-the-society-for-pediatric-dermatologys-45th-annual-meeting/)
03:06:43	1497411/1497411	---M--	200	added ('OK')	application/pdf	etag:%2266829bfb-16d943%22	http://bridgebio.com/wp-content/uploads/2020/08/BridgeBio-Pharma-Collaboration-With-Perceptive-Advisors-Founded-Company-LianBio-Chinese-Version.pdf	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2020/08/BridgeBio-Pharma-Collaboration-With-Perceptive-Advisors-Founded-Company-LianBio-Chinese-Version.pdf	(from https://bridgebio.com/news/bridgebio-pharma-expands-reach-into-china-and-other-major-asian-markets-through-strategic-collaboration-with-perceptive-advisors-founded-company-lianbio/)
03:06:43	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:38%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-8/)
03:06:43	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:36%20GMT	https://bridgebio.com/?p=2519	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexabd0.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-8/)
03:06:44	20817/20817	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:44%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2479	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2479.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-biotech-trailblazers-brent-saunders-and-randy-scott-and-renowned-economist-andrew-lo-to-board-of-directors/)
03:06:44	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-appoints-biotech-trailblazers-brent-saunders-and-randy-scott-and-renowned-economist-andrew-lo-to-board-of-directors/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-appoints-biotech-trailblazers-brent-saunders-and-randy-scott-and-renowned-economist-andrew-lo-to-board-of-directors/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-biotech-trailblazers-brent-saunders-and-randy-scott-and-renowned-economist-andrew-lo-to-board-of-directors/)
03:06:45	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:45%20GMT	https://bridgebio.com/?p=2479	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexde83.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-biotech-trailblazers-brent-saunders-and-randy-scott-and-renowned-economist-andrew-lo-to-board-of-directors/)
03:06:45	2905/2905	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:45%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-appoints-biotech-trailblazers-brent-saunders-and-randy-scott-and-renowned-economist-andrew-lo-to-board-of-directors%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede536.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-biotech-trailblazers-brent-saunders-and-randy-scott-and-renowned-economist-andrew-lo-to-board-of-directors/)
03:06:45	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.8b1.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-biotech-trailblazers-brent-saunders-and-randy-scott-and-renowned-economist-andrew-lo-to-board-of-directors/)
03:06:45	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.8b2.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-biotech-trailblazers-brent-saunders-and-randy-scott-and-renowned-economist-andrew-lo-to-board-of-directors/)
03:06:45	3094/3094	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:06:45%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-appoints-biotech-trailblazers-brent-saunders-and-randy-scott-and-renowned-economist-andrew-lo-to-board-of-directors%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2d46	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-biotech-trailblazers-brent-saunders-and-randy-scott-and-renowned-economist-andrew-lo-to-board-of-directors/)
03:06:46	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:46%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-biotech-trailblazers-brent-saunders-and-randy-scott-and-renowned-economist-andrew-lo-to-board-of-directors/)
03:06:46	19555/19555	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:46%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2455	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2455.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-university-of-florida-establish-collaboration-to-advance-therapies-for-genetically-driven-diseases/)
03:06:46	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-and-university-of-florida-establish-collaboration-to-advance-therapies-for-genetically-driven-diseases/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-and-university-of-florida-establish-collaboration-to-advance-therapies-for-genetically-driven-diseases/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-university-of-florida-establish-collaboration-to-advance-therapies-for-genetically-driven-diseases/)
03:06:47	2859/2859	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:47%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-and-university-of-florida-establish-collaboration-to-advance-therapies-for-genetically-driven-diseases%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed43d4.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-university-of-florida-establish-collaboration-to-advance-therapies-for-genetically-driven-diseases/)
03:06:47	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:47%20GMT	https://bridgebio.com/?p=2455	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexe8f9.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-university-of-florida-establish-collaboration-to-advance-therapies-for-genetically-driven-diseases/)
03:06:47	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.8b7.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-university-of-florida-establish-collaboration-to-advance-therapies-for-genetically-driven-diseases/)
03:06:47	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.8b8.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-university-of-florida-establish-collaboration-to-advance-therapies-for-genetically-driven-diseases/)
03:06:47	3048/3048	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:06:47%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-and-university-of-florida-establish-collaboration-to-advance-therapies-for-genetically-driven-diseases%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede21f	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-university-of-florida-establish-collaboration-to-advance-therapies-for-genetically-driven-diseases/)
03:06:47	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:47%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-and-university-of-florida-establish-collaboration-to-advance-therapies-for-genetically-driven-diseases/)
03:06:48	19514/19514	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:48%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2450	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2450.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-enters-into-collaboration-agreement-with-johns-hopkins-university-to-accelerate-development-of-new-medicines-in-genetically-driven-diseases/)
03:06:48	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-enters-into-collaboration-agreement-with-johns-hopkins-university-to-accelerate-development-of-new-medicines-in-genetically-driven-diseases/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-enters-into-collaboration-/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-enters-into-collaboration-agreement-with-johns-hopkins-university-to-accelerate-development-of-new-medicines-in-genetically-driven-diseases/)
03:06:48	3002/3002	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:49%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-enters-into-collaboration-agreement-with-johns-hopkins-university-to-accelerate-development-of-new-medicines-in-genetically-driven-diseases%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed64d1.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-enters-into-collaboration-agreement-with-johns-hopkins-university-to-accelerate-development-of-new-medicines-in-genetically-driven-diseases/)
03:06:49	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:49%20GMT	https://bridgebio.com/?p=2450	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index1fba.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-enters-into-collaboration-agreement-with-johns-hopkins-university-to-accelerate-development-of-new-medicines-in-genetically-driven-diseases/)
03:06:49	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.8bd.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-enters-into-collaboration-agreement-with-johns-hopkins-university-to-accelerate-development-of-new-medicines-in-genetically-driven-diseases/)
03:06:49	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.8be.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-enters-into-collaboration-agreement-with-johns-hopkins-university-to-accelerate-development-of-new-medicines-in-genetically-driven-diseases/)
03:06:49	3195/3195	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:06:49%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-enters-into-collaboration-agreement-with-johns-hopkins-university-to-accelerate-development-of-new-medicines-in-genetically-driven-diseases%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8311	(from https://bridgebio.com/news/bridgebio-pharma-inc-enters-into-collaboration-agreement-with-johns-hopkins-university-to-accelerate-development-of-new-medicines-in-genetically-driven-diseases/)
03:06:49	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:49%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-enters-into-collaboration-agreement-with-johns-hopkins-university-to-accelerate-development-of-new-medicines-in-genetically-driven-diseases/)
03:06:50	23833/23833	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:50%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2422	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2422.json	(from https://bridgebio.com/news/bridgebio-pharmas-ml-bio-solutions-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-bbp-418-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:06:50	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharmas-ml-bio-solutions-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-bbp-418-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-ml-bio-solutions-announces-do/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharmas-ml-bio-solutions-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-bbp-418-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:06:50	2997/2997	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:50%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-ml-bio-solutions-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-bbp-418-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeda214.json	(from https://bridgebio.com/news/bridgebio-pharmas-ml-bio-solutions-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-bbp-418-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:06:51	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:51%20GMT	https://bridgebio.com/?p=2422	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexdba3.html	(from https://bridgebio.com/news/bridgebio-pharmas-ml-bio-solutions-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-bbp-418-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:06:51	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.8c3.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-ml-bio-solutions-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-bbp-418-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:06:51	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.8c4.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-ml-bio-solutions-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-bbp-418-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:06:51	3190/3190	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:06:51%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-ml-bio-solutions-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-bbp-418-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb0e0	(from https://bridgebio.com/news/bridgebio-pharmas-ml-bio-solutions-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-bbp-418-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:06:51	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:51%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharmas-ml-bio-solutions-announces-dosing-of-first-subject-in-phase-1-clinical-trial-of-bbp-418-for-limb-girdle-muscular-dystrophy-type-2i-lgmd2i/)
03:06:52	13624/13624	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:52%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2412	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2412.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-7/)
03:06:52	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-7/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-7/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-7/)
03:06:52	2644/2644	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:52%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-7%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed09ca.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-7/)
03:06:52	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:52%20GMT	https://bridgebio.com/?p=2412	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index952d.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-7/)
03:06:53	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.8c9.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-7/)
03:06:53	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.8ca.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-7/)
03:06:53	2831/2831	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:06:53%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-7%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5edb	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-7/)
03:06:53	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:53%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-7/)
03:06:54	21722/21722	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:54%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2373	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2373.json	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-presents-data-on-infigratinib-in-cholangiocarcinoma-and-urothelial-carcinoma/)
03:06:54	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-presents-data-on-infigratinib-in-cholangiocarcinoma-and-urothelial-carcinoma/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-presents-data-on-infigratinib-in-cholangiocarcinoma-and-urothelial-carcinoma/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-presents-data-on-infigratinib-in-cholangiocarcinoma-and-urothelial-carcinoma/)
03:06:54	2971/2971	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:54%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-qed-therapeutics-presents-data-on-infigratinib-in-cholangiocarcinoma-and-urothelial-carcinoma%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd0a5.json	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-presents-data-on-infigratinib-in-cholangiocarcinoma-and-urothelial-carcinoma/)
03:06:54	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:54%20GMT	https://bridgebio.com/?p=2373	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index6a23.html	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-presents-data-on-infigratinib-in-cholangiocarcinoma-and-urothelial-carcinoma/)
03:06:54	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.8cf.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-presents-data-on-infigratinib-in-cholangiocarcinoma-and-urothelial-carcinoma/)
03:06:54	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.8d0.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-presents-data-on-infigratinib-in-cholangiocarcinoma-and-urothelial-carcinoma/)
03:06:54	3164/3164	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:06:55%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-qed-therapeutics-presents-data-on-infigratinib-in-cholangiocarcinoma-and-urothelial-carcinoma%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedef73	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-presents-data-on-infigratinib-in-cholangiocarcinoma-and-urothelial-carcinoma/)
03:06:55	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:55%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-presents-data-on-infigratinib-in-cholangiocarcinoma-and-urothelial-carcinoma/)
03:06:55	22820/22820	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:56%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2278	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2278.json	(from https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-provides-updates-to-its-recessive-dystrophic-epidermolysis-bullosa-rdeb-program-and-announces-new-leadership-appointments/)
03:06:56	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-provides-updates-to-its-recessive-dystrophic-epidermolysis-bullosa-rdeb-program-and-announces-new-leadership-appointments/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-provide/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-provides-updates-to-its-recessive-dystrophic-epidermolysis-bullosa-rdeb-program-and-announces-new-leadership-appointments/)
03:06:56	3010/3010	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:56%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-phoenix-tissue-repair-provides-updates-to-its-recessive-dystrophic-epidermolysis-bullosa-rdeb-program-and-announces-new-leadership-appointments%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed4ec1.json	(from https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-provides-updates-to-its-recessive-dystrophic-epidermolysis-bullosa-rdeb-program-and-announces-new-leadership-appointments/)
03:06:56	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:56%20GMT	https://bridgebio.com/?p=2278	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexb6be.html	(from https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-provides-updates-to-its-recessive-dystrophic-epidermolysis-bullosa-rdeb-program-and-announces-new-leadership-appointments/)
03:06:56	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.8d5.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-provides-updates-to-its-recessive-dystrophic-epidermolysis-bullosa-rdeb-program-and-announces-new-leadership-appointments/)
03:06:56	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.8d6.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-provides-updates-to-its-recessive-dystrophic-epidermolysis-bullosa-rdeb-program-and-announces-new-leadership-appointments/)
03:06:56	3202/3202	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:06:56%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-phoenix-tissue-repair-provides-updates-to-its-recessive-dystrophic-epidermolysis-bullosa-rdeb-program-and-announces-new-leadership-appointments%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2207	(from https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-provides-updates-to-its-recessive-dystrophic-epidermolysis-bullosa-rdeb-program-and-announces-new-leadership-appointments/)
03:06:57	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:57%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharmas-phoenix-tissue-repair-provides-updates-to-its-recessive-dystrophic-epidermolysis-bullosa-rdeb-program-and-announces-new-leadership-appointments/)
03:06:57	31731/31731	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:57%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2270	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2270.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2020-financial-results-and-business-update/)
03:06:58	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2020-financial-results-and-business-update/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2020-financial-results-and-business-update/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2020-financial-results-and-business-update/)
03:06:58	2700/2700	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:06:58%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-reports-first-quarter-2020-financial-results-and-business-update%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedcbbf.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2020-financial-results-and-business-update/)
03:06:58	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:58%20GMT	https://bridgebio.com/?p=2270	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index8ee8.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2020-financial-results-and-business-update/)
03:06:58	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.8db.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2020-financial-results-and-business-update/)
03:06:58	2891/2891	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:06:58%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-reports-first-quarter-2020-financial-results-and-business-update%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2e2c	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2020-financial-results-and-business-update/)
03:06:58	61952/61952	---M--	200	added ('OK')	image/png	etag:%2266829bfa-1b2b0%22	https://bridgebio.com/wp-content/uploads/2020/05/Screen-Shot-2020-05-13-at-12.51.22-PM.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2020/05/Screen-Shot-2020-05-13-at-12.51.22-PM.png	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2020-financial-results-and-business-update/)
03:06:59	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.8de.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2020-financial-results-and-business-update/)
03:06:59	65458/65458	---M--	200	added ('OK')	image/png	etag:%2266829bfa-1c754%22	https://bridgebio.com/wp-content/uploads/2020/05/Screen-Shot-2020-05-13-at-12.51.31-PM.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2020/05/Screen-Shot-2020-05-13-at-12.51.31-PM.png	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2020-financial-results-and-business-update/)
03:06:59	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:06:59%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-reports-first-quarter-2020-financial-results-and-business-update/)
03:07:00	22190/22190	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:00%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2227	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2227.json	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-preclinical-data-demonstrating-potential-of-low-dose-infigratinib-in-achondroplasia/)
03:07:00	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-preclinical-data-demonstrating-potential-of-low-dose-infigratinib-in-achondroplasia/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-preclinical-data-demonstrating-potential-of-low-dose-infigratinib-in-achondroplasia/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-preclinical-data-demonstrating-potential-of-low-dose-infigratinib-in-achondroplasia/)
03:07:00	2893/2893	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:00%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-qed-therapeutics-announces-preclinical-data-demonstrating-potential-of-low-dose-infigratinib-in-achondroplasia%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed4272.json	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-preclinical-data-demonstrating-potential-of-low-dose-infigratinib-in-achondroplasia/)
03:07:00	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:00%20GMT	https://bridgebio.com/?p=2227	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexf883.html	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-preclinical-data-demonstrating-potential-of-low-dose-infigratinib-in-achondroplasia/)
03:07:00	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.8e3.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-preclinical-data-demonstrating-potential-of-low-dose-infigratinib-in-achondroplasia/)
03:07:00	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.8e4.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-preclinical-data-demonstrating-potential-of-low-dose-infigratinib-in-achondroplasia/)
03:07:00	3088/3088	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:01%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-qed-therapeutics-announces-preclinical-data-demonstrating-potential-of-low-dose-infigratinib-in-achondroplasia%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed055e-2	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-preclinical-data-demonstrating-potential-of-low-dose-infigratinib-in-achondroplasia/)
03:07:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:01%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-preclinical-data-demonstrating-potential-of-low-dose-infigratinib-in-achondroplasia/)
03:07:02	12909/12909	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:02%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2218	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2218.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2/)
03:07:02	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2/)
03:07:02	2595/2595	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:02%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb5a9.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2/)
03:07:02	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:02%20GMT	https://bridgebio.com/?p=2218	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index82ae.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2/)
03:07:02	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.8e9.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2/)
03:07:02	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.8ea.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2/)
03:07:02	2782/2782	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:03%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed57cb	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2/)
03:07:03	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:03%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference-2/)
03:07:03	13136/13136	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:03%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2210	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2210.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6/)
03:07:04	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6/)
03:07:04	2643/2643	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:04%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1ef4.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6/)
03:07:04	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:04%20GMT	https://bridgebio.com/?p=2210	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index6934.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6/)
03:07:04	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.8ef.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6/)
03:07:04	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.8f0.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6/)
03:07:04	2830/2830	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:04%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed317d	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6/)
03:07:05	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:05%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6/)
03:07:05	21934/21934	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:05%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2093	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2093.json	(from https://bridgebio.com/news/a-letter-to-our-shareholders-from-ceo-neil-kumar/)
03:07:06	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/a-letter-to-our-shareholders-from-ceo-neil-kumar/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/a-letter-to-our-shareholders-from-ceo-neil-kumar/feed/index.html	(from https://bridgebio.com/news/a-letter-to-our-shareholders-from-ceo-neil-kumar/)
03:07:06	2491/2491	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:06%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fa-letter-to-our-shareholders-from-ceo-neil-kumar%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedfc91.json	(from https://bridgebio.com/news/a-letter-to-our-shareholders-from-ceo-neil-kumar/)
03:07:06	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:06%20GMT	https://bridgebio.com/?p=2093	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index13cc.html	(from https://bridgebio.com/news/a-letter-to-our-shareholders-from-ceo-neil-kumar/)
03:07:06	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.8f5.delayed	(from https://bridgebio.com/news/a-letter-to-our-shareholders-from-ceo-neil-kumar/)
03:07:06	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.8f6.delayed	(from https://bridgebio.com/news/a-letter-to-our-shareholders-from-ceo-neil-kumar/)
03:07:06	2678/2678	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:06%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fa-letter-to-our-shareholders-from-ceo-neil-kumar%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed70a8	(from https://bridgebio.com/news/a-letter-to-our-shareholders-from-ceo-neil-kumar/)
03:07:07	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:07%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/a-letter-to-our-shareholders-from-ceo-neil-kumar/)
03:07:07	13575/13575	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:07%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2074	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2074.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-5/)
03:07:07	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-5/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-5/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-5/)
03:07:08	2645/2645	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:08%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-5%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeddac1.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-5/)
03:07:08	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:08%20GMT	https://bridgebio.com/?p=2074	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexb8cb.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-5/)
03:07:08	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.8fb.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-5/)
03:07:08	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.8fc.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-5/)
03:07:08	2832/2832	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:08%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-5%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed185f	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-5/)
03:07:08	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:08%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-5/)
03:07:09	12976/12976	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:09%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2059	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2059.json	(from https://bridgebio.com/news/an-open-letter-to-patients-and-their-families-from-bridgebio-pharma-ceo-neil-kumar/)
03:07:09	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/an-open-letter-to-patients-and-their-families-from-bridgebio-pharma-ceo-neil-kumar/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/an-open-letter-to-patients-and-their-families-from-bridgebio-pharma-ceo-neil-kumar/feed/index.html	(from https://bridgebio.com/news/an-open-letter-to-patients-and-their-families-from-bridgebio-pharma-ceo-neil-kumar/)
03:07:09	2658/2658	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:10%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fan-open-letter-to-patients-and-their-families-from-bridgebio-pharma-ceo-neil-kumar%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeddd46.json	(from https://bridgebio.com/news/an-open-letter-to-patients-and-their-families-from-bridgebio-pharma-ceo-neil-kumar/)
03:07:10	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:10%20GMT	https://bridgebio.com/?p=2059	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index230e.html	(from https://bridgebio.com/news/an-open-letter-to-patients-and-their-families-from-bridgebio-pharma-ceo-neil-kumar/)
03:07:10	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.901.delayed	(from https://bridgebio.com/news/an-open-letter-to-patients-and-their-families-from-bridgebio-pharma-ceo-neil-kumar/)
03:07:10	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.902.delayed	(from https://bridgebio.com/news/an-open-letter-to-patients-and-their-families-from-bridgebio-pharma-ceo-neil-kumar/)
03:07:10	2845/2845	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:10%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fan-open-letter-to-patients-and-their-families-from-bridgebio-pharma-ceo-neil-kumar%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed6f6b	(from https://bridgebio.com/news/an-open-letter-to-patients-and-their-families-from-bridgebio-pharma-ceo-neil-kumar/)
03:07:10	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:10%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/an-open-letter-to-patients-and-their-families-from-bridgebio-pharma-ceo-neil-kumar/)
03:07:11	20973/20973	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:11%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2029	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2029.json	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-dosing-of-first-patients-in-phase-3-and-phase-2-clinical-trials-of-infigratinib/)
03:07:11	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-dosing-of-first-patients-in-phase-3-and-phase-2-clinical-trials-of-infigratinib/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-dosing-of-first-patients-in-phase-3-and-phase-2-clinical-trials-of-infigratinib/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-dosing-of-first-patients-in-phase-3-and-phase-2-clinical-trials-of-infigratinib/)
03:07:11	2951/2951	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:11%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-qed-therapeutics-announces-dosing-of-first-patients-in-phase-3-and-phase-2-clinical-trials-of-infigratinib%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed24ed.json	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-dosing-of-first-patients-in-phase-3-and-phase-2-clinical-trials-of-infigratinib/)
03:07:12	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:12%20GMT	https://bridgebio.com/?p=2029	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index7b09.html	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-dosing-of-first-patients-in-phase-3-and-phase-2-clinical-trials-of-infigratinib/)
03:07:12	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.907.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-dosing-of-first-patients-in-phase-3-and-phase-2-clinical-trials-of-infigratinib/)
03:07:12	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.908.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-dosing-of-first-patients-in-phase-3-and-phase-2-clinical-trials-of-infigratinib/)
03:07:12	3148/3148	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:12%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-qed-therapeutics-announces-dosing-of-first-patients-in-phase-3-and-phase-2-clinical-trials-of-infigratinib%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb742	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-dosing-of-first-patients-in-phase-3-and-phase-2-clinical-trials-of-infigratinib/)
03:07:12	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:12%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-announces-dosing-of-first-patients-in-phase-3-and-phase-2-clinical-trials-of-infigratinib/)
03:07:13	24322/24322	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:13%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2012	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2012.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-475-million-convertible-senior-notes/)
03:07:13	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-475-million-convertible-senior-notes/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-475-million-convertible-senior-notes/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-475-million-convertible-senior-notes/)
03:07:13	2689/2689	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:13%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-prices-upsized-offering-of-475-million-convertible-senior-notes%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8dbb.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-475-million-convertible-senior-notes/)
03:07:14	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:14%20GMT	https://bridgebio.com/?p=2012	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index28fd.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-475-million-convertible-senior-notes/)
03:07:14	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.90d.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-475-million-convertible-senior-notes/)
03:07:14	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.90e.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-475-million-convertible-senior-notes/)
03:07:14	2878/2878	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:14%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-prices-upsized-offering-of-475-million-convertible-senior-notes%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9ff6	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-475-million-convertible-senior-notes/)
03:07:14	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:14%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-prices-upsized-offering-of-475-million-convertible-senior-notes/)
03:07:15	23739/23739	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:15%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/2009	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/2009.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-350-million-convertible-senior-notes/)
03:07:15	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-350-million-convertible-senior-notes/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-350-million-convertible-senior-notes/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-350-million-convertible-senior-notes/)
03:07:15	2709/2709	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:15%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-announces-proposed-offering-of-350-million-convertible-senior-notes%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0045.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-350-million-convertible-senior-notes/)
03:07:15	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:15%20GMT	https://bridgebio.com/?p=2009	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index7ca3.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-350-million-convertible-senior-notes/)
03:07:16	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.913.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-350-million-convertible-senior-notes/)
03:07:16	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.914.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-350-million-convertible-senior-notes/)
03:07:16	2898/2898	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:16%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-announces-proposed-offering-of-350-million-convertible-senior-notes%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8e25	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-350-million-convertible-senior-notes/)
03:07:16	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:16%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-announces-proposed-offering-of-350-million-convertible-senior-notes/)
03:07:17	13075/13075	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:17%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1996	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1996.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-4/)
03:07:17	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-4/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-4/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-4/)
03:07:17	2647/2647	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:17%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-4%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5883.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-4/)
03:07:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:17%20GMT	https://bridgebio.com/?p=1996	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index9a80.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-4/)
03:07:17	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.919.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-4/)
03:07:17	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.91a.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-4/)
03:07:17	2834/2834	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:18%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-4%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3606	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-4/)
03:07:18	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:18%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-4/)
03:07:18	33743/33743	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:18%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1991	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1991.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2019-financial-results-and-highlights-portfolio-progress/)
03:07:19	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2019-financial-results-and-highlights-portfolio-progress/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2019-financial-results-and-highlights-portfolio-progress/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2019-financial-results-and-highlights-portfolio-progress/)
03:07:19	2797/2797	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:19%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-fourth-quarter-and-full-year-2019-financial-results-and-highlights-portfolio-progress%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5a95.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2019-financial-results-and-highlights-portfolio-progress/)
03:07:19	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:19%20GMT	https://bridgebio.com/?p=1991	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexe741.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2019-financial-results-and-highlights-portfolio-progress/)
03:07:19	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.91f.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2019-financial-results-and-highlights-portfolio-progress/)
03:07:19	2986/2986	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:19%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-fourth-quarter-and-full-year-2019-financial-results-and-highlights-portfolio-progress%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2c6a	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2019-financial-results-and-highlights-portfolio-progress/)
03:07:20	79773/79773	---M--	200	added ('OK')	image/png	etag:%2266829bfb-21902%22	https://bridgebio.com/wp-content/uploads/2020/03/Screen-Shot-2020-03-01-at-7.46.41-PM.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2020/03/Screen-Shot-2020-03-01-at-7.46.41-PM.png	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2019-financial-results-and-highlights-portfolio-progress/)
03:07:20	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.922.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2019-financial-results-and-highlights-portfolio-progress/)
03:07:20	51674/51674	---M--	200	added ('OK')	image/png	etag:%2266829bfa-1449b%22	https://bridgebio.com/wp-content/uploads/2020/03/Screen-Shot-2020-03-01-at-7.46.38-PM.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2020/03/Screen-Shot-2020-03-01-at-7.46.38-PM.png	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2019-financial-results-and-highlights-portfolio-progress/)
03:07:20	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:20%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-fourth-quarter-and-full-year-2019-financial-results-and-highlights-portfolio-progress/)
03:07:21	16002/16002	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:21%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1963	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1963.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-ronald-j-daniels-to-its-board-of-directors/)
03:07:21	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-appoints-ronald-j-daniels-to-its-board-of-directors/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-appoints-ronald-j-daniels-to-its-board-of-directors/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-ronald-j-daniels-to-its-board-of-directors/)
03:07:21	2658/2658	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:21%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-appoints-ronald-j-daniels-to-its-board-of-directors%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5eee.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-ronald-j-daniels-to-its-board-of-directors/)
03:07:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:22%20GMT	https://bridgebio.com/?p=1963	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexfca9.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-ronald-j-daniels-to-its-board-of-directors/)
03:07:22	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.927.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-ronald-j-daniels-to-its-board-of-directors/)
03:07:22	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.928.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-ronald-j-daniels-to-its-board-of-directors/)
03:07:22	2847/2847	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:22%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-appoints-ronald-j-daniels-to-its-board-of-directors%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedeb76	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-ronald-j-daniels-to-its-board-of-directors/)
03:07:22	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:22%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-ronald-j-daniels-to-its-board-of-directors/)
03:07:23	13959/13959	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:23%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1957	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1957.json	(from https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-to-present-at-upcoming-investor-conferences/)
03:07:23	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-to-present-at-upcoming-investor-conferences/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-to-present-at-upcoming-investor-conferences/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-to-present-at-upcoming-investor-conferences/)
03:07:23	2690/2690	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:23%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-eidos-therapeutics-to-present-at-upcoming-investor-conferences%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5b97.json	(from https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-to-present-at-upcoming-investor-conferences/)
03:07:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:23%20GMT	https://bridgebio.com/?p=1957	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexefbe.html	(from https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-to-present-at-upcoming-investor-conferences/)
03:07:23	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.92d.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-to-present-at-upcoming-investor-conferences/)
03:07:23	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.92e.delayed	(from https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-to-present-at-upcoming-investor-conferences/)
03:07:23	2878/2878	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:24%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-and-eidos-therapeutics-to-present-at-upcoming-investor-conferences%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedcd02	(from https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-to-present-at-upcoming-investor-conferences/)
03:07:24	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:24%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-and-eidos-therapeutics-to-present-at-upcoming-investor-conferences/)
03:07:24	13281/13281	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:24%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1909	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1909.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-3/)
03:07:25	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-3/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-3/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-3/)
03:07:25	2652/2652	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:25%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-3%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf846.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-3/)
03:07:25	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:25%20GMT	https://bridgebio.com/?p=1909	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexc065.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-3/)
03:07:25	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.933.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-3/)
03:07:25	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.934.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-3/)
03:07:25	2839/2839	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:25%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-3%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf35d	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-3/)
03:07:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:26%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-3/)
03:07:26	23317/23317	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:26%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1760	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1760.json	(from https://bridgebio.com/news/bridgebio-pharma-grows-pipeline-to-20-genetic-medicines-with-four-assets-focused-on-treating-genetically-driven-diseases-at-their-source/)
03:07:27	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-grows-pipeline-to-20-genetic-medicines-with-four-assets-focused-on-treating-genetically-driven-diseases-at-their-source/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-grows-pipeline-to-20-genetic-medicines-with-four-assets-focused-on-treating-genetically-driven-diseases-at-their-source/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-grows-pipeline-to-20-genetic-medicines-with-four-assets-focused-on-treating-genetically-driven-diseases-at-their-source/)
03:07:27	2909/2909	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:27%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-grows-pipeline-to-20-genetic-medicines-with-four-assets-focused-on-treating-genetically-driven-diseases-at-their-source%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embededf4.json	(from https://bridgebio.com/news/bridgebio-pharma-grows-pipeline-to-20-genetic-medicines-with-four-assets-focused-on-treating-genetically-driven-diseases-at-their-source/)
03:07:27	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:27%20GMT	https://bridgebio.com/?p=1760	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexfa5e.html	(from https://bridgebio.com/news/bridgebio-pharma-grows-pipeline-to-20-genetic-medicines-with-four-assets-focused-on-treating-genetically-driven-diseases-at-their-source/)
03:07:27	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.939.delayed	(from https://bridgebio.com/news/bridgebio-pharma-grows-pipeline-to-20-genetic-medicines-with-four-assets-focused-on-treating-genetically-driven-diseases-at-their-source/)
03:07:27	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.93a.delayed	(from https://bridgebio.com/news/bridgebio-pharma-grows-pipeline-to-20-genetic-medicines-with-four-assets-focused-on-treating-genetically-driven-diseases-at-their-source/)
03:07:27	3098/3098	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:27%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-grows-pipeline-to-20-genetic-medicines-with-four-assets-focused-on-treating-genetically-driven-diseases-at-their-source%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9398	(from https://bridgebio.com/news/bridgebio-pharma-grows-pipeline-to-20-genetic-medicines-with-four-assets-focused-on-treating-genetically-driven-diseases-at-their-source/)
03:07:27	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:28%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-grows-pipeline-to-20-genetic-medicines-with-four-assets-focused-on-treating-genetically-driven-diseases-at-their-source/)
03:07:28	22006/22006	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:28%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1755	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1755.json	(from https://bridgebio.com/news/bridgebio-pharmas-gene-therapy-subsidiaries-enter-strategic-partnership-with-catalent-for-dedicated-gene-therapy-development-and-manufacturing-capacity/)
03:07:28	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharmas-gene-therapy-subsidiaries-enter-strategic-partnership-with-catalent-for-dedicated-gene-therapy-development-and-manufacturing-capacity/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-gene-therapy-subsidiaries-ent/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharmas-gene-therapy-subsidiaries-enter-strategic-partnership-with-catalent-for-dedicated-gene-therapy-development-and-manufacturing-capacity/)
03:07:28	2986/2986	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:29%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-gene-therapy-subsidiaries-enter-strategic-partnership-with-catalent-for-dedicated-gene-therapy-development-and-manufacturing-capacity%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc637.json	(from https://bridgebio.com/news/bridgebio-pharmas-gene-therapy-subsidiaries-enter-strategic-partnership-with-catalent-for-dedicated-gene-therapy-development-and-manufacturing-capacity/)
03:07:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:29%20GMT	https://bridgebio.com/?p=1755	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index6a11.html	(from https://bridgebio.com/news/bridgebio-pharmas-gene-therapy-subsidiaries-enter-strategic-partnership-with-catalent-for-dedicated-gene-therapy-development-and-manufacturing-capacity/)
03:07:29	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.93f.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-gene-therapy-subsidiaries-enter-strategic-partnership-with-catalent-for-dedicated-gene-therapy-development-and-manufacturing-capacity/)
03:07:29	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.940.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-gene-therapy-subsidiaries-enter-strategic-partnership-with-catalent-for-dedicated-gene-therapy-development-and-manufacturing-capacity/)
03:07:29	3181/3181	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:29%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-gene-therapy-subsidiaries-enter-strategic-partnership-with-catalent-for-dedicated-gene-therapy-development-and-manufacturing-capacity%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7a54	(from https://bridgebio.com/news/bridgebio-pharmas-gene-therapy-subsidiaries-enter-strategic-partnership-with-catalent-for-dedicated-gene-therapy-development-and-manufacturing-capacity/)
03:07:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:29%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharmas-gene-therapy-subsidiaries-enter-strategic-partnership-with-catalent-for-dedicated-gene-therapy-development-and-manufacturing-capacity/)
03:07:30	23481/23481	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:30%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1751	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1751.json	(from https://bridgebio.com/news/pellepharm-initiates-phase-2-clinical-trial-of-patidegib-topical-gel-for-people-with-high-frequency-basal-cell-carcinoma/)
03:07:30	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/pellepharm-initiates-phase-2-clinical-trial-of-patidegib-topical-gel-for-people-with-high-frequency-basal-cell-carcinoma/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/pellepharm-initiates-phase-2-clinical-trial-of-patidegib-topical-gel-for-people-with-high-frequency-basal-cell-carcinoma/feed/index.html	(from https://bridgebio.com/news/pellepharm-initiates-phase-2-clinical-trial-of-patidegib-topical-gel-for-people-with-high-frequency-basal-cell-carcinoma/)
03:07:30	2847/2847	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:30%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fpellepharm-initiates-phase-2-clinical-trial-of-patidegib-topical-gel-for-people-with-high-frequency-basal-cell-carcinoma%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc20b.json	(from https://bridgebio.com/news/pellepharm-initiates-phase-2-clinical-trial-of-patidegib-topical-gel-for-people-with-high-frequency-basal-cell-carcinoma/)
03:07:31	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:31%20GMT	https://bridgebio.com/?p=1751	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexf549.html	(from https://bridgebio.com/news/pellepharm-initiates-phase-2-clinical-trial-of-patidegib-topical-gel-for-people-with-high-frequency-basal-cell-carcinoma/)
03:07:31	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.945.delayed	(from https://bridgebio.com/news/pellepharm-initiates-phase-2-clinical-trial-of-patidegib-topical-gel-for-people-with-high-frequency-basal-cell-carcinoma/)
03:07:31	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.946.delayed	(from https://bridgebio.com/news/pellepharm-initiates-phase-2-clinical-trial-of-patidegib-topical-gel-for-people-with-high-frequency-basal-cell-carcinoma/)
03:07:31	3036/3036	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:31%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fpellepharm-initiates-phase-2-clinical-trial-of-patidegib-topical-gel-for-people-with-high-frequency-basal-cell-carcinoma%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed31b5	(from https://bridgebio.com/news/pellepharm-initiates-phase-2-clinical-trial-of-patidegib-topical-gel-for-people-with-high-frequency-basal-cell-carcinoma/)
03:07:31	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:31%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/pellepharm-initiates-phase-2-clinical-trial-of-patidegib-topical-gel-for-people-with-high-frequency-basal-cell-carcinoma/)
03:07:32	22422/22422	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:32%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1746	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1746.json	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-receives-fast-track-designation-for-infigratinib/)
03:07:32	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-receives-fast-track-designation-for-infigratinib/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-receives-fast-track-designation-for-infigratinib/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-receives-fast-track-designation-for-infigratinib/)
03:07:32	3003/3003	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:32%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-qed-therapeutics-receives-fast-track-designation-for-infigratinib%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed70cf.json	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-receives-fast-track-designation-for-infigratinib/)
03:07:32	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:32%20GMT	https://bridgebio.com/?p=1746	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index807c.html	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-receives-fast-track-designation-for-infigratinib/)
03:07:32	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.94b.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-receives-fast-track-designation-for-infigratinib/)
03:07:32	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.94c.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-receives-fast-track-designation-for-infigratinib/)
03:07:32	3196/3196	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:33%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-qed-therapeutics-receives-fast-track-designation-for-infigratinib%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedccd2	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-receives-fast-track-designation-for-infigratinib/)
03:07:33	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:33%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharmas-qed-therapeutics-receives-fast-track-designation-for-infigratinib/)
03:07:34	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference/)
03:07:34	12998/12998	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:34%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1732	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1732.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference/)
03:07:34	2602/2602	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:34%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-to-present-at-upcoming-investor-conference%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedaab1.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference/)
03:07:35	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:35%20GMT	https://bridgebio.com/?p=1732	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index2cfd.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference/)
03:07:35	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.951.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference/)
03:07:35	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.952.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference/)
03:07:35	2789/2789	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:35%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-to-present-at-upcoming-investor-conference%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed65dd	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference/)
03:07:35	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:35%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-to-present-at-upcoming-investor-conference/)
03:07:36	21880/21880	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:36%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1720	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1720.json	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-enters-partnership-with-medison-to-commercialize-bbp-870-in-israel-for-mocd-type-a/)
03:07:36	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-enters-partnership-with-medison-to-commercialize-bbp-870-in-israel-for-mocd-type-a/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-origin-biosciences-enters-partnership-with-medison-to-commercialize-bbp-870-in-israel-for-mocd-type-a/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-enters-partnership-with-medison-to-commercialize-bbp-870-in-israel-for-mocd-type-a/)
03:07:36	2847/2847	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:36%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-origin-biosciences-enters-partnership-with-medison-to-commercialize-bbp-870-in-israel-for-mocd-type-a%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed54fa.json	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-enters-partnership-with-medison-to-commercialize-bbp-870-in-israel-for-mocd-type-a/)
03:07:36	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:36%20GMT	https://bridgebio.com/?p=1720	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexcda3.html	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-enters-partnership-with-medison-to-commercialize-bbp-870-in-israel-for-mocd-type-a/)
03:07:37	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.957.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-enters-partnership-with-medison-to-commercialize-bbp-870-in-israel-for-mocd-type-a/)
03:07:37	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.958.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-enters-partnership-with-medison-to-commercialize-bbp-870-in-israel-for-mocd-type-a/)
03:07:37	3038/3038	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-origin-biosciences-enters-partnership-with-medison-to-commercialize-bbp-870-in-israel-for-mocd-type-a%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd361	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-enters-partnership-with-medison-to-commercialize-bbp-870-in-israel-for-mocd-type-a/)
03:07:37	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:37%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-enters-partnership-with-medison-to-commercialize-bbp-870-in-israel-for-mocd-type-a/)
03:07:38	15452/15452	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:38%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1713	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1713.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-industry-leader-jennifer-cook-as-new-board-member/)
03:07:38	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-appoints-industry-leader-jennifer-cook-as-new-board-member/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-appoints-industry-leader-jennifer-cook-as-new-board-member/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-industry-leader-jennifer-cook-as-new-board-member/)
03:07:38	2680/2680	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:38%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-appoints-industry-leader-jennifer-cook-as-new-board-member%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed115e.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-industry-leader-jennifer-cook-as-new-board-member/)
03:07:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:38%20GMT	https://bridgebio.com/?p=1713	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index0d4d.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-industry-leader-jennifer-cook-as-new-board-member/)
03:07:39	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.95d.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-industry-leader-jennifer-cook-as-new-board-member/)
03:07:39	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.95e.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-industry-leader-jennifer-cook-as-new-board-member/)
03:07:39	2869/2869	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:39%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-appoints-industry-leader-jennifer-cook-as-new-board-member%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1b6a	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-industry-leader-jennifer-cook-as-new-board-member/)
03:07:39	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:39%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-industry-leader-jennifer-cook-as-new-board-member/)
03:07:39	16795/16795	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:40%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1703	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1703.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-eli-wallace-as-chief-scientific-officer-in-residence-for-oncology-programs/)
03:07:40	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-inc-appoints-eli-wallace-as-chief-scientific-officer-in-residence-for-oncology-programs/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-inc-appoints-eli-wallace-as-chief-scientific-officer-in-residence-for-oncology-programs/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-eli-wallace-as-chief-scientific-officer-in-residence-for-oncology-programs/)
03:07:40	2773/2773	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:40%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-appoints-eli-wallace-as-chief-scientific-officer-in-residence-for-oncology-programs%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedea5c.json	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-eli-wallace-as-chief-scientific-officer-in-residence-for-oncology-programs/)
03:07:40	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:40%20GMT	https://bridgebio.com/?p=1703	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexeb41.html	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-eli-wallace-as-chief-scientific-officer-in-residence-for-oncology-programs/)
03:07:40	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.963.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-eli-wallace-as-chief-scientific-officer-in-residence-for-oncology-programs/)
03:07:40	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.964.delayed	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-eli-wallace-as-chief-scientific-officer-in-residence-for-oncology-programs/)
03:07:41	2962/2962	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:41%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-inc-appoints-eli-wallace-as-chief-scientific-officer-in-residence-for-oncology-programs%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed6800	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-eli-wallace-as-chief-scientific-officer-in-residence-for-oncology-programs/)
03:07:41	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:41%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-inc-appoints-eli-wallace-as-chief-scientific-officer-in-residence-for-oncology-programs/)
03:07:42	13057/13057	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:42%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1700	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1700.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2/)
03:07:42	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2/)
03:07:42	2650/2650	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:42%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed73d2.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2/)
03:07:42	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:42%20GMT	https://bridgebio.com/?p=1700	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexb5db.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2/)
03:07:42	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.969.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2/)
03:07:42	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.96a.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2/)
03:07:42	2837/2837	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:42%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc1ed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2/)
03:07:43	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:43%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2/)
03:07:43	22558/22558	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:43%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1681	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1681.json	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-initiates-rolling-submission-of-new-drug-application-with-the-u-s-fda-for-bbp-870-for-the-treatment-of-mocd-type-a/)
03:07:44	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-initiates-rolling-submission-of-new-drug-application-with-the-u-s-fda-for-bbp-870-for-the-treatment-of-mocd-type-a/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-origin-biosciences-initiates-/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-initiates-rolling-submission-of-new-drug-application-with-the-u-s-fda-for-bbp-870-for-the-treatment-of-mocd-type-a/)
03:07:44	2983/2983	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:44%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-origin-biosciences-initiates-rolling-submission-of-new-drug-application-with-the-u-s-fda-for-bbp-870-for-the-treatment-of-mocd-type-a%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc8ea.json	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-initiates-rolling-submission-of-new-drug-application-with-the-u-s-fda-for-bbp-870-for-the-treatment-of-mocd-type-a/)
03:07:44	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:44%20GMT	https://bridgebio.com/?p=1681	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index3f68.html	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-initiates-rolling-submission-of-new-drug-application-with-the-u-s-fda-for-bbp-870-for-the-treatment-of-mocd-type-a/)
03:07:44	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.96f.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-initiates-rolling-submission-of-new-drug-application-with-the-u-s-fda-for-bbp-870-for-the-treatment-of-mocd-type-a/)
03:07:44	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.970.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-initiates-rolling-submission-of-new-drug-application-with-the-u-s-fda-for-bbp-870-for-the-treatment-of-mocd-type-a/)
03:07:44	3174/3174	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:44%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-origin-biosciences-initiates-rolling-submission-of-new-drug-application-with-the-u-s-fda-for-bbp-870-for-the-treatment-of-mocd-type-a%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7e25	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-initiates-rolling-submission-of-new-drug-application-with-the-u-s-fda-for-bbp-870-for-the-treatment-of-mocd-type-a/)
03:07:44	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:45%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-initiates-rolling-submission-of-new-drug-application-with-the-u-s-fda-for-bbp-870-for-the-treatment-of-mocd-type-a/)
03:07:45	21457/21457	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:45%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1678	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1678.json	(from https://bridgebio.com/news/pellepharm-completes-enrollment-of-pivotal-phase-3-clinical-trial-of-patidegib-topical-gel-in-patients-with-gorlin-syndrome/)
03:07:46	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/pellepharm-completes-enrollment-of-pivotal-phase-3-clinical-trial-of-patidegib-topical-gel-in-patients-with-gorlin-syndrome/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/pellepharm-completes-enrollment-of-pivotal-phase-3-clinical-trial-of-patidegib-topical-gel-in-patients-with-gorlin-syndrome/feed/index.html	(from https://bridgebio.com/news/pellepharm-completes-enrollment-of-pivotal-phase-3-clinical-trial-of-patidegib-topical-gel-in-patients-with-gorlin-syndrome/)
03:07:46	2862/2862	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:46%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fpellepharm-completes-enrollment-of-pivotal-phase-3-clinical-trial-of-patidegib-topical-gel-in-patients-with-gorlin-syndrome%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed047e.json	(from https://bridgebio.com/news/pellepharm-completes-enrollment-of-pivotal-phase-3-clinical-trial-of-patidegib-topical-gel-in-patients-with-gorlin-syndrome/)
03:07:46	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:46%20GMT	https://bridgebio.com/?p=1678	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexae71.html	(from https://bridgebio.com/news/pellepharm-completes-enrollment-of-pivotal-phase-3-clinical-trial-of-patidegib-topical-gel-in-patients-with-gorlin-syndrome/)
03:07:47	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.975.delayed	(from https://bridgebio.com/news/pellepharm-completes-enrollment-of-pivotal-phase-3-clinical-trial-of-patidegib-topical-gel-in-patients-with-gorlin-syndrome/)
03:07:47	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.976.delayed	(from https://bridgebio.com/news/pellepharm-completes-enrollment-of-pivotal-phase-3-clinical-trial-of-patidegib-topical-gel-in-patients-with-gorlin-syndrome/)
03:07:47	3051/3051	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:47%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fpellepharm-completes-enrollment-of-pivotal-phase-3-clinical-trial-of-patidegib-topical-gel-in-patients-with-gorlin-syndrome%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeda240	(from https://bridgebio.com/news/pellepharm-completes-enrollment-of-pivotal-phase-3-clinical-trial-of-patidegib-topical-gel-in-patients-with-gorlin-syndrome/)
03:07:47	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:47%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/pellepharm-completes-enrollment-of-pivotal-phase-3-clinical-trial-of-patidegib-topical-gel-in-patients-with-gorlin-syndrome/)
03:07:48	15486/15486	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:48%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1672	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1672.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/)
03:07:48	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/)
03:07:48	2638/2638	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:48%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedaf3a.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/)
03:07:48	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:48%20GMT	https://bridgebio.com/?p=1672	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexa890.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/)
03:07:48	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.97b.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/)
03:07:49	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.97c.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/)
03:07:49	2829/2829	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:49%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeda80d	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/)
03:07:49	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:49%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/)
03:07:50	24391/24391	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:50%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1639	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1639.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2019-financial-results-and-highlights-portfolio-progress/)
03:07:50	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2019-financial-results-and-highlights-portfolio-progress/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2019-financial-results-and-highlights-portfolio-progress/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2019-financial-results-and-highlights-portfolio-progress/)
03:07:50	2710/2710	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:50%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-third-quarter-2019-financial-results-and-highlights-portfolio-progress%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd560.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2019-financial-results-and-highlights-portfolio-progress/)
03:07:50	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:50%20GMT	https://bridgebio.com/?p=1639	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexe38d.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2019-financial-results-and-highlights-portfolio-progress/)
03:07:51	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.981.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2019-financial-results-and-highlights-portfolio-progress/)
03:07:51	2899/2899	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:51%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-third-quarter-2019-financial-results-and-highlights-portfolio-progress%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed297a	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2019-financial-results-and-highlights-portfolio-progress/)
03:07:51	29164/29164	---M--	200	added ('OK')	image/jpeg	etag:%2266829bfb-88a8%22	https://bridgebio.com/wp-content/uploads/2019/11/Table-1-1024x193.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2019/11/Table-1-1024x193.jpg	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2019-financial-results-and-highlights-portfolio-progress/)
03:07:51	97266/97266	---M--	200	added ('OK')	image/jpeg	etag:%2266829bfc-19d57%22	https://bridgebio.com/wp-content/uploads/2019/11/Table-2.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2019/11/Table-2.jpg	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2019-financial-results-and-highlights-portfolio-progress/)
03:07:51	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.985.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2019-financial-results-and-highlights-portfolio-progress/)
03:07:52	151151/151151	---M--	200	added ('OK')	image/jpeg	etag:%2266829bfd-24e6f%22	https://bridgebio.com/wp-content/uploads/2019/11/Table-3-821x1024.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2019/11/Table-3-821x1024.jpg	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2019-financial-results-and-highlights-portfolio-progress/)
03:07:52	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:52%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-third-quarter-2019-financial-results-and-highlights-portfolio-progress/)
03:07:53	22028/22028	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:53%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1598	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1598.json	(from https://bridgebio.com/news/bridgebio-pharma-gene-therapy-subsidiaries-present-data-demonstrating-potential-in-two-rare-disease-indications/)
03:07:53	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-gene-therapy-subsidiaries-present-data-demonstrating-potential-in-two-rare-disease-indications/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-gene-therapy-subsidiaries-present-data-demonstrating-potential-in-two-rare-disease-indications/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-gene-therapy-subsidiaries-present-data-demonstrating-potential-in-two-rare-disease-indications/)
03:07:53	2930/2930	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:53%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-gene-therapy-subsidiaries-present-data-demonstrating-potential-in-two-rare-disease-indications%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed745b.json	(from https://bridgebio.com/news/bridgebio-pharma-gene-therapy-subsidiaries-present-data-demonstrating-potential-in-two-rare-disease-indications/)
03:07:54	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:54%20GMT	https://bridgebio.com/?p=1598	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index1c3e.html	(from https://bridgebio.com/news/bridgebio-pharma-gene-therapy-subsidiaries-present-data-demonstrating-potential-in-two-rare-disease-indications/)
03:07:54	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.98a.delayed	(from https://bridgebio.com/news/bridgebio-pharma-gene-therapy-subsidiaries-present-data-demonstrating-potential-in-two-rare-disease-indications/)
03:07:54	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.98b.delayed	(from https://bridgebio.com/news/bridgebio-pharma-gene-therapy-subsidiaries-present-data-demonstrating-potential-in-two-rare-disease-indications/)
03:07:54	3119/3119	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:54%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-gene-therapy-subsidiaries-present-data-demonstrating-potential-in-two-rare-disease-indications%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8d80	(from https://bridgebio.com/news/bridgebio-pharma-gene-therapy-subsidiaries-present-data-demonstrating-potential-in-two-rare-disease-indications/)
03:07:54	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:54%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-gene-therapy-subsidiaries-present-data-demonstrating-potential-in-two-rare-disease-indications/)
03:07:55	24433/24433	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:55%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1552	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1552.json	(from https://bridgebio.com/news/qed-and-parent-company-bridgebio-announce-preclinical-data-supporting-tolerability-and-activity-of-low-dose-infigratinib-in-treating-achondroplasia/)
03:07:55	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/qed-and-parent-company-bridgebio-announce-preclinical-data-supporting-tolerability-and-activity-of-low-dose-infigratinib-in-treating-achondroplasia/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/qed-and-parent-company-bridgebio-announce-precl/feed/index.html	(from https://bridgebio.com/news/qed-and-parent-company-bridgebio-announce-preclinical-data-supporting-tolerability-and-activity-of-low-dose-infigratinib-in-treating-achondroplasia/)
03:07:55	2945/2945	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:55%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fqed-and-parent-company-bridgebio-announce-preclinical-data-supporting-tolerability-and-activity-of-low-dose-infigratinib-in-treating-achondroplasia%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0375.json	(from https://bridgebio.com/news/qed-and-parent-company-bridgebio-announce-preclinical-data-supporting-tolerability-and-activity-of-low-dose-infigratinib-in-treating-achondroplasia/)
03:07:55	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:55%20GMT	https://bridgebio.com/?p=1552	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index348c.html	(from https://bridgebio.com/news/qed-and-parent-company-bridgebio-announce-preclinical-data-supporting-tolerability-and-activity-of-low-dose-infigratinib-in-treating-achondroplasia/)
03:07:56	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.990.delayed	(from https://bridgebio.com/news/qed-and-parent-company-bridgebio-announce-preclinical-data-supporting-tolerability-and-activity-of-low-dose-infigratinib-in-treating-achondroplasia/)
03:07:56	3134/3134	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:56%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fqed-and-parent-company-bridgebio-announce-preclinical-data-supporting-tolerability-and-activity-of-low-dose-infigratinib-in-treating-achondroplasia%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed317b	(from https://bridgebio.com/news/qed-and-parent-company-bridgebio-announce-preclinical-data-supporting-tolerability-and-activity-of-low-dose-infigratinib-in-treating-achondroplasia/)
03:07:56	12508/12508	---M--	200	added ('OK')	image/jpeg	etag:%2266829bfc-3698%22	https://bridgebio.com/wp-content/uploads/2019/10/figure1.jpg	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2019/10/figure1.jpg	(from https://bridgebio.com/news/qed-and-parent-company-bridgebio-announce-preclinical-data-supporting-tolerability-and-activity-of-low-dose-infigratinib-in-treating-achondroplasia/)
03:07:56	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.992.delayed	(from https://bridgebio.com/news/qed-and-parent-company-bridgebio-announce-preclinical-data-supporting-tolerability-and-activity-of-low-dose-infigratinib-in-treating-achondroplasia/)
03:07:56	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:56%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/qed-and-parent-company-bridgebio-announce-preclinical-data-supporting-tolerability-and-activity-of-low-dose-infigratinib-in-treating-achondroplasia/)
03:07:57	15801/15801	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:57%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1527	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1527.json	(from https://bridgebio.com/news/bridgebio-pharma-terminates-merger-process-with-its-subsidiary-eidos-therapeutics/)
03:07:57	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-terminates-merger-process-with-its-subsidiary-eidos-therapeutics/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-terminates-merger-process-with-its-subsidiary-eidos-therapeutics/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-terminates-merger-process-with-its-subsidiary-eidos-therapeutics/)
03:07:57	2686/2686	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:57%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-terminates-merger-process-with-its-subsidiary-eidos-therapeutics%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed28f8.json	(from https://bridgebio.com/news/bridgebio-pharma-terminates-merger-process-with-its-subsidiary-eidos-therapeutics/)
03:07:58	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:58%20GMT	https://bridgebio.com/?p=1527	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexb367.html	(from https://bridgebio.com/news/bridgebio-pharma-terminates-merger-process-with-its-subsidiary-eidos-therapeutics/)
03:07:58	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.997.delayed	(from https://bridgebio.com/news/bridgebio-pharma-terminates-merger-process-with-its-subsidiary-eidos-therapeutics/)
03:07:58	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.998.delayed	(from https://bridgebio.com/news/bridgebio-pharma-terminates-merger-process-with-its-subsidiary-eidos-therapeutics/)
03:07:58	2875/2875	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:07:58%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-terminates-merger-process-with-its-subsidiary-eidos-therapeutics%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8e18	(from https://bridgebio.com/news/bridgebio-pharma-terminates-merger-process-with-its-subsidiary-eidos-therapeutics/)
03:07:58	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:07:58%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-terminates-merger-process-with-its-subsidiary-eidos-therapeutics/)
03:07:59	20596/20596	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:59%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1509	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1509.json	(from https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-subsidiary-qed-therapeutics-announce-collaboration-to-advance-cancer-research-and-treatment-options/)
03:07:59	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-subsidiary-qed-therapeutics-announce-collaboration-to-advance-cancer-research-and-treatment-options/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-subsidiary-qed-therapeutics-announce-collaboration-to-advance-cancer-research-and-treatment-options/feed/index.html	(from https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-subsidiary-qed-therapeutics-announce-collaboration-to-advance-cancer-research-and-treatment-options/)
03:07:59	2911/2911	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:07:59%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fivy-brain-tumor-center-and-bridgebio-subsidiary-qed-therapeutics-announce-collaboration-to-advance-cancer-research-and-treatment-options%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embeda50c.json	(from https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-subsidiary-qed-therapeutics-announce-collaboration-to-advance-cancer-research-and-treatment-options/)
03:08:00	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:00%20GMT	https://bridgebio.com/?p=1509	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index9e5e.html	(from https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-subsidiary-qed-therapeutics-announce-collaboration-to-advance-cancer-research-and-treatment-options/)
03:08:00	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.99d.delayed	(from https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-subsidiary-qed-therapeutics-announce-collaboration-to-advance-cancer-research-and-treatment-options/)
03:08:00	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.99e.delayed	(from https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-subsidiary-qed-therapeutics-announce-collaboration-to-advance-cancer-research-and-treatment-options/)
03:08:00	3099/3099	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:00%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fivy-brain-tumor-center-and-bridgebio-subsidiary-qed-therapeutics-announce-collaboration-to-advance-cancer-research-and-treatment-options%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedbdb3	(from https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-subsidiary-qed-therapeutics-announce-collaboration-to-advance-cancer-research-and-treatment-options/)
03:08:00	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:00%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/ivy-brain-tumor-center-and-bridgebio-subsidiary-qed-therapeutics-announce-collaboration-to-advance-cancer-research-and-treatment-options/)
03:08:01	25229/25229	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:01%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1477	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1477.json	(from https://bridgebio.com/news/alexion-and-bridgebio-announce-japanese-license-agreement-for-eidos-transthyretin-amyloidosis-attr-investigational-medicine/)
03:08:01	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/alexion-and-bridgebio-announce-japanese-license-agreement-for-eidos-transthyretin-amyloidosis-attr-investigational-medicine/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/alexion-and-bridgebio-announce-japanese-license-agreement-for-eidos-transthyretin-amyloidosis-attr-investigational-medicine/feed/index.html	(from https://bridgebio.com/news/alexion-and-bridgebio-announce-japanese-license-agreement-for-eidos-transthyretin-amyloidosis-attr-investigational-medicine/)
03:08:01	2865/2865	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:01%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Falexion-and-bridgebio-announce-japanese-license-agreement-for-eidos-transthyretin-amyloidosis-attr-investigational-medicine%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedbacc.json	(from https://bridgebio.com/news/alexion-and-bridgebio-announce-japanese-license-agreement-for-eidos-transthyretin-amyloidosis-attr-investigational-medicine/)
03:08:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:01%20GMT	https://bridgebio.com/?p=1477	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index3d9b.html	(from https://bridgebio.com/news/alexion-and-bridgebio-announce-japanese-license-agreement-for-eidos-transthyretin-amyloidosis-attr-investigational-medicine/)
03:08:02	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.9a3.delayed	(from https://bridgebio.com/news/alexion-and-bridgebio-announce-japanese-license-agreement-for-eidos-transthyretin-amyloidosis-attr-investigational-medicine/)
03:08:02	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.9a4.delayed	(from https://bridgebio.com/news/alexion-and-bridgebio-announce-japanese-license-agreement-for-eidos-transthyretin-amyloidosis-attr-investigational-medicine/)
03:08:02	3062/3062	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:02%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Falexion-and-bridgebio-announce-japanese-license-agreement-for-eidos-transthyretin-amyloidosis-attr-investigational-medicine%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed610f	(from https://bridgebio.com/news/alexion-and-bridgebio-announce-japanese-license-agreement-for-eidos-transthyretin-amyloidosis-attr-investigational-medicine/)
03:08:02	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:02%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/alexion-and-bridgebio-announce-japanese-license-agreement-for-eidos-transthyretin-amyloidosis-attr-investigational-medicine/)
03:08:02	23253/23253	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:03%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1455	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1455.json	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-presents-new-data-on-the-natural-history-of-molybdenum-cofactor-deficiency-mocd-type-a/)
03:08:03	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-presents-new-data-on-the-natural-history-of-molybdenum-cofactor-deficiency-mocd-type-a/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharmas-origin-biosciences-presents-new-data-on-the-natural-history-of-molybdenum-cofactor-deficiency-mocd-type-a/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-presents-new-data-on-the-natural-history-of-molybdenum-cofactor-deficiency-mocd-type-a/)
03:08:03	2994/2994	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:03%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-origin-biosciences-presents-new-data-on-the-natural-history-of-molybdenum-cofactor-deficiency-mocd-type-a%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed3f9e.json	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-presents-new-data-on-the-natural-history-of-molybdenum-cofactor-deficiency-mocd-type-a/)
03:08:03	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:03%20GMT	https://bridgebio.com/?p=1455	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexe11a.html	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-presents-new-data-on-the-natural-history-of-molybdenum-cofactor-deficiency-mocd-type-a/)
03:08:03	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.9a9.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-presents-new-data-on-the-natural-history-of-molybdenum-cofactor-deficiency-mocd-type-a/)
03:08:03	3187/3187	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:04%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharmas-origin-biosciences-presents-new-data-on-the-natural-history-of-molybdenum-cofactor-deficiency-mocd-type-a%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedabdc	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-presents-new-data-on-the-natural-history-of-molybdenum-cofactor-deficiency-mocd-type-a/)
03:08:04	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.9ab.delayed	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-presents-new-data-on-the-natural-history-of-molybdenum-cofactor-deficiency-mocd-type-a/)
03:08:04	71495/71495	---M--	200	added ('OK')	image/png	etag:%2266829bfc-181d0%22	https://bridgebio.com/wp-content/uploads/2019/09/image.png	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/uploads/2019/09/image.png	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-presents-new-data-on-the-natural-history-of-molybdenum-cofactor-deficiency-mocd-type-a/)
03:08:04	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:04%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharmas-origin-biosciences-presents-new-data-on-the-natural-history-of-molybdenum-cofactor-deficiency-mocd-type-a/)
03:08:05	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-expands-its-research-into-neuromuscular-disease-to-include-limb-girdle-muscular-dystrophy-type-2-lgmd2i-with-new-subsidiary-ml-bio-solutions/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-expands-its-research-into-neur/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-expands-its-research-into-neuromuscular-disease-to-include-limb-girdle-muscular-dystrophy-type-2-lgmd2i-with-new-subsidiary-ml-bio-solutions/)
03:08:05	20228/20228	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:05%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1449	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1449.json	(from https://bridgebio.com/news/bridgebio-pharma-expands-its-research-into-neuromuscular-disease-to-include-limb-girdle-muscular-dystrophy-type-2-lgmd2i-with-new-subsidiary-ml-bio-solutions/)
03:08:05	2993/2993	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:05%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-expands-its-research-into-neuromuscular-disease-to-include-limb-girdle-muscular-dystrophy-type-2-lgmd2i-with-new-subsidiary-ml-bio-solutions%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf84c.json	(from https://bridgebio.com/news/bridgebio-pharma-expands-its-research-into-neuromuscular-disease-to-include-limb-girdle-muscular-dystrophy-type-2-lgmd2i-with-new-subsidiary-ml-bio-solutions/)
03:08:06	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:06%20GMT	https://bridgebio.com/?p=1449	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexd699.html	(from https://bridgebio.com/news/bridgebio-pharma-expands-its-research-into-neuromuscular-disease-to-include-limb-girdle-muscular-dystrophy-type-2-lgmd2i-with-new-subsidiary-ml-bio-solutions/)
03:08:06	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.9b0.delayed	(from https://bridgebio.com/news/bridgebio-pharma-expands-its-research-into-neuromuscular-disease-to-include-limb-girdle-muscular-dystrophy-type-2-lgmd2i-with-new-subsidiary-ml-bio-solutions/)
03:08:06	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.9b1.delayed	(from https://bridgebio.com/news/bridgebio-pharma-expands-its-research-into-neuromuscular-disease-to-include-limb-girdle-muscular-dystrophy-type-2-lgmd2i-with-new-subsidiary-ml-bio-solutions/)
03:08:06	3182/3182	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:06%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-expands-its-research-into-neuromuscular-disease-to-include-limb-girdle-muscular-dystrophy-type-2-lgmd2i-with-new-subsidiary-ml-bio-solutions%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed25f7	(from https://bridgebio.com/news/bridgebio-pharma-expands-its-research-into-neuromuscular-disease-to-include-limb-girdle-muscular-dystrophy-type-2-lgmd2i-with-new-subsidiary-ml-bio-solutions/)
03:08:06	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:06%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-expands-its-research-into-neuromuscular-disease-to-include-limb-girdle-muscular-dystrophy-type-2-lgmd2i-with-new-subsidiary-ml-bio-solutions/)
03:08:07	14329/14329	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:07%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1365	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1365.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-its-initial-public-offering/)
03:08:07	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-its-initial-public-offering/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-pricing-of-its-initial-public-offering/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-its-initial-public-offering/)
03:08:07	2613/2613	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:07%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-pricing-of-its-initial-public-offering%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0575.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-its-initial-public-offering/)
03:08:08	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:08%20GMT	https://bridgebio.com/?p=1365	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index4c94.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-its-initial-public-offering/)
03:08:08	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.9b6.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-its-initial-public-offering/)
03:08:08	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.9b7.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-its-initial-public-offering/)
03:08:08	2802/2802	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:08%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-pricing-of-its-initial-public-offering%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1538	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-its-initial-public-offering/)
03:08:08	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:08%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-pricing-of-its-initial-public-offering/)
03:08:09	16075/16075	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:09%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1323	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1323.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-filing-of-registration-statement-for-proposed-initial-public-offering/)
03:08:09	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-announces-filing-of-registration-statement-for-proposed-initial-public-offering/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-announces-filing-of-registration-statement-for-proposed-initial-public-offering/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-filing-of-registration-statement-for-proposed-initial-public-offering/)
03:08:09	2744/2744	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:09%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-filing-of-registration-statement-for-proposed-initial-public-offering%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede761.json	(from https://bridgebio.com/news/bridgebio-pharma-announces-filing-of-registration-statement-for-proposed-initial-public-offering/)
03:08:09	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:09%20GMT	https://bridgebio.com/?p=1323	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexcd93.html	(from https://bridgebio.com/news/bridgebio-pharma-announces-filing-of-registration-statement-for-proposed-initial-public-offering/)
03:08:10	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.9bc.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-filing-of-registration-statement-for-proposed-initial-public-offering/)
03:08:10	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.9bd.delayed	(from https://bridgebio.com/news/bridgebio-pharma-announces-filing-of-registration-statement-for-proposed-initial-public-offering/)
03:08:10	2933/2933	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:10%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-announces-filing-of-registration-statement-for-proposed-initial-public-offering%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedad93	(from https://bridgebio.com/news/bridgebio-pharma-announces-filing-of-registration-statement-for-proposed-initial-public-offering/)
03:08:10	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:10%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-announces-filing-of-registration-statement-for-proposed-initial-public-offering/)
03:08:11	23197/23197	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:11%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1179	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1179.json	(from https://bridgebio.com/news/eidos-therapeutics-initiates-attribute-cm-a-phase-3-study-of-ag10-in-attr-cm-with-registrational-12-month-endpoint/)
03:08:11	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/eidos-therapeutics-initiates-attribute-cm-a-phase-3-study-of-ag10-in-attr-cm-with-registrational-12-month-endpoint/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-initiates-attribute-cm-a-phase-3-study-of-ag10-in-attr-cm-with-registrational-12-month-endpoint/feed/index.html	(from https://bridgebio.com/news/eidos-therapeutics-initiates-attribute-cm-a-phase-3-study-of-ag10-in-attr-cm-with-registrational-12-month-endpoint/)
03:08:11	2812/2812	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:11%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-initiates-attribute-cm-a-phase-3-study-of-ag10-in-attr-cm-with-registrational-12-month-endpoint%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedfdc7.json	(from https://bridgebio.com/news/eidos-therapeutics-initiates-attribute-cm-a-phase-3-study-of-ag10-in-attr-cm-with-registrational-12-month-endpoint/)
03:08:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:11%20GMT	https://bridgebio.com/?p=1179	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index1b15.html	(from https://bridgebio.com/news/eidos-therapeutics-initiates-attribute-cm-a-phase-3-study-of-ag10-in-attr-cm-with-registrational-12-month-endpoint/)
03:08:12	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.9c2.delayed	(from https://bridgebio.com/news/eidos-therapeutics-initiates-attribute-cm-a-phase-3-study-of-ag10-in-attr-cm-with-registrational-12-month-endpoint/)
03:08:12	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.9c3.delayed	(from https://bridgebio.com/news/eidos-therapeutics-initiates-attribute-cm-a-phase-3-study-of-ag10-in-attr-cm-with-registrational-12-month-endpoint/)
03:08:12	3001/3001	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:12%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-initiates-attribute-cm-a-phase-3-study-of-ag10-in-attr-cm-with-registrational-12-month-endpoint%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0fe7	(from https://bridgebio.com/news/eidos-therapeutics-initiates-attribute-cm-a-phase-3-study-of-ag10-in-attr-cm-with-registrational-12-month-endpoint/)
03:08:12	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:12%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/eidos-therapeutics-initiates-attribute-cm-a-phase-3-study-of-ag10-in-attr-cm-with-registrational-12-month-endpoint/)
03:08:13	20790/20790	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:13%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/1007	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/1007.json	(from https://bridgebio.com/news/phoenix-tissue-repair-doses-first-patient-in-phase-1-2-clinical-trial-of-ptr-01-bbp-589-for-treatment-of-recessive-dystrophic-epidermolysis-bullosa-rdeb/)
03:08:13	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/phoenix-tissue-repair-doses-first-patient-in-phase-1-2-clinical-trial-of-ptr-01-bbp-589-for-treatment-of-recessive-dystrophic-epidermolysis-bullosa-rdeb/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/phoenix-tissue-repair-doses-first-patient-in-ph/feed/index.html	(from https://bridgebio.com/news/phoenix-tissue-repair-doses-first-patient-in-phase-1-2-clinical-trial-of-ptr-01-bbp-589-for-treatment-of-recessive-dystrophic-epidermolysis-bullosa-rdeb/)
03:08:13	2987/2987	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:13%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fphoenix-tissue-repair-doses-first-patient-in-phase-1-2-clinical-trial-of-ptr-01-bbp-589-for-treatment-of-recessive-dystrophic-epidermolysis-bullosa-rdeb%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed03b7.json	(from https://bridgebio.com/news/phoenix-tissue-repair-doses-first-patient-in-phase-1-2-clinical-trial-of-ptr-01-bbp-589-for-treatment-of-recessive-dystrophic-epidermolysis-bullosa-rdeb/)
03:08:13	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:13%20GMT	https://bridgebio.com/?p=1007	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index65c1.html	(from https://bridgebio.com/news/phoenix-tissue-repair-doses-first-patient-in-phase-1-2-clinical-trial-of-ptr-01-bbp-589-for-treatment-of-recessive-dystrophic-epidermolysis-bullosa-rdeb/)
03:08:14	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.9c8.delayed	(from https://bridgebio.com/news/phoenix-tissue-repair-doses-first-patient-in-phase-1-2-clinical-trial-of-ptr-01-bbp-589-for-treatment-of-recessive-dystrophic-epidermolysis-bullosa-rdeb/)
03:08:14	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.9c9.delayed	(from https://bridgebio.com/news/phoenix-tissue-repair-doses-first-patient-in-phase-1-2-clinical-trial-of-ptr-01-bbp-589-for-treatment-of-recessive-dystrophic-epidermolysis-bullosa-rdeb/)
03:08:14	3172/3172	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:14%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fphoenix-tissue-repair-doses-first-patient-in-phase-1-2-clinical-trial-of-ptr-01-bbp-589-for-treatment-of-recessive-dystrophic-epidermolysis-bullosa-rdeb%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed89d2	(from https://bridgebio.com/news/phoenix-tissue-repair-doses-first-patient-in-phase-1-2-clinical-trial-of-ptr-01-bbp-589-for-treatment-of-recessive-dystrophic-epidermolysis-bullosa-rdeb/)
03:08:14	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:14%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/phoenix-tissue-repair-doses-first-patient-in-phase-1-2-clinical-trial-of-ptr-01-bbp-589-for-treatment-of-recessive-dystrophic-epidermolysis-bullosa-rdeb/)
03:08:14	17605/17605	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:15%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/838	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/838.json	(from https://bridgebio.com/news/bridgebio-pharma-closes-299-2-million-financing-round-to-support-its-efforts-to-target-genetic-disease-at-the-source/)
03:08:15	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-closes-299-2-million-financing-round-to-support-its-efforts-to-target-genetic-disease-at-the-source/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-closes-299-2-million-financing-round-to-support-its-efforts-to-target-genetic-disease-at-the-source/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-closes-299-2-million-financing-round-to-support-its-efforts-to-target-genetic-disease-at-the-source/)
03:08:15	2827/2827	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:15%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-closes-299-2-million-financing-round-to-support-its-efforts-to-target-genetic-disease-at-the-source%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed6ca6.json	(from https://bridgebio.com/news/bridgebio-pharma-closes-299-2-million-financing-round-to-support-its-efforts-to-target-genetic-disease-at-the-source/)
03:08:15	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:15%20GMT	https://bridgebio.com/?p=838	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexec9a.html	(from https://bridgebio.com/news/bridgebio-pharma-closes-299-2-million-financing-round-to-support-its-efforts-to-target-genetic-disease-at-the-source/)
03:08:15	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.9ce.delayed	(from https://bridgebio.com/news/bridgebio-pharma-closes-299-2-million-financing-round-to-support-its-efforts-to-target-genetic-disease-at-the-source/)
03:08:15	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.9cf.delayed	(from https://bridgebio.com/news/bridgebio-pharma-closes-299-2-million-financing-round-to-support-its-efforts-to-target-genetic-disease-at-the-source/)
03:08:15	3016/3016	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:15%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-closes-299-2-million-financing-round-to-support-its-efforts-to-target-genetic-disease-at-the-source%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb053	(from https://bridgebio.com/news/bridgebio-pharma-closes-299-2-million-financing-round-to-support-its-efforts-to-target-genetic-disease-at-the-source/)
03:08:16	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:16%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-closes-299-2-million-financing-round-to-support-its-efforts-to-target-genetic-disease-at-the-source/)
03:08:16	14063/14063	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:16%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/206	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/206.json	(from https://bridgebio.com/news/qed-therapeutics-announces-a-collaboration-with-foundation-medicine-to-develop-companion-diagnostics-for-infigratinib/)
03:08:17	2818/2818	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:17%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fqed-therapeutics-announces-a-collaboration-with-foundation-medicine-to-develop-companion-diagnostics-for-infigratinib%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed47e7.json	(from https://bridgebio.com/news/qed-therapeutics-announces-a-collaboration-with-foundation-medicine-to-develop-companion-diagnostics-for-infigratinib/)
03:08:17	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/qed-therapeutics-announces-a-collaboration-with-foundation-medicine-to-develop-companion-diagnostics-for-infigratinib/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/qed-therapeutics-announces-a-collaboration-with-foundation-medicine-to-develop-companion-diagnostics-for-infigratinib/feed/index.html	(from https://bridgebio.com/news/qed-therapeutics-announces-a-collaboration-with-foundation-medicine-to-develop-companion-diagnostics-for-infigratinib/)
03:08:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:17%20GMT	https://bridgebio.com/?p=206	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index1e11.html	(from https://bridgebio.com/news/qed-therapeutics-announces-a-collaboration-with-foundation-medicine-to-develop-companion-diagnostics-for-infigratinib/)
03:08:18	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.9d4.delayed	(from https://bridgebio.com/news/qed-therapeutics-announces-a-collaboration-with-foundation-medicine-to-develop-companion-diagnostics-for-infigratinib/)
03:08:18	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.9d5.delayed	(from https://bridgebio.com/news/qed-therapeutics-announces-a-collaboration-with-foundation-medicine-to-develop-companion-diagnostics-for-infigratinib/)
03:08:18	3007/3007	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:18%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fqed-therapeutics-announces-a-collaboration-with-foundation-medicine-to-develop-companion-diagnostics-for-infigratinib%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd9d0	(from https://bridgebio.com/news/qed-therapeutics-announces-a-collaboration-with-foundation-medicine-to-develop-companion-diagnostics-for-infigratinib/)
03:08:18	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:18%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/qed-therapeutics-announces-a-collaboration-with-foundation-medicine-to-develop-companion-diagnostics-for-infigratinib/)
03:08:19	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734503940	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style057d.css	(from https://bridgebio.com/news/eidos-therapeutics-appoints-william-lis-to-board-of-directors/)
03:08:19	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734503940	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css057d.css	(from https://bridgebio.com/news/eidos-therapeutics-appoints-william-lis-to-board-of-directors/)
03:08:19	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734503940	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust057d.css	(from https://bridgebio.com/news/eidos-therapeutics-appoints-william-lis-to-board-of-directors/)
03:08:19	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/eidos-therapeutics-appoints-william-lis-to-board-of-directors/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-appoints-william-lis-to-board-of-directors/feed/index.html	(from https://bridgebio.com/news/eidos-therapeutics-appoints-william-lis-to-board-of-directors/)
03:08:19	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734503940	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts057d.js	(from https://bridgebio.com/news/eidos-therapeutics-appoints-william-lis-to-board-of-directors/)
03:08:19	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734503940	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal057d.js	(from https://bridgebio.com/news/eidos-therapeutics-appoints-william-lis-to-board-of-directors/)
03:08:20	22023/22023	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:20%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/69	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/69.json	(from https://bridgebio.com/news/eidos-therapeutics-appoints-william-lis-to-board-of-directors/)
03:08:20	2608/2608	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:20%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-appoints-william-lis-to-board-of-directors%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf692.json	(from https://bridgebio.com/news/eidos-therapeutics-appoints-william-lis-to-board-of-directors/)
03:08:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:21%20GMT	https://bridgebio.com/?p=69	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexe2dc.html	(from https://bridgebio.com/news/eidos-therapeutics-appoints-william-lis-to-board-of-directors/)
03:08:21	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.9df.delayed	(from https://bridgebio.com/news/eidos-therapeutics-appoints-william-lis-to-board-of-directors/)
03:08:21	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.9e0.delayed	(from https://bridgebio.com/news/eidos-therapeutics-appoints-william-lis-to-board-of-directors/)
03:08:21	2799/2799	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:21%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-appoints-william-lis-to-board-of-directors%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8896	(from https://bridgebio.com/news/eidos-therapeutics-appoints-william-lis-to-board-of-directors/)
03:08:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:21%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/eidos-therapeutics-appoints-william-lis-to-board-of-directors/)
03:08:22	22761/22761	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:22%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/166	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/166.json	(from https://bridgebio.com/news/leo-pharma-and-pellepharm-announce-760-million-collaboration-to-advance-innovative-therapies-for-rare-skin-diseases/)
03:08:22	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/leo-pharma-and-pellepharm-announce-760-million-collaboration-to-advance-innovative-therapies-for-rare-skin-diseases/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/leo-pharma-and-pellepharm-announce-760-million-collaboration-to-advance-innovative-therapies-for-rare-skin-diseases/feed/index.html	(from https://bridgebio.com/news/leo-pharma-and-pellepharm-announce-760-million-collaboration-to-advance-innovative-therapies-for-rare-skin-diseases/)
03:08:22	2809/2809	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:22%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fleo-pharma-and-pellepharm-announce-760-million-collaboration-to-advance-innovative-therapies-for-rare-skin-diseases%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf7ed.json	(from https://bridgebio.com/news/leo-pharma-and-pellepharm-announce-760-million-collaboration-to-advance-innovative-therapies-for-rare-skin-diseases/)
03:08:22	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:22%20GMT	https://bridgebio.com/?p=166	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index8e01.html	(from https://bridgebio.com/news/leo-pharma-and-pellepharm-announce-760-million-collaboration-to-advance-innovative-therapies-for-rare-skin-diseases/)
03:08:23	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.9e5.delayed	(from https://bridgebio.com/news/leo-pharma-and-pellepharm-announce-760-million-collaboration-to-advance-innovative-therapies-for-rare-skin-diseases/)
03:08:23	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.9e6.delayed	(from https://bridgebio.com/news/leo-pharma-and-pellepharm-announce-760-million-collaboration-to-advance-innovative-therapies-for-rare-skin-diseases/)
03:08:23	3002/3002	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:23%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fleo-pharma-and-pellepharm-announce-760-million-collaboration-to-advance-innovative-therapies-for-rare-skin-diseases%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed633d	(from https://bridgebio.com/news/leo-pharma-and-pellepharm-announce-760-million-collaboration-to-advance-innovative-therapies-for-rare-skin-diseases/)
03:08:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:23%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/leo-pharma-and-pellepharm-announce-760-million-collaboration-to-advance-innovative-therapies-for-rare-skin-diseases/)
03:08:24	16084/16084	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:24%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/146	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/146.json	(from https://bridgebio.com/news/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics/)
03:08:24	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics/)
03:08:24	2940/2940	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:24%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede0c4.json	(from https://bridgebio.com/news/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics/)
03:08:24	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:24%20GMT	https://bridgebio.com/?p=146	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexf488.html	(from https://bridgebio.com/news/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics/)
03:08:24	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.9eb.delayed	(from https://bridgebio.com/news/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics/)
03:08:25	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.9ec.delayed	(from https://bridgebio.com/news/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics/)
03:08:25	3137/3137	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:25%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb479	(from https://bridgebio.com/news/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics/)
03:08:25	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:25%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-llc-signs-joint-collaboration-agreement-with-cincinnati-childrens-to-accelerate-development-of-genetic-disease-therapeutics/)
03:08:25	23558/23558	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:26%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/70	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/70.json	(from https://bridgebio.com/news/eidos-therapeutics-announces-positive-phase-2-data-for-ag10-in-symptomatic-patients-with-mutant-or-wild-type-ttr-amyloid-cardiomyopathy/)
03:08:26	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/eidos-therapeutics-announces-positive-phase-2-data-for-ag10-in-symptomatic-patients-with-mutant-or-wild-type-ttr-amyloid-cardiomyopathy/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-announces-positive-phase-2-data-for-ag10-in-symptomatic-patients-with-mutant-or-wild-type-ttr-amyloid-cardiomyopathy/feed/index.html	(from https://bridgebio.com/news/eidos-therapeutics-announces-positive-phase-2-data-for-ag10-in-symptomatic-patients-with-mutant-or-wild-type-ttr-amyloid-cardiomyopathy/)
03:08:26	2868/2868	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:26%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-announces-positive-phase-2-data-for-ag10-in-symptomatic-patients-with-mutant-or-wild-type-ttr-amyloid-cardiomyopathy%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed643e.json	(from https://bridgebio.com/news/eidos-therapeutics-announces-positive-phase-2-data-for-ag10-in-symptomatic-patients-with-mutant-or-wild-type-ttr-amyloid-cardiomyopathy/)
03:08:26	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:26%20GMT	https://bridgebio.com/?p=70	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index3f3a.html	(from https://bridgebio.com/news/eidos-therapeutics-announces-positive-phase-2-data-for-ag10-in-symptomatic-patients-with-mutant-or-wild-type-ttr-amyloid-cardiomyopathy/)
03:08:26	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.9f1.delayed	(from https://bridgebio.com/news/eidos-therapeutics-announces-positive-phase-2-data-for-ag10-in-symptomatic-patients-with-mutant-or-wild-type-ttr-amyloid-cardiomyopathy/)
03:08:26	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.9f2.delayed	(from https://bridgebio.com/news/eidos-therapeutics-announces-positive-phase-2-data-for-ag10-in-symptomatic-patients-with-mutant-or-wild-type-ttr-amyloid-cardiomyopathy/)
03:08:26	3057/3057	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:26%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-announces-positive-phase-2-data-for-ag10-in-symptomatic-patients-with-mutant-or-wild-type-ttr-amyloid-cardiomyopathy%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed89a5	(from https://bridgebio.com/news/eidos-therapeutics-announces-positive-phase-2-data-for-ag10-in-symptomatic-patients-with-mutant-or-wild-type-ttr-amyloid-cardiomyopathy/)
03:08:27	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:27%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/eidos-therapeutics-announces-positive-phase-2-data-for-ag10-in-symptomatic-patients-with-mutant-or-wild-type-ttr-amyloid-cardiomyopathy/)
03:08:27	19256/19256	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:27%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/81	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/81.json	(from https://bridgebio.com/news/eidos-therapeutics-receives-positive-opinion-for-orphan-designation/)
03:08:28	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/eidos-therapeutics-receives-positive-opinion-for-orphan-designation/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-receives-positive-opinion-for-orphan-designation/feed/index.html	(from https://bridgebio.com/news/eidos-therapeutics-receives-positive-opinion-for-orphan-designation/)
03:08:28	2873/2873	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:28%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-receives-positive-opinion-for-orphan-designation%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9279.json	(from https://bridgebio.com/news/eidos-therapeutics-receives-positive-opinion-for-orphan-designation/)
03:08:28	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:28%20GMT	https://bridgebio.com/?p=81	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index44d0.html	(from https://bridgebio.com/news/eidos-therapeutics-receives-positive-opinion-for-orphan-designation/)
03:08:28	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.9f7.delayed	(from https://bridgebio.com/news/eidos-therapeutics-receives-positive-opinion-for-orphan-designation/)
03:08:28	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.9f8.delayed	(from https://bridgebio.com/news/eidos-therapeutics-receives-positive-opinion-for-orphan-designation/)
03:08:28	3064/3064	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:28%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-receives-positive-opinion-for-orphan-designation%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd5a9	(from https://bridgebio.com/news/eidos-therapeutics-receives-positive-opinion-for-orphan-designation/)
03:08:28	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:28%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/eidos-therapeutics-receives-positive-opinion-for-orphan-designation/)
03:08:29	17860/17860	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:29%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/163	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/163.json	(from https://bridgebio.com/news/data-published-in-nature-communications-demonstrates-coa-therapeutics-potential-to-treat-genetically-driven-pantothenate-kinase-associated-neurodegeneration-pkan/)
03:08:29	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/data-published-in-nature-communications-demonstrates-coa-therapeutics-potential-to-treat-genetically-driven-pantothenate-kinase-associated-neurodegeneration-pkan/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/data-published-in-nature-communications-demonst/feed/index.html	(from https://bridgebio.com/news/data-published-in-nature-communications-demonstrates-coa-therapeutics-potential-to-treat-genetically-driven-pantothenate-kinase-associated-neurodegeneration-pkan/)
03:08:29	3024/3024	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:29%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fdata-published-in-nature-communications-demonstrates-coa-therapeutics-potential-to-treat-genetically-driven-pantothenate-kinase-associated-neurodegeneration-pkan%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed685a.json	(from https://bridgebio.com/news/data-published-in-nature-communications-demonstrates-coa-therapeutics-potential-to-treat-genetically-driven-pantothenate-kinase-associated-neurodegeneration-pkan/)
03:08:30	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:30%20GMT	https://bridgebio.com/?p=163	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index4034.html	(from https://bridgebio.com/news/data-published-in-nature-communications-demonstrates-coa-therapeutics-potential-to-treat-genetically-driven-pantothenate-kinase-associated-neurodegeneration-pkan/)
03:08:30	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.9fd.delayed	(from https://bridgebio.com/news/data-published-in-nature-communications-demonstrates-coa-therapeutics-potential-to-treat-genetically-driven-pantothenate-kinase-associated-neurodegeneration-pkan/)
03:08:30	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.9fe.delayed	(from https://bridgebio.com/news/data-published-in-nature-communications-demonstrates-coa-therapeutics-potential-to-treat-genetically-driven-pantothenate-kinase-associated-neurodegeneration-pkan/)
03:08:30	3217/3217	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:30%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fdata-published-in-nature-communications-demonstrates-coa-therapeutics-potential-to-treat-genetically-driven-pantothenate-kinase-associated-neurodegeneration-pkan%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0793	(from https://bridgebio.com/news/data-published-in-nature-communications-demonstrates-coa-therapeutics-potential-to-treat-genetically-driven-pantothenate-kinase-associated-neurodegeneration-pkan/)
03:08:30	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:30%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/data-published-in-nature-communications-demonstrates-coa-therapeutics-potential-to-treat-genetically-driven-pantothenate-kinase-associated-neurodegeneration-pkan/)
03:08:31	17097/17097	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:31%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/207	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/207.json	(from https://bridgebio.com/news/qed-therapeutics-presents-data-for-infigratinib-in-cholangiocarcinoma-in-late-breaking-abstract-at-the-european-society-of-medical-oncology-2018-congress/)
03:08:31	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/qed-therapeutics-presents-data-for-infigratinib-in-cholangiocarcinoma-in-late-breaking-abstract-at-the-european-society-of-medical-oncology-2018-congress/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/qed-therapeutics-presents-data-for-infigratinib/feed/index.html	(from https://bridgebio.com/news/qed-therapeutics-presents-data-for-infigratinib-in-cholangiocarcinoma-in-late-breaking-abstract-at-the-european-society-of-medical-oncology-2018-congress/)
03:08:31	2956/2956	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:31%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fqed-therapeutics-presents-data-for-infigratinib-in-cholangiocarcinoma-in-late-breaking-abstract-at-the-european-society-of-medical-oncology-2018-congress%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2901.json	(from https://bridgebio.com/news/qed-therapeutics-presents-data-for-infigratinib-in-cholangiocarcinoma-in-late-breaking-abstract-at-the-european-society-of-medical-oncology-2018-congress/)
03:08:32	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:32%20GMT	https://bridgebio.com/?p=207	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexeb91.html	(from https://bridgebio.com/news/qed-therapeutics-presents-data-for-infigratinib-in-cholangiocarcinoma-in-late-breaking-abstract-at-the-european-society-of-medical-oncology-2018-congress/)
03:08:32	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a03.delayed	(from https://bridgebio.com/news/qed-therapeutics-presents-data-for-infigratinib-in-cholangiocarcinoma-in-late-breaking-abstract-at-the-european-society-of-medical-oncology-2018-congress/)
03:08:32	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a04.delayed	(from https://bridgebio.com/news/qed-therapeutics-presents-data-for-infigratinib-in-cholangiocarcinoma-in-late-breaking-abstract-at-the-european-society-of-medical-oncology-2018-congress/)
03:08:32	3145/3145	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:32%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fqed-therapeutics-presents-data-for-infigratinib-in-cholangiocarcinoma-in-late-breaking-abstract-at-the-european-society-of-medical-oncology-2018-congress%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed75e5	(from https://bridgebio.com/news/qed-therapeutics-presents-data-for-infigratinib-in-cholangiocarcinoma-in-late-breaking-abstract-at-the-european-society-of-medical-oncology-2018-congress/)
03:08:32	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:32%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/qed-therapeutics-presents-data-for-infigratinib-in-cholangiocarcinoma-in-late-breaking-abstract-at-the-european-society-of-medical-oncology-2018-congress/)
03:08:33	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/pellepharm-presents-updated-data-from-two-phase-2-studies/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/pellepharm-presents-updated-data-from-two-phase-2-studies/feed/index.html	(from https://bridgebio.com/news/pellepharm-presents-updated-data-from-two-phase-2-studies/)
03:08:33	18711/18711	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:33%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/167	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/167.json	(from https://bridgebio.com/news/pellepharm-presents-updated-data-from-two-phase-2-studies/)
03:08:33	2909/2909	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:33%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fpellepharm-presents-updated-data-from-two-phase-2-studies%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2aa1.json	(from https://bridgebio.com/news/pellepharm-presents-updated-data-from-two-phase-2-studies/)
03:08:33	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:33%20GMT	https://bridgebio.com/?p=167	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index3350.html	(from https://bridgebio.com/news/pellepharm-presents-updated-data-from-two-phase-2-studies/)
03:08:34	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a09.delayed	(from https://bridgebio.com/news/pellepharm-presents-updated-data-from-two-phase-2-studies/)
03:08:34	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a0a.delayed	(from https://bridgebio.com/news/pellepharm-presents-updated-data-from-two-phase-2-studies/)
03:08:34	3100/3100	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:34%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fpellepharm-presents-updated-data-from-two-phase-2-studies%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9bab	(from https://bridgebio.com/news/pellepharm-presents-updated-data-from-two-phase-2-studies/)
03:08:34	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:34%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/pellepharm-presents-updated-data-from-two-phase-2-studies/)
03:08:35	14914/14914	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:35%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/82	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/82.json	(from https://bridgebio.com/news/eidos-therapeutics-to-present-phase-2-data-for-ag10-in-ttr-amyloidosis-cardiomyopathy/)
03:08:35	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/eidos-therapeutics-to-present-phase-2-data-for-ag10-in-ttr-amyloidosis-cardiomyopathy/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-to-present-phase-2-data-for-ag10-in-ttr-amyloidosis-cardiomyopathy/feed/index.html	(from https://bridgebio.com/news/eidos-therapeutics-to-present-phase-2-data-for-ag10-in-ttr-amyloidosis-cardiomyopathy/)
03:08:35	2880/2880	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:35%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-to-present-phase-2-data-for-ag10-in-ttr-amyloidosis-cardiomyopathy%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedbf83.json	(from https://bridgebio.com/news/eidos-therapeutics-to-present-phase-2-data-for-ag10-in-ttr-amyloidosis-cardiomyopathy/)
03:08:35	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:35%20GMT	https://bridgebio.com/?p=82	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index287b.html	(from https://bridgebio.com/news/eidos-therapeutics-to-present-phase-2-data-for-ag10-in-ttr-amyloidosis-cardiomyopathy/)
03:08:35	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a0f.delayed	(from https://bridgebio.com/news/eidos-therapeutics-to-present-phase-2-data-for-ag10-in-ttr-amyloidosis-cardiomyopathy/)
03:08:35	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a10.delayed	(from https://bridgebio.com/news/eidos-therapeutics-to-present-phase-2-data-for-ag10-in-ttr-amyloidosis-cardiomyopathy/)
03:08:36	3071/3071	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:36%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-to-present-phase-2-data-for-ag10-in-ttr-amyloidosis-cardiomyopathy%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8539	(from https://bridgebio.com/news/eidos-therapeutics-to-present-phase-2-data-for-ag10-in-ttr-amyloidosis-cardiomyopathy/)
03:08:36	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:36%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/eidos-therapeutics-to-present-phase-2-data-for-ag10-in-ttr-amyloidosis-cardiomyopathy/)
03:08:36	19425/19425	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:37%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/83	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/83.json	(from https://bridgebio.com/news/fda-grants-orphan-drug-designation-to-eidos-therapeutics-product-candidate-ag10-for-treatment-of-transthyretin-amyloidosis/)
03:08:37	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/fda-grants-orphan-drug-designation-to-eidos-therapeutics-product-candidate-ag10-for-treatment-of-transthyretin-amyloidosis/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/fda-grants-orphan-drug-designation-to-eidos-therapeutics-product-candidate-ag10-for-treatment-of-transthyretin-amyloidosis/feed/index.html	(from https://bridgebio.com/news/fda-grants-orphan-drug-designation-to-eidos-therapeutics-product-candidate-ag10-for-treatment-of-transthyretin-amyloidosis/)
03:08:37	2857/2857	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Ffda-grants-orphan-drug-designation-to-eidos-therapeutics-product-candidate-ag10-for-treatment-of-transthyretin-amyloidosis%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed0197.json	(from https://bridgebio.com/news/fda-grants-orphan-drug-designation-to-eidos-therapeutics-product-candidate-ag10-for-treatment-of-transthyretin-amyloidosis/)
03:08:37	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:37%20GMT	https://bridgebio.com/?p=83	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index55e4.html	(from https://bridgebio.com/news/fda-grants-orphan-drug-designation-to-eidos-therapeutics-product-candidate-ag10-for-treatment-of-transthyretin-amyloidosis/)
03:08:37	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a15.delayed	(from https://bridgebio.com/news/fda-grants-orphan-drug-designation-to-eidos-therapeutics-product-candidate-ag10-for-treatment-of-transthyretin-amyloidosis/)
03:08:37	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a16.delayed	(from https://bridgebio.com/news/fda-grants-orphan-drug-designation-to-eidos-therapeutics-product-candidate-ag10-for-treatment-of-transthyretin-amyloidosis/)
03:08:37	3050/3050	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Ffda-grants-orphan-drug-designation-to-eidos-therapeutics-product-candidate-ag10-for-treatment-of-transthyretin-amyloidosis%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed875f	(from https://bridgebio.com/news/fda-grants-orphan-drug-designation-to-eidos-therapeutics-product-candidate-ag10-for-treatment-of-transthyretin-amyloidosis/)
03:08:38	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:38%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/fda-grants-orphan-drug-designation-to-eidos-therapeutics-product-candidate-ag10-for-treatment-of-transthyretin-amyloidosis/)
03:08:38	21058/21058	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:38%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/84	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/84.json	(from https://bridgebio.com/news/eidos-therapeutics-presents-data-from-its-phase-1-clinical-trial-of-ag10-at-the-22nd-annual-scientific-meeting-of-the-heart-failure-society-of-america/)
03:08:39	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/eidos-therapeutics-presents-data-from-its-phase-1-clinical-trial-of-ag10-at-the-22nd-annual-scientific-meeting-of-the-heart-failure-society-of-america/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-presents-data-from-its-phase/feed/index.html	(from https://bridgebio.com/news/eidos-therapeutics-presents-data-from-its-phase-1-clinical-trial-of-ag10-at-the-22nd-annual-scientific-meeting-of-the-heart-failure-society-of-america/)
03:08:39	2964/2964	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:39%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-presents-data-from-its-phase-1-clinical-trial-of-ag10-at-the-22nd-annual-scientific-meeting-of-the-heart-failure-society-of-america%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedcf05.json	(from https://bridgebio.com/news/eidos-therapeutics-presents-data-from-its-phase-1-clinical-trial-of-ag10-at-the-22nd-annual-scientific-meeting-of-the-heart-failure-society-of-america/)
03:08:39	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:39%20GMT	https://bridgebio.com/?p=84	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index735a.html	(from https://bridgebio.com/news/eidos-therapeutics-presents-data-from-its-phase-1-clinical-trial-of-ag10-at-the-22nd-annual-scientific-meeting-of-the-heart-failure-society-of-america/)
03:08:39	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a1b.delayed	(from https://bridgebio.com/news/eidos-therapeutics-presents-data-from-its-phase-1-clinical-trial-of-ag10-at-the-22nd-annual-scientific-meeting-of-the-heart-failure-society-of-america/)
03:08:39	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a1c.delayed	(from https://bridgebio.com/news/eidos-therapeutics-presents-data-from-its-phase-1-clinical-trial-of-ag10-at-the-22nd-annual-scientific-meeting-of-the-heart-failure-society-of-america/)
03:08:39	3153/3153	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:39%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-presents-data-from-its-phase-1-clinical-trial-of-ag10-at-the-22nd-annual-scientific-meeting-of-the-heart-failure-society-of-america%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5bc2	(from https://bridgebio.com/news/eidos-therapeutics-presents-data-from-its-phase-1-clinical-trial-of-ag10-at-the-22nd-annual-scientific-meeting-of-the-heart-failure-society-of-america/)
03:08:39	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:39%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/eidos-therapeutics-presents-data-from-its-phase-1-clinical-trial-of-ag10-at-the-22nd-annual-scientific-meeting-of-the-heart-failure-society-of-america/)
03:08:40	19807/19807	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:40%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/85	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/85.json	(from https://bridgebio.com/news/eidos-therapeutics-announces-publication-of-ag10-molecular-design-in-journal-of-medicinal-chemistry/)
03:08:40	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/eidos-therapeutics-announces-publication-of-ag10-molecular-design-in-journal-of-medicinal-chemistry/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-announces-publication-of-ag10-molecular-design-in-journal-of-medicinal-chemistry/feed/index.html	(from https://bridgebio.com/news/eidos-therapeutics-announces-publication-of-ag10-molecular-design-in-journal-of-medicinal-chemistry/)
03:08:40	2743/2743	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:40%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-announces-publication-of-ag10-molecular-design-in-journal-of-medicinal-chemistry%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed67f8.json	(from https://bridgebio.com/news/eidos-therapeutics-announces-publication-of-ag10-molecular-design-in-journal-of-medicinal-chemistry/)
03:08:41	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:41%20GMT	https://bridgebio.com/?p=85	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index648c.html	(from https://bridgebio.com/news/eidos-therapeutics-announces-publication-of-ag10-molecular-design-in-journal-of-medicinal-chemistry/)
03:08:41	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a21.delayed	(from https://bridgebio.com/news/eidos-therapeutics-announces-publication-of-ag10-molecular-design-in-journal-of-medicinal-chemistry/)
03:08:41	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a22.delayed	(from https://bridgebio.com/news/eidos-therapeutics-announces-publication-of-ag10-molecular-design-in-journal-of-medicinal-chemistry/)
03:08:41	2932/2932	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:41%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-announces-publication-of-ag10-molecular-design-in-journal-of-medicinal-chemistry%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedba87	(from https://bridgebio.com/news/eidos-therapeutics-announces-publication-of-ag10-molecular-design-in-journal-of-medicinal-chemistry/)
03:08:41	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:41%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/eidos-therapeutics-announces-publication-of-ag10-molecular-design-in-journal-of-medicinal-chemistry/)
03:08:42	15721/15721	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:42%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/125	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/125.json	(from https://bridgebio.com/news/eidos-therapeutics-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares/)
03:08:42	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/eidos-therapeutics-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares/feed/index.html	(from https://bridgebio.com/news/eidos-therapeutics-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares/)
03:08:42	2930/2930	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:42%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede65a.json	(from https://bridgebio.com/news/eidos-therapeutics-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares/)
03:08:43	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:43%20GMT	https://bridgebio.com/?p=125	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index5070.html	(from https://bridgebio.com/news/eidos-therapeutics-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares/)
03:08:43	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a27.delayed	(from https://bridgebio.com/news/eidos-therapeutics-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares/)
03:08:43	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a28.delayed	(from https://bridgebio.com/news/eidos-therapeutics-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares/)
03:08:43	3121/3121	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:43%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede32e	(from https://bridgebio.com/news/eidos-therapeutics-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares/)
03:08:43	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:43%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/eidos-therapeutics-announces-closing-of-initial-public-offering-and-exercise-in-full-of-the-underwriters-option-to-purchase-additional-shares/)
03:08:44	14124/14124	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:44%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/126	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/126.json	(from https://bridgebio.com/news/eidos-therapeutics-announces-pricing-of-initial-public-offering/)
03:08:44	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/eidos-therapeutics-announces-pricing-of-initial-public-offering/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-announces-pricing-of-initial-public-offering/feed/index.html	(from https://bridgebio.com/news/eidos-therapeutics-announces-pricing-of-initial-public-offering/)
03:08:44	2618/2618	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:44%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-announces-pricing-of-initial-public-offering%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb914.json	(from https://bridgebio.com/news/eidos-therapeutics-announces-pricing-of-initial-public-offering/)
03:08:44	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:44%20GMT	https://bridgebio.com/?p=126	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index4ab3.html	(from https://bridgebio.com/news/eidos-therapeutics-announces-pricing-of-initial-public-offering/)
03:08:44	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a2d.delayed	(from https://bridgebio.com/news/eidos-therapeutics-announces-pricing-of-initial-public-offering/)
03:08:44	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a2e.delayed	(from https://bridgebio.com/news/eidos-therapeutics-announces-pricing-of-initial-public-offering/)
03:08:45	2807/2807	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:45%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-announces-pricing-of-initial-public-offering%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede1f7	(from https://bridgebio.com/news/eidos-therapeutics-announces-pricing-of-initial-public-offering/)
03:08:45	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:45%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/eidos-therapeutics-announces-pricing-of-initial-public-offering/)
03:08:45	18427/18427	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:46%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/165	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/165.json	(from https://bridgebio.com/news/neurovive-out-licenses-targeted-lhon-therapy-to-bridgebio-pharmas-new-subsidiary-fortify-therapeutics/)
03:08:46	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/neurovive-out-licenses-targeted-lhon-therapy-to-bridgebio-pharmas-new-subsidiary-fortify-therapeutics/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/neurovive-out-licenses-targeted-lhon-therapy-to-bridgebio-pharmas-new-subsidiary-fortify-therapeutics/feed/index.html	(from https://bridgebio.com/news/neurovive-out-licenses-targeted-lhon-therapy-to-bridgebio-pharmas-new-subsidiary-fortify-therapeutics/)
03:08:46	2769/2769	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:46%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fneurovive-out-licenses-targeted-lhon-therapy-to-bridgebio-pharmas-new-subsidiary-fortify-therapeutics%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedaf52.json	(from https://bridgebio.com/news/neurovive-out-licenses-targeted-lhon-therapy-to-bridgebio-pharmas-new-subsidiary-fortify-therapeutics/)
03:08:46	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:46%20GMT	https://bridgebio.com/?p=165	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index17d5.html	(from https://bridgebio.com/news/neurovive-out-licenses-targeted-lhon-therapy-to-bridgebio-pharmas-new-subsidiary-fortify-therapeutics/)
03:08:46	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a33.delayed	(from https://bridgebio.com/news/neurovive-out-licenses-targeted-lhon-therapy-to-bridgebio-pharmas-new-subsidiary-fortify-therapeutics/)
03:08:46	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a34.delayed	(from https://bridgebio.com/news/neurovive-out-licenses-targeted-lhon-therapy-to-bridgebio-pharmas-new-subsidiary-fortify-therapeutics/)
03:08:46	2964/2964	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:46%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fneurovive-out-licenses-targeted-lhon-therapy-to-bridgebio-pharmas-new-subsidiary-fortify-therapeutics%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed38a9	(from https://bridgebio.com/news/neurovive-out-licenses-targeted-lhon-therapy-to-bridgebio-pharmas-new-subsidiary-fortify-therapeutics/)
03:08:47	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:47%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/neurovive-out-licenses-targeted-lhon-therapy-to-bridgebio-pharmas-new-subsidiary-fortify-therapeutics/)
03:08:47	16572/16572	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:47%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/164	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/164.json	(from https://bridgebio.com/news/bridgebio-pharma-launches-coa-therapeutics-to-target-coenzyme-a-for-rare-genetic-disorders/)
03:08:47	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-launches-coa-therapeutics-to-target-coenzyme-a-for-rare-genetic-disorders/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-launches-coa-therapeutics-to-target-coenzyme-a-for-rare-genetic-disorders/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-launches-coa-therapeutics-to-target-coenzyme-a-for-rare-genetic-disorders/)
03:08:48	2714/2714	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:48%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-launches-coa-therapeutics-to-target-coenzyme-a-for-rare-genetic-disorders%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5596.json	(from https://bridgebio.com/news/bridgebio-pharma-launches-coa-therapeutics-to-target-coenzyme-a-for-rare-genetic-disorders/)
03:08:48	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:48%20GMT	https://bridgebio.com/?p=164	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index7760.html	(from https://bridgebio.com/news/bridgebio-pharma-launches-coa-therapeutics-to-target-coenzyme-a-for-rare-genetic-disorders/)
03:08:48	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a39.delayed	(from https://bridgebio.com/news/bridgebio-pharma-launches-coa-therapeutics-to-target-coenzyme-a-for-rare-genetic-disorders/)
03:08:48	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a3a.delayed	(from https://bridgebio.com/news/bridgebio-pharma-launches-coa-therapeutics-to-target-coenzyme-a-for-rare-genetic-disorders/)
03:08:48	2903/2903	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:48%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-launches-coa-therapeutics-to-target-coenzyme-a-for-rare-genetic-disorders%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedf9e1	(from https://bridgebio.com/news/bridgebio-pharma-launches-coa-therapeutics-to-target-coenzyme-a-for-rare-genetic-disorders/)
03:08:48	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:48%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-launches-coa-therapeutics-to-target-coenzyme-a-for-rare-genetic-disorders/)
03:08:49	16712/16712	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:49%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/67	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/67.json	(from https://bridgebio.com/news/bridgebio-pharma-enters-into-agreement-to-acquire-late-stage-therapy-for-ultra-rare-disorder-from-alexion/)
03:08:49	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-enters-into-agreement-to-acquire-late-stage-therapy-for-ultra-rare-disorder-from-alexion/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-enters-into-agreement-to-acquire-late-stage-therapy-for-ultra-rare-disorder-from-alexion/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-enters-into-agreement-to-acquire-late-stage-therapy-for-ultra-rare-disorder-from-alexion/)
03:08:49	2901/2901	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:50%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-enters-into-agreement-to-acquire-late-stage-therapy-for-ultra-rare-disorder-from-alexion%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5260.json	(from https://bridgebio.com/news/bridgebio-pharma-enters-into-agreement-to-acquire-late-stage-therapy-for-ultra-rare-disorder-from-alexion/)
03:08:50	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:50%20GMT	https://bridgebio.com/?p=67	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index96f1.html	(from https://bridgebio.com/news/bridgebio-pharma-enters-into-agreement-to-acquire-late-stage-therapy-for-ultra-rare-disorder-from-alexion/)
03:08:50	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a3f.delayed	(from https://bridgebio.com/news/bridgebio-pharma-enters-into-agreement-to-acquire-late-stage-therapy-for-ultra-rare-disorder-from-alexion/)
03:08:50	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a40.delayed	(from https://bridgebio.com/news/bridgebio-pharma-enters-into-agreement-to-acquire-late-stage-therapy-for-ultra-rare-disorder-from-alexion/)
03:08:50	3090/3090	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:50%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-enters-into-agreement-to-acquire-late-stage-therapy-for-ultra-rare-disorder-from-alexion%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2ea6	(from https://bridgebio.com/news/bridgebio-pharma-enters-into-agreement-to-acquire-late-stage-therapy-for-ultra-rare-disorder-from-alexion/)
03:08:50	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:50%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-enters-into-agreement-to-acquire-late-stage-therapy-for-ultra-rare-disorder-from-alexion/)
03:08:51	20744/20744	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:51%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/162	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/162.json	(from https://bridgebio.com/news/pellepharm-to-present-topical-patidegib-and-skin-cancer-epidemiological-data-at-the-7th-international-investigative-dermatology-meeting/)
03:08:51	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/pellepharm-to-present-topical-patidegib-and-skin-cancer-epidemiological-data-at-the-7th-international-investigative-dermatology-meeting/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/pellepharm-to-present-topical-patidegib-and-skin-cancer-epidemiological-data-at-the-7th-international-investigative-dermatology-meeting/feed/index.html	(from https://bridgebio.com/news/pellepharm-to-present-topical-patidegib-and-skin-cancer-epidemiological-data-at-the-7th-international-investigative-dermatology-meeting/)
03:08:51	2901/2901	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:51%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fpellepharm-to-present-topical-patidegib-and-skin-cancer-epidemiological-data-at-the-7th-international-investigative-dermatology-meeting%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embede02d.json	(from https://bridgebio.com/news/pellepharm-to-present-topical-patidegib-and-skin-cancer-epidemiological-data-at-the-7th-international-investigative-dermatology-meeting/)
03:08:51	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:52%20GMT	https://bridgebio.com/?p=162	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexbbc7.html	(from https://bridgebio.com/news/pellepharm-to-present-topical-patidegib-and-skin-cancer-epidemiological-data-at-the-7th-international-investigative-dermatology-meeting/)
03:08:52	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a45.delayed	(from https://bridgebio.com/news/pellepharm-to-present-topical-patidegib-and-skin-cancer-epidemiological-data-at-the-7th-international-investigative-dermatology-meeting/)
03:08:52	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a46.delayed	(from https://bridgebio.com/news/pellepharm-to-present-topical-patidegib-and-skin-cancer-epidemiological-data-at-the-7th-international-investigative-dermatology-meeting/)
03:08:52	3090/3090	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:52%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fpellepharm-to-present-topical-patidegib-and-skin-cancer-epidemiological-data-at-the-7th-international-investigative-dermatology-meeting%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1a62	(from https://bridgebio.com/news/pellepharm-to-present-topical-patidegib-and-skin-cancer-epidemiological-data-at-the-7th-international-investigative-dermatology-meeting/)
03:08:52	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:52%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/pellepharm-to-present-topical-patidegib-and-skin-cancer-epidemiological-data-at-the-7th-international-investigative-dermatology-meeting/)
03:08:53	20596/20596	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:53%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/127	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/127.json	(from https://bridgebio.com/news/eidos-therapeutics-initiates-phase-2-clinical-trial-for-ag10-targeting-transthyretin-amyloidosis-cardiomyopathy/)
03:08:53	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/eidos-therapeutics-initiates-phase-2-clinical-trial-for-ag10-targeting-transthyretin-amyloidosis-cardiomyopathy/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-initiates-phase-2-clinical-trial-for-ag10-targeting-transthyretin-amyloidosis-cardiomyopathy/feed/index.html	(from https://bridgebio.com/news/eidos-therapeutics-initiates-phase-2-clinical-trial-for-ag10-targeting-transthyretin-amyloidosis-cardiomyopathy/)
03:08:53	2803/2803	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:53%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-initiates-phase-2-clinical-trial-for-ag10-targeting-transthyretin-amyloidosis-cardiomyopathy%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd588.json	(from https://bridgebio.com/news/eidos-therapeutics-initiates-phase-2-clinical-trial-for-ag10-targeting-transthyretin-amyloidosis-cardiomyopathy/)
03:08:53	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:53%20GMT	https://bridgebio.com/?p=127	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index9751.html	(from https://bridgebio.com/news/eidos-therapeutics-initiates-phase-2-clinical-trial-for-ag10-targeting-transthyretin-amyloidosis-cardiomyopathy/)
03:08:54	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a4b.delayed	(from https://bridgebio.com/news/eidos-therapeutics-initiates-phase-2-clinical-trial-for-ag10-targeting-transthyretin-amyloidosis-cardiomyopathy/)
03:08:54	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a4c.delayed	(from https://bridgebio.com/news/eidos-therapeutics-initiates-phase-2-clinical-trial-for-ag10-targeting-transthyretin-amyloidosis-cardiomyopathy/)
03:08:54	2992/2992	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:54%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-initiates-phase-2-clinical-trial-for-ag10-targeting-transthyretin-amyloidosis-cardiomyopathy%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed135b	(from https://bridgebio.com/news/eidos-therapeutics-initiates-phase-2-clinical-trial-for-ag10-targeting-transthyretin-amyloidosis-cardiomyopathy/)
03:08:54	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:54%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/eidos-therapeutics-initiates-phase-2-clinical-trial-for-ag10-targeting-transthyretin-amyloidosis-cardiomyopathy/)
03:08:54	17021/17021	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:55%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/128	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/128.json	(from https://bridgebio.com/news/eidos-therapeutics-completes-64m-series-b-financing/)
03:08:55	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/eidos-therapeutics-completes-64m-series-b-financing/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-completes-64m-series-b-financing/feed/index.html	(from https://bridgebio.com/news/eidos-therapeutics-completes-64m-series-b-financing/)
03:08:55	2550/2550	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:55%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-completes-64m-series-b-financing%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedb479.json	(from https://bridgebio.com/news/eidos-therapeutics-completes-64m-series-b-financing/)
03:08:55	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:55%20GMT	https://bridgebio.com/?p=128	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index913e.html	(from https://bridgebio.com/news/eidos-therapeutics-completes-64m-series-b-financing/)
03:08:55	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a51.delayed	(from https://bridgebio.com/news/eidos-therapeutics-completes-64m-series-b-financing/)
03:08:55	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a52.delayed	(from https://bridgebio.com/news/eidos-therapeutics-completes-64m-series-b-financing/)
03:08:55	2739/2739	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:56%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-completes-64m-series-b-financing%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedd9e0	(from https://bridgebio.com/news/eidos-therapeutics-completes-64m-series-b-financing/)
03:08:56	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:56%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/eidos-therapeutics-completes-64m-series-b-financing/)
03:08:56	15635/15635	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:56%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/129	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/129.json	(from https://bridgebio.com/news/eidos-therapeutics-to-host-symposium-on-ttr-stabilization-at-the-16th-international-symposium-on-amyloidosis/)
03:08:57	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/eidos-therapeutics-to-host-symposium-on-ttr-stabilization-at-the-16th-international-symposium-on-amyloidosis/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-to-host-symposium-on-ttr-stabilization-at-the-16th-international-symposium-on-amyloidosis/feed/index.html	(from https://bridgebio.com/news/eidos-therapeutics-to-host-symposium-on-ttr-stabilization-at-the-16th-international-symposium-on-amyloidosis/)
03:08:57	2785/2785	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:57%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-to-host-symposium-on-ttr-stabilization-at-the-16th-international-symposium-on-amyloidosis%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5eb8.json	(from https://bridgebio.com/news/eidos-therapeutics-to-host-symposium-on-ttr-stabilization-at-the-16th-international-symposium-on-amyloidosis/)
03:08:57	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:57%20GMT	https://bridgebio.com/?p=129	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index1c00.html	(from https://bridgebio.com/news/eidos-therapeutics-to-host-symposium-on-ttr-stabilization-at-the-16th-international-symposium-on-amyloidosis/)
03:08:57	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a57.delayed	(from https://bridgebio.com/news/eidos-therapeutics-to-host-symposium-on-ttr-stabilization-at-the-16th-international-symposium-on-amyloidosis/)
03:08:57	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a58.delayed	(from https://bridgebio.com/news/eidos-therapeutics-to-host-symposium-on-ttr-stabilization-at-the-16th-international-symposium-on-amyloidosis/)
03:08:57	2974/2974	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:57%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-to-host-symposium-on-ttr-stabilization-at-the-16th-international-symposium-on-amyloidosis%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedcd54	(from https://bridgebio.com/news/eidos-therapeutics-to-host-symposium-on-ttr-stabilization-at-the-16th-international-symposium-on-amyloidosis/)
03:08:58	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:58%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/eidos-therapeutics-to-host-symposium-on-ttr-stabilization-at-the-16th-international-symposium-on-amyloidosis/)
03:08:58	17222/17222	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:58%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/145	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/145.json	(from https://bridgebio.com/news/bridgebio-pharma-licenses-late-stage-oncology-drug-infigratinib/)
03:08:58	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-licenses-late-stage-oncology-drug-infigratinib/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-licenses-late-stage-oncology-drug-infigratinib/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-licenses-late-stage-oncology-drug-infigratinib/)
03:08:59	2835/2835	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:08:59%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-licenses-late-stage-oncology-drug-infigratinib%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed965f.json	(from https://bridgebio.com/news/bridgebio-pharma-licenses-late-stage-oncology-drug-infigratinib/)
03:08:59	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:59%20GMT	https://bridgebio.com/?p=145	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexbe3b.html	(from https://bridgebio.com/news/bridgebio-pharma-licenses-late-stage-oncology-drug-infigratinib/)
03:08:59	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a5d.delayed	(from https://bridgebio.com/news/bridgebio-pharma-licenses-late-stage-oncology-drug-infigratinib/)
03:08:59	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a5e.delayed	(from https://bridgebio.com/news/bridgebio-pharma-licenses-late-stage-oncology-drug-infigratinib/)
03:08:59	3024/3024	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:08:59%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-licenses-late-stage-oncology-drug-infigratinib%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed29b9	(from https://bridgebio.com/news/bridgebio-pharma-licenses-late-stage-oncology-drug-infigratinib/)
03:08:59	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:08:59%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-licenses-late-stage-oncology-drug-infigratinib/)
03:09:00	16082/16082	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:00%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/66	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/66.json	(from https://bridgebio.com/news/bridgebio-pharma-appoints-sanuj-ravindran-m-d-and-eric-michael-david-m-d-as-ceos-in-residence-to-lead-dermatology-and-gene-therapy-programs/)
03:09:00	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-appoints-sanuj-ravindran-m-d-and-eric-michael-david-m-d-as-ceos-in-residence-to-lead-dermatology-and-gene-therapy-programs/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-appoints-sanuj-ravindran-m-d-and-eric-michael-david-m-d-as-ceos-in-residence-to-lead-dermatology-and-gene-therapy-programs/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-appoints-sanuj-ravindran-m-d-and-eric-michael-david-m-d-as-ceos-in-residence-to-lead-dermatology-and-gene-therapy-programs/)
03:09:00	2925/2925	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:00%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-appoints-sanuj-ravindran-m-d-and-eric-michael-david-m-d-as-ceos-in-residence-to-lead-dermatology-and-gene-therapy-programs%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed64c3.json	(from https://bridgebio.com/news/bridgebio-pharma-appoints-sanuj-ravindran-m-d-and-eric-michael-david-m-d-as-ceos-in-residence-to-lead-dermatology-and-gene-therapy-programs/)
03:09:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:01%20GMT	https://bridgebio.com/?p=66	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index4f61.html	(from https://bridgebio.com/news/bridgebio-pharma-appoints-sanuj-ravindran-m-d-and-eric-michael-david-m-d-as-ceos-in-residence-to-lead-dermatology-and-gene-therapy-programs/)
03:09:01	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a63.delayed	(from https://bridgebio.com/news/bridgebio-pharma-appoints-sanuj-ravindran-m-d-and-eric-michael-david-m-d-as-ceos-in-residence-to-lead-dermatology-and-gene-therapy-programs/)
03:09:01	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a64.delayed	(from https://bridgebio.com/news/bridgebio-pharma-appoints-sanuj-ravindran-m-d-and-eric-michael-david-m-d-as-ceos-in-residence-to-lead-dermatology-and-gene-therapy-programs/)
03:09:01	3114/3114	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:09:01%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-appoints-sanuj-ravindran-m-d-and-eric-michael-david-m-d-as-ceos-in-residence-to-lead-dermatology-and-gene-therapy-programs%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1f07	(from https://bridgebio.com/news/bridgebio-pharma-appoints-sanuj-ravindran-m-d-and-eric-michael-david-m-d-as-ceos-in-residence-to-lead-dermatology-and-gene-therapy-programs/)
03:09:01	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:01%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-appoints-sanuj-ravindran-m-d-and-eric-michael-david-m-d-as-ceos-in-residence-to-lead-dermatology-and-gene-therapy-programs/)
03:09:02	18352/18352	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:02%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/203	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/203.json	(from https://bridgebio.com/news/pellepharm-appoints-sanuj-k-ravindran-m-d-as-president-and-chief-executive-officer/)
03:09:02	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/pellepharm-appoints-sanuj-k-ravindran-m-d-as-president-and-chief-executive-officer/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/pellepharm-appoints-sanuj-k-ravindran-m-d-as-president-and-chief-executive-officer/feed/index.html	(from https://bridgebio.com/news/pellepharm-appoints-sanuj-k-ravindran-m-d-as-president-and-chief-executive-officer/)
03:09:02	2686/2686	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:02%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fpellepharm-appoints-sanuj-k-ravindran-m-d-as-president-and-chief-executive-officer%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed38be.json	(from https://bridgebio.com/news/pellepharm-appoints-sanuj-k-ravindran-m-d-as-president-and-chief-executive-officer/)
03:09:02	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:02%20GMT	https://bridgebio.com/?p=203	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexc39e.html	(from https://bridgebio.com/news/pellepharm-appoints-sanuj-k-ravindran-m-d-as-president-and-chief-executive-officer/)
03:09:03	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a69.delayed	(from https://bridgebio.com/news/pellepharm-appoints-sanuj-k-ravindran-m-d-as-president-and-chief-executive-officer/)
03:09:03	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a6a.delayed	(from https://bridgebio.com/news/pellepharm-appoints-sanuj-k-ravindran-m-d-as-president-and-chief-executive-officer/)
03:09:03	2874/2874	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:09:03%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fpellepharm-appoints-sanuj-k-ravindran-m-d-as-president-and-chief-executive-officer%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedca12	(from https://bridgebio.com/news/pellepharm-appoints-sanuj-k-ravindran-m-d-as-president-and-chief-executive-officer/)
03:09:03	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:03%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/pellepharm-appoints-sanuj-k-ravindran-m-d-as-president-and-chief-executive-officer/)
03:09:04	19053/19053	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:04%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/148	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/148.json	(from https://bridgebio.com/news/fda-grants-breakthrough-therapy-designation-and-orphan-drug-designation-to-pellepharm-for-topical-patidegib-in-gorlin-syndrome/)
03:09:04	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/fda-grants-breakthrough-therapy-designation-and-orphan-drug-designation-to-pellepharm-for-topical-patidegib-in-gorlin-syndrome/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/fda-grants-breakthrough-therapy-designation-and-orphan-drug-designation-to-pellepharm-for-topical-patidegib-in-gorlin-syndrome/feed/index.html	(from https://bridgebio.com/news/fda-grants-breakthrough-therapy-designation-and-orphan-drug-designation-to-pellepharm-for-topical-patidegib-in-gorlin-syndrome/)
03:09:04	2862/2862	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:04%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Ffda-grants-breakthrough-therapy-designation-and-orphan-drug-designation-to-pellepharm-for-topical-patidegib-in-gorlin-syndrome%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9e11.json	(from https://bridgebio.com/news/fda-grants-breakthrough-therapy-designation-and-orphan-drug-designation-to-pellepharm-for-topical-patidegib-in-gorlin-syndrome/)
03:09:04	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:04%20GMT	https://bridgebio.com/?p=148	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexa36b.html	(from https://bridgebio.com/news/fda-grants-breakthrough-therapy-designation-and-orphan-drug-designation-to-pellepharm-for-topical-patidegib-in-gorlin-syndrome/)
03:09:05	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a6f.delayed	(from https://bridgebio.com/news/fda-grants-breakthrough-therapy-designation-and-orphan-drug-designation-to-pellepharm-for-topical-patidegib-in-gorlin-syndrome/)
03:09:05	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a70.delayed	(from https://bridgebio.com/news/fda-grants-breakthrough-therapy-designation-and-orphan-drug-designation-to-pellepharm-for-topical-patidegib-in-gorlin-syndrome/)
03:09:05	3051/3051	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:09:05%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Ffda-grants-breakthrough-therapy-designation-and-orphan-drug-designation-to-pellepharm-for-topical-patidegib-in-gorlin-syndrome%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8efc	(from https://bridgebio.com/news/fda-grants-breakthrough-therapy-designation-and-orphan-drug-designation-to-pellepharm-for-topical-patidegib-in-gorlin-syndrome/)
03:09:05	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:05%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/fda-grants-breakthrough-therapy-designation-and-orphan-drug-designation-to-pellepharm-for-topical-patidegib-in-gorlin-syndrome/)
03:09:06	18367/18367	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:06%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/205	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/205.json	(from https://bridgebio.com/news/preclinical-data-demonstrates-potential-of-eidos-therapeutics-lead-compound-for-the-treatment-for-transythyretin-amyloidosis/)
03:09:06	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/preclinical-data-demonstrates-potential-of-eidos-therapeutics-lead-compound-for-the-treatment-for-transythyretin-amyloidosis/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/preclinical-data-demonstrates-potential-of-eidos-therapeutics-lead-compound-for-the-treatment-for-transythyretin-amyloidosis/feed/index.html	(from https://bridgebio.com/news/preclinical-data-demonstrates-potential-of-eidos-therapeutics-lead-compound-for-the-treatment-for-transythyretin-amyloidosis/)
03:09:06	2870/2870	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:06%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fpreclinical-data-demonstrates-potential-of-eidos-therapeutics-lead-compound-for-the-treatment-for-transythyretin-amyloidosis%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8ccb.json	(from https://bridgebio.com/news/preclinical-data-demonstrates-potential-of-eidos-therapeutics-lead-compound-for-the-treatment-for-transythyretin-amyloidosis/)
03:09:06	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:06%20GMT	https://bridgebio.com/?p=205	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexc140.html	(from https://bridgebio.com/news/preclinical-data-demonstrates-potential-of-eidos-therapeutics-lead-compound-for-the-treatment-for-transythyretin-amyloidosis/)
03:09:06	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a75.delayed	(from https://bridgebio.com/news/preclinical-data-demonstrates-potential-of-eidos-therapeutics-lead-compound-for-the-treatment-for-transythyretin-amyloidosis/)
03:09:06	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a76.delayed	(from https://bridgebio.com/news/preclinical-data-demonstrates-potential-of-eidos-therapeutics-lead-compound-for-the-treatment-for-transythyretin-amyloidosis/)
03:09:06	3061/3061	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:09:07%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fpreclinical-data-demonstrates-potential-of-eidos-therapeutics-lead-compound-for-the-treatment-for-transythyretin-amyloidosis%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedc3f9	(from https://bridgebio.com/news/preclinical-data-demonstrates-potential-of-eidos-therapeutics-lead-compound-for-the-treatment-for-transythyretin-amyloidosis/)
03:09:07	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:07%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/preclinical-data-demonstrates-potential-of-eidos-therapeutics-lead-compound-for-the-treatment-for-transythyretin-amyloidosis/)
03:09:07	20374/20374	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:08%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/149	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/149.json	(from https://bridgebio.com/news/md-anderson-and-bridgebio-pharma-launch-navire-pharma-to-develop-targeted-therapy-for-patients-with-difficult-to-treat-cancer/)
03:09:08	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/md-anderson-and-bridgebio-pharma-launch-navire-pharma-to-develop-targeted-therapy-for-patients-with-difficult-to-treat-cancer/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/md-anderson-and-bridgebio-pharma-launch-navire-pharma-to-develop-targeted-therapy-for-patients-with-difficult-to-treat-cancer/feed/index.html	(from https://bridgebio.com/news/md-anderson-and-bridgebio-pharma-launch-navire-pharma-to-develop-targeted-therapy-for-patients-with-difficult-to-treat-cancer/)
03:09:08	2844/2844	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:08%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fmd-anderson-and-bridgebio-pharma-launch-navire-pharma-to-develop-targeted-therapy-for-patients-with-difficult-to-treat-cancer%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed6c67.json	(from https://bridgebio.com/news/md-anderson-and-bridgebio-pharma-launch-navire-pharma-to-develop-targeted-therapy-for-patients-with-difficult-to-treat-cancer/)
03:09:08	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:08%20GMT	https://bridgebio.com/?p=149	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index8bc8.html	(from https://bridgebio.com/news/md-anderson-and-bridgebio-pharma-launch-navire-pharma-to-develop-targeted-therapy-for-patients-with-difficult-to-treat-cancer/)
03:09:09	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a7b.delayed	(from https://bridgebio.com/news/md-anderson-and-bridgebio-pharma-launch-navire-pharma-to-develop-targeted-therapy-for-patients-with-difficult-to-treat-cancer/)
03:09:09	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a7c.delayed	(from https://bridgebio.com/news/md-anderson-and-bridgebio-pharma-launch-navire-pharma-to-develop-targeted-therapy-for-patients-with-difficult-to-treat-cancer/)
03:09:09	3033/3033	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:09:09%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fmd-anderson-and-bridgebio-pharma-launch-navire-pharma-to-develop-targeted-therapy-for-patients-with-difficult-to-treat-cancer%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed37a6	(from https://bridgebio.com/news/md-anderson-and-bridgebio-pharma-launch-navire-pharma-to-develop-targeted-therapy-for-patients-with-difficult-to-treat-cancer/)
03:09:09	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:09%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/md-anderson-and-bridgebio-pharma-launch-navire-pharma-to-develop-targeted-therapy-for-patients-with-difficult-to-treat-cancer/)
03:09:10	21068/21068	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:10%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/147	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/147.json	(from https://bridgebio.com/news/eidos-therapeutics-initiates-first-clinical-study-for-ag10-targeting-transthyretin-amyloidosis-appoints-camille-landis-as-chief-business-officer/)
03:09:10	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/eidos-therapeutics-initiates-first-clinical-study-for-ag10-targeting-transthyretin-amyloidosis-appoints-camille-landis-as-chief-business-officer/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/eidos-therapeutics-initiates-first-clinical-stu/feed/index.html	(from https://bridgebio.com/news/eidos-therapeutics-initiates-first-clinical-study-for-ag10-targeting-transthyretin-amyloidosis-appoints-camille-landis-as-chief-business-officer/)
03:09:10	2941/2941	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:11%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-initiates-first-clinical-study-for-ag10-targeting-transthyretin-amyloidosis-appoints-camille-landis-as-chief-business-officer%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2f07.json	(from https://bridgebio.com/news/eidos-therapeutics-initiates-first-clinical-study-for-ag10-targeting-transthyretin-amyloidosis-appoints-camille-landis-as-chief-business-officer/)
03:09:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:11%20GMT	https://bridgebio.com/?p=147	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index2fa7.html	(from https://bridgebio.com/news/eidos-therapeutics-initiates-first-clinical-study-for-ag10-targeting-transthyretin-amyloidosis-appoints-camille-landis-as-chief-business-officer/)
03:09:11	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a81.delayed	(from https://bridgebio.com/news/eidos-therapeutics-initiates-first-clinical-study-for-ag10-targeting-transthyretin-amyloidosis-appoints-camille-landis-as-chief-business-officer/)
03:09:11	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a82.delayed	(from https://bridgebio.com/news/eidos-therapeutics-initiates-first-clinical-study-for-ag10-targeting-transthyretin-amyloidosis-appoints-camille-landis-as-chief-business-officer/)
03:09:11	3130/3130	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:09:11%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Feidos-therapeutics-initiates-first-clinical-study-for-ag10-targeting-transthyretin-amyloidosis-appoints-camille-landis-as-chief-business-officer%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed6f51	(from https://bridgebio.com/news/eidos-therapeutics-initiates-first-clinical-study-for-ag10-targeting-transthyretin-amyloidosis-appoints-camille-landis-as-chief-business-officer/)
03:09:11	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:11%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/eidos-therapeutics-initiates-first-clinical-study-for-ag10-targeting-transthyretin-amyloidosis-appoints-camille-landis-as-chief-business-officer/)
03:09:12	17205/17205	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:12%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/68	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/68.json	(from https://bridgebio.com/news/bridgebio-pharma-expands-investor-base-raising-an-additional-135-million-and-discloses-genetic-disease-pipeline-programs/)
03:09:12	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-expands-investor-base-raising-an-additional-135-million-and-discloses-genetic-disease-pipeline-programs/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-expands-investor-base-raising-an-additional-135-million-and-discloses-genetic-disease-pipeline-programs/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-expands-investor-base-raising-an-additional-135-million-and-discloses-genetic-disease-pipeline-programs/)
03:09:12	2819/2819	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:12%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-expands-investor-base-raising-an-additional-135-million-and-discloses-genetic-disease-pipeline-programs%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed1730.json	(from https://bridgebio.com/news/bridgebio-pharma-expands-investor-base-raising-an-additional-135-million-and-discloses-genetic-disease-pipeline-programs/)
03:09:13	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:13%20GMT	https://bridgebio.com/?p=68	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index7ef4.html	(from https://bridgebio.com/news/bridgebio-pharma-expands-investor-base-raising-an-additional-135-million-and-discloses-genetic-disease-pipeline-programs/)
03:09:13	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a87.delayed	(from https://bridgebio.com/news/bridgebio-pharma-expands-investor-base-raising-an-additional-135-million-and-discloses-genetic-disease-pipeline-programs/)
03:09:13	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a88.delayed	(from https://bridgebio.com/news/bridgebio-pharma-expands-investor-base-raising-an-additional-135-million-and-discloses-genetic-disease-pipeline-programs/)
03:09:13	3008/3008	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:09:13%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-expands-investor-base-raising-an-additional-135-million-and-discloses-genetic-disease-pipeline-programs%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9a70	(from https://bridgebio.com/news/bridgebio-pharma-expands-investor-base-raising-an-additional-135-million-and-discloses-genetic-disease-pipeline-programs/)
03:09:13	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:13%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-expands-investor-base-raising-an-additional-135-million-and-discloses-genetic-disease-pipeline-programs/)
03:09:14	19426/19426	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:14%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/202	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/202.json	(from https://bridgebio.com/news/pellepharm-announces-topline-results-from-phase-2-study-of-topical-patidegib/)
03:09:14	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/pellepharm-announces-topline-results-from-phase-2-study-of-topical-patidegib/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/pellepharm-announces-topline-results-from-phase-2-study-of-topical-patidegib/feed/index.html	(from https://bridgebio.com/news/pellepharm-announces-topline-results-from-phase-2-study-of-topical-patidegib/)
03:09:14	2849/2849	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:14%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fpellepharm-announces-topline-results-from-phase-2-study-of-topical-patidegib%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed9293.json	(from https://bridgebio.com/news/pellepharm-announces-topline-results-from-phase-2-study-of-topical-patidegib/)
03:09:14	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:15%20GMT	https://bridgebio.com/?p=202	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index6452.html	(from https://bridgebio.com/news/pellepharm-announces-topline-results-from-phase-2-study-of-topical-patidegib/)
03:09:15	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a8d.delayed	(from https://bridgebio.com/news/pellepharm-announces-topline-results-from-phase-2-study-of-topical-patidegib/)
03:09:15	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a8e.delayed	(from https://bridgebio.com/news/pellepharm-announces-topline-results-from-phase-2-study-of-topical-patidegib/)
03:09:15	3038/3038	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:09:15%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fpellepharm-announces-topline-results-from-phase-2-study-of-topical-patidegib%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2ba1	(from https://bridgebio.com/news/pellepharm-announces-topline-results-from-phase-2-study-of-topical-patidegib/)
03:09:15	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:15%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/pellepharm-announces-topline-results-from-phase-2-study-of-topical-patidegib/)
03:09:16	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-launches-eidos-therapeutics-to-develop-targeted-therapy-for-fatal-heart-disease/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-launches-eidos-therapeutics-to-develop-targeted-therapy-for-fatal-heart-disease/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-launches-eidos-therapeutics-to-develop-targeted-therapy-for-fatal-heart-disease/)
03:09:16	16804/16804	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:16%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/131	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/131.json	(from https://bridgebio.com/news/bridgebio-pharma-launches-eidos-therapeutics-to-develop-targeted-therapy-for-fatal-heart-disease/)
03:09:16	2739/2739	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:16%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-launches-eidos-therapeutics-to-develop-targeted-therapy-for-fatal-heart-disease%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed8618.json	(from https://bridgebio.com/news/bridgebio-pharma-launches-eidos-therapeutics-to-develop-targeted-therapy-for-fatal-heart-disease/)
03:09:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:17%20GMT	https://bridgebio.com/?p=131	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexd52d.html	(from https://bridgebio.com/news/bridgebio-pharma-launches-eidos-therapeutics-to-develop-targeted-therapy-for-fatal-heart-disease/)
03:09:17	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a93.delayed	(from https://bridgebio.com/news/bridgebio-pharma-launches-eidos-therapeutics-to-develop-targeted-therapy-for-fatal-heart-disease/)
03:09:17	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a94.delayed	(from https://bridgebio.com/news/bridgebio-pharma-launches-eidos-therapeutics-to-develop-targeted-therapy-for-fatal-heart-disease/)
03:09:17	2928/2928	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:09:17%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-launches-eidos-therapeutics-to-develop-targeted-therapy-for-fatal-heart-disease%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedcc88	(from https://bridgebio.com/news/bridgebio-pharma-launches-eidos-therapeutics-to-develop-targeted-therapy-for-fatal-heart-disease/)
03:09:17	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:17%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-launches-eidos-therapeutics-to-develop-targeted-therapy-for-fatal-heart-disease/)
03:09:18	15138/15138	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:18%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/144	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/144.json	(from https://bridgebio.com/news/bridgebio-pharma-launches-with-a-focus-on-precision-medicines-for-genetic-diseases/)
03:09:18	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-launches-with-a-focus-on-precision-medicines-for-genetic-diseases/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-launches-with-a-focus-on-precision-medicines-for-genetic-diseases/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-launches-with-a-focus-on-precision-medicines-for-genetic-diseases/)
03:09:18	2669/2669	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:18%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-launches-with-a-focus-on-precision-medicines-for-genetic-diseases%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedfb68.json	(from https://bridgebio.com/news/bridgebio-pharma-launches-with-a-focus-on-precision-medicines-for-genetic-diseases/)
03:09:19	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:19%20GMT	https://bridgebio.com/?p=144	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index421d.html	(from https://bridgebio.com/news/bridgebio-pharma-launches-with-a-focus-on-precision-medicines-for-genetic-diseases/)
03:09:19	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a99.delayed	(from https://bridgebio.com/news/bridgebio-pharma-launches-with-a-focus-on-precision-medicines-for-genetic-diseases/)
03:09:19	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.a9a.delayed	(from https://bridgebio.com/news/bridgebio-pharma-launches-with-a-focus-on-precision-medicines-for-genetic-diseases/)
03:09:19	2858/2858	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:09:19%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-launches-with-a-focus-on-precision-medicines-for-genetic-diseases%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed242e	(from https://bridgebio.com/news/bridgebio-pharma-launches-with-a-focus-on-precision-medicines-for-genetic-diseases/)
03:09:19	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:19%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-launches-with-a-focus-on-precision-medicines-for-genetic-diseases/)
03:09:20	21107/21107	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:20%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/204	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/204.json	(from https://bridgebio.com/news/pellepharm-launches-with-financing-from-bridgebio-pharma-to-develop-topical-therapy-for-basal-cell-carcinomas-and-gorlin-syndrome/)
03:09:20	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/pellepharm-launches-with-financing-from-bridgebio-pharma-to-develop-topical-therapy-for-basal-cell-carcinomas-and-gorlin-syndrome/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/pellepharm-launches-with-financing-from-bridgebio-pharma-to-develop-topical-therapy-for-basal-cell-carcinomas-and-gorlin-syndrome/feed/index.html	(from https://bridgebio.com/news/pellepharm-launches-with-financing-from-bridgebio-pharma-to-develop-topical-therapy-for-basal-cell-carcinomas-and-gorlin-syndrome/)
03:09:20	2881/2881	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:20%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fpellepharm-launches-with-financing-from-bridgebio-pharma-to-develop-topical-therapy-for-basal-cell-carcinomas-and-gorlin-syndrome%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed6f4a.json	(from https://bridgebio.com/news/pellepharm-launches-with-financing-from-bridgebio-pharma-to-develop-topical-therapy-for-basal-cell-carcinomas-and-gorlin-syndrome/)
03:09:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:21%20GMT	https://bridgebio.com/?p=204	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexcb89.html	(from https://bridgebio.com/news/pellepharm-launches-with-financing-from-bridgebio-pharma-to-develop-topical-therapy-for-basal-cell-carcinomas-and-gorlin-syndrome/)
03:09:21	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.a9f.delayed	(from https://bridgebio.com/news/pellepharm-launches-with-financing-from-bridgebio-pharma-to-develop-topical-therapy-for-basal-cell-carcinomas-and-gorlin-syndrome/)
03:09:21	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.aa0.delayed	(from https://bridgebio.com/news/pellepharm-launches-with-financing-from-bridgebio-pharma-to-develop-topical-therapy-for-basal-cell-carcinomas-and-gorlin-syndrome/)
03:09:21	3070/3070	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:09:21%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fpellepharm-launches-with-financing-from-bridgebio-pharma-to-develop-topical-therapy-for-basal-cell-carcinomas-and-gorlin-syndrome%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedfb37	(from https://bridgebio.com/news/pellepharm-launches-with-financing-from-bridgebio-pharma-to-develop-topical-therapy-for-basal-cell-carcinomas-and-gorlin-syndrome/)
03:09:21	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:21%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/pellepharm-launches-with-financing-from-bridgebio-pharma-to-develop-topical-therapy-for-basal-cell-carcinomas-and-gorlin-syndrome/)
03:09:22	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734497820	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style23ec.css	(from https://bridgebio.com/news/archive/page/2/)
03:09:22	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734497820	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css23ec.css	(from https://bridgebio.com/news/archive/page/2/)
03:09:22	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734497820	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust23ec.css	(from https://bridgebio.com/news/archive/page/2/)
03:09:23	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734497820	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts23ec.js	(from https://bridgebio.com/news/archive/page/2/)
03:09:23	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734497820	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal23ec.js	(from https://bridgebio.com/news/archive/page/2/)
03:09:23	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.aa7.delayed	(from https://bridgebio.com/news/archive/page/2/)
03:09:23	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:23%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/archive/page/2/)
03:09:24	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.aa9.delayed	(from https://bridgebio.com/news/archive/page/3/)
03:09:24	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:24%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/archive/page/3/)
03:09:24	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.aab.delayed	(from https://bridgebio.com/news/archive/page/4/)
03:09:24	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:24%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/archive/page/4/)
03:09:25	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.aad.delayed	(from https://bridgebio.com/news/archive/page/5/)
03:09:25	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:25%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/archive/page/5/)
03:09:25	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734504660	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style2dcf.css	(from https://bridgebio.com/news/archive/page/6/)
03:09:26	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734504660	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css2dcf.css	(from https://bridgebio.com/news/archive/page/6/)
03:09:26	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734504660	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust2dcf.css	(from https://bridgebio.com/news/archive/page/6/)
03:09:26	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734504660	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts2dcf.js	(from https://bridgebio.com/news/archive/page/6/)
03:09:26	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734504660	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal2dcf.js	(from https://bridgebio.com/news/archive/page/6/)
03:09:26	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.ab4.delayed	(from https://bridgebio.com/news/archive/page/6/)
03:09:27	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:27%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/archive/page/6/)
03:09:27	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.ab6.delayed	(from https://bridgebio.com/news/archive/page/7/)
03:09:27	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:27%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/archive/page/7/)
03:09:28	86677/86677	---MCZ	200	added ('OK')	text/css	etag:W/%226740f475-15295%22	https://bridgebio.com/wp-content/themes/bridgebio/style.css?ver=1734510600	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/style9af0.css	(from https://bridgebio.com/news/archive/page/8/)
03:09:28	53379/53379	---MCZ	200	added ('OK')	text/css	etag:W/%226740f476-d083%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css.css?ver=1734510600	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/secondary-css9af0.css	(from https://bridgebio.com/news/archive/page/8/)
03:09:28	5403/5403	---MCZ	200	added ('OK')	text/css	etag:W/%2266b4e50c-151b%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust.css?ver=1734510600	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/css/onetrust9af0.css	(from https://bridgebio.com/news/archive/page/8/)
03:09:28	12374/12374	---MCZ	200	added ('OK')	application/javascript	etag:W/%226740f475-3056%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts.js?ver=1734510600	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/scripts9af0.js	(from https://bridgebio.com/news/archive/page/8/)
03:09:29	0/0	---M--	200	added ('OK')	application/javascript	etag:%2266e85bb6-0%22	https://bridgebio.com/wp-content/themes/bridgebio/assets/js/modal.js?ver=1734510600	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-content/themes/bridgebio/assets/js/modal9af0.js	(from https://bridgebio.com/news/archive/page/8/)
03:09:29	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.abd.delayed	(from https://bridgebio.com/news/archive/page/8/)
03:09:29	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:29%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/archive/page/8/)
03:09:29	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.abf.delayed	(from https://bridgebio.com/news/archive/page/9/)
03:09:30	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:30%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/archive/page/9/)
03:09:33	23143/23143	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:33%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6135	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6135.json	(from https://bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-aha)
03:09:33	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-aha/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-aha/feed/index.html	(from https://bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-aha)
03:09:33	3196/3196	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:34%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-attribute-cm-phase-3-data-aha	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed5d6f.json	(from https://bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-aha)
03:09:34	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:34%20GMT	https://bridgebio.com/?p=6135	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/indexebf5.html	(from https://bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-aha)
03:09:34	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.ac4.delayed	(from https://bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-aha)
03:09:34	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.ac5.delayed	(from https://bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-aha)
03:09:34	3387/3387	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:09:34%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-attribute-cm-phase-3-data-aha&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embedbac9	(from https://bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-aha)
03:09:34	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:34%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-aha)
03:09:36	13980/13980	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:36%20GMT	https://bridgebio.com/wp-json/wp/v2/posts/6389	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/wp/v2/posts/6389.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/)
03:09:36	33382/33382	---MCZ	404	error ('Not%20Found')	application/rss+xml	etag:W/%22b355423258f4dcd7be4e353e432cbe53%22	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/feed/	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/feed/index.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/)
03:09:36	2979/2979	---MCZ	200	added ('OK')	application/json	date:Wed,%2018%20Dec%202024%2011:09:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march%2F	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed2b3c.json	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/)
03:09:37	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:37%20GMT	https://bridgebio.com/?p=6389	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/index5410.html	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/)
03:09:37	0/-1	---M--	301	error ('')			https://bridgebio.com/pipeline	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/pipeline.aca.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/)
03:09:37	0/-1	---M--	301	error ('')			https://bridgebio.com/about-us	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/about-us.acb.delayed	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/)
03:09:37	3179/3179	---MCZ	200	added ('OK')	text/xml	date:Wed,%2018%20Dec%202024%2011:09:37%20GMT	https://bridgebio.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Fbridgebio.com%2Fnews%2Fbridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march%2F&format=xml	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/wp-json/oembed/1.0/embed7029	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/)
03:09:37	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:37%20GMT	https://bridgebio.com/careers	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/careers	(from https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/)
03:09:51	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:51%20GMT	https://bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-aha?p=6135	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-ahaebf5	(from https://bridgebio.com/?p=6135)
03:09:52	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:52%20GMT	https://bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-aha?p=6135	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-attribute-cm-phase-3-data-ahaebf5	(from https://bridgebio.com/?p=6135)
03:09:53	0/0	---MC-	301	error ('Moved%20Permanently')	text/html	date:Wed,%2018%20Dec%202024%2011:09:53%20GMT	https://bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/?p=6389	C:/Users/HP/Documents/programming/clones/bridge-original/bridgebio.com/news/bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-36-march/index5410.html	(from https://bridgebio.com/?p=6389)
